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Summary 
The main determinants of the cytoplasmic fate of an mRNA are the 
interactions between RNA-binding proteins (RBPs) and cis-regulatory motifs, 
present in the untranslated regions (UTRs) of the mRNAs. It is expected that 
translating mRNAs associate with many RBPs and other proteins that are 
recruited but do not necessarily interact directly with the mRNA, thus forming 
the messenger ribonucleo-protein particles (mRNPs). In the present 
dissertation, a method to detect key factors involved in the regulation of gene 
expression in trypanosomes was tested. The aim was to affinity purify specific 
ribosome-associated mRNPs and detect their protein components. The 
purification relies on three streptavidin binding peptides (3SBPs) at the N-
terminus of the nascent polypeptide. These 3SBPs connected to the actively 
translating mRNAs on polyribosomes will bind to the streptavidin matrix. The 
average yield of the reporter mRNA was 16% relative to the input polysomal 
fraction. The reporter was also eight-fold enriched compared to the 
housekeeping gene.  
The method was validated using a known RNA-protein interaction in 
trypanosomes. A zinc finger protein, ZC3H11, binds to an AU-rich element 
present in the HSP70 3’-UTR and stabilizes this mRNA upon heat shock. Two 
independent purifications were made, one using a reporter containing the 
complete HSP70 3’-UTR and another without the AU-rich element, as a 
negative control. Indeed, ZC3H11 was detected in the purification when the 
AU-rich element was present in the HSP70 3’-UTR, and was absent from the 
control purification. The limitation of the method was the detection by mass 
spectrometry. 
Furthermore, two RBPs were studied, zinc finger proteins ZC3H22 and 
ZC3H38. ZC3H22 was found by quantitative mass spectrometry when 
purifying the EP 3’-UTR reporter using the affinity purification method 
described above. This protein seems to be present in the polyribosomes but 
down regulation of the gene by RNAi was only achieved to 30%, the protein 
was still produced and no changes in the growth phenotype observed. Only a 
single conditional knockout was obtained but not the double knockout. The 
role of this protein in procyclic trypanosomes is still not discovered.  
The protein ZC3H38 was previously found in our laboratory by Dr. Erben to 
increase target mRNA expression. My Tethering assay showed indeed, that 
the protein stabilized the reporter mRNA approximately 2-fold and increased 
1.5-folds the amount of reporter protein produced. Analysing different parts of 
the protein by tethering assay also indicates that a region containing the 
HNPY domain might be responsible for the reporter mRNA stabilization.  
ZC3H38 protein is mainly localized in the cytoplasm. RNAi against ZC3H38 
mRNA presents a change in the growth phenotype after 24 hours of 
tetracycline induction in bloodstream trypanosomes. Currently, more 
experiments are being carried out in order to further characterize this protein. 
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Zusammenfassung 
Die wichtigsten Determinanten des cytoplasmatischen Schicksals einer 
mRNA sind die Interaktionen zwischen RNA-bindenden Proteinen (RBPs) und 
cis-regulatorischen Motiven in den nicht-translatierten Regionen (UTR) dieser 
mRNA. Es wird erwartet, dass mRNAs mit vielen RBPs und anderen 
Proteinen, die nicht notwendigerweise direkt mit der mRNA interagieren, 
assoziieren, wodurch sie die Boten-ribonucleoprotein Partikel (mRNPs) 
formen. In der vorliegenden Dissertation wurde eine Methode entwickelt, um 
Regulatoren der Genexpression in Trypanosomen zu identifizieren. Das Ziel 
war die Affinitätsreinigung spezifischer Ribosomen-assoziierter mRNPs sowie 
die Detektion ihrer Proteinkomponenten. Die Aufreinigung beruht auf drei 
Streptavidin-bindenden Peptiden (3SBPs) am N-terminus des naszenten 
Polypeptids. Diese 3SBPs, die mit der aktiv translatierenden polyribosomalen 
mRNA verbunden sind, binden an eine Streptavidin-Matrix. Die 
durchschnittliche Ausbeute an Reporter-mRNA lag bei 16% relativ zum 
anfänglich eingesetzten Polyribosomen-Material.   Die Reporter-mRNA war 
um ein achtfaches angereichert verglichen mit einem Haushaltsgen. 
Die Methode wurde validiert mithilfe einer bekannten RNA-Protein Interaktion 
in Trypanosomen.  Ein zinc finger Protein, ZC3H11, bindet ein AU-reiches 
Element in der 3’-UTR der HSP70 mRNA und stabilisiert diese unter 
Hitzeschock-Bedingungen. Zwei unabhängige Aufreinigungen wurden 
durchgeführt, eine mit einem Reporter, der die komplette HSP70 3’-UTR 
enthält, und die andere, ohne das AU-reiche Element, als Kontrolle. 
Tatsächlich wurde ZC3H11 nur detektiert, wenn das AU-reiche Element 
vorhanden war. Eine Einschränkung der Methode war allerdings die 
Identifikation von Peptiden mittels Massenspektrometrie.  
Überdies, wurden zwei RBPs untersucht, die zinc finger Proteine ZC3H22 und 
ZC3H38. ZC3H22 wurde mittels quantitativer Massenspektrometrie bei einer 
Affinitätsaufreinigung der EP 3’-UTR Reporter-mRNA identifiziert. Dieses 
Protein scheint mit Polyribosomen zu assoziieren aber es konnte nur eine 30-
prozentige Verringerung der Expression mittels RNAi erreicht werden, das 
Protein wurde immer noch produziert und keine Veränderung im 
Wachstumsphänotyp war zu beobachten. Lediglich für ein Allel des Gens 
konnte ein konditionales Knockout erzeugt werden. Die Rolle dieses Proteins 
in procyclischen Trypanosomen ist weiterhin unklar. 
Bereits zuvor wurde in unserem Labor von Dr. Erben entdeckt, dass das 
Protein ZC3H38 die Expression einer Ziel-mRNA steigert. Mein tethering-
Experiment zeigte dass das Protein die Stabilität einer Reporter-mRNA etwa 
verdoppelt und die Menge an produziertem Reporter-Protein um ein 1.5-
faches erhöht. Die Analyse verschiedener Domänen des Proteins mittels 
tethering-Assay deutet darauf hin, dass eine Region, die eine HNPY-Domäne 
enthält, für die Stabilisierung der Reporter-mRNA verantwortlicht ist. ZC3H38 
ist ein zytoplasmatisches Protein. RNAi gegen ZC3H38 führt 24 Stunden nach 
Induktion zu verlangsamtem Wachstum von Blutstromform Trypanosomen. Im 
Moment werden weitere Experimente durchgeführt, um dieses Protein 
eingehender zu charakterisieren. 
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1. Introduction 
Trypanosoma brucei, the protozoan pathogen used as model organism in the 
present work, belongs, among others such as Trypanosoma cruzi and 
Leishmania species, to the family Trypanosomatidae, order Kinetoplastida. T. 
brucei is the causative agent of the neglected tropical disease Human African 
Trypanosomiasis, also called sleeping sickness [1]. Two subspecies of 
trypanosomes are infective to mammals. T. brucei rhodesiense is endemic in 
east and southern Africa, infects game animals, cattle and humans and is 
responsible for producing the more severe and acute disease. In cattle the 
disease is called Nagana and is caused mainly by T. congolense and T. vivax. 
T.brucei gambiense, found in west and central Africa, infects humans and a 
wide range of animals, mostly pigs; leading to the chronic disease that can 
persist for months or years without major symptoms [2, 3]. 
 
African trypanosomes are introduced to the host bloodstream by the bite of 
infected Tsetse flies of the genus Glossina. After the Tsetse fly had a blood 
meal, the parasite establishes itself in the mid gut of the insect where it 
expresses the EP/GPEET proline-rich surface proteins. After this, procyclic 
trypanosomes migrate to the salivary glands, where epimastigotes expressed 
the brucei alanine-rich proteins (BARP), a stage specific glycosylphosphatidyl 
inositol-anchored proteins [4]. Later on, the metacyclics change the surface 
protein for the variant surface glycoprotein (VSG) and are ready to be 
transmitted to the human host [5]. In the bloodstream of the host, the parasite 
evades the immune response by antigenic variation, changing its VSG coat in 
order to avoid antibody recognition. The parasites proliferate in the 
bloodstream as slender forms and change to stumpy forms, cell cycle 
arrested forms, when the levels of parasitemia increase (Figure 1) [5-7].  
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Figure 1. Life cycle of Trypanosoma brucei 
The figure shows the two major replicative stages of trypanosomes, the bloodstream 
form trypomastigote, that proliferates in the blood and mammalian tissue fluids and 
the procyclic form, found in the midgut and salivary glands of Tsetse flies 
(trypomastigotes, epimastigotes and metacyclic forms). This picture was extracted 
from reference [5].  
 
Due to the different trypanosome habitats, the mammalian bloodstream, the 
Tsetse midgut and the salivary gland of Tstse flies, this parasitic protozoa 
must be able to adapt to the environment. For instance, morphological and 
biochemical changes must happen in order to evade the mammalian immune 
response or to program and trigger differentiation. To perform these changes, 
a stringent developmental program and control of gene expression are 
required.   
1.1 Trypanosome gene arrangement and expression 
 
The unicellular eukaryotic parasite T. brucei contains a two unit genome, a 
nuclear and a mitochondrial (Kinetoplast) one. The total haploid genome has 
35 megabases and contains approximately 8100 protein-coding genes. The 
nuclear genome is distributed over 11 diploid chromosomes (0.9-5.7 Mb), 
intermediate (300-900 Kb) and more than 100 minichromosomes (50-100 Kb) 
[8, 9].   
 
One characteristic feature of the trypanosome genome is the organization of 
genes in large transcription units [9-11]. These units can contain several (100-
200) open reading frames (ORFs) and are transcribed into polycistronic 
mRNA precursors [12-14], which are later processed into mature 
monocistronic mRNAs by trans-splicing and polyadenylation (Figure 2) [15]. 
The trans-splicing reaction consists of the addition of a 39 nucleotide spliced 
leader sequence [8] to an AG dinucleotide downstream of a polypyrimidine 
tract [15, 16] and is coupled to the addition of a poly(A) tail to the upstream 
gene [17, 18].  
 
AAAA
AAAA
A
A
A
A
RNA polymerase II
Spliceosome/polyadenylation
Capped SL
Cap
Histone acetylation
AAAA Poly(A) tail
 
 
Figure 2. Gene distribution scheme in trypanosomes. 
Trypanosomal genes are transcribed in multiple protein coding genes and individual 
mRNAs are generated by coupled trans-splicing and polyadenylation reaction. The 
genes that belong to a polycistronic unit do not necessarily have a similar function 
and transcription can start in each due to epigenetic marks, such as histone 
acetylation. Each mRNA contains a cap structure called the spliced leader [8]. This 
picture was kindly provided by C. Clayton (unpublished)  
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The spliced leader [8] was found first at the 5’-end of the VSG mRNA. 
Interestingly, the splice leader it is not encoded in the VSG polycistron [19, 
20]. The precursor of the SL has 141nt and is called SLRNA or mini-exon 
derived RNA, its genes are arranged in tandem and individually transcribed 
from a well characterized RNA polymerase II (RNApol II) promoter [1, 21-23]. 
The SLRNA is composed of a 39nt SL sequence located upstream of an 
intron that can fold in two-stem loops (sl II and sl III) and a single stranded 
region that connects these loops. The SL RNA contains an unusual cap-
structure (named cap4), where the first 4 nucleotides after the 7-
methylguanosine (m7G) are methylated [24-26].   
 
In T. brucei trans-splicing is a universal mechanism, whereas cis-splicing is 
rare. Polyadenylation occurs 200–500 nucleotides upstream of the SL 
addition site [27-29]. Although, there are some examples of cis-splicing in T. 
brucei, so far only four genes were reported to contain introns and undergo 
cis-splicing in trypanosomatids, these are the poly (A) polymerase genes of T. 
brucei and T. cruzi [30] the ATP-dependent DEAD/H RNA helicase, and two 
conserved hypothetical RNA binding proteins [8, 31]. 
 
Only few promoters have been described in trypanosomes that are regulated 
transcriptionally. Among the genes that presented this type of regulation are 
genes encoding the major surface glycoproteins of the parasite, the EPs and 
GPEETs in procyclic forms of the parasite and the bloodstream-form variant 
surface glycoproteins (VSGs). Genes in these clusters as well as the 18S, 
5.8S and 28S rDNA units are transcribed by RNA polymerase I [32-35].  
 
In trypanosomatids most of the mRNAs are transcribed by RNA polymerase II 
(RNA pol II), which also transcribes the SLRNA gene [28]. Although the SL 
RNA promoter has been well characterized [28, 36] there is a lack of evidence 
of RNA pol II regulation for protein coding genes. No promoters for this 
polymerase have been identified [34, 37]. Experimental evidence suggests 
that transcription by RNA pol II seems to initiate usually bi-directionally and in 
between two gene clusters (strand-switch regions), diverting or converging 
from the ends of the chromosome [29]. Transcription usually terminates by the 
presence of distinct chromatin modifications, such as histone modifications 
(acetylation and methylation) and histone variations [38].   
 
Due to the fact that the trypanosome genome contains few transcription 
factors and that the regulation of transcription by RNA pol II is almost absent, 
the trypanosomes render the regulation of gene expression to the post 
transcriptional level [34]. Furthermore, tandem arranged genes are 
transcribed constitutively by RNA pol II. These genes encode usually very 
abundant proteins such as the heat shock protein 70 (HSP70), cytoskeletal 
proteins (for instance α-tubulin and β-tubulin) and histones [39-41]. 
Interestingly, with the exception of the genes mentioned above, genes present 
in a polycistronic unit usually do not have the same regulatory mechanisms 
and their proteins do not share a similar function. 
 
  
13 
RNA polymerase III transcribes tRNAs, 5S RNA, the 7SL RNA (the RNA 
component of the signal recognition particle) and also most trans-
spliceosomal uridyl acid-rich small nuclear RNAs (U snRNAs), such as the U6 
snRNA and the U-snRNA B (U3 homolog), which are involved in the 
processing of rRNAs [42, 43]. The transcription of these snRNAs and of the 
7SL RNA depends on regulatory A and B box cis-elements (promoter 
elements) present on a tRNA gene that is located upstream and oriented 
oppositely to these genes [44, 45].  
1.2 Regulation of gene expression in trypanosomatids 
 
In order to progress through the different life-cycle stages, trypanosomes 
must regulate their gene expression, to control mRNA expression and protein 
abundance. Due to the polycistronic gene distribution of trypanosomatids, the 
individual regulation of genes is not possible. Therefore, trypanosomes used 
the combinatory effects of trans-actiing factors and cis-regulatory motifs for 
control of mRNA export, localization, and degradation as well as protein 
translation, modification and stability. 
 
1.2.1 mRNA degradation in trypanosomatids 
 
The degradation of mRNA is one of the ways to regulate gene expression in 
trypanosomes and it has been widely studied [46, 47]. The average half-life of 
bloodstream form mRNAs has been estimated to be 12 min and 20 min in 
procyclics [48], long stable mRNAs can exhibit half-lives of 4 hours and the 
very unstable ones approximately 10 min. Degradation of an mRNA starts 
with the removal of the poly(A) tail by the CAF1/NOT complex [49-51].  
 
The major deadenylase for trypanosomes is CAF1. When performing RNAi 
against this protein, increase on the average lengths of poly(A) tails was 
observed, causing a delay in the decay of constitutively expressed mRNAs 
[52]. The removal of the poly(A) tail prevents the binding of the poly(A) binding 
protein (PABP) and exposes the mRNA to be degraded by other enzymes 
and complexes, as is the case for the degradation mediated by the 5’-
exoribonuclease XRNA. This type of degradation immediately stops 
translation initiation. Interestingly, the 5’-3’ exoribonuclease, XRNA is also 
involved in the degradation of developmentally regulated mRNAs, some of 
these unstable mRNAs are decapped and degraded by this exoribonuclease 
without previous removal of their poly(A) tails [51].    
 
Once the poly(A) tail is removed by the CAF1/NOT complex, the 3’-end of the 
mRNA is also available for degradation by the RNA exosome protein 
complex. The T. brucei exosome is a 3’ to 5’ exonucleases complex and its 
components are similar to the yeast exosome [53]. It is involved in the 
maturation of 5.8S rRNA in trypanosomes [53, 54] and in the degradation of 
stage-specific mRNAs that contain U-rich elements (UREs) in their 3’-UTRs. 
These encoding the major surface protein in procyclic trypanosomes EP1, the 
cytosolic phosphoglycerate kinase PGKB and the pyruvate phosphate 
dikinase PPDK in bloodstream form trypanosomes [53, 54].  
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1.2.2 Developmental regulation in trypanosomatids 
 
The differentiation from bloodstream trypanosomes to procyclic forms, 
involves the loss of the VSG in bloodstreams and the acquisition of the major 
surface protein in procyclics, the EP procyclin protein [55, 56]. The procyclin 
gene has four different isoforms, the highly phosphorylated GPEET and the 
EP1, EP2 and EP3 which contain glutamic acid-proline dipeptide repeats [57, 
58]. EP1 and EP3 contain specific glycosylated residues whereas the EP2 is 
not modified by N-linked carbohydrates [57]. After 24 hours of triggering 
differentiation in media containing glycerol, the cells differentiate as early 
procyclic, expressing GPEET in high levels and traces of EP [59]. If glycerol is 
not present in the media, the cells proliferate to late phase procyclics in 7 to 9 
days, replacing GPEET by EP1 and EP3 [60, 61]. The repression of GPEET 
is due to the glycerol responsive element, a 25mer element, present on its 3’-
UTR [60, 62]. These changes happen in culture as well as in the insect vector 
[63]. 
 
Stage-specific transcripts, such as the EP procyclin, are unstable and have 
short half-lifes specifically in the life-cycle stages that have no use for them 
(EP half-life in bloodstreams is 5 min), but are stable in the stage that requires 
them (EP half-life 30 min in procyclics). The EP mRNA is 11-fold more 
abundant in the procyclic than in bloodstream forms and translation of the EP 
protein is repressed approximately 10-fold in the mammalian form 
trypanosome compared to the insect form [64, 65].  
The EP 3’-UTR contains U-rich elements (UREs) and forms 3 domains 
(Figure 3), two of stable domains (I and III) and domain II [65, 66]. Domain I is 
present in the first 40bp of the EP 3’-UTR, contains sequences that decrease 
translation in procyclics but is not necessary for developmental regulation [64, 
65, 67]. The central domain (domain II) contains a 26mer regulatory element 
that is used in bloodstreams trypanosomes for the rapid degradation and 
translation repression of the EP mRNA [64, 65, 67]. It has also been shown 
that domain II interactions are very unstable, no stable interactions within itself 
or other parts of the 3’-UTR were determined by RNase digestion or lead ion 
hydrolysis [66]. The 3’-most domain, domain III is a conserved stem-loop of 
16mer that stabilizes the EP mRNA [64, 67]. This element is necessary for the 
adequate expression of a reporter gene (CAT reporter) and upon deletion of 
this element, the expression of the reporter protein decreased 10- to 12-fold, 
without a change in the reporter mRNA levels; therefore, this element has an 
effect in translation. Furthermore, not only the sequence but also the 
secondary structure of the 16mer are necessary for its effects [68].  
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Figure 3. Predicted secondary structure of the EP1 3’-UTR 
Predicted structure showing the three domains (I to III). Domains I and III are more 
stable and form hairpins with internal loops. Digestion with RNase T1 and T2 are 
shown as white and grey arrows respectively. Lead ions promote the cleavage of 
unstructured RNA. Therefore to further determine the structure of domain II, lead 
ions were used to hydrolyse this RNA. Black arrows show the sites of lead 
hydrolysis, the black ones with an asterisk at the end are sites of strong catalytic 
cleavage also produced by lead ions. This picture was extracted from reference [66]. 
 
Post-transcriptional regulation of gene expression is not as simple as one 
mRNA interacting with a specific set of RNA binding proteins (RBPs). 
Genome-wide screens indicate that distinct groups of RNAs can interact with 
several RBPs and that different RBPs can compete for the target mRNA; 
these dynamic interactions regulate the fate of mRNAs at different levels, 
such as export, localization, degradation, stability and translation; increasing 
the complexity of post-transcriptional regulation [69-71].  
1.3 RNA binding proteins 
 
The RNA binding proteins (RBPs) are key regulatory factors that can interact 
not only with sequences present on target mRNAs but also interact with other 
proteins that help them determine the fate of their target mRNAs [72]. For 
instance, if an RBP interacts with or is able to recruit XRNA, a member of the 
degradation machinery, then this mRNA will undergo 5′-3′ degradation; or if 
another RBP is able to recruit the CAF1/NOT complex, then the target mRNA 
will be deadenylated and rapidly degraded. In an opposite case, if a trans-
acting factor binds to the PABP, this will stabilize its target mRNAs and if it 
interacts with translation factors then translation will be increased. 
Furthermore, regulatory proteins can also render their effects by interfering 
with the binding of proteins that enhance degradation or translation.  
 
The RBPs are usually classified according to their structural domains, which 
allow the binding to the mRNA [73]. For instance, proteins containing CCCH 
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zinc finger domains (zinc finger proteins ZFPs), RNA recognition domains 
(RRM proteins), PUF proteins and K homology domain (KH proteins, two 
predicted in T.brucei genome) among others, such as the arginine glycine rich 
motif (RGG proteins) and the cold shock domain (CSD proteins).  
 
More than 125 proteins containing RNA binding domains are encoded in the 
trypanosome genome. A genome-wide screen in order to find potential mRNA 
regulators using a tethering system, performed in our laboratory, identified 
300 proteins that can be involved in the regulation of mRNA; among these 
proteins 39 were RBPs, 16 were shown to inhibit mRNA expression and 23 
were implicated in the stabilization of the reporter mRNAs [74]. Complete 
information about and characterization of most of these regulatory proteins is 
still missing. In the pages below, a summary of what is known about relevant 
proteins for this work is provided.  
1.3.1 The RRM Proteins  
 
Proteins that contain an RNA recognition motif (RRM) are among the most 
abundant in eukaryotes and have a great diversity of functions, mainly due to 
the presence and structure of the RRM motif [75]. The RRM motif is 90 
amino-acid long, containing a RNP1 (K/R)G(F/Y)(G/A)FVX(F/Y) octapeptide 
and a RNP2 sequence-motif [76]. The structure of this motif contains two α-
helixes and a four-stranded β-sheet (βαββαβ topology) [75]. The β-sheet 
structures, composed of the RNP1 and RNP2 motifs, are directly responsible 
for RNA binding; they can bind single stranded RNA (2-8 nucleotides) as well 
as other RRM proteins [77, 78].  
 
In trypanosomes approximately 75 RRM proteins were identified [76]. An 
example of RRM proteins that perform different functions is the case of the 
polypyrimidine track binding proteins (PTBs) DRBD3/PTB1 (two RRM 
domains) and DRBD4/PTB2 (4 RRM domains), which can bind directly to the 
mRNA and are involved in the stabilization of their target mRNAs [79, 80], as 
well as in translation initiation [81], processing of the 3’-end [82] and splicing 
regulation [83, 84].  
 
The most known RRM proteins involved in translation are the poly(A) binding 
proteins PABP1 and PABP2, in charge of stabilizing the mRNA via binding to 
the poly(A) tail and interaction with the translation initiation complex [85].  
There are many RRM proteins involved in a variety of functions such as 
splicing regulators, like U2 snRNP (UAF2), an heterodimer involved in pre-
mRNA processing [78] and RBP24, a component of the spliceosome [86]. 
Other RRM proteins are nuclear processors, for instance NRBD1 and NRBD2 
involved in the import and assembly of rRNAs [87, 88]. There are also 
proteins that might be involved in the regulation of mRNA turnover like UBP1, 
UBP2 and RBP3, which contain a single RRM domain [76].  
1.3.2 Pumilio-Domain Proteins 
 
The Pumilio-Fem3 proteins (PUF proteins) are composed of multiple copies of 
a tri-helical PUF repeat, each of which binds to a nucleotide sequence 
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(consensus UGUA) in the mRNA via three amino-acid residues [89, 90]. The 
mRNA targets of PUF proteins are often functionally related. The T. brucei 
genome encodes for 11 PUF proteins that are involved in very different 
aspects of mRNA metabolism, playing key roles in the degradation as well as 
in the stabilization of mRNAs. For instance PUF9, composed of 6 copies of 
the tri-helical PUF repeat acts in the mid-to-late S-phase of cell cycle 
neutralizing a destabilization motif on its target mRNAs. PUF9 target mRNAs 
are a kDNA ligase, histone H4 and two unknown proteins named PUF nine 
target 1 and 2 (PNT1 and PNT2) [91]. It could be that some of these mRNAs 
encode proteins that function in the S-phase of the cell cycle and therefore 
their regulation by PUF9 is essential.  In contrast, other pumilio-domain 
proteins like PUF2 may be involved in targeting a subset of mRNAs to 
degradation (results of tethering experiments) [92]. Other proteins such as 
PUF7 and PUF8 localize in the nucleolus and are involved in rRNA 
processing [93].   
1.3.3 The Zinc Finger Proteins 
 
The CCCH zinc finger domain proteins are composed of a well conserved 
cysteine-histidine motif, Cx4-15-Cx4-6-Cx3-H which is often present in two 
copies. These proteins bind with higher affinity to single-stranded RNA and 
are involved in most processes of mRNA metabolism [94, 95]. T. brucei 
genome encodes for 49 CCCH proteins that can be divided in two families, 
the cell cycle sequence binding proteins (CSBP) and the ZFP proteins [96].  
The CSBPs that were identified first in Crithidia fasciculata, CSBPA (T. brucei 
ZC3H39) and CSBPB (T. brucei ZC3H40), bind to their target mRNAs and 
regulate them during S-phase of the cell cycle. The target mRNAs reported so 
far are the dihydrofolate reductase-thymidylate synthase DHFR-TS, the 
kinetoplast associated type II DNA topoisomerase (TOP2), the large sub-unit 
of the nuclear replication protein-A (RPA1) and the kinetoplast histone H1-like 
DNA binding protein KAP3 [97].  In the case of TOP2 and RPA1 mRNAs, the 
sequences responsible for the CSBPA dimer binding were found in the 5’-
UTR, whereas for KAP3 in the 3’-UTR. The motifs present in the UTRs were 
two or more octamers (CAUAGAAG or similar) that are necessary but not 
always sufficient for the cycling of these transcripts [98, 99].  
 
The ZFP proteins containing only one CCCH domain involved in T. brucei 
differentiation are ZFP1, ZFP2 and ZFP3. ZFP1 contains two additional 
proline-rich domains and is up-regulated during differentiation [100, 101]. 
ZFP2 has a WW domain and is able to bind to proline-rich regions. Down-
regulation of this protein delays the expression of EP procyclin [101-103]. 
ZFP3 also contains a WW domain and possesses additionally an RGG motif 
that is involved in the assembly of RNP complexes. ZFP3 binds to two cis-
regulatory elements present in loop II of the EP1 and GPEET mRNAs via its 
CCCH domain and acts as a translation regulator [104, 105].  
 
The zinc finger protein ZC3H20 is necessary for procyclic forms to grow and 
stabilizes two developmentally regulated mRNAs, the mitochondrial carrier 
protein (MCP12) and trans-sialidase (TS-like E) [106]. 
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Procyclic trypanosomes grow in normal culture conditions at 27°C and heat 
shock response can be induced by 37 to 41°C. The protein ZC3H11 is part of 
the heat shock response for both life cycle stages. This protein is essential in 
bloodstream forms and is necessary to maintain appropriate levels of 
chaperone mRNAs (such as HSP70 mRNA) during heat shock in procyclic 
forms. ZC3H11 recognizes AU-rich elements present in the 3’-UTRs of its 
target mRNAs. It has been proposed that this protein acts as a dimer and that 
phosphorylation could be implicated on its function. The protein also binds 
other protein transcripts involved in the heat shock response, such as HSP83, 
HSP100 and HSP110 as well as transcripts necessary for stress recovery 
[107]. In order to stabilize transcripts during heat shock ZC3H11 binds to 
other regulatory proteins, such as MKT1 and poly(A) binding protein-binding 
protein (PBP1), these interactions are necessary for the stabilization of its 
target mRNAs and for the heat shock response in T. brucei.  
The proposed mechanism is as follows, the N-terminal part of ZC3H11, where 
the CCCH domain is, binds to the mRNA and the C-terminal part interacts 
with MKT1 and PBP1. Then PBP1 recruits other proteins such as LSM12 and 
PABP1or PABP2. This last protein binds to the poly(A) tail of the mRNA and 
to the initiation factor eIF4G making the mRNP stable [108]. 
 
 
 
 
Figure 4. Proposed model of mRNA stabilization 
This mechanism for mRNA stabilization involves an RBP (in blue) that can be 
ZC3H11 recognizing its target mRNA (HSP70) via a specific cis-regulatory motif 
(UAUU for ZC3H11). The interactions between ZC3H11 (in blue), MKT1 (purple), 
PBP1 and PABP stabilize this mRNP. This stabilization is only achieved by the 
combinatory effects of all these regulatory proteins. The model is dynamic because it 
shows the possibility to have interactions with proteins of the degradation machinery, 
such as CAF1/NOT complex, that can target the mRNA for degradation. This picture 
belongs to reference [108]. 
 
In the present work, the interaction between ZC3H11 and the AU-rich element 
present in the 3’-UTR of HSP70 mRNA was used as proof of concept for my 
method.  
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1.4 Searching for transcriptional regulators in Trypanosome brucei   
 
The function of RBPs can be assessed by a genome-wide tethering screen 
[74]. In this method target RNA bearing the 19 nucleotide boxB sequence is 
co-transfected with the protein of interest fused to the lambda N peptide (λN-
peptide). Due to the presence of the boxB, the tagged protein binds to the 
reporter. This way the potential effect of the tethered protein on bound mRNA 
can be measured [109].    
 
The aim of the genome-wide tethering screen was to identify post-
transcriptional regulators in T. brucei. Using random fragments of the T. 
brucei genome, a library of fusion proteins was generated. Since there is a 
lack of introns in trypanosomes, one can expect that one of twelve plasmids 
cloned encoded a fusion protein in frame with the λN-peptide. This method 
has two steps, one is the generation of the fusion proteins and the other one 
is the creation of the tethering reporters, both have to be transfected in the 
same cell lines [74]. 
The fusion proteins consist of the λN-peptide at the N-terminus of the genomic 
fragment and a myc-tag at the C-terminus. The expression of the fusion 
proteins is induced upon tetracycline addition, whereas the tethering reporters 
are transcribed constitutively [74].  
Three different kinds of reporters were generated (Figure 5).  
1. To identify proteins that increase expression upon tethering. The 
reporter contains a GFP and blasticidin resistance (BLA) gene, both 
ORFs have a 5x boxB element on their 3’-ends and are transcribed as 
a single transcript.  
2. The control reporter consists of a GFP ORF upstream of the 5x boxB 
element and a BLA gene without the downstream 5x boxB element.  
3. To detect proteins that decrease expression. The reporter has a PGKB 
ORF with a 5x boxB element on its 3’-end and also the BLA construct 
(without boxB). Both ORFs are separated by independent promoters, 
meaning that two transcripts will be generated.      
 
 
 
Figure 5. Genome-wide tethering screen 
This approach searches for regulators of the mRNA fate in the model organism 
Trypanosoma brucei. The figure shows a schematic representation of the reporters 
used in this screen. This picture was taken form reference [74]. 
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The blasticidin library: To detect possible expression repressors, cells were 
grown in 1x-2x blasticidin and to identify expression activator candidates, cells 
were grown in increasing concentrations of blasticidin (6x-20x). The cells that 
recover express proteins, which might be associated with the increase of the 
BLA reporter or enhanced translation [74]. 
It has previously been shown that inducible expression of cytosolic 
phosphoglycerate kinase B (PGKB) is lethal in bloodstream trypanosomes 
[110]. Therefore the PGKB construct contains an inducible promoter in order 
to regulate its expression. Using the PGKB library, one can detect repressors 
of expression, because these proteins will impair PGKB expression and allow 
the cells to grow [74]. 
The genomic fragments (cloned as fusion proteins) were extracted from the 
cells and PCR amplified, using specific primers in the λN-peptide and at the 
3’-end of the cloning site and send for high-throughput sequencing.  
This method allowed the confirmation of regulatory proteins that determine the 
fate of mRNAs. For instance, eIF4E1, ZC3H13, RBP9 and RBP12 that reduce 
mRNA stability, on the other hand, proteins such as ZC3H37, PUF9 and 
eIF4G4 that are implicated in mRNA stabilization. Furthermore, it also 
identified several proteins that have not been associated to mRNA regulation 
[74].    
1.5 Methods to characterize the composition of mRNPs 
 
There have been many approaches previously reported that tried to identify 
the composition of messenger ribonucleoprotein particles (mRNPs). In a 
general way, one can divide them in two main groups, the approaches 
designed to identify the RNA components of the mRNPs (CLIP and variants) 
and the ones that try to detect the protein components. 
 
1.5.1 Methods to identify the RNA components of mRNPs. 
 
1.5.1.1 Early methods 
 
The study of mRNP composition started with biochemical in vitro approaches, 
for instance, proteins that bind to specific sequences were detected by 
electrophoretic mobility shift assay (EMSA, also called gel shift assay) [111]. 
Formaldehyde or UV cross-linking (at 254nm) of direct RNA and protein 
interactions represented an alternative for in vivo studies. In some cases the 
complexes were cross-linked and immune-purified using epitope-tags [112, 
113]. In other cases, the mRNPs were subjected to two rounds of 
purifications, for instance, first using oligo (dT)-cellulose and then with 
antibodies raised against a protein component of the mRNP [114]. 
 
1.5.1.2 RNA immunoprecipitation on chip (RIP-chip) 
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Some approaches used the purification of a specific RBP in order to identify 
its potential targets using microarrays. This is achieved by tagging the RBP of 
interest or raising antibodies against it, that will immunoprecipitate the target 
RNAs, and subsequently labelling the samples and hybridizing them to DNA 
microarrays [115]. Alternatively, protein microarrays containing the complete 
proteome of the organism of interest can be hybridized with different RNAs 
(total RNA labelled with Cy3 and oligo-dT purified RNA labelled with Cy5) 
[116]. This method is limited to the use of stable RNPs for the purification and 
the site of interaction in the RNA was unresolved. 
 
1.5.1.3 Cross-linking and immunoprecipitation (CLIP) 
 
The method is used to map RNA-protein interactions in vivo, for example it 
can be used to discover new binding sites for a specific RBP, to determine 
small RNA-RNA interactions, for miRNA target detection etc.  
The samples used for CLIP, which can be organisms or cells, are irradiated 
with UV at 254nm to covalently cross-linked RNA-protein complexes (Figure 6 
#1). Once cross-link, the RNA is partially digested (using RNases) into 
fragments between 30-50 nucleotides (Figure 6 #2). Later on, the complexes 
are purified by immunoprecipitation of the known RBP. After stringent 
washings the 3’-end of the RNAs is dephosphorylated and ligated to an 
adaptor (Figure 6 #3-4). Then the RNAs are radioactively-labelled at the 5’-
end (Figure 6 #5). The non-covalently associated RNA is removed using 
denaturing gel electrophoresis and nitrocellulose membrane transfer. The 
membrane is exposed to an X-ray film where the radioactively labelled RNA 
determines the position of the complex on the membrane (Figure 6 #6). After 
the complex is excised from the membrane, it is treated with proteinase K, 
which degrades the protein components, leaving only a small peptide at the 
cross-linked site (Figure 6 #7). In the next step, an adaptor is added to the 5’-
end of the purified RNA (Figure 6 #8) and the products are amplified by 
reverse transcription (RT-PCR) using primers complementary to the linkers 
(Figure 6 #9).  Then the cDNAs of individual clones are send to Sanger 
sequencing. In the final step the sequences obtained are mapped to the 
reference genome (Figure 6) [117-119].  
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Figure 6. Cross-linking and Immunoprecipitaion method 
The figure provides a general view of the principle used by CLIP. RNA and protein 
complexes are cross-linked (UV or formaldehyde). The cell lysate is then digested 
with RNases before the immunoprecipitation of RBPs. The next step is to gel purify 
the complexes and treat them with Proteinase K in order to obtain only the RNA 
component. After the RNA linker ligation RT-PCR is performed and the cDNA 
samples are used for microarray analysis or sent for RNA sequencing. This figure 
was taken from reference [118]. 
 
1.5.1.4 High-throughput methods 
 
1.5.1.4.1 Affinity purification tags and high-throughput analysis 
 
Tags are widely used in the purification of mRNPs. For instance, the tandem 
affinity purification (TAP-tagging), where two different tags are used to purify a 
known RBP (two-step purification). This purification allows the determination 
of the proteins that co-purify with the tagged protein. Some approaches used 
the TAP purification in combination with high-throughput sequencing to 
determine the target mRNAs of the purified RBP. These purifications have 
contributed to the characterization of mRNPs. In yeast for example, TAP-
tagging of the poly(A) binding protein Nab2 revealed the co-purification of 
mRNA-export factors as well as the interaction of the tagged protein with 
different classes of mRNAs [120]. 
 
An alternative method to purify mRNPs is by ribosome affinity purification 
[121] [121]. This method is base on tagging a ribosomal protein and purify the 
complexes bound to it. RAP can be done with different tags. For instance 
using the protein A and the tobacco-etch virus protease tag (A-TEV-tag). The 
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cells are lysed and the tagged-ribosomal protein is affinity purified via the 
binding of protein A to the IgG matrix. The mRNP complexes are later 
released by cleavage with TEV protease. The mRNA is later on purified and 
the translatome assessed by microarrays or RNA sequencing. RAP allows the 
study of translational regulation in different conditions without the use of 
sucrose gradient centrifugation [122].  
 
1.5.1.4.2 Cross-linking and immunoprecipitation (CLIP) with high-throughput 
analysis and its variants 
 
The main problem with CLIP was that this method required specific antibodies 
for the purification. As an alternative, the cross-linking and analysis of cDNAs 
(CRAC) approach was designed. This method relies on the generation of a 
His6-Tev-Protein A tag (HTP-tag). The HTP tag is similar to the TAP-tag but 
the calmodulin binding peptide (CBP) is replaced by a six histidine tag (Figure 
7B) [123].  
 
In the CRAC strategy, the RNA-protein complexes are UV cross-linked at 
254nm (like in CLIP) followed by a first purification step using IgG beads and 
a partial digestion with RNases. The second step uses a denaturing affinity 
purification on a nickel matrix that binds the His6 part of the HTP-tag. Then the 
linkers are added to the RNA and the product eluted with imidazole. This 
eluate is run in a gel and transferred to a nitrocellulose membrane. After 
proteinase K digestion the RNAs are purified, amplified by RT-PCR and 
sequenced (Figure 7) [123]. The main difference of this method when 
comparing to CLIP is the cross-linking strategy and the specific use of the 
His6-tag. Using the CRAC method pinpoint protein-RNA interactions can be 
assessed in vivo as well as in-vitro. To map precisely cross-linking sites this 
method used Sanger sequencing of multiple cloned fragments as well as 
high-throughput RNASeq. 
 
 
 
Figure 7. Schematic representation of CRAC method 
This method is based on CLIP but it was developed in order to purify complexes via 
a His6-Tev-Protein A tag (HTP-tag) in two steps.  
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A. Flow of the method: The samples are UV cross-linked and then purified on an 
IgG matrix. After partial RNase digestion the second purification is done (nickel 
beads), then the adaptors are incorporated and the RNA amplified by RT-PCR 
and sent for sequencing.  
B. Schematic representation comparing the HTP-tag and the TAP-tag. The main 
difference is that the in the HTP-tag the calmodulin binding protein (CBP) is 
replaced by a six histidine tag. This figure was taken from reference [123].  
 
High-throughput sequencing (HITS) in combination with cross-linking and 
immunoprecipitation (CLIP) was developed to identify RBP targets on a 
genome-wide scale and to contribute to the analysis of RNA-protein 
interactions that were not seen by other methods (Figure 8 middle). The only 
difference between CLIP and HITS CLIP is that the first one uses Sanger 
sequencing and the second one RNASeq to obtain the sequenced data. For 
instance, using HITS CLIP it was discovered that in alternative splicing, the 
position at which Nova (an RBP involved in neuronal synapsis) binds has a 
direct implication on the result of splicing, meaning, it determines if to exclude 
or include an exon [124]. This type of study allows the generation of 
regulatory maps for RBPs. 
 
The resolution of the binding site in the traditional CLIP protocol is limited by 
the length of the fragmented RNAs. Therefore, two strategies improved the 
CLIP protocol to achieve single-nucleotide resolution. One of them is the 
photoactivatable-ribonucleotide-enhanced crosslinking (PAR-CLIP), which 
uses the deletions and point mutations caused by cross-linking to identify the 
cross-linked site of a specific RBP within its target RNA. This approach 
incorporates photoreactive ribonucleoside analogues, such as 4-thiouridine 
(4-SU) and 6-thioguanosine (6-SG) in the transcripts during cell culture. The 
cells are UV irradiated at 365nm to efficiently cross-link the photoreactive-
labelled RNA to the RBPs. The RBP-binding sites are detected by the change 
from thymidine to cytosine and guanosine to adenosine in the cDNA 
sequences (Figure 8 left) [125].  
 
The individual-nucleotide resolution cross-linking and immunoprecipitation 
(iCLIP), is an alternative approach to increase the specificity and obtain 
nucleotide resolution of the transcript-RBP interaction.  
One problem during the preparation of cDNA libraries for the traditional CLIP 
method is that reverse transcription can stop due to the presence of peptides 
that remain cross-linked to specific nucleotides after proteinase K digestion. 
This truncated cDNA will not contain the 5’-linker and will not be included in 
the library. To solve this problem, iCLIP captures these truncated cDNAs by 
adding an oligonucleotide that contains a 3’ and a 5’ adaptor region allowing 
the circularization of the cDNAs. After reverse transcription the 5’-linker is 
added and the samples sent to high-throughput sequencing (Figure 8 right). 
Due to this strategy, iCLIP has the advantage that it can identify sites of 
cross-linking independently of mutations generated in the cDNA by the 
reverse transcription [126].  
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Figure 8. Scheme of high-throughput methods using CLIP 
The right panel shows the photoactivatable-ribonucleotide-enhanced crosslinking 
(PAR-CLIP) strategy. In this method cells incorporate ribonucleoside analogues such 
as 4-thiouridine in the newly transcribed RNAs. These analogues are efficiently 
cross-linked with UV light at 365nm. During the reverse transcription the nucleotide 
analogues lead to a base transition at the cross-linking site allowing the detection of 
cross-linking sites at a nucleotide resolution.    
The middle panel represents the high-throughput sequencing with cross-linking and 
immunoprecipitation (HITS-CLIP). This method is like the CLIP strategy described 
above with the only difference that the final cDNAs are submitted to RNASeq and not 
to Sanger sequencing. 
The left panel is a scheme of the individual-nucleotide resolution cross-linking and 
immunoprecipitation (iCLIP) method. The main difference of this protocol when 
comparing it to HITS-CLIP is that truncated cDNAs can be capture by the addition of 
a 3’-linker that contains a 3’ and a 5’ region followed by the circularization of the 
cDNA. The 5’-linker is added after reverse transcription. This way the exact position 
where the reverse transcription stopped can be mapped. 
This picture was obtained from reference [127]. 
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1.5.2 Methods to detect the protein components of mRNPs. 
 
1.5.2.1 Early methods 
 
The first methods used in the detection and purification of mRNP protein 
components were developed in the 70s-80s. The development of these 
methods was encouraged by the discovery that the polyribosomal mRNA is 
associated to different proteins in different cell compartments (nucleus and 
cytosol) and that these complexes were not simply a lysis artefact [128]. The 
protein components of globin mRNPs were dissociated using reagents such 
as DTT and urea [129], puromycin or EDTA and also low or high salt 
treatments were assessed [130]. These experiments contributed with the 
finding of the poly(A) binding protein and confirmed that the mRNA is 
associated with proteins different than the ribosomes [130, 131].  
 
1.5.2.2 Density gradient centrifugation and immunoprecipitation 
 
The characterization of mRNAs was possible due to the combination of the 
sucrose gradient centrifugation with immunoprecipitation. An example is the 
purification of myosin mRNA from embryonic cells. After linear sucrose 
gradient centrifugation the fractions corresponding to the polyribosomes are 
collected and their RNA purified using phenol-chloroform. These RNAs are 
later added to muscle ribosomes in a cell free system to generate de novo 
proteins. Finally, myosin mRNA was purified using specific antibodies against 
the myosin protein [132, 133]. Another example is the myeloma light-chain 
mRNA purification. Linear sucrose gradient centrifugation and 
oligothymidylate (oligo-dT) chromatography were used to purify all mRNAs. 
The purified mRNAs were then used to produce proteins in a cell-free system 
and finally the light-chain mRNA obtained by immunoprecipitation using an 
antibody specific to the light-chain myeloma protein [134].  
Other mRNAs were also obtained in a similar way, such as the hemoglobin 
mRNA [135, 136] and ovalbumin mRNA from rabbit reticulocytes [137]. For 
the purification of the heavy-chain immunoglobulin mRNA in a mouse 
myeloma model, the mRNA was immunoprecipitated using an antibody 
against the myeloma protein H2L2 that binds specifically to the heavy-chain 
immunoglobulin mRNA [138]. Another example, is the purification of the 
ovalbumin from Hen oviduct, the translating polyribosomes were separated 
first by sucrose gradient centrifugation, then immunopurified using an 
antibody against ovalbumin and later the mRNA extracted using poly(U) 
sepharose chromatography  [139].  
In trypanosomes, the VSG mRNA was also purified using sucrose gradient 
centrifugation and oligo (dT)-cellulose. The purified mRNAs were used in a 
reticulocyte cell-free system to produced VSG protein. As in the other cases, 
the VSG mRNA was purified using antiserum raised against a previously 
purified VSG [140-142]. 
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It is important to mention that in these early studies highly specialized cells 
were used, producing predominantly one protein, where the purified mRNA 
represents approximately 10-5% of all mRNAs in the cell. The abundance of 
these mRNAs was the key determinant for a successful purification. 
 
The method developed in the present dissertation is based on a previously 
published method [143] that used a matrix-bound antibody against the 
ovalbumin nascent peptide to isolate specific mRNPs from total polysomes 
(Figure 9).  
Prior to the purification, antibodies against the ovalbumin protein of hen 
oviduct are raised. There are three main steps in the purification of ovalbumin 
mRNA from hen oviduct. The first is the separation of polyribosomes from hen 
oviduct via discontinuous sucrose gradient centrifugation, and then the 
polyribosomes are incubated with the first antibody, in order to allow the 
recognition of the nascent peptide (Figure 9 step I). In the second step, the 
antibody-polyribosome complex is recognized by the secondary antibody that 
is covalently cross-linked to the para-aminobenzyl cellulose (PAB cellulose) 
matrix (Figure 9 step II). In the final step, the complexes are dissociated by 
EDTA and the cellulose is separated by centrifugation (Figure 9 step III) [143]. 
 
 
 
Figure 9. Isolation of specific mRNPs 
Schematic representation of a method used to isolate specific mRNPs described in 
1977. An antibody against the ovalbumin nascent peptide was used to purify the 
ovalbumin mRNP complexes (step I). These purified complexes are later recognized 
by a secondary antibody that is immobilized on the PAB cellulose matrix (step II). In 
the final step the complexes are released from the cellulose and the matrix can be 
regenerated for a second use (step III). This picture was obtained from reference 
[143] and is the base of the method used in the present dissertation. 
 
The main reason for the purification of a specific mRNA was to produce 
cDNAs and clone them to generate libraries for further mRNP characterization 
studies. For instance, one study purified VSG mRNA using an oligo (dT)-
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cellulose from four different VSG variants, each of them expected to 
expressed a different type of VSG. These mRNAs were used for cDNA 
preparations, cloned into a recombinant plasmid and transformed in 
Escherichia coli. Positive clones were selected by clone hybridization [144].   
 
An interesting approach was developed 30 years later by Oeffinger et al [145]. 
In this mRNP purification method, cells are frozen in liquid nitrogen and lysed 
with a planetary ball that generates particles of 1-2 µm. The lysate is cleared 
by filtration and the complexes are separated from the rest of the lysate with 
an antibody coupled to magnetic beads. With the use of a magnet the beads 
containing the mRNPs are purified and later on the complexes are eluted 
under denaturing conditions [145]. 
 
1.5.2.3 Purification using affinity-tags 
 
Most of these methods were developed from the 90s on, the simplest 
approaches purified mRNPs by immunoprecipitation, using antibodies against 
a tagged-protein component of the mRNP of interest. Different tags can be 
used for this purpose, such as the FLAG-tag, a small protein tag that is 
recognized by the M2 antibody. For instance, FLAG-tagging the insulin-like 
growth factor II protein (3xFLAG-IMP1) of human embryonic kidney cells 
allows to purify this mRNP from total lysates and to detect its protein 
components by mass spectrometry [146].     
 
The homotetrameric protein streptavidin (SA) is produced by Streptomyces 
avidinii and when used as a tag its main advantage is that the purified 
complexes can be eluted with biotin. Also each monomer of streptavidin can 
bind one molecule of biotin with femtomolar affinity. This non-covalent biotin-
streptavidin interaction is one of the strongest in nature (biotin dissociation 
constant Kd 10-14 M) [147, 148]. A variation of this system was done by the 
design of a Strep-tag composed of nine amino acids (AWRHPQFGG) that 
binds streptavidin using the same binding site as biotin. The limitation of this 
tag was that it could only be used in the C-terminus of a protein, because the 
free carboxy-terminus of the tag is required for binding  [149]. The Strep-tag 
was later on modified in order to be cloned also in the N-terminus and it was 
called StrepII-tag (AWRHPQFGL) [150]. The conserved HPQ motif present in 
both tags is involved in the interaction with SA, the main disadvantage of 
these tags was that they bind SA with low affinity (37 µM for Strep-tag and 72 
µM in the case of StrepII-tag) [149]. Many optimizations have been assayed in 
order to improve the Strep-tag for protein detection, for instance, the 
possibility of having two StrepII-tags separated by 12 aminoacids (StrepIII-
tag) improved the detection of protein complexes [151]. In a later study, the 
use of multivalent StrepII-tags was assessed, either one or up to 5 StrepII-
tags were fused to the N-terminus of the Sefin A Quadruple Mutant (SQM) 
scaffold protein, each tag was separated by 3 glycine linkers. The results of 
this study show that when using 2 StrepII-tags the relative binding capacity of 
the tagged protein is increased 5-fold compared to the monomeric tag and 
more importantly, there is a significant increase  when using 3 StrepII-tags 
(12-fold increase compared to a single-tag)  [152]. 
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In the present dissertation I make use of the StrepII-tag and it is referred to as 
streptavidin binding peptide (SBP). The first studies were done using only one 
StrepII-tag and later on, the size of the tag was increased to three tags, 
separated by three glycine linkers (GGGS) as in reference [152].    
 
1.5.2.4 Purification using aptamers 
 
RNA affinity tags are short sequence tags, called aptamers, which were 
created to allow the purification of tagged-RNAs. Among the first aptamers 
designed were the ones that bind streptavidin (S1 aptamer) and Sephadex 
(D8 aptamer) [153]. One of the most used aptamers was discovered in the E. 
coli bacteriophage MS2 coat protein (CP) that binds to a 21 nucleotide stem-
loop structure on its genomic RNA [154]. For the use as a purification system, 
the RNA of interest containing the stem-loop binds to the coat protein that can 
be covalently linked to a solid matrix. The advantage of this system is that a 
specific RNA containing the stem-loop can be purified from a mixture of RNAs 
in a single step [155].     
 
Another method that uses the MS2 aptamer system is the RNA binding 
protein purification and identification (RaPID) technique. RaPID uses a 
fluorescent fusion protein composed of the MS2 coat protein fused with the 
green fluorescent protein (MS2-CP-GFP) to bind RNAs containing the MS2 
stem-loop. This method can be used for studying localization of specific 
mRNAs by fluorescence microscopy.  The fusion protein (MS2-CP-GFP) is 
coupled to a streptavidin binding protein that later on allows the purification of 
the mRNPs via streptavidin conjugated beads. Samples for RNA and protein 
isolation can be taken. Detection of bound proteins can be done by Western 
blot and mass-spectrometry [156]. This method involves the reversal of in vivo 
cross-linking with formaldehyde and two independent blocking steps. One 
step is to block biotinylated proteins present in the lysate with avidin, a biotin 
binding protein. The other step is to block the streptavidin beads with yeast 
tRNA to eliminate nonspecific binding [156]. These two blocking steps were 
included in the method developed in the present dissertation (see material 
and methods 2.4). 
 
The streptavidin-binding aptamer (S1) is a 44 nucleotide long RNA sequence 
and consists of two double-stranded RNA helices connected by an internal 
loop of 13 nucleotides and a terminal loop of 9 nucleotides [148, 153]. It is 
also one of the most commonly used RNA affinity tags and it has been used 
to purify different RNP complexes. For instance, this tag was used in the RNA 
subunit of the human nuclear RNase P in HeLa cells, which was found to be 
part of the active RNase P enzyme. The tagged RNA was able to bind to the 
protein components of the enzyme and was later on purified using a 
streptavidin matrix whereas the mutant version could not form the active 
enzyme [157]. Another example is the purification of RBPs that interact with 
the intron2 or the 3′-UTR of the polarity protein Crumbs3 transcript. For this 
purification, a tRNA was added to the streptavidin aptamer (tRSA) increasing 
its binding efficiency 10-fold [158].   
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A later method optimized the interaction of the SA-binding aptamer (S1m 
modified) to streptavidin. The modification of the SA-binding aptamer was 
done by introduction of a strand complementary structure in the terminal loop 
of the S1, generating a more stable structure of a 15 bp perfect stem. The 
final modification was the introduction of multiple copies of the modified 
aptamers. Using four stem-loop conformations (4xS1m) is 15-fold more 
efficient than using S1 to bind to the streptavidin matrix [159]. 
 
This method has the advantage that different RNA sequences can be used for 
the purification of regulatory proteins. The approach is based on the in-vitro 
transcription of the 4xS1m aptamer placed downstream of the AU-rich 
element (35 nucleotides long ARE) of TNFα. The in-vitro transcribed 
sequences are later on coupled to streptavidin sepharose beads and 
incubated with total cell lysates. After this incubation period and several 
washing steps, the specific RBPs that bind to the ARE element are eluted with 
RNaseA and identified by mass-spectrometry (Figure 9) [159].  
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Figure 9. Schematic representation 
of the in-vitro 4xS1-mRNP 
purification. 
A modified 4xSm aptamer placed 
upstream of an ARE element is in-vitro 
transcribed and coupled to a 
streptavidin matrix (SA). After 
incubation of the matrix with 
concentrated cellular extracts, the 
RBPs that bind specifically to this ARE 
and other common RBPs are eluted 
using RNases. In the final step the 
bound proteins are detected by mass-
spectrometry. This figure was taken 
from reference [159].
 
 
To gather information on the RBP targets as well as on the proteins 
interacting with a specific mRNA it is a key step to characterize and 
understand the composition, and later on dynamic, of mRNPs, which are part 
of the elements involved in post-transcriptional regulation of gene expression 
in trypanosomes. In order to contribute to the characterization of mRNPs in 
trypanosomes, the method described in the present dissertation tries to purify 
actively translating mRNPs and to detect their protein components. 
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2. Materials and Methods 
Some of the standard procedures described below were taken and modified 
from previous dissertations. 
2.1 Cell culture 
2.1.1 Procyclic form trypanosome culture 
Monomorphic Lister 427 procyclic trypanosomes were cultured in 
supplemented MEM-Pros medium in tightly closed cell culture flasks at 27oC 
at densities between 1-2x106 cells/ml. All work was done under sterile 
conditions in a laminar flow hood.  
 
Supplemented MEM-Pros medium, 500mL 
MEM-PROS mixture was mixed with MEM vitamins, MEM non-essential 
amino acid solution and 100mg phenol red (pH 7.4). The media was sterilized 
by filtration and stored at 4°C. 
 
Additional components to be added to 450ml MEM-Pros before use:  
 
Heat-inactivated FBS  10% (v/v) (50ml) 
Hemin     7.5mg/l (1.5ml of stock solution) 
Penicillin/Streptomycin   50U/ml (5ml of stock (5000U/ml), Sigma) 
 
Heat inactivation of FBS was done at 55°C for 30 min. 
2.1.2 Bloodstream-form trypanosome culture 
Monomorphic Lister 427 bloodstream form trypanosomes were cultured on 
incubators, in a humid atmosphere, at 37°C with 5% CO2 in supplemented 
HMI-9 medium. In order to allow gaseous exchange the lid of the culture 
flasks were slightly loose. Cell densities (determined using Neubauer counting 
chamber) did not exceed 1.5 x 106 cells/ml for experiments. Cell culture work 
was done in sterile conditions under a laminar flow hood. 
 
Supplemented HMI-9 medium, 500ml 
HMI-9 medium contained; 17.66g/l Iscove’s modified Dulbecco’s medium, 
3.024g/l NaHCO3, 136mg/l hypoxanthine, 110mg/l sodium pyruvate, 39mg/l 
thymidine and 28mg/l bathocuprono disulfonic acid disodium salt at (pH 6.3). 
The media was sterilized by filtration and stored at -20°C. 
 
Additional components to be added to 450ml HMI-9 before use 
 
Heat-inactivated FBS 10% (v/v) (50ml) 
Penicillin/Streptomycin  50U/l (5ml of Penicillin-Streptomycin mix) 
L-Cysteine   1.5mM (5ml of stock solution)  
-mercaptoethanol   0.14% (7µl in 5ml frozen stock) 
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2.1.3 Antibiotics 
For selection of transgenic trypanosomes antibiotic resistance genes were 
used and antibiotics added in the given concentrations: 
 
Antibiotic Bloodstream 
tripanosomes 
tripanosomes 
tdsstrypanosomestryp
anosomes 
Procyclic 
tripanosomes Phleomycin  1µg/ml 1µg/ml 
aaaaaaa G418  5µg/ml 15µg/ml 
Hygromycin 
 
 
 
 
15µg/ml 50µg/ml 
Puromycin 0.2µg/ l 1µg/ml 
dfgh Blasticidin 5µg/ml 10µg/ml 
 
All growth experiments were performed in the absence of selective drugs. For 
inducible expression, tetracycline was added to a final concentration of 
200 ng/ml 
2.1.4 Transfection of bloodstream / procyclic trypanosomes 
A total of 1-2x107 cells were used per transfection. Cells were washed twice in 
the appropriate transfection buffer (see below) and resuspended in a final 
volume of 0.5ml. 6-10µg of digested plasmid was mixed with the cells and 
transferred to a 2mm gap cuvette for electroporation. When transfecting 
bloodstream trypanosomes the electroporation was performed using the 
program X-001 of the Amaxa Nucleofactor (Lonza Cologne AG, Germany). In 
the case of procyclic trypanosomes the settings used were 1.5 kV and 
resistance R2 in the BTX, Harvard apparatus. On the next day, the selection 
antibiotic was added and the cells were plated in serial dilution on a 24 well 
plate. Proliferating clones were picked from the plate days later and checked 
for expression of the transgene. Aliquots of the generated cell lines were 
frozen in medium with 10% glycerol and stored in liquid nitrogen. 
 
Transfection buffers: 
Zimmerman's Post Fusion Medium (ZPFM) Used for transfection in 
procyclic trypanosomes; the buffer was composed of 132mM NaCl, 8mM KCl, 
8mM Na2HPO4, 1.5mM KH2PO4,1.5mM MgAc x 4 H2O, 90µM Ca(OAc)2 
(pH 7.0), filter-sterilized and stored at 4°C 
 
Cytomix Used for procyclic and/or bloodstream trypanosomes. Components: 
2mM EGTA, 120mM KCl, 0.15mM CaCl2, 10mM K2HPO4/KH2PO4 (pH 7.6), 
25mM HEPES, 5mM MgCl2, 0.5% Glucose, 100µg/ml BSA, 
1mM Hypoxanthine (pH 7.6), filter-sterilized and stored at 4°C 
 
Amaxa Used for bloodstream trypanosomes. Tb-BSF buffer: 90mM sodium 
phosphate, 5mM potassium chloride, 0.15mM calcium chloride, 50mM 
HEPES (pH7.3) [160]  
2.2 Cloning 
Cloning experiments were done using the supplied buffers and as stated in 
the manufacturer instructions. Enzymes from NEB or fast digest from 
Fermentas were used for the restriction reactions. In the case of 
dephosphorylation of linearized plasmids Antarctic Phosphatase (NEB) was 
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used. For standard PCR reactions or colony PCRs GoTaq® DNA Polymerase 
from Promega was used. Only when cloning ZC3H22 or ZC3H38 the 
Phusion® High-Fidelity DNA Polymerase from Finnzymes was used. PCR 
products and digests were confirmed on 1% agarose gels prepared with 
1xTAE buffer and addition of ethidium bromide to the gel. Gel extraction kits 
from Macherey-Nagel were used in the purification of plasmid DNA and PCR 
products. The illustrTM tissue & cells genomicPrep Mini Spin Kit from GE 
Healthcare was used to extract genomic DNA. DNA and RNA concentrations 
were measured using the NanoDrop machine (peqlab) 
2.3 Digitonin fractionation 
Digitonin fractionation was used to determine the localization of proteins 
within the cell. Digitonin interacts with sterols, the more sterols a membrane 
contains, the less digitonin is needed to permeabilise it. For instance, the 
plasma membranes are broken first, followed by mitochondrial and then 
glycosomal. In the present dissertation, digitonin was used as part of the 
affinity purification of cytoplasmic polyribosomes in order to determine if the 
mature CAT protein (3SBPs-CAT-SKL) was indeed being targeted to the 
glycosomes. It was also used to confirm that the glycosomes remain intact 
after SiC treatment. 
 
Trypanosome Homogenization Buffer (THB buffer): 25mM Tris-Cl 
(pH 7.8), 1mM EDTA, 150mM NaCl and 0.3M Sucrose.  
The buffer was supplemented with protease inhibitors such as 
2µg/ml leupeptin and 100µM TLCK, also 1mM DTT were added when 
required.  
Digitonin stock solution 1mg/ml dissolved in THB buffer and heat 10 min at 
95ºC. 
 
Digitonin fractionation: 2.5x106 cells were pelleted for 10 min at 3500 g, 
followed by a washing step with 1X PBS and spun down for one min at 
11,600 g. A second step of washing was done with THB buffer without 
protease inhibitors. Digitonin was added at different concentrations (0, 25 or 
50, 100, 150 and 200µg/ml) and the samples were filled up to 250µl with THB 
buffer plus inhibitors and 1mM DTT. Mild lysis with digitonin was achieved by 
1 hour of incubation on ice followed by 5 min at 25ºC. After lysis, the pellets 
were resuspended in 10µl laemmli buffer and the supernatant precipitated by 
TCA.  
 
TCA precipitation: Add ¼ volumes of 100% TCA to the samples and 
incubate for 2 hours or overnight at -20°C. The precipitates were washed 
twice with 1ml of ice-cold acetone and the pellet solved in 10µl laemmli buffer.    
2.4 Affinity purification of cytosolic polyribosomes 
This method was used in order to purify cytosolic polyribosomes from 
membrane bound polyribosomes and it was adapted from protocols for 
glycosome purification [161] and [162]. Lysis was performed in the absence of 
detergents, to maintain the organelles intact. 
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Glycosome buffer (2x): 40mM Tris-Cl (pH 7.8), 20mM MgCl2 and 600mM 
KCl. At the moment of the experiment add: 2mM DTT, 2µg/ml leupeptin, 
100µM TLCK, 40U/µl rRNasin (Promega 100U/ml), 100µg/ml cycloheximide 
and 200mM sucrose.  
Leupeptin and TLCK can replace a pill of Protease Inhibitors Cocktail EDTA 
free (Roche Diagostics GmbH). 
 
Biotin Buffer: Make 10mM from 50mM stock (Invitrogen) diluted in 
glycosome buffer. Samples were eluted in 50µl of buffer. 
 
Lysis: The lysis was done using carbamide, an abrasive substance, in an 
amount that was roughly equal to the pellet volume (for 109 cells, 100µl). The 
carbamide was pre-washed twice with glycosome buffer and spun at 900 g for 
2 min.  
For short scale purifications, 108 cells were centrifuged at 900 g for 3 min, 
then washed twice with glycosome buffer and resuspended in 300µl of 
glycosome buffer. The cells were then transferred to the washed carbamide 
and centrifuged at 900 g for 2 min to remove all the supernatant. Cells were 
ground on ice for 5 to 8 min using a pellet pestle. For control breakage, before 
the lysis, a 1:100 dilution in glycosomal buffer was made. After the grinding, 
again a 1:100 dilution of the sample was taken and loaded (10µl each) in a 
Newbauer chamber (90 to 95% breakage was ideal). To remove the 
carbamide and collect the lysate, 200µl of glycosome buffer was added to the 
the pellet pestle, spun down for 2 min at 400 g and transferred to a new tube. 
The pestle was washed once more with 100µl of glycosome buffer and the 
lysate collected in a final volume of 300µl. The lysate was transferred to the 
pre-washed Avidin-agarose beads for blocking. 
 
Blocking step: To block free biotinylated proteins present in the sample, the 
lysate was incubated with Avidin-agarose beads (Thermo-Pierce). 25µl of 
50% Avidin slurry were pre-wash trice with glycosome buffer and spun at 20 g 
for 1 min at 4°C. For the blocking step, the mixture lysate and Avidin beads 
were tumbled for 10 min at 4°C and spun down at 400 g for 5 min [159]. The 
supernatant was collected in a new Eppendorf.  
 
Sucrose density gradient fractionation: After the blocking step, the lysate 
was centrifuged at 33,000 g for 15 min to pellet the glycosomes (first step of 
ultracentrifugation). Later on the supernatant was loaded into a sucrose 
gradient and ultracentrifuged at 164,326 g for 2 hours in a SW60 rotor. The 
samples were fractionated by time (22 seconds Program #4) using the 
ISCO160 fractionator. The polyribosome profile was recorded at 454nm. 
 
Affinity purification with SA-sepharose beads: This step was performed 
after the polyribosomal fractionation, all the polysomal fractions were pooled. 
50µl of Streptavidin-sepharose (SA, GE Healthcare) slurry were taken and 
washed 3 times with glycosome buffer. The pooled polysomal fractions were 
tumbled for 1 to 1.5 hours at 4°C. The unbound fraction was collected by 
centrifugation at 2400 g for 3 min. The beads were washed once with 
glycosome buffer. The supernatant (wash fraction) was removed into a new 
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tube and the RNA present in the beads extracted using peqGold TriFast 
(peqLab) as stated in the manufacturer’s instructions.  
Alternatively, after the washing step, mRNP complexes were eluted from the 
beads by adding 50µl of 10mM biotin-containing buffer at 4°C as detailed in 
the Strp-tagged Protein Purification Handbook (Strep-Tactin Magnetic Beads, 
Qiagen). 
 
2.5 Nascent peptide affinity purification method 
This method was designed to purify non-abundant mRNPs from the cell and is 
based on a method that purified polyribosomes with a matrix-bound 
antibodies [143]. The purification of mRNPs could help to identify trans 
activating factors that might influence the cytoplasmic fate of the mRNA to 
which they bind. Therefore, the main goal was to detect the protein 
components of the specific mRNPs purified.  
 
Polyribosome buffer: Two different polyribosomal buffers were tested, both 
buffers allow the specific purification of the multi-tag reporter mRNA. 
Polyribosome buffer Kramers’ modified: This buffer gave a better 
resolution of the polyribosomal fractions and is composed of 20mM Tris 
(pH 7.5), 20mM KCl and 2mM MgCl2 [163]. 
Polyribosome buffer Schutzs’ modified: Alternative polyribosomal buffer, 
composed of 20mM Hepes (pH 7.5), 25mM NaCl and 5mM MgCl2 [143]. 
Both buffers were supplemented with the following regents, at the moment of 
the experiment; 5µg/ml leupeptin, 0.5mg/ml heparin, 2mM DTT, 100µg/ml 
cycloheximide, 40U/µl rRNasin, 200mM Sucrose, 1pill/10mL of Protease 
Inhibitors EDTA-free and 0.2% NP40 (the detergent was only added at the 
moment of lysis). 
 
Affinity Purification buffer (AP buffer): This buffer is based in the 
polyribosomal buffer.  
Affinity Purification buffer Kramers’ modified: 20mM Tris (pH 7.5), 120mM 
KCl, 2mM MgCl2 and 0.4 mg/ml of heparin, added at the moment of the 
experiment [163]. 
Affinity Purification buffer Schutzs’ modified: Alternative affinity 
purification buffer, composed of 20mM Hepes (pH 7.5), 280mM NaCl, 5mM 
MgCl2 and 0.4 mg/ml of heparin, added at the moment of the experiment 
[143]. 
 
Blocking buffer: Based on the polyribosomal buffer. 
Blocking buffer Kramers’ modified: 20mM Tris (pH 7.5), 20mM KCl and 
2mM MgCl2 [163]. 
Blocking buffer Schutzs’ modified: Alternative to blocking buffer, composed 
of 20mM Hepes (pH 7.5), 25mM NaCl and 5mM MgCl2 [143]. 
For both buffers, add at the moment of the experiment 0.1mg/ml tRNA from 
E.coli (Roche Diagostics GmbH) and 0.4mg/ml heparin. 
 
Blocking Step: 50µl of Streptavidin Sepharose High Performance beads 
(GE healthcare) were used for 3x108 cells, in the case of heat shock 
experiments; the same amount of beads was used for 6x108 cells. The beads 
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were washed once with polyribosome buffer without detergent, spun at 900 g 
for 2 min and blocked for 2 hours with 1ml of blocking buffer per 25µl beads. 
After the blocking step, the beads were washed twice with polyribosome 
buffer without detergent before and once with the AP buffer.  
 
Pre-lysis treatments: Cells were collected by centrifuging at 500 g for 10 min 
and the pellet was washed with 20ml MEM Pros media without serum. In 
order to avoid ribosome disasembly, 100µg/ml of cycloheximide (100 mg/ml) 
were added to the media and incubated for 5 min at room temperature. After 
cycloheximide treatment, the cells were centrifuged at 500 g for 8 min, the 
pellet resuspended in 1ml of polyribosome buffer without detergent and 
transferred to a 1.5ml LoBind eppendorf tube. Then the cells were spun at 
900 g for 3 min and the supernatant removed. In this step, the cell pellets 
could be frozen in liquid nitrogen and store at -80°C or continue with the 
purification. 
In special cases, depending on the protein of interest, the RNA-protein 
complexes were cross-linked before cycloheximide treatment (as was the 
case of V5-ZC3H11 or V5-MKT1). The cell pellet, corresponding to 
approximately 3x108 cells, was washed in 10ml of MEM Pros media without 
FBS and distributed in a Petri dish (145mm radius). The RNA-protein 
complexes were cross-linked at 254nm in the UV StratalinkerTM 2400, 
Stratagene (3-6x108 cells in 10ml of cells per petri dish). The treated cells 
were collected in a 50ml falcon and the petri dish washed, to collect the rest of 
the cells, with 10ml more of MEM Pros media without FBS. 
 
Lysis: The cell pellets were resuspended in 200µl of polyribosome lysis buffer 
supplemented with RNase inhibitors. Cell lysis was carried out by passing the 
cells 15 to 30 times through a 21G 11/2 needle (BD Microlance). To clear the 
lysate, the samples were centrifuged at 16,000 g for 10 min and the salt 
concentration adjusted to 120mM KCl. The supernatant was loaded carefully 
in a sucrose gradient.  
 
Sucrose gradients: Gradients were prepared by adding the AP buffer 
supplemented with 5µg/ml leupeptin, 0.5mg/ml heparin and 2mM DTT to 15% 
and 50% sucrose mixtures. The sucrose layers were made by leaving the 
gradients in a 90° position for 2 hours. Gradients were stored at -80°C. 
 
Sucrose density gradient fractionation: The gradients were ultra-
centrifuged at 164,326 g for 2 hours in the SW60 rotor. The samples were 
fractionated by time (22 seconds, Program #4) using the ISCO160 
fractionator. The polyribosome profile was recorded at 454nm.  
 
Affinity Purification: Pooled polyribosome fractions were added in an equal 
volume to the pre-blocked Streptavidin Sepharose beads and tumbled for 
1 hour. Afterwards, the beads were spun down at 900 g for 3 min and left on 
ice to settle, due to the high concentration of sucrose, this step can take 
approximately 20 min. The unbound fraction was taken and the beads 
washed 3 times with AP buffer. Protein elution for Western blot or mass 
spectrometry was achieved by adding SDS laemmli buffer and boiling the 
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samples at 95°C for 10 min. Samples for Northern blot were resuspended in 
peqGold TriFast (peqLab).  
 
Proteinase K treatment: In case cross-linked samples, proteinase K 
treatment previous to TriFast was performed as follows; 400µg/µl of 
Proteinase K, 8mM of EDTA (4M) and 0.2% of SDS (10%) per 50µl beads 
and incubated for 20 min at 42°C with.  
2.6 CAT Assay 
Chloramphenicol acetyl transferase [124] assay was use in tethering 
experiments to determine the effect of a protein on translation. Also it was 
used to measure the activity of the mature 3SBP-CAT-SKL protein in the 
polyribosome fractions and to ensure intact glycosomes.  
The CAT enzyme transfers an acetyl group from radioactivetively 14C labeled 
butryl CoA to chloramphenicol. As chloramphenicol takes up an acetyl group, 
it becomes water insoluble and therefore move from the aqueous phase of the 
reaction solution to the upper non-aqueous phase of the scintillation solution.  
For CAT assay, 107 cells were spun down 900 g for 5 min, washed once with 
5ml cold 1x PBS and centrifuged at 900 g for 5 min. The pellets were 
resuspended in 300µl of CAT assay buffer (200µl 100mM Tris-HCl (pH 7.8), 
2µl chloramphenicol 40mg/ml) and transferred to new Eppendorf tube. The 
samples were lysed by freezing-thawing thrice on liquid nitrogen and 
centrifuged at 16,200 g at 4°C for 3 min. The supernatant was transferred to a 
new tube and stored at -80°C. In order to determine the protein concentration 
of the samples, the Bradford assay was performed. 
Bradford’s Standard curve: 
0, 5, 10, 15, 20µg of BSA (0.5µg/µl stock) in 800µl. 
50µl of each sample was taken and 750µl of sterile water added. 
To all the samples, 200µl of Bradford reagent (Biorad) was added and 
incubated for 5 min. The protein concentration was measured at 595nm.  
The relative CAT activity was determined by taken 0.5 to 1µg of total protein 
from each sample and scaled up to a total volume of 50 µl using 100mM Tris-
HCl, pH7.8. In the final step, CAT assay buffer containing 10µl butryl CoA per 
sample and 4ml scintillation cocktail (Econofluor-2) were added. The counts 
were measured in a scintillation counter (Beckman LS6000IC) using program 
#7 (0.50 seconds per sample measuring 14C).  
2.7 Tethering Assay 
For the tethering experiment, two stable cell lines were used, one expressing 
a reporter containing the 5 box B element in the 3’ –UTR of the CAT gene 
(pHD2277) and the control cell line, expressing a reporter which does not 
contain the box B element (pHD1991). Both cell lines were transfected with a 
fusion protein composed of the λN peptide at the N-terminal of the protein of 
interest and a myc-tagged at the C-terminal. This approach was tested in both 
life cycle forms, for λN-ZC3H22-myc in procyclic form trypanosomes and λN-
ZC3H38-myc in bloodstream forms. The effect of the protein on the tethered 
reporter mRNA was determined by CAT assay (material and methods 2.6). 
2.8 RNA extraction and Northern Blot 
Total RNA and RNA from sucrose gradients was extracted using peqGold 
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Trifast (peqLab) for liquid and solid samples. The extraction was performed 
following the manufacturer instructions. Formaldehyde gels were used in 
order to separate the RNA and the gel blotted onto Nytran membranes 
(GE Healthcare). Northern blots were hybridized with radioactively labelled 
DNA (Prime-IT RmT Random Primer Labeling Kit, Stratagene) or RNA 
(MAXIscript, Ambion) probes. Measurement of the signals was done using 
phosphorimager (Fuji, FLA7000). For normalization purposes the signal for 
HSP70 mRNA, tubulin mRNA or the structural RNA SRP were used.  
2.9 RNA-Immunoprecipitation (RNA-IP) 
2x108 procyclic trypanosomes or 4x108 bloodstream forms were used per 
experiment. Only for the RNA-IP using the cell line that express V5-ZC3H22, 
RNA-protein complexes were UV cross-linked at 254nm (UV StratalinkerTM 
2400, Stratagene). Cells were concentrated in 10ml of media and plated on a 
145mm radius Petri dish. Then, the cells were collected in 1ml PBS, pelleted 
by centrifugation at 900 g for 3 min and the pellet stored at -80C. 
 
Immunoprecipitation buffer IPP150: 150mM NaCl, 10mM Tris-HCl (pH 7.5) 
and 0.1% IGEPAL. 
 
Lysis buffer: 10mM NaCl, 10mM Tris-HCl (pH 7.5) and 0.1% IGEPAL. 
For 5ml of lysis buffer add a tablet of Protease Inhibitors Cocktail EDTA free 
(Roche Diagostics GmbH)  
 
Washing step: 50µl of anti-V5-bead or anti-myc-bead slurry (Biomol) were 
used per immunoprecipitation. The beads were spun for 1 min at 400 g and 
washed twice with IPP150. 
 
Lysis: Cells were lyzed in 450µl of lysis buffer supplemented with 200μg/ml of 
RNasin® Ribonuclease inhibitor (Promega) and 20µl VRCs. Lysis was 
performed by passing the cells 15 times through a 27G 11/2 needle 
(BD Microlance). The lysate was cleared by centrifugation at 3,500 g for 5 min 
and the supernatant added to the pre-washed beads. At the moment of the IP, 
the concentration of NaCl was adjusted to 150mM and the samples tumbled 
for 1 hour. Afterwards, the beads were washed 5-10 times with IPP150. 
Samples for Western blot and Northern blot were taken. 
In case of cross-linked samples, proteinase K treatment was necessary prior 
to RNA extraction by Trifast (see material and methods 2.5). 
 
Preparation of samples for RNA sequencing: Approximately, 1x109 
bloodstream form trypanosomes were harvested for RNA-IP. A Northern blot 
was performed in order to determine the quality of the mRNA, the samples 
with visible ribosomal RNA (by methylene blue staining) were depleted of it 
using oligos against the ribosomal RNA [164].  
The samples were sent to the Bioquant facility to perform the Illumina 
sequencing.  
This protocol is currently under optimization in our laboratory. 
2.10 Tandem affinity purification [140] 
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To determine the interaction partners of ZC3H38, TAP-tag purification was 
performed. The ZC3H38 protein was fused to a C-terminal TAP-tag. TheTAP-
tag is compose of a calmodulin binding peptide (CBP), a tobacco etch virus 
protease (TEV protease) cleavage site and two IgG binding domains from 
Staphylococcus aureus Protein A [121].  
 
Lysis buffer: 20mM Tris (pH 7.8), 10mM NaCl and 0.1% IGEPAL 
 
IPP150 IP buffer: 150mM NaCl, 20mM Tris (pH 7.8) and 0.1% IGEPAL 
 
TEV cleaveage buffer: 150mM NaCl, 20mM Tris (pH 7.8), 0.5mM EDTA, 
1mM DTT and 0.1% IGEPAL 
 
Calmodulin binding buffer: 150mM NaCl, 20mM Tris (pH 7.8), 10mM β-
mercaptoethanol, 1mM magnesium acetate, 1mM imidazole, 2mM CaCl2 and 
0.1% IGEPAL 
 
Calmodulin elution buffer: 150mM NaCl, 20mM Tris (pH 7.8), 10mM β–
mercaptoethanol, 1mM magnesium acetate, 1mM imidazole, 2mM EGTA and 
0.1% IGEPAL 
 
Lysis: Approximately, 1x1010 bloodstream form trypanosomes were lysed in 
4ml of buffer supplemented with 1 tablet of Protease Inhibitors Cocktail EDTA 
free (Roche Diagnostics GmbH). Lysis was done by passage of the cells 
through a 21G 11/2 needle (BD Microlance) for 20 times. Cell debris was 
pelleted by centrifugation at 10,000 g for 15 min. The clear lysate was 
transferred to a new tube and the concentration of NaCl adjusted to 150mM 
(sample for input after lysis, equivalent to 6x108 cells was taken). 
 
IgG purification: The IgG sepahrose beads (approximately 200µl) were 
transferred to a Bio-Rad column and pre washed with 10ml of IPP150 buffer. 
The clear lysate was then transferred to the column and tumbled for 1 hour at 
4°C. The unbound sample was collected by gravity flow and an equivalent 
number of 6x108 cells was taken for further analysis. The beads were washed 
3 times with 10ml of IPP150 and once with 10ml TEV cleavage buffer. The 
cleavage was done with 100 units of TEV protease (Gibco) in 1ml of TEV 
cleavage buffer added directly to the column and incubated overnight at 4°C 
in slow rotation. The elution was obtained by gravity flow and a sample, 
equivalent to 1.5x107 cells was taken as the eluate after TEV cleavage. 
 
Calmodulin purification: Approximately, 200µl of calmodulin bead 
suspension were transferred to a column (BioRad) and pre washed with 10ml 
of calmodulin buffer. The eluate recovered from the IgG sepharose beads 
(after the TEV cleavage) was approximately 1ml, to this sample, 3ml of 
calmodulin binding buffer and 3µl of 1M CaCl2 were added. Then this solution 
was transferred to the calmodulin beads and tumbled for 1 hour at 4°C. The 
column was washed 3 times with calmodulin binding buffer. In the final step, 
the bound proteins were eluted with 1ml of calmodulin elution buffer and 
concentrated by TCA precipitation. Samples were loaded in a SDS-PAGE gel 
and sent to mass spectrometry. 
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2.11 Yeast two hybrid high-throughput screen 
 
Yeast two-hybrid analysis: The Matchmaker Yeast Two-Hybrid System 
(Clontech) was used according to the manufacturer's instructions. The 
ZC3H38 ORF was PCR-amplified and cloned into pBD-gate2 [165] used as 
bait. As prey, the pGADT7 vector was used. As controls we used the pGBKT7 
bait plasmid containing murine p53, which interacts with the SV40 large T-
antigen (positive control) and the pGBKT7 bait plasmid containing Lamin, 
which does not interact with the SV40 large T-antigen (negative control). The 
bait plasmid contains an N-terminal-GAL4 DNA binding domain and myc-tag. 
The prey has an N-terminal fused GAL4 activation domain and HA-tag. The 
pairwise co-transformation of the bait and prey plasmids was done into AH109 
yeast strains (Matchmaker 3 System, Clontech). Positive clones were 
selected on quadruple drop-out medium (minimal SD media lacking 
tryptophan, leucine, histidine and adenine) and positive interactions were 
indicated by growth on SD-QDO and by the change to blue color due to the 
presence of X-α-gal in the medium. Protein expression was confirmed by 
Western blotting, using the myc and HA tags for detection for further 
reference see [108]. 
 
High-throughput screen: The positive cell line containing the ZC3H38 ORF 
was used as bait (cloned into pGBKT7 plasmid) and mated with Y187 MAT α 
strain, which carried a random genomic fragment library of T. brucei made by 
Dr. Esteban Erben in our laboratory (prey, in pGADT7). Selection of 
transformants was performed on SD-QDO medium after 5 days of incubation 
at 30°C. After selection, yeast cells were harvested and plasmid DNA isolated 
by cell wall digestion with lyticase, followed by NucleoSpin Plasmid alkaline 
lysis spin kit (Macherey Nagel). To identify putative interactors, PCR 
amplification was carried out using pGADT7 vector-specific primers [108]. 
The conditions necessary for the amplifications were as described below. 
Using GoTaq polymerase 94°C for 5 min, 94°C for 40 sec, 63°C for 40 sec, 
72°C for 4 min, 22 cycles and a final step of 72°C for 5 min. 
In case of amplification with Q5 polymerase use 98°C for 10 sec, 98°C for 10 
sec, 65°C for 20 sec, 72°C for 3 min, 22 cycles and a final step of 72°C for 5 
min.  
Quality of the amplified products was checked on an agarose gel. Samples 
were prepared for Illumina sequencing using standard Illumina kits and 
sequenced for 50 cycles on an Illumina MiSeq. 
 
Bioinformatic analysis: Custom scripts designed by Dr. Abeer Fadda in our 
laboratory, in order to identify only mRNA sequences that were fused in-frame 
to the pGADT7 activation domain will be use in the analysis.  
Currently, the samples are in the Bioquant sequencing facility, but when the 
results be available, the sequences containing the terminal junction of the 
insert-vector sequence will be identify and remove. The remaining sequences 
will be map to the T. brucei 927 genome using Bowtie and allowing one base 
mismatch. Sequences that are in frame with an annotated ATG start codon 
and in-frame sequences in 5’ -UTRs will be selected and analyzed using 
customize SAMtools and Perl scripts.  
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2.12 List of plasmid generated for this study 
Plasmid No Description 
PHD2174 
EP 5'UTR backbone + 1SBPat N-term of CAT ORF and  SKL at C-term + 
EP 3'UTR 
PHD2306 
EP 5'UTR backbone + 3SBPs at N-term of CAT ORF and  SKL at C-term 
+ EP 3'UTR 
PHD2319 
EP 5'UTR backbone + No SBPs on CAT ORF and  SKL at C-term + EP 
3'UTR 
PHD2320 
EP 5'UTR backbone + 3SBPs at N-term of CAT ORF and  SKL at C-term 
+ VSG117 3'UTR 
PHD2376 
EP 5'UTR backbone + 3SBPs at N-term of CAT ORF and  SKL at C-term 
+ HSP70 3'UTR 
PHD2392 ZC3H22 N-term ORF (in p2T7) 
PHD2414 
EP 5'UTR backbone + 3SBPs at N-term of CAT ORF and  SKL at C-term 
+ AATP11 3'UTR (BamHI/MluI) 
PHD2415 
EP 5'UTR backbone + 3SBPs at N-term of CAT ORF and  SKL at C-term 
+ HSP70 3'UTR delAUU 
PHD2416 in situ V5-tagged ZC3H22 
PHD2417 ZC3H22 middle ORF (in p2T7) 
PHD2440 
EP 5'UTR backbone + 3SBPs at N-term of CAT ORF and  SKL at C-term 
+ AATP11 3'UTR del328nt 
PHD2517 ZC3H22-myc, in pHD1700 (C-term tags) 
PHD2526 ZC3H22 KO plasmid, Puromycin (in pHD1747) 
PHD2528 ZC3H22 for tethering (in pHD2451) 
PHD2604 ZC3H22 KO plasmid, Blasticidin  
PHD2614 Exogenous V5-ZC3H38 (in EP locus) 
PHD2616 ZC3H38 for tethering (in pHD2451) 
PHD2620 P2T7 RNAi Tb927.10.12790 
PHD2621 CAT SKL no SBP in T7 plasmid for in-vitro transcription 
PHD2629 in situ V5-tagged ZC3H38 
PHD2651 p2T7 RNAi ZC3H37ORF 
PHD2652 ZC3H38 without HNPY domain for tethering (1-813bp) 
PHD2653 ZC3H38-myc, in pHD1700 (C-term tags) 
PHD2654 ZC3H38 without 1st CCCH for tethering (193-847bp) 
PHD2656 ZC3H38 without both CCCH for tethering, only HNPY (475-843bp) 
PHD2666 ZC3H38 KO plasmid, Blasticidin (in pHD1748) 
PHD2668 ZC3H38 C-terminal TAP-tag (in PHD918) 
PHD2681 ZC3H37 and ZC3H38 KO plasmid, Blasticidin (in pHD1748) 
PHD2702 ZC3H37 and ZC3H38 KO plasmid, Puromycin (in pHD1747) 
PHD2759 ZC3H38 N-terminal TAP-tag (in pHD2643) 
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2.13 List of primers designed  
 
Numbers Sequence 
Restriction 
site 
Description 
CZ 3848  
 
agcttgccaccatggctagctggagccacccgcagttcgagaagggtggcggcagcctcgaga
tctt  
 
FW with 1SBP  
CZ 3849  
 
agctaagatctcgaggctgccgccacccttctcgaactgcgggtggctccagctagccatggtgg
ca  
 
RV with 1SBP  
CZ 3932   gctcaagcttgccaccatggctagctggag  
 
FW with SKL signal  
CZ 3933   ctatggatcctcagagtttagaccatctattcgccccgccctgccactcatcgcagtac  
 
RV with SKL signal  
CZ 4494   gatctggtggcggcagctggagccacccgcagttcgagaagggtggcggcagca  BglII FW  with 2 SBPs  
CZ 4495   agcttgctgccgccacccttctcgaactgcgggtggctccagctgccgccacca  BglII RV with 2 SBPs  
CZ 4496   agcttaccatggcgtggagccacccgcagttcgagaagggtggcggcagcggtggcg  BamHI FW  with 2 SBPs  
CZ 4497   gatccgccaccgctgccgccacccttctcgaactgcgggtggctccacgccatggta  BamHI RV with 2 SBPs  
CZ 4550   cacaagcttcgacgagattttcagg  
 
FW upstream CAT ORF for cloning the control without 
3SBPs  
CZ 4556   cacaagcttatgactagtgtgagcaagg  HindIII FW for eGFP ORF instead of CAT  
CZ 4557   gatcggatcctcagagtttagaccatctattcttgtacagctcgtccatgccgag  BamHI RV for eGFP ORF instead of CAT+SKL  
CZ 4615   atggagaaaaaaatcactggatat  
 
FW for CAT ORF  
CZ 4847   gacccgcggttgttacacccctttccctc  SacII FW ZC3H22 5'-UTR  
CZ 4848   gctctagaatccgtgaaaattcaaaagt  XbaI RV ZC3H22 5'-UTR  
CZ 4849   gatgtcgacttccttcccgaacaatcgaa  SalI FW ZC3H22 ORF  
CZ 4850   atgggcccagacttccatccactccctc  ApaI RV ZC3H22 ORF  
CZ 4874   atgaccacagcaactgatgtg  
 
FW on N-term ZC3H38 ORF  
CZ 4875   caaagaacacgtttggagctg  
 
RV middle of ZC3H38 ORF  
CZ 4884   gctctcgagatgaccacagcaactgatgtg  XhoI FW ZC3H38 ORF for V5 in situ tag  
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CZ 4885   actgggccctcggtctccggcgaggaataa  ApaI RV ZC3H38 ORF for V5 in situ tag  
CZ 4886   tgcccgcggtgacatcagcggaaaacattc  SacII FW 5'-UTR ZC3H38 for V5 in situ tag  
CZ 4887   acgactagtcttgactttgtttggttcttc  SpeI RV 5'-UTR ZC3H38 for V5 in situ tag  
CZ 4892   gatccgaggggaggcggcgtagcagg  BamHI FW 3'-UTR AATP11  
CZ 4913   agtacgcgttttgcgcgcttgcgcatagttttg  MluI RV 3'-UTR AATP11  
CZ 4916   tctcagattacgccgagctt  
 
FW middle ZC3H22 ORF  
CZ 4917   acataccaacagtccgctcc  
 
RV middle ZC3H22 ORF  
CZ 4920   tggctcgagttccttcccgaacaatcgaa  XhoI FW N-term ZC3H22 without ATG  
CZ 4931   ccgccgcgccctttattaagat  
 
RV middle ZC3H22 ORF  
CZ 4947   cttattttcgttctgtttgttgtc  
 
FW 3'-UTR AATP11 deletion  
CZ 4948   ttgatttatagagacactgagctg  
 
RV 3'-UTR AATP11 deletion  
CZ 5017   gatagcgtaatgaatgtccacacttgtttta  MluI RV 3'-UTR EP 26mer deletion  
CZ 5018   aggacgcgtgtgacatcctttctaatgcct  MluI FW 3'-UTR EP 26mer deletion  
CZ 5019   tggaaactcgagcgaacccaaaaga  PspXI RV 3'-UTR EP 26mer deletion  
CZ 5020   tgaggatccgcggatgcaagcgtgt  BamHI FW 3'-UTR EP 26mer deletion  
CZ 5037   gatcgttaactgtgatgtttcggttgcgtattc  HpaI FW 3'-UTR EP 16mer deletion  
CZ 5038    atccgttaactgggtctcaggcgatggttaata  HpaI RV 3'-UTR EP 16mer deletion  
CZ 5066   agctctcgagatccgtgaaaattcaaaagtactgg  XhoI RV 5'-UTR ZC3H22 knockout   
CZ 5067   actcgaattcggtaagaaaagaaaaaaagtaacaa  EcoRI FW 3'-UTR ZC3H22 knockout  
CZ 5068   cgtggatcccccttcatttcgccgctcatttctc  BamHI RV 3'-UTR ZC3H22 knockout  
CZ 5078   acggtaccttctcaccgttttgccaattttgaa  KpnI FW 5'-UTR ZC3H22 knockout  
CZ 5091   gatcctcgaggggcctttccaagattgctgttt  XhoI FW HSP70 3'-UTR  
CZ 5092   atagggcccgccattccattttagacgctatg  ApaI RV HSP70 3'-UTR  
CZ 5093   agagcggccgcaccatggcgtggagccaccc  NotI FW 3SBP-CAT-SKL  
CZ 5094   tcagctcgagtcagagtttagaccatctatt  XhoI RV 3SBP-CAT-SKL  
CZ 5150   aaagcaggctccatgttccttcccgaacaatcgaa  
 
FW ZC3H22 for tethering  
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CZ 5151   gtacaagaaagctgggttcaaaagggtacgtgtaggggaa  
 
RV ZC3H22 for tethering  
CZ 5152   gatctgcatcctgggatcaa  
 
FW blasticidin ORF for sequencing  
CZ 5153   cattgacaccagtgaagatgc  
 
RV blasticidin ORF for sequencing  
CZ 5154   caccagggcaagggtctg  
 
FW puromycin ORF for sequencing  
CZ 5155   agttcttgcagctcggtgac  
 
RV puromycin ORF for sequencing  
CZ 5173   gcataagcttatgttccttcccgaacaatc  HindIII FW ZC3H22 for over-expression (PHD1700)  
CZ 5174   gacggatccaaagggtacgtgtagggga  BamHI RV ZC3H22 for over-expression (PHD1700)  
CZ 5231   ccccgatgagcaatgcttttttataatgccaactttgtacaaaaaagcaggctccatg  
 
attL1 for tethering (Ph.D. Esteban Erben)  
CZ 5232   gggggataagcaatgctttcttataatgccaactttgtacaagaaagctgggt  
 
attL2 or tethering (Ph.D. Esteban Erben)  
CZ 5528   taatcacaatacgctggtacggtga  
 
FW Tb927.7.2690  
CZ 5558   gatcggatcctcagtgattcatcaggaaaaca  BamHI RV Tb927.10.12770 ORF  
CZ 5559   gatcgtcgacaaaaaataattatatatatata  SalI FW Tb927.10.12770 ORF  
CZ 5560   gatcgtcgactgaatggaacgggttacgccat  SalI FW Tb927.10.12790 ORF for RNAi  
CZ 5561   gatcggatcccatatattgactgagcgaataa  BamHI RV Tb927.10.12790 ORF for RNAi  
CZ 5562   gatcgtcgacaacccgtgtgctgcaggagtac  SalI FW ZC3H38 ORF unique region for RNAi    
CZ 5563   gatcggatccatattgcatacttccaactgca  BamHI RV ZC3H38 ORF unique region for RNAi  
CZ 5588   tcagtgtatcatcaggaaaacaataaaaa  
 
RV Tb927.10.12770 ORF for RNAi  
CZ 5589   cacttcctttttctttactcctcatg  
 
FW Tb927.10.12770 ORF for RNAi  
CZ 5629   gatcgtcgaccggttcatttcccgatgg  SalI FW ZC3H37 ORF unique region for RNAi  
CZ 5630   gatcggatccgagatgcccgttatcgc  BamHI RV ZC3H37 ORF unique region for RNAi  
CZ 5654   accactttgtacaagaaagctgggtttacagctgctggtaag  
 
RV ZC3H38 for 1st and/or 2nd CCCH deletion  
CZ 5655   gatcgggcccgatttacgtatcgccccattt  ApaI FW_5'-UTR_ApaI  
CZ 5656   gatcctcgagcttgactttgtttggttcttctt  XhoI RV_5'-UTR_XhoI  
CZ 5657   gatcggatccatgtggggaatcccttct  BamHI FW ZC3H38 3'-UTR for knockout  
CZ 5658   gatcactagtcgaacgaaaattaaaacggc  SpeI RV ZC3H33 3'-UTR for knockout  
CZ 5682   aaagcaggctccatgaatgttgattacagcacgc  
 
FW ZC3H38 for 1st CCCH deletion  
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CZ 5683   aaagcaggctccatggttgccgtcgaccctga  
 
FW ZC3H38 for 2nd CCCH and/or HNPY deletion  
CZ 5684   gtacaagaaagctgggttcagaaacgtgggcgc  
 
RV ZC3H38 for HNPY deletion  
CZ 5685   gatcggatccttcgctgagtttaattgtaacc  BamHI FW ZC3H37 3'-UTR for knockout  
CZ 5686   gatcactagtcgaaatgacgcataaaagaagt  SpeI RV ZC3H37 3'-UTR for knockout  
CZ 5697   gatcaagcttatgaccacagcaactga  HindIII 
FW ZC3H38 ORF for over-expression (PHD1700) and 
TAP-tag (PHD918)  
CZ 5698   gatcggatcccagctgctggtaaggatta  BamHI RV ZC3H38 ORF for over-expression (PHD1700)  
CZ 5718   gatcgttaaccagctgctggtaaggatt  HpaI RV ZC3H38 ORF for TAP-tag (PHD918)  
CZ 5741   gatcgaattcatgaccacagcaactgatgtg  EcoRI FW ZC3H38 ORF for yeast two hybrid  
CZ 5742   gatcggatccttacagctgctggtaaggat  BamHI RV ZC3H38 + Stop odon for yeast two hybrid  
CZ 5860   gatcgagctcgatttacgtatcgccccattt  SacI FW 5'-UTR ZC3H38 N-term TAP (in situ)  
CZ5900   gatcaagctttgaccacagcaactga  HindIII 
FW ZC3H38 ORF N-term TAP-tag (PHD2643) no 
ATG!  
CZ4874   atgaccacagcaactgatgtg  
 
FW ZC3H38 and ZC3H37 homologous part of the ORF  
CZ4875   caaagaacacgtttggagctg  
 
RV ZC3H38 and ZC3H38 homologous part of the ORF  
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2.14 Plasmids Maps 
2.14.1 Affinity Purification Plasmids 
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2.14.2 Plasmids for ZC3H22 
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2.14.3 Plasmids for ZC3H38 
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3. Results 
3.1 Principle of the nascent polypeptide affinity purification 
 
The method described in the present dissertation is based on a previously 
published method that purified polyribosome complexes using an antibody 
against the nascent peptide of hen oviduct. The immunoprecipitation was 
achieved using an antibody covalently cross-linked to para-aminobenzyl-
cellulose matrix [143]. Others had also succeeded in the purification of 
polyribosome complexes before, but most of them had purified abundant 
mRNAs such as those encoding ovalbumin [166, 167], histone F2c [168], 
histone H5 [169] and globin [170] among others. 
 
The method described below was designed to purify a specific mRNP from 
translating polyribosomes using the strong interaction of a streptavidin binding 
peptide (SBP) and a streptavidin matrix [149, 171, 172]. The main goal of this 
method is to detect trans-activating factors, that are usually of low abundance, 
but influence the cytoplasmic fate of an mRNA, either by binding directly to 
the target mRNA or in association with other proteins present in the mRNP. 
  
A graphic representation of the reporters used in the present study is shown 
below (Figure 10). The reporter mRNA of interest contained a sequence 
encoding three streptavidin binding peptides (3SBPs) at the 5’-end of the 
open reading frame (ORF, Figure 10a). As control, a reporter mRNA without 
the 3 SBPs was used (Figure 10b). Both reporters contained the same 
untranslated regions (5’-UTR and 3’-UTR).  
 
With this technique, the relevance of motifs or specific sequences present in 
the UTRs can be tested. For instance, by comparing a reporter containing an 
intact 3’-UTR (Figure 10c) to a reporter with a deletion on the 3’-UTR (Figure 
10d). This will allow the identification of proteins that bind to this specific 
region, as both reporters contain the same ORF and the 3SBPs and differ 
only in this specific region of the UTR.  
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Figure 10. Reporters used in the affinity purification method  
(a) Multi-tag reporter composed of three streptavidin binding peptides (3SBPs) at the 
5’-end of the open reading frame [173] and the RNA binding proteins (RBPs) bound 
to the 3’-untranslated region (3’-UTR). The blue circles represent the translated 
SBPs that came out of the ribosomal tunnel as nascent peptide and the black ones 
the CAT protein.  
(b) Control reporter, same as in (a) but without the 3SBPs.  
(c) Multi-tag reporter with a complete 3’-UTR, containing the cis-regulatory element 
of interest. 
(d) Multi-tag reporter without the cis-regulatory element, shown as two squares 
connected by dashed lines.  
 
The strategy relies on the purification of translating polyribosomes via the 
affinity of the 3SBP multi-tag to a streptavidin matrix. Due to the fact that the 
multi-tag reporter mRNAs designed, contained the 3SBPs at the 5’-end of the 
ORF, the first part of the reporter mRNA to be translated and to exit the 
ribosomal tunnel, as a nascent peptide, were the 3SBPs-tag. The complexes 
expressing the multi-tag were pooled and affinity purified using streptavidin 
beads (Figure 11).  
 
In the first step of the purification, RNA-protein complexes were UV cross-
linked at 254nm. Using this approach, covalent bonds are formed between 
RNA and proteins that reside in close proximity, maintaining theses direct 
interactions is essential to proceed further with this method, allowing the 
purification of mRNP complexes under stringent conditions (Figure 11a).  
 
In the next step, cycloheximide was added prior to cell lysis with detergents, in 
order to avoid polyribosome disassembly (Figure 11b). Then, the lysate was 
cleared by centrifugation and the translating mRNAs obtained by performing a 
polyribosomal fractionation. In this type of fractionation, the translating 
polyribosomes, present in the higher sucrose fractions were separated from 
the lower sucrose fractions containing ribosomal complexes (40S, 60S and 
80S) and other proteins that did not bind to the translating mRNPs (Figure 
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11c). The fractions containing the actively translating polyribosomes were 
pooled (fractions 6-10 of the polyribosome gradient in Figure 11c) and 
incubated with the streptavidin matrix (affinity purification step), allowing the 
interaction between the 3SBPs-tag (nascent peptide) and the streptavidin 
matrix (Figure 11d). In the final step, the specificity of the pull down was 
tested by Northern blot and the proteins bound to the purified mRNPs were 
detected by Western blot and mass spectrometry (Figure 11e). 
 
  
 
Figure 11. Workflow of the mRNP affinity purification.  
(a) RNA and proteins were UV-cross linked at 254nm followed by (b) 5 min of 
incubation with cycloheximide, CHX. (c) Cells were lysed with detergent and the 
clear lysate loaded onto a sucrose gradient. (d) The fractions containing actively 
translating polyribosomes were pooled and incubated with streptavidin beads for 1 h. 
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(e) Proteins present in the purified mRNPs were detected by mass spectrometry 
(MS), Western blot and the pull down was assessed by Northern blot.  
SBP, streptavidin binding peptide; RBPs RNA binding proteins; UTR, untranslated 
regions; ORF, open reading frame. 
 
Table 1. Summary of problems found in the affinity purification method 
The table shows the expected problems in the purification, the measures taken to 
overcome these problems and the outcome. 
 
Problem 1. Mature SBP-CAT protein contains the tag and could represent a major 
contaminant. 
Possible solution  Outcome  
Target the mature protein to the glycosomes 
via a glycosome targeting signal (SKL) at the 
3’-end of the CAT open reading frame. 
Successful, the SKL signal targets the 
mature protein to the glycosomes, this was 
measured using CAT assay 
(Figure 7b). 
Separation of cytosol from organellar fraction 
(where glycosomes are present). 
Successful, the glycosomes are separated 
by an initial ultra-centrifugation step. This 
was measured by CAT assay (Results 
Figures 4b and 7b). 
Trial of different lysis methods without 
detergents (carbamide and glass beads), to 
avoid lysis of glycosomes. 
Both methods gave similar results, 
carbamide method was chosen because it 
requires less time to partially lyse the cells 
(Figure 3).  
Problem 2. SBP-tag not binding to the streptavidin beads  
Possible solution  Outcome  
Increase the number of SBP-tags  
Successful, CAT mRNA was detected by 
Northern blot (Figure 8). 
Use of different matrixes (magnetic or 
sepharose beads) 
Sepharose beads were chosen because 
less unspecific mRNAs bind (Figure 6). Also 
the amount of sepharose beads to use was 
tested (Figure 9). 
Problem 3. Poor yield  
Possible solution  Outcome  
Compare lysis with and without detergents. 
Lysis with detergents gave a higher yield; 
represented by the CAT mRNA being 
detected by Northern blot (Figure 8).  
Optimization of the cell number. 
3-6x108 cells were used when lysing with 
detergent. 
Problem 4. Higher background; abundant mRNAs binding unspecifically to the matrix 
Possible solution  Outcome  
Block the lysate with Avidin-agarose beads to 
avoid the binding of biotinylated proteins to 
the matrix.  
Not sure if it makes a difference 
Block streptavidin beads with tRNA and 
heparin. 
Not sure if it makes a difference 
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Problem 5. Not enough reporter mRNA produced 
Possible solution  Outcome  
Calculate the number of reporter mRNA per 
cell. 
Approximately, 400 molecules of CAT 
mRNA were produced in our cell lines 
(Figure 10).  
Change the promoter to T7 polymerase. Not used in the present work 
Problem 6. Few peptides identified by mass spectrometry 
Possible solution  Outcome  
Perform MS or DL-MS  
Using DL-MS the number of proteins 
identified was less then when using only 
MS (compared Tables 3 and 4). 
UV cross-link the samples.  
This is protein dependent and it was 
successful for the purification of ZC3H11 
(Figure 14). 
If known, perform the MS search using data 
of modified peptides of the protein of interest 
One modified peptide form ZC3H11 was 
found by MS 
 
The following sections describe the standardization of the affinity purification 
method (results sections 3.2 to 3.8), the validation of the technique (results 
section 3.9 and 3.10) and the results obtained using this purification (results 
section 3.11 to 3.13). 
3.2 Affinity purification of cytosolic polyribosomes 
 
In order to overcome one of the main problems of this method (the mature 
protein containing the SBP-tag, see Table 1), it was decided to separate the 
cytosol from the organellar fraction.  
 
The chloramphenicol acetyltransferase [124] gene was chosen as the ORF for 
the SBP-reporters because it allows the quantitative detection of the CAT 
mRNA by Northern blot and the mature protein detected by CAT assay or 
Western blot. Unfortunately, the currently available antibodies for the CAT 
protein do not work in trypanosomes, giving no specific signal in Western 
blots using total lysate (data not shown). Nevertheless, there is a strong CAT 
activity detected by CAT assay, so the protein was detected using this assay 
only. Furthermore, the inclusion of a serine-lysine-leucine signal (SKL) 
targeted the mature SBP-CAT-SKL proteins to the glycosomes, peroxisomal-
like organelles, which were separated from the sample by an initial ultra-
centrigugation step (separation of cytosol from organelles).  
 
Initially, the purification of cytosolic mRNPs was performed using Strep-Tactin 
magnetic beads (Qiagen). In order to obtain enough cytosolic polyribosomes 
for the pull down and to detect proteins by mass spectrometry, different 
conditions were tried; such as different lysis methods (Figure 12), different 
initial ultracentrifugation conditions (Figure 13) and variations in the cell 
number.  
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3.2.1 Carbamide lysis was more efficient than glass beads lysis 
 
Different lysis methods were tried, except for the use of detergents in the lysis 
buffer, this was not an option when purifying cytosol because the organelles, 
especially the glycosomes, had to remain intact.  
 
Lysis by vortexing with glass beads was one of the tested methods; the other 
one was the carbamide method. Carbamide is an abrasive substance and 
lysis was accomplished by grinding the cells with a pellet pestle on ice 
(materials and methods 2.4). When using glass beads, the lysis was 
performed by vortexing for 25 min, 5 min vortex and 2 min pause on ice.  
For both methods, the lysate was cleared by centrifugation and the 
supernatant was transferred to a new tube. A sample of input before lysis (In), 
pellet (P) and cleared lysate (C) were taken in order to determine which 
method was better to obtain CAT mRNA without degradation. Both 
experiments were done in parallel. For the quantification, the input from lysis 
was taken as 1.00 and the intensity of the other signals calculated with 
respect to 1.00 (Figure 12). 
 
Lysis using the glass beads method rendered 25% of the CAT mRNA present 
in the lysate (Figure 12b), whereas using carbamide, 34% of CAT mRNA 
present in the input was obtained (Figure 12a). The other 70% could still be 
bound to the carbamide, degraded or precipitated with the nuclear and debris 
fraction. Taken together these results, it was concluded that both methods are 
similar. It was decided to use the carbamide method because it requires less 
time to achieve lysis, therefore reducing the possibility of CAT mRNA 
degradation (Figure 12).  
 
 
 
Figure 12. Different lysis methods 
(a) Carbamide lysis (3x107 cells used).  
(b) Lysis with glass beads (3x107 cells used).   
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(a) and (b) are Northern blots 
rRNA, ribosomal RNA; CAT, chloramphenicol acetyltransferase mRNA; TUB, tubulin 
mRNA; In, input from lysis; P, pellet after the initial centrifugation; C, cleared lysate; 
TUB, tubulin mRNA; an abundant mRNA of approximately 2kb used as cytosolic 
loading control. 
 
Alternatively, lysis with an electric pistol was also tried. The results showed 
that lysis with a pistol was similar to lysing with detergents, i.e. no 
preservation of the glycosomal membranes. Using this method, the cells were 
lysed completely, represented by higher CAT activity in the supernatant than 
in the pellet, measured by CAT assay. 
3.2.2 Ultracentrifugation at 33,000 g separates cytosolic polyribosomes from 
the organellar fraction 
 
To further continue with the standardization of the method, different 
centrifugation conditions were assessed. Cells were lysed using carbamide as 
described above (results 3.2.1). Additionally, an initial centrifugation step was 
added to pellet the glycosomes, this pellet was then lysed with Triton-X to 
release the content of the glycosomes. The integrity of the glycosomes was 
measured by CAT assay, which determined the relative CAT activity in the 
samples.  
 
Initial ultracentrifugation at 17,000 g proved not to be enough to pellet all 
glycosomes. The relative CAT activity measured in the supernatant was 
higher than in the pellet, suggesting that there was more CAT protein in the 
supernatant (Figure 13a). Using 33,000 g was more effective in separating 
intact glycosomes, represented by a higher relative CAT activity in the pellet 
fraction, presumably containing the intact glycosomes (Figure 13b). 
Interestingly, it seemed to be more relative CAT activity in the pellet fraction 
than in the input in Figure 4b, this might be due to incomplete cell lysis in the 
input fraction, or perhaps the accumulation of CAT protein in the glycosomes 
(pellet) increases the signal.   
 
 
 
Figure 13. Centrifugation conditions tested  
(a) Centrifugation using 17,000 g. 
(b) Centrifugation using 33,000 g. 
The presence of CAT protein was detected by measuring the activity of the CAT 
enzyme present in the samples via CAT assay.  
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In, Input of lysis; P, pellet (organellar fraction); S, supernatant (cytosolic fraction, 
without organelles).   
 
Additionally, it was noticed that 6-8x108 cells were needed to obtain a 
detectable signal for the CAT mRNA in the cytosolic purification, using less 
cells made the detection by Northern blot difficult.  
 
Once the conditions for lysis (carbamide lysis), cell number (8x108 cells) and 
initial centrifugation (33,000 g) were decided, the next step was to determine 
the number of tags to use. In previous experiments, the purification of 
cytosolic polyribosomes was performed with cells expressing reporters that 
contained only one SBP. Despite the standardization, no CAT mRNA was 
detected in the beads by Northern blot. The experiment was repeated using 
different incubation times but there was no change in the results, maybe 
because the nascent peptide tag and the streptavidin beads were not 
interacting properly.  
3.3 Multi-tag purification of cytosolic polyribosomes  
 
The idea to change the number of tags was taken from a previously published 
article, where it was shown that the use of one SBP was not sufficient for 
protein detection using a streptavidin matrix [152]. N-terminal strep tags were 
fused to a model protein using the SQM protein (Stefin A Quadruple Mutant). 
Fusion proteins containing from 1 to 5 SBPs, separated by glycine linkers 
were tested. Busby et al showed that adding 3SBPs increased the binding to 
streptavidin 12-fold compared to a single strep-tag (Busby, Stadler et al. 
2010). Taking these results into consideration, it was decided to increase the 
amount of SBPs to three with glycine linkers separating the tags. With this 
strategy the multi-tag present at the 3’-end of the CAT when translated was 
30 amino acids long.  
3.3.1 Purification using 3SBPs was more efficient than using a single tag  
 
For these purifications only the number of SBPs was changed, the rest of the 
procedure remained the same. When using 3SBPs at the 3’-end of the CAT, 
less cells were needed for the detection of CAT by Northern blot, thus half the 
amount of cells was taken to purify cytosolic polyribosomes translating the 
reporters containing 3SBPs.  
 
3 x 108 cells were lysed with carbamide and the 3SBPs-CAT mRNA purified 
using magnetic beads. Samples of the input from polyribosomes (In pol), 
unbound fraction (UB) and beads (B) were taken for Northern blot. In case of 
In pol and UB, the same amount of sample was used for RNA extraction and 
loaded in the Northern blot. For the beads, 5 times more sample was taken. 
To quantify the amount of CAT mRNA obtained in the purification, the signal 
of input from polyribosomes was taken as 1,00 and the other signals 
calculated in respect to this one. Approximately 20% of CAT present in the 
polyribosomes was purified, although a signal for α-tubulin, TUBA was also 
detected, representing the presence of contaminants. With this purification, 
CAT was enriched 1.6-fold when compared with TUB (Figure 14). 
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Figure 14. Multi-tag purification of cytosolic polyribosomes 
Northern blot showing the amount of 3SBPs-CAT mRNA obtained from the cytosolic 
purification. Five times more sample was loaded for the beads (5x) and the same 
equivalent cell number taken for Input and unbound (1x). The ratio CAT versus TUB 
represents the enrichment of CAT in the samples. This experiment was repeated at 
least three times giving similar results. 
rRNA, ribosomal RNA; CAT, chloramphenicol acetyltransferase mRNA; TUB, tubulin 
mRNA; In pol, input from polyribosomes; UB, unbound; B, beads. 
3.4 Biotin was not sufficient to elute the purified cytosolic mRNPs 
 
As shown in Figure 14, there was still TUBA mRNA present in the purification. 
To reduce unspecific interactions, different types of streptavidin beads and 
biotin elution were tested (Figure 15). TUBA, was used as control for 
unspecifically purified contaminants.  
 
An experiment using sepharose and magnetic streptavidin coated beads was 
performed in parallel. In both cases, 6x108 cells were used for the purification. 
Elution with biotin was performed using 10mM biotin in the elution buffer 
(elution was done according to Qiagen protocol). To quantify the samples, the 
intensity of the signals were measured and compared to the signal of the input 
from polyribosomes (taken as 1.00). The ratio CAT versus TUB was used to 
determine the enrichment of CAT over TUB in the samples.  
 
Neither CAT nor TUB signals could be measured by Northern blot in the 
eluates of either magnetic or sepharose beads. When measuring the signal in 
the magnetic beads, 7% of the CAT present in the polyribosomes still remains 
in this fraction (Figure 15a). Using sepharose beads, stronger signal intensity 
for CAT in the beads was measured when compared to the magnetic beads 
(Figure 15b).  
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It appears that most of the CAT mRNA was still bound to the beads; the signal 
in both eluates could not be quantified. The elution with biotin was not efficient 
for any of the matrixes used.  
 
 
 
Figure 15. Elution using biotin 
(a) Purification using magnetic beads.  
(b) Purification using Sepharose beads.  
For quantification purposes, the input from polyribosomes was assumed to be the 
1.00. The ratio CAT/TUB determined the enrichment of CAT in the samples. 
rRNA, ribosomal RNA; CAT, chloramphenicol acetyltransferase mRNA; TUB, tubulin 
mRNA; In, input from polyribosomes; UB, unbound; W, wash; B, magnetic or 
sepharose beads; E, eluate. 
 
This experiment was repeated at least once more giving similar results.  
Additionally, the purification using sepharose beads was repeated and the 
eluate and beads were loaded onto a SDS-PAGE gel and silver staining was 
performed. In both cases, no bands were observed in the eluted fraction, only 
in the beads, corroborating the inefficiency of the elution with biotin maybe 
because of many proteins or other RNAs binding to the beads, blocking the 
interaction between biotin and the streptavidin present in the beads. 
3.5 CAT protein was mainly detected in the organellar fraction 
 
In order to measure the amount of CAT protein present in each step of the 
cytosolic purification a CAT assay was performed. In this assay 8x108 cells 
were lysed with carbamaide and the cleared lysate loaded onto a sucrose 
gradient. The polyribosome profile obtained is shown in Figure 16a 
representing a profile of cytosolic polyribosomes (not membrane bound 
polyribosomes). The polyribosomes, fractions 6-9, were pooled and the 
affinity purification using sepharose beads performed (Figure 16a). The 
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protein amount in each sample was measured by Bradford assay. For CAT 
assay, 0.5 µg of total protein was used. Samples from each step of the 
purification were taken (Figure 16b).  
 
Almost half of the CAT activity was detected in the pellet (P), which 
represents the intact glycosomes (organellar fraction). 25% was detected in 
the input from polyribosomes (In pol), corresponding to fractions 6 to 9 of the 
polyribosome profile and approximately, 7% of the CAT activity was detected 
in the eluate. This demonstrates that the mature CAT protein did not really 
represent a main contaminant in the samples and that this protein was 
partially separated from the cytosolic polyribosomes by the initial 
ultracentrifugation. Also by performing a polyribosomal fractionation the 
mature CAT protein was further separated from the sample, most of it was 
detected to be present in the protein peak fraction (Figure 16b). 
 
The results of the CAT assay showed that only a small percentage of the 
activity of the protein was still present in the eluate (Figure 16b), meaning that 
the step of sucrose gradient centrifugation was necessary to separate the 
mature CAT protein from the purification. Nevertheless, the amount of 
polyribosomes obtained did not allow the detection of CAT mRNA via 
Northern blot.  
 
  
 
Figure 16. Cytosolic polyribosome fractionation and CAT activity 
(a) Cytosolic polyribosome profile. Cells lysed with carbamide.  
(b) Relative CAT activity measure throughout the purification. 
This experiment was repeated twice with the same results.  
CAT, chloramphenicol acetyltransferase; In, input from lysis; P, pellet; Sp, 
supernatant (cytosolic polyribosomes); 40S and 60S, ribosomal subunits; 80S, 
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monosomes; In pol, input from polyribosomes (fractions 6 to 9); UB, unbound; W, 
wash; E, eluate.    
 
The cytosolic purification was repeated and the entire sample from the beads 
loaded onto an SDS-PAGE and stained with Colloidal Coomassie. 
Unfortunately, almost no proteins were observed with the Coomassie blue or 
silver staining. The main problem of the cytosolic purification was the lower 
yield obtained compared to other purifications (such as V5-pull down or TAP 
purification). The amount of material needed for mass spectrometry would 
have to be higher, at least to allow the visualization of stained proteins by 
Coomassie blue. For this reason, the step of separating cytosolic and 
membrane bound polyribosomes was omitted from further purifications. 
Instead, lysis with detergents was chosen although this implied the disruption 
of glycosomal membranes.  
3.6 Lysis with NP40 allowed the detection of the 3SBPs-CAT reporter 
 
To further standardize the technique, another purification was tried by lysing 
the cells with detergents. When lysing with detergents, the amount of mRNAs 
containing polyribosomes increased in comparison with the ones obtained in 
the cytosolic purification (compare figures 16a and 17a). The amount of highly 
translated mRNAs, represented as mRNAs containing several ribosomes, 
increased; noticed by the higher absorbance in the last sucrose fractions 
(compare figures 16a and 17a).  
 
In this case the affinity purification was performed using sepharose beads and 
cells were lysed with 0.01% of NP40. After performing the affinity purification, 
approximately 20% of the CAT present in the polyribosomes was purified; 
also 8-fold enrichment of CAT mRNA in comparison to other abundant 
mRNAs such as TUBA was measured (Figure 17b). The amount of abundant 
mRNAs such as TUBA, which bind unspecifically to the beads, was slightly 
reduced (compare Figure 15b and 17b). This purification was repeated and 
beads were loaded into an SDS-PAGE, this time there were protein bands 
visible after Coomassie blue staining and the samples were send to dimethyl-
labelled quantitative mass spectrometry (DL-MS). 
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Figure 17. Affinity purification using detergent 
(a) Polyribosome profile of cells lysed with 0.01% of NP40. 
(b) Affinity purification of pooled polyribosomes (fractions 6 to 9).  
The intensity of the signals was measured by taking the input from polyribosomes as 
1,00. The ratio CAT versus TUB was used to determine the enrichment of CAT over 
TUB present in the samples. 
rRNA, ribosomal RNA; CAT, chloramphenicol acetyltransferase mRNA; TUB, tubulin 
mRNA; In pol, input from polyribosomes; UB, unbound; W, wash and B, beads 
 
Since total polyribosomes were used for the affinity purification, the number of 
washes with high salt buffer (AP buffer) was increased to five; this seemed to 
reduce the unspecific binding of abundant mRNAs.  
 
Furthermore, two different polyribosomal buffers were tested (see material 
and methods section 2.5), one of them used 280mM NaCl (Schutz modified) 
and the second one used 120mM KCl (Kramer modified). Similar results were 
obtained using both buffers, meaning, that when performing the polyribosomal 
purification in both cases the 3SBP-CAT mRNA was detected to be bound to 
the matrix whereas the signal of the control reporter was not detectable by 
Northern blot. The main difference was that Kramers’ modified buffer seems 
to give a better resolution of the polyribosomal fractions, for this reason, it was 
chosen to work with the KCl buffer. 
3.7 Optimization of the amount of beads per purification 
 
In order to improve the purification efficiency, different amounts of beads were 
tested.  
 
The polyribosomes of three independent sucrose gradient centrifugations 
were pooled together, then separated into three affinity purifications and 
purified using different amount of beads (Figure 18a).  
 
The amount of CAT purified from the polyribosomes was similar using 50µl 
and 75µl of beads. Half of the CAT signal was detected by purifying with 25µl 
of beads compared to 50µl. Furthermore, when looking for abundant mRNAs 
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that can bind unspecifically to the beads, the signal for TUBA was lower with 
25µl of beads in comparison to 50µl or 75 µl of streptavidin sepharose beads.  
 
The ratio CAT versus TUB, representing the enrichment of CAT mRNA, was 
the same using 25µl and 50µl of beads, 30% of the CAT mRNA present in the 
polyribosomes was purified. In the case of the purification using 75 µl 25% of 
CAT was purified (Figure 18b).  
 
 
 
 
Figure 18. Different amounts of sepharose beads tested 
(a) Representative polyribosome profile. The polyribosomes of three independent 
gradients (approximately 7x108 each) were pooled to test the adequate number of 
beads necessary for the purification.  
(b) Northern blot of the three parallel affinity purifications. The signal of input from 
polyribosomes was taken as 100% and the intensity of the other signals compared to 
it.  
rRNA, ribosomal RNA; CAT, chloramphenicol acetyltransferase mRNA; TUB, tubulin 
mRNA; In pol, input from polyribosomes; UB, unbound; W, wash and B, beads (in 
bold). 
 
The conditions used for further purifications were as followed: 3-6x108 cells 
were collected for lysis with detergents and the clear lysate loaded onto a 
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sucrose gradient. The polyribosome fractions were pooled and specific 
mRNPs purified using 25µl of streptavidin coated sepharose beads. 
 
3.8 Measurement of 3SBPs-CAT mRNA molecules per cell 
 
After the optimization steps being done, the last step was to calculate the 
number of CAT mRNA molecules produced per cell because it gave an idea 
of the amount of mRNA available for translation, pull-down and purification.  
 
To determine the number of the 3SBPs-CAT molecules per cell, an in vitro 
transcription reaction was performed using a plasmid that encoded the CAT 
reporter gene under the control of a T7 promoter. The in vitro transcribed CAT 
was compared to the lysate of the in vivo 3SBPs-CAT reporter.  
 
For the quantification, serial dilutions of defined amounts of in vitro transcribed 
CAT mRNA in picomol were loaded (2-0.03pmol) in the formaldehyde gel and 
compared with distinct equivalent cell numbers of total RNA extracted from 
distinct equivalent numbers of cells expressing the 3SBPs-CAT mRNA. The 
difference in sizes of the CAT mRNAs were due to the lack of 5’-cap and the 
3’-poly(A) tail in the in vitro transcribed CAT (Figure19a). 
 
The intensity of the signals for the in vitro transcribed CAT gave the values of 
the standard curve and were compared to the quantification of the signals for 
an equivalent cell number of 6x106, 3x106, 1.5x106, 7.5x105 and 3.75x105 
(Figure 19a). This allowed the determination of 5.7fmol/μl of 3SBPs-CAT 
reporter mRNA in the sample, approximately 34.2x108 molecules.  
 
A total of 3x108 cells were lysed for this experiment, obtaining 17.4µg of total 
RNA from this amount of cells. In the Northern blot an equivalent of 6x106 
cells were loaded, corresponding to 8.7µg of total RNA.  
 
The calculations indicate that 3.4x109 molecules of 3SBP-CAT mRNA were 
present in 8.7µg of total RNA. Assuming that one trypanosome cell contains 
1.1pg of total RNA, it was calculated that the cells used for the affinity 
purification produced 429 molecules of 3SBPs-CAT mRNA per cell (Figure 
19b). This number is comparable to other multi-copy genes that produce 
abundant mRNAs, such as TUBA [48]. The reason behind this was that 
RNAPI transcribes the single copy 3SBP-CAT gene, whereas RNAPII 
transcribes TUBA and as it was previously been published, transcription by 
RNAPI produces 10-fold more protein than RNAPII [32]. 
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Figure 19. Number of 3SBPs-CAT mRNA per cell 
(a) Northern blot comparing the in vitro transcribed CAT mRNA, under the control of 
a T7 promoter (dilution series in picomol), with the in vivo 3SBPs-CAT mRNA, under 
the control of the polymerase I promoter (different equivalent cell numbers).  
(b) Calculation of the number of 3SBPs-CAT mRNA per cell. The in vitro CAT was 
used as standard. The standard curve was calculated from three samples of the 
serial dilutions and the signals detected from the in vivo experiment included. The 
calculation of RNA molecules was done taking in consideration that a single 
trypanosome cell contains 1.1pg of total RNA [48]. 
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3.9 Purification of the HSP70 3’-UTR reporter 
 
Validation of the method was done using a known RNA-protein interaction. It 
has previously been shown [107] that in trypanosomes, the zinc finger protein, 
ZC3H11 binds to an AU-rich element present in the HSP70 3’-UTR. This 
interaction stabilizes the mRNA upon heat shock. 
 
Therefore, stable cell lines expressing an endogenous V5-tagged ZC3H11 
were transfected with reporters containing the HSP70 3’-UTR or the reporter 
containing the HSP70 3’-UTR without the AU-rich element.  
3.9.1 Heat shock at 39°C allows the purification of the HSP70 3’-UTR reporter 
and detection of ZC3H11 
 
As a first step it was necessary to determine the heat shock conditions for 
these purifications. Heat shock was necessary because the ZC3H11 protein is 
only expressed in detectable levels under stress. Another important criteria 
was to heat shock the cells using a temperature that allows the purification, 
meaning when polyribosomes do not disassemble completely.  
 
For this experiment, an exponentially growing culture of procyclic 
trypanosomes was divided in four parts to test the different heat shock 
conditions. It is important to mention that, procyclic form trypanosomes are 
grown in culture conditions at 27°C. The polyribosome profiles show the effect 
that a change of only two degree Celsius has on translation (Figure 20). 
 
According to the heat shock experiments, it appears that at 37°C (Figure 20b) 
the polyribosomes of procyclic trypanosomes were similar to cells without 
treatment (27°C), only a slight reduction of polyribosomes was observed 
when comparing to standard culture conditions. Furthermore, when using 
37°C the V5-ZC3H11 protein was barely detectable by Western blot after the 
affinity purification (data not shown).  
 
When using 41°C (Figure 20d), almost all the polyribosomes were 
disassembled, the reduction observed was similar to cells treated with 
RNases.  
 
The best condition was heat shock at 39°C (Figure 20c), the effect on 
translation was clear, the polyribosomes disassembled (fractions 6-9) and the 
monosomes increased (fractions 4-5). Nevertheless, there were still 
polyribosomes present to perform the pull down and the V5-ZC3H11 protein 
was detectable by Western blot. For this reason, heat shock at 39°C was 
chosen for further heat shock experiments. 
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Figure 20. Polyribosome profiles in culture and heat shock conditions 
(a) Polyribosome profile of untreated cells. Normally procyclic form trypanosomes are 
cultured at 27°C. 
(b) Heat shock using 37°C for 1 hour.  
(c) Heat shock at 39°C for 1 hour. 
(d) Heat shock at 41°C for 1 hour. 
Pp, protein peak; 40S, ribosomal subunit 40S; 60S/80S, ribosomal subunit 60S and 
monosomes 80S (the peak for these fractions could not always be separated). 
 
Additionally, the presence of the 3SBP-CAT-HSP70 3’-UTR mRNA was 
detected by polyribosomal fractionation. Upon 1 hour heat shock at 39°C, the 
reporter mRNA remained in the polyribosomal fractions and it seems to be 
evenly distributed among the higher sucrose fractions (8-11, Figure 21).  
As loading control, the ribosomal bands of the rRNA are shown (methylene 
blue staining), indicating that the polyribosomes, corresponding to fractions 8 
to 11, were equally loaded.  
 
An additional control was the HSP70 mRNA that is stable upon heat shock. 
The signal of the HSP70 mRNA was more abundant in the higher sucrose 
fractions (10-11), characteristic of a highly translated mRNA, multiple 
ribosomes associated to this necessary mRNA upon heat shock. Its pattern 
was different to the one exhibit by the CAT mRNA, despite the fact that both 
mRNAs contained the same 3’-UTR (Figure 21b), maybe because the HSP70 
mRNA is approximately 2.8Kb and the CAT 1.5Kb. 
Also it was noticed that the CAT mRNA was distributed equally throughout the 
polyribosomal fractions, maybe because the 5’-UTR of the reporter is different 
(EP 5’-UTR). The advantage of this distribution is that, at least in theory, this 
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can allow the purification of proteins that are bound initially to the translating 
mRNPs and of proteins that are recruited later on during translation. 
 
 
 
Figure 21. Distribution of the HSP70 reporter in the polysomal gradient 
(a) Polyribosome profile of the cell line expressing the HSP70 reporter. 6x108 cells 
were heat shocked for 1 hour at 39°C 
(b) Northern blot showing the distribution of the reporter. As heat shock control, the 
pattern of HSP70 mRNA is shown. Ratio CAT/HSP70 was shown as a reference of 
the different translation patterns of the mRNAs throughout the sucrose gradient.  
Pp, protein peak (fractions 2-3); 40S, ribosomal subunit 40S (fraction 4); 60S/80S, 
ribosomal subunit 60S and monosomes 80S (fractions 5-6); rRNA, ribosomal RNA; 
CAT, chloramphenicol acetyltransferase reporter mRNA (contains the 3SBPs and the 
HSP70 3’-UTR); HSP70, heat shock protein 70 mRNA; In, input from lysis (2x107 
cells used for RNA extraction). 
3.9.2 ZC3H11 co-purified with the HSP70 3’-UTR reporter  
 
To validate the technique, the detection of proteins bound to the HSP70 
mRNA was necessary. This includes proteins that bind directly to the mRNA, 
like ZC3H11 [107] and also proteins that do not bind directly to the mRNA, 
such as MKT1 [108]. For this experiment, 4 cell lines were generated; two 
expressing the tagged proteins of interest, V5-ZC3H11 and V5-MKT1. Each of 
them was transfected with the 3SBPs-CAT-HSP70 3’-UTR reporter. In parallel 
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cell lines expressing the 3SBPs-CAT-HSP70 AUU-del reporter were 
generated. 
 
The cell lines used were: 
1. V5-ZC3H11 transfected with 3SBPs-CAT-HSP70 3’-UTR reporter 
2. V5-MKT1 transfected with 3SBPs-CAT-HSP70 3’-UTR reporter 
3. V5-ZC3H11 transfected with 3SBPs-CAT-HSP70 AUU-del control reporter 
4. V5-MKT1 transfected with 3SBPs-CAT-HSP70 AUU-del control reporter 
 
The conditions established were as follows: Heat shock the cells for 1 hour at 
39°C then proceed with the UV cross-linking of RNA-protein complexes in 
order to detect the protein by Western bot. Addition of cycloheximide and 
ultracentrifugation of the cleared lysate to obtain the polyribosomes. As a final 
step the polyribosomes were pooled and affinity purification performed (Figure 
11). All procedures were done on ice and as fast as possible to avoid 
recovery of the cells from heat shock, as the published estimated time of 
recovery was 30 min [163]. 
 
The affinity purifications for each V5-tagged protein was performed in parallel, 
using cells translating the mRNA containing the complete HSP70 3’-UTR and 
the deleted version. Note that both reporters can bind to the streptavidin 
beads because both contained the 3SBPs (Figure 22a). Prior to the extraction 
of RNA samples for Northern blot; Proteinase K treatment was necessary 
(material and methods 2.5). Northern blots were used in order to confirm that 
the pull downs worked.  
Northern blots using the cell line with the V5-ZC3H11 were repeated more 
than 3 times obtaining the same results, meaning that both reporters were 
bound to the beads.  
The pull down using a cell line expressing V5-MKT1 was repeated three times 
but only in one of them the CAT signal was detected for both reporters by 
Northern blot (Figure 22c). The quantitation of this blot was done taking the 
unbound as 1.00 because the signal for the input seem to be degraded and 
cannot be consider as 100%, in the purification with the deletion. In the other 
Northern blots no CAT signal was detected, probably because there was not 
enough RNA extracted from the sample, since most of it was used for the 
Western blot (Figure 22b and c).  
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Figure 22. Pulling down the CAT-HSP70 reporters using the affinity purification 
method 
(a) Schematic representation of the reporters used for the purification. The control 
reporter has a deletion of the AU rich element present in the HSP70 3’-UTR. Both 
reporters were able to bind to the matrix.  
(b) Northern blot of the affinity purification in V5-ZC3H11 cell line. The signal for CAT 
mRNA was present in both purifications. 
(c) Northern blot of the affinity purification in V5-MKT1 cell line. The signal for CAT 
mRNA was detected in both purifications. The unbound was taken as 1.00 to 
measure the CAT mRNA signal. 
In the Northern blots HSP70 mRNA was used as loading control.  
3SBPs, three streptavidin binding proteins; CAT, chloramphenicol acetyl-transferase; 
ZC3H11, zinc finger protein 11; MKT-1, maintenance of k2 killer toxin; PABP, poly A 
binding protein, binding protein; HSP70, heat shock protein 70; In, input from lysis; In 
pol, input from polyribosomes; UB, unbound; W, wash; B, beads. 
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Among the proteins of interest was V5-ZC3H11, which, as previously 
published [107], binds directly to the mRNA via the AU-rich element present in 
the HSP70 3’-UTR, when this AU-rich element was not present, then ZC3H11 
was not able to bind its target mRNA.  
 
Figure 23b showed that ZC3H11 was enriched 26-fold in the purification using 
the complete HSP70 3’-UTR reporter, whereas, it is impossible to quantify in 
the purification with the AU rich element deleted. This experiment was 
repeated at least three times and in all the experiments V5-ZC3H11 was 
enriched (2 to 5-fold) in the purifications containing the complete HSP70 3’-
UTR when comparing with the deleted one. 
 
In the case of MKT1, this protein was found to be enriched 4-fold in the 
purification containing the complete HSP70 3’-UTR (Figure 23c). This 
experiment was repeated four times and in all replicates MKT1 was enriched 
between 4.7-1.3 fold in the complete HSP70 3’-UTR purification compared to 
the deleted HSP70 3’-UTR purification. 
 
  
73 
 
 
Figure 23.  Proteins bound to HSP70 3’-UTR detected by the affinity purification 
method 
(a) Schematic representation of the reporters used for the HSP70 3’-UTR 
purifications. As in Figure 22a both reporters contained the 3SBPs and were able to 
bind to the matrix.  
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(b) Western blot comparing both HSP70 purifications using the cell line expressing 
V5-ZC3H11. For the beads forty times more sample was loaded in comparison to 
input polyribosomes and unbound.  
(c) Western blot in order to detect the co-purification of V5-MKT1 and the HSP70 3’-
UTR reporters. 5x106 cells were loaded for input from polyribosomes, 3x108 for the 
unbound, and for the beads the approximate number of 1x109 cells was loaded.  
As controls trypanothione reductase (TR) and the ribosomal protein S9 were used, 
TR is not associated with polyribosomes whereas S9 is part of the ribosome. 
3SBPs, three streptavidin binding proteins; CAT, chloramphenicol acetyl-transferase; 
ZC3H11, zinc finger protein 11 or V5-ZC3H11 (V5-tagged protein); MKT-1, 
maintenance of k2 killer toxin or V5-MKT1 (V5-tagged protein); HSP, heat shock 
protein; In, input from lysis; In pol, input from polyribosomes; UB, unbound; W, wash; 
B, beads. 
 
The purification corresponding to the complete HSP70 3’-UTR, showed in 
Figure 23b, was send to MS, the gel was cut into 3 gel pieces, named 4-6. 
The aim was to detect the proteins bound to this 3’-UTR and specifically 
peptides from the V5-ZC3H11 protein. Previous attempts to detect this protein 
by MS and DL-QMS were done in our laboratory, but the protein is highly 
phosphorylated making its detection a challenge.  
 
Table 2 shows a list of the proteins that co-purify with the HSP70 3’-UTR, 
among them; many RBPs were found as well as proteins of the degradation 
machinery and translation factors. Interestingly, peptides for MKT1 were not 
found and only one single modified peptide for V5-ZC3H11 was detected. The 
reason why no peptides were detected for MKT1 could be the fact that 
approximately 140 times more of sample was used to detect this protein by 
Western blot in the purification (Figure 14c) and the peptides from this protein 
could be masked by peptides from other abundant proteins such as ribosomal 
and mitochondrial peptides whereas in the Western blot the V5-antibody is 
very efficient and sensitive. This could also be the case for V5-ZC3H11.   
 
Table 2. Proteins that co-purify with the HSP70 3’-UTR 
List of selected candidate proteins detected in the purification with the complete 
HSP70 3’-UTR. The sample was cut in 3 pieces (numbers 4 to 6), the number of 
peptides for each protein is depicted on the table for each gel piece. 
 
Gene number Proteins found Category 
Number of unique 
peptides  
1 2 3 
Tb927.10.240 PEX14 peroxin 14 
Glycosome 
biogenesis 
0 0 2 
Tb927.9.8740 DRBD3 (PTB1) RNA binding 0 0 2 
Tb927.7.2670 ZC3H21 RNA binding 0 0 6 
Tb927.10.14950 ZC3H40 RNA binding 0 3 0 
Tb927.11.14100 DRBD4 (PTB2) RNA binding 2 0 0 
Tb927.10.4430 PUF1 RNA binding 8 0 0 
Tb927.10.11760 PUF6 RNA binding 2 0 0 
Tb927.11.510 UBP2 RNA binding 2 0 2 
Tb927.11.1980 ZC3H41 RNA binding 7 5 0 
Tb927.10.3990 DHH1  RNA degradation 0 0 3 
Tb927.10.8720 NOT10 RNA degradation 0 7 0 
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Tb927.10.6630 
ATP-dependent 
DEAD/H RNA 
helicase HEL64, 
putative (cytosolic) 
RNA helicase 6 0 0 
Tb927.10.4640 eIF-3 subunit L Translation 0 0 3 
Tb927.6.1870 eIF4E4 Translation 0 0 4 
Tb927.6.4370 
eIF3 subunit 7-like 
protein 
Translation 0 4 0 
Tb927.10.2090 
EF1-alpha elongation 
factor 1-alpha, 
(TEF1) 
Translation 2 0 0 
Tb927.9.9290 PABP1 Translation 10 0 0 
Tb927.10.2100 
EF1-alpha elongation 
factor 1-alpha, 
(TEF1) 
Translation 0 6 19 
Tb927.11.1900 
T-complex protein 1, 
beta subunit, putative 
(TCP-1-beta) 
Translation 0 32 3 
Tb927.10.14550 
DED1-1, ATP-
dependent DEAD/H 
RNA helicase, 
Translation 9 5 3 
Tb927.9.10770 PABP2 Translation 26 20 22 
 
The co-purification of HSP70 3’-UTR with ZC3H11 validate the technique. It 
showed that the purification of specific mRNPs and detection of proteins 
bound to these mRNPs was possible, at least by Western blot. 
3.10 DRBD3 co-purified with the AATP11 3’-UTR reporters 
 
The affinity purification method allows the exchange of almost all the 
components of the reporters used. Therefore, as another proof of principle, 
the 3’-UTR of HSP70 was changed for the amino acid transporter 11 
(AATP11) 3’-UTR, to proof another known protein-mRNA interaction.  
 
As shown previously, the RNA binding protein DRBD3 (also known as PTB1, 
Tb927.9.8740) binds and stabilizes the AATP11 mRNA [79, 80]. It has also 
been proposed that a region between 290 and 618 (328bp) in the AATP11 3’-
UTR contains regulatory elements that are involved in DRBD3 binding to its 
target mRNA [79, 174].  
 
The affinity purification technique was used to confirm the interaction between 
DRBD3 and the AATP11 3’-UTR. Two different CAT reporters were 
generated, one containing the complete AATP11 3’-UTR and another with a 
328 nucleotide deletion (290-618 region deleted). Both reporters contained 
the 3SBPs at the 5’ of the CAT open reading frame (Figure 24a). 
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Figure 24. Co-purification of the AATP11 3’-UTR reporters and DRBD3 
(a) Schematic representation of the reporters used in this experiment. Both reporters 
contained the multi-tag. The control reporter had a 328 nucleotide deletion in the 
AATP11 3’-UTR.  
(b) Northern blot of the affinity purification, both reporters bind to the beads. The 
AATP11 mRNA has two different polyadenylation sites; therefore there were two 
bands for the CAT mRNAs. The CAT- AATP11 reporters were 1.9 Kb and 1.8 Kb 
whereas the control reporters were 1.7 Kb and 1.6 Kb. From the lysis input 5x106 
cells were used for Northern blot, in case of In pol, UB and W, approximately 1.5x107 
cells were loaded and for the beads 4.5x107 cells. SRP was used as loading control; 
the size of this structural RNA is approximately 0.25 Kb. 
  
77 
(c) Western blot showing the co-purification of DRBD3 and the AATP11 3’-UTR 
reporters. The Western blot was performed using and antibody against DRBD3 
(kindly provided by Antonio Estevez). Input from lysis contained 5x106 cells, In pol 
and UB, an approximately of 1.5x107 cells and the beads 2x109 cells. 
3SBPs, three streptavidin binding proteins; CAT, chloramphenicol acetyl-transferase; 
SRP, signal recognition particle, an structural RNA; AATP11, amino acid transporter 
11; UTR, untranslated region; DRBD3, RNA binding protein; S9, ribosomal protein 
S9; In, input from lysis; In pol, input from polyribosomes; UB, unbound; W, wash; B, 
beads.  
 
Both reporters could be detected in the beads because both of them contain 
the 3SBPs. The AATP11 3’-UTR presents a second polyadenylation site as 
previously reported [174]. Interestingly, DRBD3 binds to the reporter 
containing the complete AATP11 3’-UTR as well as to the one carrying the 
328mer deletion (Figure 24c). It should be noted that the RNA-protein 
complexes were UV cross-linked prior to the purification and that DRBD3 is 
an abundant protein that binds to many mRNAs [79] and it was expected to 
unspecifically bind to the beads. This experiment was done only once, 
nevertheless it showed that DRBD3 was 2.4-fold enriched in the complete 
AATP11 3’-UTR purification compared to the deleted one.  
3.11 Purification of the EP 3’-UTR reporters and detection of the proteins 
bound 
 
In parallel to the AATP11 purifications, work on the EP1 3’-UTR was carried 
out. So far, no trans-acting factors have been identified to dictate the fate of 
the EP1 procyclin mRNA. The EP1 mRNA is developmentally regulated, 
meaning that this mRNA accumulates (is 10-folds higher) in procyclic forms 
compared to the bloodstream form trypanosomes and its regulatory regions 
are present mainly on the 3’-UTR [63, 175]. The EP1 3’-UTR is composed of 
three stem-loops containing two positive regulatory elements (LI and LIII) and 
one negative (LII), the LI regulatory element is present on the first 40 bases; 
the LIII has a 16mer region that enhances translation while its deletion 
decreases the mRNA-polyribosome complexes [58, 64, 67, 68]. On the other 
hand, the 26mer element present in LII is involved in rapid degradation of the 
mRNA and reduces its steady state levels [65].   
 
To detect the proteins bound to the EP1 3’-UTR, affinity purifications using the 
3SBPs-CAT reporter containing the EP–UTRs were performed. The affinity 
purifications were done, as described previously, by pooling the translating 
3SBPs-CAT-EP polyribosomes and incubating them with the streptavidin 
beads. Samples of the 3SBPs-CAT-EP and control purifications (reporter 
without 3SBPs) were sent to mass-spectrometry.  
 
Four independent affinity purifications were done for the reporter containing 
the 3SBPs-CAT-EP-UTRs and for the control reporter (Figure 25a). To ensure 
that the CAT reporters were pulled down, samples for Northern blot were 
taken (Figure 25b) and the rest (corresponding to an equivalent cell number of 
3x108 cells) was sent for DL-QMS.  
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The EP purification performed showed that approximately 7% of the CAT 
present in the polyribosomes was purified using this method. The signal for 
tubulin was barely measurable, which indicates that there were few mRNA 
contaminants in the sample. Also, when measuring the ratio between the two 
mRNAs, a 7-fold increase of CAT versus tubulin was observed (Figure 25b).  
 
In the case of the control purification, the signals were barely detectable. A 
signal for tubulin in the wash and beads fraction was observed, but in the 
case of CAT, no signal was detected, even when over-exposure was done for 
3 days (Figure 25b). This experiment was repeated more than 3 times with 
similar results. The samples presented in Figure 25 were the ones send to 
DL-QMS. 
 
  
 
Figure 25: Affinity purification of the EP 3’UTR reporters  
(a) Schematic representation of the reporters used in these purifications. Both 
reporters contain the same ORF [124], 5’ and 3’-UTRs from EP. The control reporter 
does not contain the 3SBPs.  
(b) Northern blot showing the binding of the CAT reporters to the beads. Only the 
mRNA containing the multi-tag (1.5Kb) was able to bind to the beads, but not the 
control one (1.3Kb). Tubulin (1.8Kb) was used as loading control and to assess the 
purity of the purification. For input from polyribosomes and unbound the equivalent of 
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6 x107 cells were taken. In the case of the beads, approximately 8x107 cells were 
used for Northern blot. 
3SBPs, three streptavidin binding proteins; ORF, open reading frame; CAT, 
chloramphenicol acetyl-transferase; TUB, tubulin mRNA; EP, glutamic acid and 
proline procyclin protein, the major surface protein on procyclic trypanosomes; rRNA, 
ribosomal RNA; In, input from lysis; In pol, input from polyribosomes; UB, unbound; 
W, wash; B, beads. 
 
The results obtained from DL-QMS revealed not only translation factors and 
ribosomal proteins, but also proteins of the degradation machinery such as 
XRNA and NOT1, and other proteins associated with mRNPs. Interestingly, 
peptides corresponding to a CCCH zinc-finger protein that has not been 
detected before in other purifications, ZC3H22 were also detected (Table 3). 
 
Table 3. Proteins co-purifying with the EP 3’-UTR reporter 
This table shows selected candidate proteins detected by DL-QMS. The enrichment 
was determined by comparing the peptides found in the multi-tag purification with the 
ones found in the control purification (same reporter without the 3SBPs). The 
coverage represents the percentage covered by the detected peptides in terms of the 
length of the protein.  
DHH1, dead box protein 1, an ATP dependent RNA helicase; MKT1, maintenance of 
K2 killer toxin; NOT1, negative on TATA 1, a protein component of the degradation 
machinery; XRNA, 5’-3’ exoribonuclease; RBP42, RNA binding protein 42; DRBD3, 
an RNA binding protein; PUF1, pumilio-fem-3-binding factor and RNA binding 
protein; ZC3H22, Zinc finger protein 22.   
 
Gene number Proteins found Category Enrichment 
Coverage 
(in %) 
Tb927.10.3990 DHH1  
RNA 
degradation 
26 14 
Tb927.6.4770 MKT1 
RNA 
metabolism 
5 5 
Tb927.10.1510 NOT1  
RNA 
degradation 
3 3 
Tb927.7.4900 XRNA 
RNA 
degradation 
147 4 
Tb927.6.4440 RBP42 
RNA 
binding 
3 33 
Tb927.9.8740 DRBD3 
RNA 
binding 
84 7 
Tb927.10.4430 PUF1 
RNA 
binding 
66 4 
Tb927.7.2680 ZC3H22 
RNA 
binding 
3 12 
 
Large-scale purifications of the reporters containing the EP 3’-UTR were sent 
once more to DL-QMS. Due to the long time required to process the samples 
in the MS facility, it was decided to start studying some of the proteins 
obtained in the first trial (for instance, ZC3H22) and to generate the 
corresponding cell lines to confirm the results obtained.  
 
The EP-big scale purifications were repeated two times more with and without 
cross-linking but only few proteins were detected by DL-QMS, most of them 
being abundant proteins that bind unspecifically to the beads. Additionally, it is 
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important to mention that when using DL-QMS, the sample was diluted 
because it had to be mixed with the control one compromising the detection of 
underrepresented proteins, such as peptides belonging to RBPs. Therefore it 
was decided not to continue processing the samples using DL-QMS. 
 
Further purifications of the CAT-EP 3’UTR reporters were performed without 
cross-linking. Four replicate samples were sent to the Mass Spectrometry 
Facility University of Dundee. Northern blot results confirmed that the pull 
down was performed correctly (Figure 25b). The results of MS are listed in 
table 4. Most of the hits were hypothetical proteins and contaminants, such as 
tubulin, mitochondrial and nuclear proteins (supplementary table 3).  
Only two RBPs were identified, ZC3H13 and ZC3H21. In the case of ZC3H13, 
a cell line expressing a V5-tagged protein was created and the affinity 
purification method was used in order to determine if V5-ZC3H13 co-purifies 
with the 3SBPs-CAT-EP 3’-UTR reporter. A signal for V5-ZC3H13 was 
detected in both, the 3SBPs-CAT-EP 3’-UTR and the control purification 
(without the tags). Although, V5-ZC3H13 was found to be 6.8-fold enriched in 
the 3SBP-CAT purification compared to the control. Unfortunately, the protein 
controls such as the ribosomal protein S9 or the initiation factor eIF4G3 were 
not detected by Western blot, probably because of blotting problems (data not 
shown). Furthermore, this experiment was only done once; therefore the 
repetition of this purification might be of use.  
 
Table 4. Proteins that co-purified with the EP 3’UTR reporters 
Results of four replicates sent to MS. The control reporter did not contain the 3SBPs 
and therefore was not able to bind to the streptavidin beads.  
The ratio of peptides corresponding to a specific gene present in the 3SBP-EP 3’-
UTR purification was compared to the counts in the control sample (no SBPs) for 
each replicate. The table includes a list of genes that had 2-fold increase for at least 
two independent replicates. The replicates were arranged accordingly to the highest 
ratio.  
Accession Description 
Replicates  
(ratio 3SBPs/no SBP) 
1 2 3 4 
Tb927.1.2400 alpha tubulin 34,0 30,0 1,2 1,0 
Tb927.1.2390 beta tubulin 29,0 28,0 1,0 1,0 
Tb927.3.1010 
hypothetical protein, 
Trypanosoma-specific 
9,0 1,0 3,0 1,0 
Tb927.3.3300 hypothetical protein 2,0 1,0 8,0 0,3 
Tb927.9.8820 hypothetical protein 7,0 0,7 3,0 0,4 
Tb927.9.12200 60S ribosomal protein L31 6,0 5,0 1,0 1,7 
Tb927.5.2530 hypothetical protein 3,0 1,0 6,0 1,0 
Tb927.9.6920 hypothetical protein 3,0 1,0 5,0 1,0 
Tb927.11.9080 hypothetical protein 4,0 1,0 5,0 1,0 
Tb927.11.510 UBP2 5,0 4,0 0,8 1,3 
Tb927.3.2050 hypothetical protein 5,0 1,0 2,0 0,3 
Tb927.3.3150 hypothetical protein 5,0 1,0 3,0 0,2 
Tb927.7.4500 hypothetical protein 5,0 5,0 2,3 0,1 
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3.12 MKT1 does not interact specifically with the 3SBPs-CAT-EP reporter  
 
In order to confirm the results from MS (Table 3), the affinity purifications were 
repeated using cell lines expressing a V5-tagged MKT1 and the EP reporters 
(Figure 26a).  
 
The Northern blot shows that the pull down was successful, by a slight signal 
for CAT present only on the 3SBPs mRNA (Figure 26b).  
 
The Western blot showed that the V5-MKT1 protein co-purifies with both CAT 
reporters. MKT1 is an abundant protein that binds to PBP, present in all 
mRNAs with a polyA binding protein [108], therefore it was possible that 
MKT1 interacted unspecifically with the beads (Figure 26c). This experiment 
was repeated twice and in both cases the V5-MKT1 signal was found in both 
purifications (with and without the multi-tags). Nevertheless, for both 
experiments there was more MKT1 in the purification with the 3SBPs, 
approximately 2-fold and 3.6-fold increased per replicate, when compared to 
the control purification.   
In Figure26c, the unbound was taken as 1.00 for the quantitation because 
there was not signal detected in the input of the 3SBP-EP purification. 
Tb927.6.2010 hypothetical protein 4,7 1,0 2,5 0,3 
Tb927.10.1100 60S ribosomal protein L9 4,0 1,0 1,0 2,0 
Tb927.3.3460 hypothetical protein  4,0 1,0 3,0 1,0 
Tb927.10.8270 eIF3 subunit 8, putative 4,0 1,0 3,0 1,0 
Tb927.10.14700 hypothetical protein 1,0 1,0 4,0 3,0 
Tb927.7.5340 hypothetical protein 3,0 1,0 4,0 1,0 
Tb927.5.1580 ZC3H13 1,8 4,0 3,0 1,0 
Tb927.11.2600 hypothetical protein 3,0 1,0 4,0 0,3 
Tb927.7.3550 hypothetical protein 2,0 1,0 4,0 0,3 
Tb927.6.4320 hypothetical protein 3,5 1,0 2,3 0,4 
Tb927.7.2670 ZC3H21 2,3 1,0 3,3 0,3 
Tb927.9.8070 60S ribosomal protein L10 2,2 1,0 3,0 1,8 
Tb927.11.9570 hypothetical protein 3,0 1,0 3,0 1,0 
Tb927.3.4580 hypothetical protein 3,0 1,0 3,0 0,3 
Tb927.11.9780 hypothetical protein 3,0 0,3 2,7 0,3 
Tb927.6.5070 hypothetical protein 3,0 1,0 2,2 0,3 
Tb927.8.1270 hypothetical protein 2,0 0,3 2,7 0,3 
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Figure 26. Co-purification of V5-MKT1 with both EP reporters 
(a) Schematic representation of the purified reporters. The purifications were made in 
stable cell lines expressing the V5-tagged MKT1 protein. Both reporters contain the 
EP 5’ and 3’-UTRs, but the control reporter does not contain the 3SBPs. 
(b) Detection of the EP reporters by Northern blot. The signal for TUB (1.8Kb) was 
used as loading control and control of contamination. For the CAT mRNAs the sizes 
were 1.5Kb (multi-tag) and 1.3Kb (control reporter). 
(c) Co-purification of V5-MKT1 and the EP reporters by Western blot. Equal amount 
of sample was loaded for In pol and UB; 153 times more sample was loaded for the 
beads.  
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3SBPs, three streptavidin binding proteins; CAT, chloramphenicol acetyl-transferase; 
TUB, tubulin mRNA; EP, glutamic acid and proline procyclin, the major surface 
protein on procyclic trypanosomes; UTR, untranslated region; MKT1, maintenance of 
K2 killer toxin protein; S9, ribosomal protein S9; In, input from lysis; In pol, input from 
polyribosomes; UB, unbound; W, wash; B, beads. 
 
3.13 ZC3H22 does not interact specifically with the 3SBP-CAT-EP reporter 
 
Stable cell lines were generated in order to assess the interaction between 
ZC3H22 and the EP 3’-UTR reporter. The purification of the cell line 
expressing V5-tagged ZC3H22 and the 3SBP-CAT-EP 3’-UTR was compared 
with the control purification, a cell line expressing the V5-ZC3H22 protein and 
the CAT reporter without the 3SBPs (Figure 27a).  
 
The Northern blot results showed only a slight signal detected for the CAT 
mRNA in the multi-tag cell line and none for the control purification (Figure 
27b). Indicating that the 3SBP reporter binds to the beads whereas the one 
without did not.  
 
In the Western blot, the signal for V5-ZC3H22 was found in both purifications, 
implying that the binding of this protein was not specific for the reporter 
containing the 3SBPs-CAT-EP-UTRs. It could be that this protein binds 
unspecifically to the beads. The ribosomal protein S9 was used as a loading 
control. Furthermore, there were three bands detected for V5-ZC3H22, 
meaning that the protein is subjected to post-translational modifications, such 
as phosphorylation (Figure 27c).   
 
This experiment was repeated two times, but only in one of the replicates the 
signal for CAT mRNA was detected in the Northern blots, in the other one the 
amount of mRNA was not enough for the detection and the signals for the 
beads in the Western blot were barely detectable. In the experiment shown in 
Figure 27c, it seems that V5-ZC3H22 is 2.4-fold more in the multi-tag 
purification than in the control one.    
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Figure 27. V5-ZC3H22 co-purified with both EP reporters 
(a) Schematic representation of the reporters used in the purification. The 
purifications were made in stable cell lines expressing the V5-tagged ZC3H22 
protein. Both reporters contain the EP UTRs, but the control reporter does not 
contain the multi-tag. 
(b) Detection of the EP reporters by Northern blot. TUB (1.8Kb) was used as loading 
control. The sizes for the CAT mRNAs were 1.5Kb (reporter with the 3SBPs) and 
1.3Kb (control reporter) 
(c) Co-purification of V5-ZC3H22 with both EP reporters.  
3SBPs, three streptavidin binding proteins; CAT, chloramphenicol acetyl-transferase 
mRNA; TUB, tubulin mRNA; EP, glutamic acid and proline procyclin protein; UTR, 
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untranslated region; ZC3H22, zinc finger protein 22; S9, ribosomal protein S9; In, 
input from lysis; In pol, input from polyribosomes; UB, unbound; W, wash; B, beads. 
3.14 Zinc Finger Protein 22 (ZC3H22) 
 
The gene of the zinc finger protein 22 (Tb427.07.2680) is part of the 
transcription unit where two other zinc finger proteins are present 
(Tb427.07.2660, ZC3H20 and Tb427.07.2670, ZC3H21). Both, ZC3H21 and 
ZC3H20 presented a growth defect phenotype on procyclic form 
trypanosomes upon knock-down and overexpression respectively [106].  
 
So far, TbZC3H22 has not been characterized and it has not been found in 
any other purifications. According to the transcriptomes obtained by RNA 
sequencing published in www.tritrypdb.org [176], many reads aligning to a 
long stretch of the gene were detected, indicating that probably the 3’-UTR is 
shorter than predicted (Figure 28a). Also, the predicted poly(A) sites seem to 
be in the wrong position. The 77 KDa protein contains two CCCH zinc finger 
domains.  
 
The main reason why it was decided to work with this protein was because it 
was found by quantitative mass spectrometry in one of the affinity purifications 
using the reporters expressing the EP 3’-UTR (Table 3).  
 
The present work on ZC3H22 started while waiting for the mass spectrometry 
results (EP replicates) and was done before obtaining the stable cell lines 
expressing the CAT-EP reporters to confirm the results obtained by DL-QMS 
(Table 3) and before obtaining the results of Figure 27. Therefore, at that time, 
it was thought that this protein might be involved in EP mRNA regulation.  
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Figure 28.  TbZC3H22 transcription unit 
The TbZC3H22 is located in the same transcription unit as TbZC3H20 and 
TbZC3H21 (source www.tritrypdb.org). The figure shows the predicted 
polyadenylation sites and the RNAseq coverage of the different reads obtained for 
the genes of this transcription unit. 
3.14.1 The V5-ZC3H22 protein localizes in the cytoplasm 
 
Immunofluorescence was performed in cells expressing the V5-tagged 
ZC3H22 and compared with wild type cells. DAPI was used as nuclear and 
kinetoplast staining. The DIC pictures showed the integrity of the 
trypanosomes. These results showed that V5-ZC3H22 localizes mainly in the 
cytoplasm (Figure 29). The dots in the V5-ZC3H22 could be an artifact of the 
V5-antibody, or some precipitation due to the fixation with paraformaldehyde.  
 
 
 
 
Figure 29. Localization of ZC3H22 
Immunofluorescence of cells expressing V5-ZC3H22, compared with wild type cells.  
ZC3H22, zinc finger protein 22 (V5-tagged); wt, wild type, Lister 927 cells; DIC, 
differential interference contrast; DAPI, 4',6-diamidino-2-phenylindole, marker for 
nucleus and kinetoplast; GFP, green fluorescent protein filter, Merge, mixed of DAPI 
and GFP pictures. 
3.14.2 The V5-ZC3H22 was not associated with polyribosomes 
 
The distribution of V5-ZC3H22 protein in the polyribosome profile was also 
studied (Figure 30a).  
 
6x108 cells were used in this experiment. The ZC3H22 protein had a similar 
pattern to the one of the RNA binding protein DRBD3. Only when UV cross-
linking of RNA-protein complexes was performed both proteins were detected 
in the polyribosome gradient. V5-ZC3H22 as well as DRBD3 seemed to leak 
through the gradient, implying that part of the proteins was associated with 
polyribosomes, but most of them not. This was easily corroborated by 
comparing with the pattern exhibited by the ribosomal protein S9, which was 
included as control for proteins that are part of the polyribosomes. Instead 
both proteins were detected with higher intensity in the protein peak, meaning 
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that these proteins were free in the cytoplasm without interacting with the 
translating mRNAs (Figure 30b). Furthermore, previously it was shown that 
DRBD3 is not bound to the polyribosomes [79]. 
 
 
 
Figure 30. Distribution of the V5-ZC3H22 protein throughout the polyribosomal 
gradient 
(a) Polyribosome profile of UV cross-linked complexes in procyclic trypanosomes.  
(b) Western blot showed a similar distribution for V5-ZC3H22 and DRBD3 throughout 
the polyribosomal gradient. For the Pp sample (fractions 1-2) only 3µl were loaded. 
For the 40S, 60S and 80S fractions (3-4) 10 µl were loaded and for the polyribosome 
fractions (5-9) 30 µl of the sample was used in the Western blot.  
Pp, protein peak; 40S, ribosomal subunit 40S; 60S/80S, ribosomal subunit 60S and 
monosomes 80S; ZC3H22, zinc finger protein 22 (V5-tagged ZC3H22); S9, 
ribosomal protein S9; DRBD3, RNA binding protein.  
3.14.3 ZC3H22 RNAi did not affect growth of procyclic form trypanosomes  
 
A change in growth was not observed when I performed RNAi against 
ZC3H22 (Figure 31a), it is possible that the ZC3H22 mRNA and protein levels 
could not be reduced sufficiently. After 24 hours, 60% or more of the mRNA 
was still present in the tested clones (Figure 31b, clone 3).  
 
When testing the presence of ZC3H22 protein in a Western blot, it was 
observed that the protein was still present even after 48 hours of induction 
with tetracycline (Figure 31c). Several transfections using different parts of the 
ORF, as ZC3H22 mRNA targets for RNAi, and longer growth curves were 
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done but none of them gave a change in growth or a sufficient reduction of 
mRNA levels.  
 
 
 
 
Figure 31. No effect of RNAi on ZC3H22 mRNA and protein 
(a) Effect of ZC3H22 depletion on procyclic form trypanosomes. The results of the 
samples – tet and + tet represent the average of three independent clones. 
(b) Effect of RNAi against ZC3H22 in Northern blot. HSP70 was used as loading 
control. ZC3H22 mRNA was approximately 5Kb and HSP70 2.7Kb 
(c) Effect of ZC3H22 depletion on the protein level. Detected by the presence of the 
protein on Western blot. 
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wt, wild type, Lister 427 2060; -/+ Tet, with or without tetracycline; rRNA, bands of the 
ribosomal RNA; ZC3H22, zinc finger protein 22, mRNA or V5-tagged protein (V5-
ZC3H22); HSP70, heat shock protein 70 mRNA; S9, ribosomal protein S9. 
3.14.4 Tethering of ZC3H22 to a reporter mRNA does not have a significant 
effect on the reporter 
 
The tethering strategy relies on a λN-peptide that has the capacity to bind to 
the five boxB elements. Therefore, when fused to the ZC3H22-myc protein 
the effect of this protein on a reporter mRNA can be tested. These results are 
usually compared with a cell line that did not contain the boxB elements on 
the reporter mRNA (Figure 32a). If λN-ZC3H22-myc stabilizes its target 
mRNAs upon binding then the CAT reporter expression will be enhanced and 
the activity of the CAT protein measured by CAT assay will increase. In the 
opposite case, the reporter mRNA will be degraded and the signal measured 
over time will reduce. In case the protein does not have any effect on the 
mRNA, then the signal will be the same as the one of the control cell lines. 
 
This tethering experiment was done using a cell line which constitutively 
expressed a CAT reporter followed by 5 boxB elements and have an actin 3’-
UTR (CAT-boxB). This cell line was compared with a cell line containing only 
the CAT reporter (without the boxB element). Both cell lines expressed the 
ZC3H22 fusion protein, with a λN peptide at the N-terminus and a myc-tag at 
the C-terminus of the protein (Figure 32a).  
As additional controls, cell lines expressing the CAT-boxB or the CAT reporter 
alone without the presence of the fusion protein were tested.  
 
Upon induction of λN-ZC3H22-myc expression by addition of tetracycline, the 
relative CAT activity present in the samples was measured by CAT assay. 
There was no difference between the samples without tetracycline and the 
ones induced by tetracycline, as shown in Figure 32c, because the expression 
of the fusion protein was leaky. Therefore, in Figure 32b only samples 
induced with tetracycline are shown.  The effect of the λN-ZC3H22-myc 
protein on the CAT-boxB reporter was very similar to the control cell line 
(without the λN-ZC3H22-myc protein), suggesting that there might not be an 
effect of λN-ZC3H22-myc protein when tethered to a reporter mRNA (Figure 
32b). Interestingly, the relative CAT activity measured in the cell lines without 
boxB was 1.5-fold higher than in the cell lines with this element (Figure 32b) 
and the signal for CAT mRNA in the Northern blot seemed to smear slightly in 
the samples containing the boxB when comparing with the cell line without the 
element (Figure 32c), this might be due to degradation of the sample.  
 
Interestingly, the CAT activity of the cell lines without the boxB element was 
higher than the ones with this element.  
In order to confirm that the reporter mRNAs and the fusion proteins were 
being expressed, Northern and Western blots were performed. The 
expression of the CAT and CAT-boxB reporters was detected by Northern blot 
(Figure 32c) and the presence of λN-ZC3H22-myc protein was assessed by 
Western blot (Figure 32d).  
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Figure 32. Tethering ZC3H22 to a CAT reporter had no effect 
(a) Schematic representation of ZC3H22 tethering strategy  
(b) Relative CAT activity measuring the effect of λN-ZC3H22-myc protein on the CAT 
without boxB and on the CAT-boxB reporter upon tetracycline [8] induction. The 
results of 3 independent clones were shown in this experiment over time. 
(c) CAT-boxB mRNA compared to the cell line without boxB was detected by 
Northern blot. These cell lines also express the λN-ZC3H22-myc protein. As controls, 
wild type (wt) cells without the λN-ZC3H22-myc protein were used. Two controls 
were used, one that expressed the CAT-box B mRNA and an additional control 
without the boxB but only expressing CAT mRNA. The signal recognition particle 
(SRP) was used as loading control. 
(d) λN-ZC3H22-myc expression as determined by Western blot. The protein was not 
present in the wild type cell lines. The ribosomal protein S9 was used as loading 
control. 
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3.14.5 RNA-Immunoprecipitation of V5-ZC3H22 
 
As mentioned previously, TbZC3H22 was not characterized previously nor 
found in other purifications. For this reason, it was interesting to detect which 
RNAs were bound to it. Initially, it was thought that the EP1 mRNA was a 
target of ZC3H22, due to the results of DL-QMS (Table 3).  
 
Therefore, a cell line expressing the 3SBPs-CAT reporter and a V5-tagged 
ZC3H22 was generated. The main idea was to pull the V5-ZC3H22 using V5-
beads and detect the 3SBPs-CAT mRNA. Three replicates were done, but 
only in one of them signals in Northern and Western blot were detected.  
Figure 33a shows the Northern blot performed where only a slight signal for 
3SBPs-CAT was detected, although the V5-ZC3H22 was efficiently pulled by 
the V5-beads (Figure 33b). Note that abundant proteins such as TR and S9 
were able to bind unespecifically to the beads. 
 
As an alternative, the presence of the endogenous EP1 mRNA was also 
assessed by Northern blot. A signal was detected in both, the V5-beads as 
well as in the control IP (wild type cells), probably because EP1 is an 
abundant mRNA in procyclic form trypanosomes (Figure 33a).  
 
The CAT mRNA designed in the present study, as well as the EP1 mRNA are 
both transcribed by RNAPI and probably expressed in similar levels. Thus, it 
could be possible that both mRNAs compete for the binding to V5-ZC3H22. 
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Figure 33. Pull down of V5-ZC3H22 using V5-beads 
(a) Northern blot showing the pull down of V5-ZC3H22 and the CAT mRNA bound to 
it. The EP1 mRNA was used to determine if it is a target of ZC3H22 but in the RNA-
IP it is shown to also bind to the beads in the wild type sample. CAT mRNA was 
approximately 1.5 Kb and the EP1 was 0.9 Kb. 
(b) Western blot showing the pull down of V5-ZC3H22 using V5-beads. 2x107 cells 
were loaded for input of lysis and unbound, 2x106 for the wash and 1.8x108 for the 
beads.  
In, input of lysis; UB, unbound; W, wash; B, V5-agarose beads; ZC3H22, zinc finger 
protein 22 (V5-tagged version); TR, trypanothione reductase, a cytosolic protein; S9, 
ribosomal protein S9; EP, EP procyclin mRNA. 
3.14.6 Single knockout of TbZC3H22 had no effect on the growth phenotype 
of procyclic trypanosomes 
 
Due to the fact that RNAi against ZC3H22 was not functional (Figure 31) and 
no growth defect phenotype was observed, it was attempted to knock out both 
alleles of TbZC3H22. The strategy consisted in replacing them with puromycin 
or blasticidin resistance markers (Figure 34a). A puromycin acetyltransferase 
cassette containing the 5’ and 3’-UTR of TbZC3H22 was transfected in 
procyclic form trypanosomes and positive clones were analyzed by extraction 
of genomic DNA followed by PCR (Figure 34b).  
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Clone 1 was a successful single knock-out, contained the second allele of 
TbZC3H22 and was also positive for puromycin resistance. This cell line had 
no change in the growth phenotype. 
In order to have a conditional knockout an over-expression plasmid (with 
ZC3H22-myc) was transfected in the single knockout cell line (Figure 34c).  It 
was difficult to obtain a cell line over-expressing ZC3H22-myc, most of the 
ones obtained did not over-express the protein. It seemed that the over-
expression of this protein was not well tolerated in procyclic trypanosomes. 
After five trials of transfection, changing the transfection buffers and the 
amount of plasmid transfected, one conditional knock out cell line over-
expressing ZC3H22-myc was obtained. This cell line had no change in growth 
phenotype either.  
 
 
 
Figure 34. Single knockout of TbZC3H22 
(a) Schematic representation of TbZC3H22 locus. The generation of the single 
knockout was done by replacing one of the copies of the TbZC3H22 allele for a 
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puromycin resistance cassette. Primers used to amplify the TbZC3H22 alleles are 
depicted in the picture. 
(b) PCR products using different sets of primers in order to confirm the knockout 
clones. Clone 1 contains the puromycin gene and also one of the copies of 
TbZC3H22. Primers aF (cz4849) and aR (cz4850) amplified the ORF ZC3H22; bF 
(cz5078) and bR (cz5155) gave a product that goes from the 5’ –UTR of TbZC3H22 
until puromycin ORF; cF (cz5154) and cR (cz5068) amplified a product from the 
puromycin ORF to the ZC3H22 3’-UTR; dF (cz3294) and dR (cz2460) amplified the 
puromycin ORF; eF (cz4850) and eR (cz5078) gave a product that comprises the 5’-
UTR of ZC3H22 and ZC3H22 ORF. 
(c) Western blot showing the overexpression of ZC3H22-myc, the single knockout 
cell line was used as a base to transfect the overexpression plasmid of ZC3H22-myc. 
This plasmid is under the control of a polymerase I promoter and transcribed 10 
times more than with polymerase II. Aldolase was used as loading control. 
ZC3H22, zinc finger protein 22 or the tagged version (ZC3H22-myc); UTR, 
untranslated region; tet, tetracycline. 
 
Unfortunately, it was not possible to generate the double knockout cell line; 
only the inducible cell line with a single knockout allele for TbZC3H22 was 
obtained and exhibited no change in the growth phenotype. Despite the fact 
that different concentrations of plasmid were transfected, no living clones 
were observed. After these results and the ones obtained in Figure 27, it was 
decided to stop the work on ZC3H22 completely. 
3.15 The transcription unit of TbZC3H37 and TbZC3H38 
 
The RNA binding protein, ZC3H37 has previously been detected in a screen 
looking for potential post-transcriptional regulators in T. brucei made by Dr. 
Esteban Erben in our laboratory [74]. The results of the screen suggested that 
this protein might stabilize its target mRNAs [74]. The transcription unit where 
TbZC3H37 is located comprises several other RBPs such as TbZC3H38, 
TbZC3H36 and TbZC3H35, which have not been characterized so far. 
Interestingly, the main difference between sequences of these two genes is a 
117mer region at the 3’-end of the ORF (data obtained using MegaAling). For 
these reasons, it was decided to study one of them, TbZC3H38, in blood 
stream form trypanosomes.  
 
When looking at the transcriptomes of this transcription unit, it was observed 
that for TbZC3H38 the reads align throughout the gene without gaps and go 
on until the adjacent region annotated as Tb927.10.12790. According to the 
trypanosome database www.tritrypdb.org (TritrypDB data base), possible 
splice sites have not been identified for Tb927.10.12790, but instead, the 
splicing sites are located in the 5’-UTR of the downstream gene TbZC3H38 
(Figure 35a). Furthermore, when looking at the ribosome profiling data, it 
seems that no ribosomes are on the region annotated as Tb927.10.12790. 
Therefore, it was suspected that Tb427.10.12790 was actually the 3’-UTR of 
TbZC3H38 and not a real gene. This was confirmed by Northern blot, using a 
probe specific for ZC3H38. The predicted size of the ZC3H38 mRNA is 3.5kb, 
but the signal detected in the Northern blot was approximately 5kb, exceeding 
the predicted size of the annotated ZC3H38 mRNA, most probably containing 
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the Tb427.10.12790 region. These results were obtained by Jannik Traut and 
are published in his Bachelor thesis. 
 
   
 
Figure 35. TbZC3H38 transcription unit 
(a) Schematic representation of the TbZC3H38 transcription unit, picture taken from 
TriTrypDB. 
TbZC3H38 is highlighted in yellow. Reads detected by RNAseq are depicted in black 
(unique) and grey (non-unique) for both life cycle stages of the parasite. In the upper 
panel, possible spliced sites are also shown. 
(b) Schematic representation of the ZC3H38 protein, the two zinc finger domains are 
depicted in black and the HNPY domain in blue. The numbers of the amino-acid 
residues for each domain are depicted in the picture too.  
 
ZC3H38 contains two zinc finger domains and a HNPY domain (Figure 35b). 
The HNPY domain has been reported previously [108], to be necessary for 
the binding to MKT1, a protein that is involved in the stabilization of its target 
mRNAs and binds to PBP1, polyA-binding protein binding protein.  
3.15.1 ZC3H38 localizes mainly to the cytoplasm of bloodstream form 
trypanosomes 
 
In order to determine the localization of ZC3H38 a cell fractionation assay was 
performed using two different lysis methods, glass beads or carbamide. The 
lysis with both methods does not require the use of detergent therefore the 
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organelles remained intact. The pellet fraction represents the organellar 
fraction and the supernatant the cytosolic fraction.  
 
In the case of lysis with glass beads no signal was detected for the V5-tagged 
ZC3H38, neither for the nuclear protein XRND, only the signal for the 
cytosolic protein trypanothion reductase (TR) was detected by Western blot, 
perhaps due to blotting problems or to insufficient lysis. When lysing with 
carbamide, all proteins could be detected and V5-ZC3H38 presents a similar 
pattern than TR. When comparing the V5-ZC3H38 signal with the one of 
XRND, a nuclear protein, it seems that V5-ZC3H38 is 2.8-fold more in the 
cytosolic fraction than XRND, suggesting that this protein was mainly present 
in the cytoplasm (Figure 36).  
 
  
 
Figure 36. Cellular localization of ZC3H38. 
Cell fractionation to determine the localization of ZC3H38. Lysis with carbamide and 
a pellet pestle. For the input 2.6x106 cells were loaded. In case of pellet and 
supernatant 6.3x106 cells were loaded. 
XRND, exoribonuclease D, nuclear marker; TR, trypanothion reductase used as 
cytosolic marker; V5-ZC3H38, endogenous V5-tagged ZC3H38, In, input of lysis; P, 
pellet; S, supernatant.  
 
The predicted molecular weight for ZC3H38 is 31 KDa. The signal detected 
for V5-ZC3H38 presents several bands that range between 31 to 40 KDa. 
This pattern implied the presence of post-transcriptional modifications, such 
as glycosylation or protein phosphorylation. Jannik Traut, a Bachelor student 
in our laboratory, performed experiments for localization and protein 
phosphorylation. He corroborated the presence of ZC3H38 in the cytosol and 
its phosphorylation by immunofluorescence and phosphatase assay 
respectively. These results were published in his Bachelor thesis. 
3.15.1 ZC3H38 was not associated with polyribosomes 
 
In order to determine whether V5-ZC3H38 is associated with polyribosomes, 
a sucrose gradient centrifugation was performed.  
V5-ZC3H38 had the same pattern as trypanothione reductase (TR), a 
cytosolic protein that is not associated with polyribosomes, but leaks 
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throughout the gradient (Figure 37a). These experiments were repeated in 
triplicates and the pattern obtained was similar in all the cases.  
When treating the cells with RNases, the polyribosome profile changed. The 
polyribosomes as well as the monosome peak (80S) and the 40S-60S 
collapsed, all ribosomes bound to the mRNAs and other proteins 
disassembled and form only one peak (compare upper panels of Figure 37a 
and b). 
Interestingly, when treating the samples with RNases, V5-ZC3H38 collapsed 
with the polyribosomes whereas TR was present in almost all the fractions. It 
was possible that only a fraction of the V5-ZC3H38 protein was associated 
with polyribosomes (Figure 37b).  
As an additional control, the eIF4G3 protein was used; this protein is part of 
the initiation complex of translation. The signal for this protein seems to leak 
throughout the gradient, but appeared slightly intense in fraction 4, 
corresponding to the initiation complex fraction, compared to the 
polyribosomal fractions (5-7). eIF4G3 protein moves to the first fractions upon 
RNaseA treatment, showing the characteristic patter of a protein associated to 
polyribosomes (compare Figure 37a and b).   
 
 
 
Figure 37. Distribution of ZC3H38 throughout the sucrose gradient. 
(a) Polyribosome profiles of cells expressing V5-ZC3H38. 
(b) Like (a), but lysis was performed in the presence of 1mg/ml of RNaseA.  
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Polyribosome profiles shown in the upper panels and Western blots in the lower one. 
TR was used as cytosolic control, not associated with polyribosomes and the 
initiation factor eIF4G3 as a control of a protein that is associated with polysomes. 
Pp, protein peak; 40S, ribosomal subunit 40S; 60S, ribosomal subunit 60S; 80S, 
monosomes; eIF4G3, initiation factor of translation; TR, trypanothion reductase an 
abundant cytosolic protein; V5-ZC3H38 zinc finger protein 38 (endogenous V5-tag). 
3.15.2 ZC3H38 and ZC3H37 knock down strategy 
 
In order to elucidate the importance of TbZC3H38 several RNAi constructs 
were made and stable cell lines generated (Figure 38a). Since ZC3H38 and 
ZC3H37 have 77% of protein homology; differing only in 39 amino acids 
(Figure 38b), RNAi was generated for the specific region of difference, in 
order to target either TbZC3H38 or TbZC3H37 separately (Figure 38). 
Furthermore, RNAi targeting the 3’-UTR of TbZC3H38 annotated as 
Tb427.10.12790 was also made (Figure 38a).  
 
  
 
Figure 38. TbZC3H38 transcription unit and protein homology to TbZC3H37 
(a) Schematic representation of the TbZC3H38 transcription unit and RNAi targets. 
The primers used to generate the RNAi against a common region for TbZC3H37 and 
TbZC3H38 are aF=CZ4874 and aR=CZ4875. Primers used only for TbZC3H38 RNAi 
are bF=CZ5562 and bR=CZ5563. In the case of the Tb427.10.12790 gene, the 
oligos designed to generate the RNAi against the mRNA of this gene are cF=CZ5560 
and cR=CZ5561. Finally, the ones used specifically for TbZC3H37 RNAi are 
dF=CZ5629 and dR=CZ5630. 
(b) Sequence alignment of ZC3H38 and ZC3H37 proteins, the regions in green are 
not homologous. The region in a square is the 39 amino acids that differ between the 
two proteins; this region was the one chosen to target the specific RNAis against 
ZC3H37 and ZC3H38 mRNAs 
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Data previously obtained in our laboratory (unpublished) showed that RNAi 
against a common region of TbZC3H37 and TbZC3H38 lead to a slight 
growth defect. Also, when performing a Northern blot with the same probe to 
detect ZC3H38, another band was also detected, corresponding to the size of 
the ZC3H37 mRNA. The intensity of both bands was reduced upon RNAi 
induction. These results were obtained only once from one of the clones. 
Unfortunately, it was impossible to reproduce these results, most probably 
because by freezing and thawing the clones the RNAi effect was lost. 
3.15.3 RNAi against ZC3H38 results in a slight growth defect  
 
The RNAi was inducible by tetracycline and was designed using the sequence 
of the 117mer that differs between TbZC3H37 and TbZC3H38, targeting only 
ZC3H38 (Figure 39a).  
 
Upon RNAi induction, the cells presented a slight growth defect compared to 
wild type cells. Due to the fact that the induction by tetracycline was leaky, the 
cells without tetracycline (-Tet) and the ones were tetracycline was added 
(+Tet) had the same growth phenotype (Figure 39b). Furthermore the signal 
for ZC3H38 mRNA reduces after 24 hours of tetracycline induction, measured 
by Northern blot (Figure 39c). The V5-ZC3H38 protein signal reduced also 
after 24 hours of tetracycline induction (Figure 39d), this western blot includes 
the V5-ZC3H38 protein without the RNAi plasmid and the wild type, without 
any plasmid, as controls. The Northern and Western blot experiments were 
repeated at least three times obtaining similar results ZC3H38 decreases after 
24 hours of tetracycline induction in the mRNA level and at the protein level, 
while the signal of the V5-tagged cell line was still present without any 
variation in the case of the Western blot.  
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Figure 39. Effect of RNAi against ZC3H38  
(a) Schematic representation of the TbZC3H38 transcription unit. The primers used 
to amplify the 117bp probe against ZC3H38 are depicted as arrows (bF=CZ5562 and 
bR=CZ5563).  
(b) Growth curve for cell lines where the RNAi against ZC3H38 was induced (+Tet) 
and uninduced (-Tet) compared to the wild type (wt). 
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(c) Northern blot showing the decreased in the ZC3H38 signal upon RNAi induction. 
HSP70, the heat shock protein 70 mRNA, was used as loading control.  
(d) Western blot showing the effect on V5-tagged ZC3H38 protein upon RNAi 
induction. TR, trypanotion reductase was used as control 
 
Furthermore, a construct that targeted only the 3’-UTR of TbZC3H38 gene 
(annotated as Tb927.10.12790) was also designed to generate an RNAi 
specifically for this gene (Figure 40a). A slight growth defect in the phenotype 
was observed using this RNAi when comparing to wild type cells (Figure 40b). 
The growth defect obtained by this RNAi was similar to the one caused by the 
RNAi specifically against TbZC3H38 ORF. Samples with (+Tet) and without (-
Tet) presented the same growth phenotype as in Figure 39b. 
 
In the Northern blot (Figure 40c) and Western blot (Figure 40d) the signal for 
ZC3H38 also reduced after 24 hours of tetracycline induction. Especially in 
the Western blot, when comparing the signal for the tagged protein at 24 
hours of tetracycline induction with the one of the control cell line containing 
only the V5-tag and not the RNAi (named V5 in Figure 40d). Approximately, 
70% of the V5-ZC3H38 protein has disappeared and it is not being produced 
anymore.  
 
In order to find the RNAs that can be affected by the reduction of the ZC3H38 
protein, it was decided to perform a time course experiment to determine the 
exact time at which the V5-ZC3H38 is reduced but there is no growth defect. 
The time course experiment was done using both RNAi cell lines, the one 
targeting the ORF and the 3’-UTR of TbZC3H38. Time points were taken from 
2 to 24 hours, no reduction in the protein level was observed up to 8 hours, 
only when inducing the cells for 12 hours there was a reduction of the V5-
ZC3H38 protein without presenting a change in the growth phenotype. Further 
experiments will be conducted by Vikram Kumar to solve this open question. 
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Figure 40. Effect of RNAi against Tb427.10.12790 mRNA  
(a) Schematic representation of the Tb427.10.12790 transcription unit. The primers 
used to amplify the 239 bp probe against this mRNA were depicted as arrows 
(cF=CZ5560 and cR=CZ5561). 
(b) Growth curve for cell lines where the RNAi against Tb427.10.12790 was induce 
(+Tet) and uninduce (-Tet) compared to the wild type (wt). 
 
It was also interesting to determine the effect of RNAi on ZC3H37. Therefore, 
an RNAi construct (that was generated using the primers cz5629 and cz5630) 
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was used to target specifically TbZC3H37 (Figure 41a). Preliminary results, 
showed no changes in the growth phenotype upon the addition of tetracycline 
compared to the wild type (Figure 41b). The cell line expressing this RNAi 
behaved in terms of growth like wild type cells. This results was ontained only 
once with one clone. 
 
  
 
Figure 41. Effect of RNAi against ZC3H37   
(a) Schematic representation of the TbZC3H37 transcription unit. The primers used 
to amplify the 117bp probe against this mRNA are depicted as arrows (dF=CZ5629 
and dR=CZ5630). 
(b) Growth curve for cell lines where the RNAi against ZC3H37 was induce (+Tet) 
and uninduce (-Tet) compared to the wild type (wt). 
 
Due to the results obtained by the different RNAi against these genes, it was 
decided that knockout cells lines were required. The plasmids to generate the 
knockouts for TbZC3H38 only and for a region containing TbZC3H38-
Tb927.10.12790-TbZC3H37 were designed and cloned. These plasmids were 
transfected into bloodstream form trypanosomes. So far, only clones for a 
single knockout against TbZC3H38 were obtained. Efforts are being made in 
order to obtain the knockout of the long stretch of the transcription unit 
corresponding to TbZC3H38-Tb927.10.12790-TbZC3H37. 
3.15.4 Tethering of ZC3H38 
 
In order to determine the effect of ZC3H38 on its target mRNAs, the ZC3H38 
protein was tethered to two different reporter mRNAs, one containing a CAT-
5 boxB and another cell line expressing only the CAT reporter without the 
5 boxB elements. The protein generated was a fusion protein (λN-ZC3H38-
myc) composed of a λN at the N-terminus and a myc-tag at the C-terminus 
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(Figure 42a). As additional controls, cell lines that did not express the protein 
were tested. 
 
Results obtained previously by Dr. Esteban Erben in our laboratory [74] 
indicated that this protein might be able to stabilize its target mRNAs. 
Therefore, to determine exactly which region of the ZC3H38 protein was 
responsible for its effect on the reporter mRNA, different constructs were 
made (Figure 42b):  
 
1. The complete protein λN-ZC3H38-myc (1104bp) 
2. The λN-ZC3H38-myc protein with the two CCCH domains, without the 
HNPY (deletion of a region compromising the 814-843mer of the 
ZC3H38 ORF, named CCCHs) 
3. The λN-ZC3H38-myc protein with a deletion on the N-terminal part of 
the protein, this part contains the first CCCH domain (deletion 1-218, 
named N-term del) 
4. The λN-ZC3H38-myc protein and a region containing the HNPY 
domain, without the two CCCH domains (deletion 1-493, named 
HNPY) 
 
The tethering assay confirmed the results previously obtained in our 
laboratory [74]. The complete λN-ZC3H38-myc protein stabilized its target 
mRNAs, which was indicated by the increase in CAT mRNA in the samples 
containing the CAT-boxB reporter, but not in the samples containing the CAT 
reporter alone. The amount of CAT reporter RNA containing the boxB element 
was also increased compared to the controls (Figure 42b).  
 
When testing different parts of the protein, it was noticed that the CCCH 
domains were not required for the stabilization of the tethered target mRNAs. 
The cell line without the HNPY domain, containing the CCCH domains 
(deletion 814-843, named CCCHs) exhibits a reduction of CAT activity and 
CAT-boxB mRNA expression compared to the cell line expressing the 
complete protein and the CAT-boxB reporter. Also, the CAT activity and CAT 
mRNA values were similar to the wild type cell lines (Figure 42b, CCCHs).  
 
In the case of the cell lines containing the N-terminal deletion (deletion 1-218), 
the CAT activity increased almost 1.5-fold when comparing to the wild type 
and the activity was similar to the complete protein (Figure 42b, N-term del).  
The CAT mRNA results for the N-terminal deletion must be repeated. The 
Northern blots were quantified using the bands of the rRNA (methylene blue 
staining) as loading control and some of the Northern blots had problems with 
blotting. This could generate problems in the quantification, which might be 
the reason for the apparent 20-fold excess of CAT mRNA in the samples for 
N-terminal deletion with boxB and for the cell line expressing the HNPY 
domain without boxB (Figure 42b). In these both cases, the data for the CAT 
activity rather represent a more reliable result.  
 
The samples containing the HNPY domain (N-term del, deletion 1-218 and 
HNPY, deletion 1-493) exhibited stabilization of the CAT-boxB mRNA, 
resulting in a 1.5-fold increase of the CAT activity, when comparing to the wild 
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type. The CAT activity and CAT mRNA expression were similar to the ones of 
the complete fusion protein (Figure 42b, HNPY). 
 
The expression of the λN-ZC3H38-myc protein was tested by Western blot. 
Figure 42c shows the expression of the complete fusion protein with the 
characteristic pattern of phosphorylation in cell lines containing CAT and CAT-
boxB reporters. Interestingly, when detecting the λN-ZC3H38-myc protein 
without the HNPY motif, the phosphorylation reduced and only one single 
band could be detected (Figure 42d). 
 
These results indicate that ZC3H38 stabilize its target mRNAs and that the 
regulation of the mRNA abundance depends on the presence of its HNPY 
domain.  
The tethering results were obtained with the help of Jannik Traut. 
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Figure 42. The HNPY domain of ZC3H38 stabilized the CAT-boxB reporter  
(a) Schematic representation of the λN-ZC3H38-myc tethered to a reporter mRNA. 
(b) Relative CAT expression. White bars represent the CAT activity and the black 
ones represent the CAT mRNA. This experiment was done in cell lines that 
expressed the different parts of the λN-ZC3H38-myc protein on both reporters (with 
and without boxB). The error bars represent the difference between experiments 
(standard deviation). Each experiment in this figure was repeated at least three 
times.  
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(c) Western blot of the cell lines expressing the complete λN-ZC3H38-myc protein. 
The ribosomal protein S9 was used as loading control.  
(d) Western blot showing the expression of the λN-ZC3H38-myc protein without the 
HNPY motif. Note that the phosphorylated bands of ZC3H38 were lost. The eIF4G3 
protein was used as loading control. 
 
3.15.5 Yeast two hybrid high-throughput screen of ZC3H38 
 
To further characterize the ZC3H38 protein, it was of interest to know the 
interaction partners of this protein. Therefore, a genome-wide yeast two 
hybrid screen was performed.  
 
For this experiments ZC3H38 was used as bait protein. In order to perform 
the genome-wide screen, our bait protein containing strain was mated with a 
strain containing random genomic fragments of T.brucei. Dr. Esteban Erben 
made the yeast two-hybrid library in our laboratory.  
The mating was performed at 30°C and 1.2x105 diploid cells were obtained 
with an efficiency of 2%. After the diploids were obtained, a white blue 
screening was performed and 444 positive blue colonies were taken and 
grown. The plasmids containing candidate interactors (preys interacting with 
our ZC3H38-bait plasmid) were isolated and the PCR for the prey plasmids 
was standardized using different conditions.  
 
The pattern obtained after the amplification with the adaptors is shown in 
Figure 43. Two different enzymes were tested in order to determine the best 
conditions for this amplification. Both enzymes gave a similar pattern, so the 
amplification was done with both, then purified and send for DNA sequencing. 
 
 
 
 
Figure 43. PCR amplification of the positive Y2H clones with ZC3H38 as bait. 
The primers used for the amplification were CZ5278 and CZ5472. Two different 
PCRs were done using different polymerases (Q5 and GoTaq) in order to determine 
the best conditions for the amplification. 
 
The yeast two-hybrid screen was repeated twice and the samples mixed in 
order to obtain a better coverage of target protein sequences. The results are 
shown in Table 5, the data were selected in order to obtain proteins with the 
mayor number of reads present in more than one location. The table 
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compares proteins that were found in other purifications, such as the NOT1 
yeast-two hybrid purification and a screen made in our laboratory by Dr. 
Esteban Erben, which used a plasmid library of random genomic fragments 
from T.brucei to identify proteins that might be involved in the stabilization a 
reporter mRNA upon the addition of different concentrations of blasticidin 
(BLA up). Most of the proteins identified were hypothetical proteins and 
parafagellar rod proteins.   
  
Table 5. Yeast-two hybrid screen using ZC3H38 as bait 
The table shows the number of reads obtained for each gene of interest, as well as 
the number of locations and number of reads per gene. Reads located only in one 
place in the gene were excluded from the analysis. Strand (+) or (-) correspond to the 
reads that are in-frame and aligned to the sense strand or anti-sense strand of the 
T.brucei genome.  
NOT1 represents a yeast-two hybrid screen of this protein. The table shows common 
proteins found in the NOT1 and the ZC3H38 genome-wide yeast two-hybrid screens.  
BLAup compares a screen made in order to identify proteins involved in the up-
regulation of reporter mRNAs (BLAup) with the ZC3H38 yeast two-hybrid screen. 
The numbers under the BLAup column represent the folds of mRNA up-regulation for 
each gene. n.d. no data 
 
Accession 
number 
No 
reads 
No 
locations 
ORF 
length 
Strand Description NOT1 
BLA 
up 
Tb927.11.3300 
16 
3 2799 + 
hypothetical 
protein, 
conserved 
0 
6,45 27 
17 
Tb927.3.1580 
569 
2 1641 - 
hypothetical 
protein, 
conserved 
n.d 
417 
Tb927.4.3400 
11 
2 1818 - 
hypothetical 
protein, 
conserved, 
ARM repeat 
2268 
Tb927.7.6920 
125 
2 1875 - 
hypothetical 
protein, 
conserved 850 
Tb927.9.4390 
185 
2 1137 + 
DNA-
damage 
inducible 
protein DDI1-
like protein 
54 
Tb927.10.11380 
13 
2 1173 + 
hypothetical 
protein, 
conserved 
25 
1532 
Tb927.3.920 
3851 
2 3810 + 
hypothetical 
protein, 
conserved 
69 
20 
Tb927.1.2570 
830 
2 2949 + 
coatomer 
beta subunit  
86 
15 
Tb927.9.2700 
14 
4 1452 - 
hypothetical 
protein, 
conserved 
113 
13 
74 
7548 
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Tb927.6.3670 
87 
3 9669 - 
paraflagellar 
rod protein 
PFC8 
117 79 
12 
Tb927.9.7690 
27 
4 5574 - 
hypothetical 
protein, 
conserved  
184 15,64 
67 
16 
17425 
Tb927.3.5310 
13 
2 6387 + 
paraflagellar 
rod protein 
318 39,54 
41 
 
3.15.6 RNA-IP of ZC3H38 for RNAseq 
 
In order to determine which RNAs are the targets of ZC3H38, an RNA 
immunoprecipitation (RNA-IP) was performed using the tethering cell lines 
(Figure 44a), because the integrity of the mRNA in the preparation could be 
checked by Northern blot and the success of the pull down by Western blot. 
 
Figure 44b shows that the CAT mRNA was not degraded during the pull down 
and the Western blot confirmed that ZC3H38-myc was efficiently being pulled 
down using myc-beads (Figure 44c). In the next step, the samples were 
depleted from the ribosomal RNA using oligos [164], after this step the signal 
of CAT mRNA could not be detected in the Northern blot. 
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Figure 44. RNA pull down of ZC3H38 for RNAseq 
(a) Schematic representation of the cell lines used for the pull down. 
(b) Northern blot shows that CAT mRNA can be detected during this pull down and 
that the mRNA was not degraded at this stage. For In, UB and W, 3x107 cells from 
each were taken for RNA extraction and loaded onto the gel, in case of the beads, 
7.5x108 cells were used. 
(c) Western blot confirming the pull down. ZC3H38-myc was pulled down using myc-
beads. The ribosomal protein S9 was used as a loading control. For In 1x107 cells 
were leaded, in case of the UB and W 2.5x106 cells were used and for the beads an 
equivalent to 2x107 cells were taken. 
In, Input after lysis; UB, unbound; W, wash; B, beads. 
 
The facility informed us that the samples were degraded. A possible 
explanation could be that the temperature conditions inflicted by the rRNA 
depletion procedure caused the degradation of the mRNA. This experiment 
could be repeated in the future using a modified protocol for rRNA depletion.  
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3.15.7 Co-IP of ZC3H38 and MKT1 
 
The ZC3H38 protein contains a HNPY motif, which was previously published 
to be a putative binding motif of MKT1, a protein that binds to the PBP1 and 
stabilizes its targets mRNAs [108]. A Co-IP was performed in order to 
determine if these two proteins co-purify. 
 
 
 
Figure 45. Co-immunoprecipitation of V5-ZC3H38 and MKT1-myc 
(a) Co-immunoprecipitation of MKT1-myc and V5-ZC3H38 using α-myc beads in 
bloodstream form cells.  
(b) Co-immunoprecipitation of MKT1-myc and V5-ZC3H38 using α-V5 beads in 
bloodstream form cells. 
For input and unbound fractions 5x106 cells were taken for the Western blot. In the 
case of the eluates 1.5x108 cells were loaded in (a) and (b). 
In, input; UB, unbound; B, beads. 
 
Figure 45a shows the results of the co-immunoprecipitation done using α-myc 
agarose beads. The pull down was done using a cell line expressing the V5-
ZC3H38 and MKT1-myc. Control pull downs were done in parallel, using a 
cell line expressing only V5-ZC3H38 and MKT1-myc, respectively.  
 
When pulling down with α-myc beads, V5-ZC3H38 was detected in the beads 
of the cell line containing both tagged proteins as well as in the cell line 
containing only V5-taged ZC3H38. These results imply that V5-ZC3H38 
bound unspecifically to the α-myc beads.  
 
In the co-immunoprecipitation using α-V5 beads (Figure 45b), MKT1-myc was 
found present in the beads of the cell line containing both tagged proteins, but 
was also found in the control pull down. This indicates that myc-MKT1 binds 
unspecifically to the V5-beads. 
 
Since there was a signal for aldolase detected in all the beads fractions, it is 
possible that higher number of washes is necessary.  
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Taking in consideration the results obtained, it was not possible to reach a 
conclusion if these proteins co-purify, and therefore different approaches were 
taken to identify the proteins that can interact with ZC3H38. 
3.15.8 Proteins co-purifing with ZC3H38 
 
In order to determine the protein interaction partners of ZC3H38, two 
approaches were made. TAP purification of ZC3H38 and immunoprecipitation 
of a V5-ZC3H38 protein using V5-beads.  
3.15.8.1 TAP purification of ZC3H38 
 
Small scale TAP-tag purification were performed and it was noticed that the 
phosphorylation pattern of ZC3H38 was lost, when trying to detect the TAP-
ZC3H38 fusion protein by Western blot. Furthermore, it seemed that almost 
50% of the TAP fusion protein was not able to bind to the beads; most of it 
was found to be on the unbound fraction in the Western blot (compare In and 
UB, Figure 46). In the eluate no signal was detected because the TEV 
protease released the ZC3H38 with the calmodulin-binding domain of the 
TAP-tag and the Protein A remains bound to the IgG matrix. Since the 
antibody used in Figure 46 recognizes only Protein A, there was no signal in 
the eluate.  
It is important to mention that the TAP-tag is approximately 183 amino acids 
long and that the TAP-tag was fused to the C-terminal end of the ZC3H38 
protein, near the HNPY domain, this might be the cause of the loss of 
phosphorylation.  
 
 
 
Figure 46. TAP-tag purification 
Western blot showing the purification of ZC3H38 using a C-terminal TAP-tag. The 
purification using a cell line expressing the fusion protein TAP-ZC3H38 was 
compared to the control purification, using Bf1313 cell line. 
For input and unbound an equivalent of 6x106 cells were taken for Western blot. In 
case of eluate after TEV cleavage 1.5x107 cells were used for Western blot. 
In, input; UB, unbound; E, eluate represent the first eluate, after TEV cleavage. 
 
A stable cell line expressing the N-terminal TAP-ZC3H38 fusion protein was 
obtained. The TAP purification experiment will be conducted in the near 
future. 
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3.15.8.2 Immunopurification of V5-ZC3H38 
 
This experiment was performed as an alternative method to identify the 
proteins that co-purify with ZC3H38. V5-ZC3H38 protein was pulled down 
using V5-agarose beads and was compared to a control cell line that did not 
contain the V5-tagged protein (Bf1313 cell line).  
The pull down was split in two, a small part of the sample was used for 
Western blot and the rest was loaded on a gel that was stained with 
Coomassie blue and sent to DL-QMS. 
 
The pull down was repeated four times and triplicates were tested by Western 
blot and sent to DL-QMS. Figure 47 shows the results of one of the replicates.  
The Western blot confirmed that the pull down was successful; the V5-
ZC3H38 protein binds specifically to the V5-beads (Figure 47a). The rest of 
the samples were loaded on a Coomassie blue stained gel as it is shown in 
Figure 47b. The pattern of proteins between the control pull down and the pull 
down using V5-ZC3H38 looks similar; therefore it was decided to do DL-QMS. 
 
  
 
Figure 47. Pull down of V5-ZC3H38 using V5-agarose beads 
(a) Western blot showing the specificity of the pull down.  
In, input; UB, unbound; B, beads eluted by boiling in sample buffer for 10 min. 
For input and unbound 5x106 cells were loaded in the Western blot. In case of the 
beads, 3.7x108 cells were used for Western blot. 
(b) Coomassie blue staining of the pull down comparing the eluates of the control cell 
line with the one of the cell line expressing the V5-ZC3H38. 
For both samples 7x108 cells were loaded in the Coomassie blue gel. 
 
Due to problems with the trypsinization of the samples, two replicates were 
lost. Only results from one of the replicates were delivered but the V5-
ZC3H38 was not detected among the proteins found. 
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4. Discussion 
 
4.1 Affinity purification of translating polyribosomes  
 
Several aspects of mRNA metabolism can be controlled by post-
transcriptional mechanisms, such as localization, translation, storage and 
decay, among others. The key components of these mechanisms are 
regulatory proteins present in the mRNPs. For this reason the study and 
characterization of the RNP components is fundamental to elucidate these 
regulators. In the present dissertation, a method to purify translating mRNPs 
and to detect its protein components is described. 
 
The affinity purification of translating polyribosomes is based on a previously 
published method from the 70s [143], which purified translating polyribosomes 
via immunoprecipitation, using an antibody against the ovalbumin nascent 
peptide in hen oviduct cells. In early studies (methods developed in the 60s-
70s), many mRNAs were purified using sucrose gradient centrifugation and 
immunoprecipitation. The success of these purifications was based on the 
abundance of the mRNAs purified, as well as the use of very specialized cells, 
such as the purification of ovalbumin mRNA from rabbit reticulocytes [137] or 
VSG from bloodstream form trypanosomes [140-142]. Methods developed 
later (from 90s on) made use of affinity purification tags [146] to determine the 
protein components bound to the purified mRNA. More specialized methods 
used aptamers [156, 159] to purify mRNPs. Most of these approaches used 
total or concentrated cell lysates for the purification, others have a system that 
produced abundant mRNAs containing the aptamer-cis element of interest 
and, more important, were in-vitro. The problem with the in-vitro methods is 
that such assays may not represent what is happening in vivo. Therefore, the 
method developed here allows the purification of a specific mRNP in vivo in 
order to identify regulatory proteins on the untranslated regions of interest. 
 
Initially, I tried to purify cytosolic polyribosomes from membrane bound ones.  
Leaving the organelles intact allows the separation of the mature 3SBPs-CAT 
protein (consider to be a contaminant) from the samples. This strategy was 
successful (Figure 14), but the main problem encountered was the poor yield 
obtained. It is possible that part of the polyribosomes with mRNAs containing 
many ribosomes (present in higher sucrose fractions) were also spun down in 
the first centrifugation step, along with the organellar fraction (compare 
polyribosome profiles Figure 16a with Figure 17a). Another possibility is that 
the mRNAs were degraded during this longer process, which included a 
double step of ultracentrifugation.  
 
After several optimization steps the purification of 3SBP-CAT-mRNPs from 
translating polyribosomes consisted on lysis using detergents and only one 
step of ultracentrifugation (Figure 11). In this affinity purification method, it 
was expected that many 3SBP-CAT mRNAs containing several regulatory 
proteins interact with the multiple streptavidin binding sites in the beads and 
that these complexes can be easily eluted using biotin. Nevertheless, the 
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elution with biotin was inefficient (Figure 15). A possible explanation might be 
that there are many 3SBPs-CAT-mRNPs bound to the beads. Also one must 
consider that mRNAs can interact with other, sharing regulatory proteins, 
which can bind to the 3SBP-CAT-mRNPs. These interactions could block the 
access of eluting agents such as biotin or RNases. Therefore, it was decide to 
elute the purified mRNPs using SDS, boiling the beads in Laemmli buffer. 
 
4.2 The affinity purification method corroborates known RBP-mRNA 
interactions 
 
As proof of concept my goal was to detect the well-characterized interaction 
between ZC3H11 and the AU-rich element present in the HSP70 3’-UTR [107] 
using my purification method. It was noticed that the 3SBP-CAT-HSP70 3’-
UTR reporter is equally distributed in each polyribosomal fraction of the 
sucrose gradient and this might represent a benefit for the purification (Figure 
21). It could allow the purification of proteins that interact at different stages 
with a specific mRNA, such as proteins that interact at the initiation of 
translation and proteins of the degradation machinery that could interact when 
the mRNA is prepared for degradation, most of them present in the 
polyribosomes.    
 
Western blot results confirm that ZC3H11 co-purified with the HSP70 3’-UTR 
only when the AU-rich element is present (Figure 23). Unfortunately, since the 
ZC3H11 protein is highly phosphorylated and it cannot be easily detected by 
mass spectrometry, only one modified peptide for this protein was identified. 
Other purifications performed in the laboratory also fail to detect this protein 
by mass-spectrometry. To make possible the detection of this protein, a 
higher expression might be needed, for instance to expressed the protein 
using an over-expressed TAP-tag version or maybe in fusion with other 
protein like the green fluorescent protein (GFP). Maybe these fusion proteins 
will increase the chance to detect ZC3H11 in the purifications, but will not 
discard the possibility that the function of the protein is compromised.  
 
Other proteins that co-purified with the HSP70 3’-UTR reporter are listed in 
Table 2. Initiation factors as wells as the poly (A) binding proteins PABP1 and 
2 were detected. This was expected because this HSP70 reporter was 
purified from translating polyribosomes and is stabilized during heat shock. 
Interestingly, also protein components of the degradation machinery or factors 
involved in mRNA degradation, such as NOT10, DHH1 and PUF6 were found 
to co-purify with this mRNA. For instance, PUF6 in T. cruzi has been 
implicated in the destabilization of mRNAs [177]. This might imply that upon 
heat shock, when global translation is reduced, proteins of the degradation 
machinery are in close proximity with translating mRNAs and that the 
regulatory proteins are in dynamic interaction with the mRNAs. Although more 
experiments should be done to probe this hypothesis. Some RBPs that are 
regularly found in purifications were also detected, such as DRBD3, which 
binds regions of poly-pyrimidines in the mRNAs [178], or abundant proteins 
such as UBP2 [179]. 
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Purifications in order to detect MKT1, a protein that binds to ZC3H11 but does 
not directly bind mRNAs were done using the HSP70 reporters. This protein is 
found to be 4-fold enriched in the purification of the complete HSP70 3’-UTR 
when comparing with the deleted one (Figure 23). This finding indicates that 
the method can purify protein components of mRNPs that are indirectly 
interacting with the target mRNA. 
 
Another well-known mRNA-protein interaction was also tried. The detection of 
the RNA binding protein DRBD3/PTB1 bound to a reporter containing the 
AATP11 3’-UTR. It is known that this RBP stabilizes AATP11 mRNA upon 
binding [79].  Results show that DRBD3/PTB1 co-purified with both reporters, 
the one containing the complete AATP11 3’-UTR as well as the one with the 
deletion. Nevertheless, quantification of Western blot reveals that DRBD3 is 
2.4-fold enriched in the purification of the complete AATP11 3’UTR compared 
to the deleted one. The main problem here is that DRBD3/PTB1 binds to 
pyrimidine-rich stretches on mRNAs, which might be present in the reporters 
used. 
 
4.3 Possible regulators of the EP mRNA 
 
The purification using the EP 3’UTR was one of the most interesting ones, 
because the EP 3’-UTR contains three well characterized regulatory domains, 
but so far no regulatory proteins have been found to be directly involved in the 
developmental regulation of this mRNA. I tried to identify regulatory proteins 
that co-purified with the EP 3’-UTR. In a first trial, samples were processed 
using quantitative mass-spectrometry. Proteins detected to be enriched in the 
purification of the EP 3’-UTR include proteins involved in the stabilization of 
mRNA and enhance translation, such as MKT1 that binds to PBP1, a protein 
that binds to poly(A) binding protein. Interestingly, other proteins found were 
components of the degradation machinery, such as XRNA and NOT1. It is 
possible that these proteins are in close proximity with the EP-mRNP purified 
and are inactive or passively waiting for a signal to start the degradation.  
 
One interesting candidate that was not previously found in other purifications 
was detected, the RNA binding protein ZC3H22. The V5-tagged ZC3H22 
seems to be enriched in the 3SBP-CAT-EP 3’-UTR purification when 
compared to the control purification (Figure 27). Unfortunately, the RNA-IP 
using V5-ZC3H22 showed that the EP mRNA binds unspecifically to the V5-
beads and no signal for the 3SBP-CAT-EP 3’-UTR mRNA was detected 
(Figure 33).  It came to my interest that although both mRNAs are transcribed 
by the same polymerase, the expression is not the same, it seems that EP is 
expressed more than the 3SBPs-CAT reporter (compared inputs in Figure 
33). Maybe because the 3SBP-CAT reporter contains also the EP UTRs and 
the expression of this mRNA is tightly regulated. As it has been reported 
before, over-expression of the two EP isoforms impaired trypanosome growth 
generating disturbances in the parasite membrane [180]. So it is possible that 
the CAT mRNA is regulated to reduce its expression and also that both 
mRNAs compete for the binding to V5-ZC3H22. The results obtained for the 
interaction between EP mRNA and ZC3H22 are inconclusive. One of the 
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problems is that the quantitative mass spectrometry of the EP purifications as 
well as the RNA-IP were repeated only once and peptides from this protein 
were not found to be enriched in further purifications (Table 4), thus there is a 
high possibility that ZC3H22 does not really interact with the EP mRNA.   
 
There were several problems encountered when performing quantitative mass 
spectrometry (DL-QMS). One of the main problems was the poor yield, 
despite the fact that the RBPs could be detected by Western blot and the CAT 
mRNAs by Northern blot, the detection of peptides by DL-QMS in the samples 
was a big issue. It might be because when performing DL-QMS the control 
and target sample must be labelled and mixed, this implies the dilution of the 
sample. There were also technical problems, like failures of the instrument, as 
well as problems in handling the samples, such as inadequate gel-purification, 
trypsinization or labelling. For this reason, it was decided not to use DL-QMS 
and only to count and compare the peptides present in both samples. 
 
Further EP purifications were repeated four times. Table 4 shows the ratio of 
peptides found for a specific protein in the 3SBP purification compared to the 
control purification for each of the four replicates. Most of the proteins found to 
co-purify with the EP 3’-UTR are conserved hypothetical proteins, with 
unknown functions. Only two RBPs were found to be enriched at least in two 
replicates, ZC3H13 and ZC3H21. Both RBPs, ZC3H13 [181] as well as 
ZC3H21 (data not published only presented on a congress) have an effect 
impairing growth in procyclic trypanosomes upon over-expression. The affinity 
purification using V5-ZC3H13 and the reporter mRNAs was done only once 
but lead to inconclusive results due to the lack of signal for the control 
proteins in the Western blot. ZC3H13-TAP purification was only performed in 
bloodstream trypanosomes and the same tag seems to be harmful in 
procyclic trypanosomes [181]. It would be interesting to see if the same 
hypothetical proteins found by the affinity purification can be found also in the 
TAP purification of this proteins (ZC3H13 and ZC3H21) in procyclic forms. 
Maybe with an N-terminal TAP-tagged and not an over-expressed one, at 
least in the case of ZC3H13. Knock-out cell lines, neither single nor double, 
were possible to be obtained for any of these proteins. In the future it might be 
of use to generate these knockouts and check if the expression of the EP 
mRNA has reduced. More experiments are necessary to corroborate the 
interaction of these two candidates with the EP mRNA. 
 
The results in Table 4 were sorted for proteins with more than 1.5-fold 
enrichment for all replicates, but most of the proteins found are enriched only 
in two replicates. This indicates the necessity of more replicates for the 
selection of candidates. It might also imply that the samples are in the 
detection limit of mass-spectrometry.  
 
Two hypothetical proteins, Tb927.7.4500 and Tb927.8.1270 were found to be 
more than two-fold enriched in three of the replicates. These two proteins do 
not contain any known functional domains but their mRNAs, judging by the 
ribosome profiling data available in Trytrip.db, indicates that are really 
express. It could be possible that some of these hypothetical proteins are 
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regulators of EP mRNA, the fact that no know RBP has been found to be 
implicated directly in the regulation of this mRNA supports this hypothesis.  
 
4.4 The RNA binding protein ZC3H38 as a possible mRNA regulator 
 
In parallel to my purification method I also started the characterization of an 
RBP found previously in a screen made in the laboratory [74]. In this screen, 
the ZC3H38 protein was implied to have a stabilizing effect on a reporter 
mRNA. The results of my tethering assay corroborate that the full length 
ZC3H38 protein stabilizes the reporter mRNA and increases the CAT activity 
(Figure 42). Also, it seems that the HNPY domain, which had previously been 
found to be a MKT1 interaction motif [108], might be responsible for the 
effects of this protein on the reporter mRNA. These preliminary results 
indicate that ZC3H38 can act as a potential mRNA regulator, stabilizing its 
target mRNAs upon binding. Further studies are being carried out to fully 
characterize this protein.   
 
4.5 Concluding remarks 
 
The main advantage of this method is that allows the purification of translating 
mRNPs and the detection of the proteins bound to them in vivo. Shown by the 
co-purification of V5-ZC3H11 and the HSP70 3’-UTR reporter, as well as by 
the detection of MKT1, which does not interact directly with the mRNAs. 
Another advantage is that all the components of the reporter mRNA can be 
changed, as it has been demonstrated in the present dissertation by the use 
of different 3’-UTRs. Furthermore, due to the fact that the 3SBPs-tag is in the 
N-terminus of the ORF, secondary structures present in the untranslated 
regions of the mRNA that might be important for regulation are not altered. 
 
However, this technique has its limitations, one of them is the excessive 
presence of peptides from abundant proteins such as mitochondrial and 
nuclear proteins and also proteins that bind in a nonspecific manner to the 
beads. It seems that blocking the beads with tRNA and heparin is not efficient 
enough to avoid the binding of such proteins. One partial solution could be the 
addition of DNases to the samples before loading onto the sucrose gradient, 
at least this way abundant nuclear proteins, which bind unspecifically to the 
beads should be separated before the affinity purification. 
 
The copy number of 3SBPs-CAT mRNAs was calculated to be 400 per cell, a 
number that is comparable to the tubulin mRNA, an abundant mRNA in the 
cell. These results showed that there is enough reporter produced in order to 
be translated and purified. Nevertheless, the main problem that my method 
confronted was the detection of the purified samples by mass spectrometry. It 
seems that the detection of the V5-tagged proteins by western blot gave more 
reproducible and quantitative results when comparing to mass-spectrometry. 
This might be possibly due to the high sensitivity and specificity of the used 
V5-antibody, whereas in mass-spectrometry the peptides for an RBP can be 
masked by peptides of other abundant proteins. Although, the use of sucrose 
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gradient centrifugation combined with the affinity purification eliminates most 
of the contaminants, there are still some present. It seems that the affinity-
purified samples are in the limit of detection for mass-spectrometry. In this 
case the generation of replicates as well as the quantification of the protein 
signals in Western blot is of vital importance.  
 
As a final remark, I would like to point out that this work shows the 
development of an in vivo method, which allows the purification of translating 
mRNAs and the detection, at least by Western blot, of the protein components 
of a specific mRNP.  
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6. Supplementary material 
Supplementary table 1: Proteins found in the HSP70 3’-UTR purification  
Three gel pieces were send to mass-spectrometry in order to find the proteins that 
co-purified with the 3SBP-CAT-HSP70 3’-UTR reporter. 
 
Accession Description 
Peptide counts 
gel 1 gel 2 gel 3 
Tb927.8.7100 acetyl-CoA carboxylase, putative 104 115 116 
Tb927.9.6460 hypothetical protein, conserved 70 74 75 
Tb927.2.4230 Nucleoporin NUP-1 protein, putative 63 65 66 
Tb927.7.6670 hypothetical protein, conserved 56 63 64 
Tb927.8.3950 hypothetical protein, conserved 53 60 61 
Tb927.4.2880 Nucleoporin (TbNup225) 49 54 55 
Tb927.10.6400 chaperonin HSP60, mitochondrial precursor 53 51 52 
Tb927.11.330 Nucleoporin (TbMlp-1) 43 48 49 
Tb927.11.980 Nucleoporin (TbNup158) 46 46 47 
Tb927.5.3400 calcium-translocating P-type ATPase, calcium pump 45 28 29 
Tb927.11.2650 heat shock protein 84, putative, mit HSp90 41 18 19 
Tb927.11.2950 Nucleoporin (TbNup89) 36 40 41 
Tb927.11.1900 
T-complex protein 1, beta subunit, putative (TCP-1-
beta) 
40 33 34 
Tb927.6.3750 
heat shock 70 kDa protein, mitochondrial precursor, 
putative 
40 36 37 
Tb927.9.10770 PABP2 32 38 39 
Tb927.4.4490 
multidrug resistance protein E,p-glycoprotein 
(MRPE) 
39 11 12 
Tb927.10.2100 EF1-alpha elongation factor 1-alpha, (TEF1) 38 20 21 
Tb927.6.890 hypothetical protein, conserved 37 24 25 
Tb927.11.11330 heat shock protein 70, major HSP70 37 31 32 
Tb927.10.7060 
nucleoporin interacting component (NUP93), 
putative 
30 35 36 
Tb927.10.9650 hypothetical protein, conserved 32 35 36 
Tb927.9.5900 glutamate dehydrogenase (GDH) 35 14 15 
Tb927.7.2300 Nucleoporin (TbNup132) 27 34 35 
Tb927.10.10900 heat shock protein 83, HSP83 35 13 14 
Tb927.9.9290 PABP1 33 26 27 
Tb927.11.6630 
3-methylcrotonoyl-CoA carboxylase beta subunit, 
putative 
31 32 33 
Tb927.10.8170 Nucleoporin  (NUP155) 32 16 17 
Tb927.9.2470 nucleolar protein (NOP86) 18 31 32 
Tb927.10.1510 NOT1 32 10 11 
Tb927.9.8820 
hypothetical protein, conserved, no yeast or human 
match 
31 27 28 
Tb927.9.11150 hypothetical protein, conserved 28 30 31 
Tb927.11.7460 BiP 30 22 23 
Tb927.11.6280 pyruvate phosphate dikinase (PPDK) 29 1 2 
Tb927.11.3600 40S ribosomal protein S4 29 24 25 
Tb927.10.4570 EF2 elongation factor 2 29 12 13 
Tb927.9.12570 glycerol kinase, glycosomal (glk1) 29 27 28 
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Tb927.11.15040 chaperonin HSP60, mitochondrial precursor 17 27 28 
Tb927.7.4900 XRNA 27 1 2 
Tb927.4.1800 Mitochondrial LSU ribosomal protein L3 27 22 23 
Tb927.4.4310 Nucleoporin (TbNup64) 22 25 26 
Tb927.3.3130 POMP24 25 6 7 
Tb927.4.590 
hypothetical protein, quinoprotein alchohol 
dehydrogenase-like domain 
25 16 17 
Tb927.11.15990 Nucleoporin  (TbNup109) 25 23 24 
Tb927.3.3180 Nucleoporin (TbNup98) 22 24 25 
Tb927.9.6170 arginine kinase (AK) in cytosol and flagellum 25 1 2 
Tb927.8.650 cation-transporting ATPase, putative 24 3 4 
Tb927.11.7290 pantothenate kinase subunit, putative 24 5 6 
Tb927.11.15370 hypothetical protein, conserved (TbKap123) 20 23 24 
Tb927.11.11360 
guanine nucleotide-binding protein beta subunit- like 
protein (TRACK) 
24 18 19 
Tb927.3.5050 60S ribosomal protein L4 24 19 20 
Tb927.9.14240 Nucleoporin (Nup82) 20 23 24 
Tb927.10.7680 GTPase activating protein, putative 24 17 18 
Tb927.2.4550 FtsJ cell division protein, putative (30M24.305) 7 22 23 
Tb927.11.11460 POMP9 23 10 11 
Tb927.10.1060 
T-complex protein 1, delta subunit, putative (TCP-1-
delta) 
23 7 8 
Tb927.3.3270 ATP-dependent phosphofructokinase (TbPFK) 23 13 14 
Tb927.11.16760 
T-complex protein 1, alpha subunit, putative (TCP-1-
alpha) 
23 17 18 
Tb927.5.440 trans sialidase, putative 17 22 23 
Tb927.9.11270 
T-complex protein 1, eta subunit, putative, (TCP-1-
eta) 
23 16 17 
Tb927.1.2370 beta tubulin 22 22 23 
Tb927.8.2630 
Kinesin KIN-C. Trypanosome-specific kinesin family 
2 
19 21 22 
Tb927.2.4400 Mitchondrial SSU ribosomal protein 20 21 22 
Tb927.11.4320 hypothetical protein, conserved, PF02622 DUF179 22 1 2 
Tb927.9.9660 
Archaic translocase of the outer mitochondrial 
membrane ATOM 
22 17 18 
Tb927.10.6050 clathrin heavy chain (CHC) 14 21 22 
Tb927.2.5610 POMP22 22 5 6 
Tb927.8.1590 TOM1, HECT ubiquitin-protein ligase 22 1 2 
Tb927.9.6230 arginine kinase (AK) 6 20 21 
Tb927.7.990 chaperone protein DNAj, putative 15 20 21 
Tb927.11.3240 
T-complex protein 1, zeta subunit, putative (TCP-1-
zeta) 
21 14 15 
Tb927.10.2900 importin beta-1 subunit, putative 18 20 21 
Tb927.8.4820 eIF4G3 21 14 15 
Tb927.3.1380 ATP synthase F1, alpha subunit 21 15 16 
Tb927.7.900 hypothetical protein, conserved 21 14 15 
Tb927.9.1410 hypothetical protein, conserved 16 20 21 
Tb927.10.12500 P-type H -ATPase, putative 9 20 21 
Tb927.11.7380 
glycerol-3-phosphate dehydrogenase (FAD-
dependent), mitochondrial 
20 11 12 
Tb927.4.3950 
cytoskeleton-associated protein CAP5.5, 
putative,cysteine peptidase 
13 19 20 
Tb927.11.7780 POMP16 20 14 15 
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Tb927.10.14710 40S ribosomal protein S2 20 17 18 
Tb927.11.13180 POMP10 20 11 12 
Tb927.10.8940 hypothetical protein, conserved 20 12 13 
Tb927.10.14830 mitochondrial carrier protein, MCP5b 20 17 18 
Tb927.10.3940 40S ribosomal protein S3A 20 16 17 
Tb927.7.7420 ATP synthase F1, alpha subunit 20 16 17 
Tb927.3.4760 dynamin, putative,vacuolar sortin protein 1, putative 17 19 20 
Tb927.2.3030 
ATP-dependent Clp protease subunit, heat shock 
protein 78 (HSP78) 
20 12 13 
Tb927.10.8080 hypothetical protein, conserved 19 3 4 
Tb927.5.1060 
mitochondrial processing peptidase, beta subunit, 
MMPbeta 
19 14 15 
Tb927.11.2340 hypothetical protein, conserved 13 18 19 
Tb927.11.2050 60S acidic ribosomal subunit 19 15 16 
Tb927.9.8880 actin A 19 16 17 
Tb927.10.3260 
Long-chain-fatty-acid--CoA ligase 5, Acyl-CoA 
synthetase 5  (LACS 5) 
19 17 18 
Tb927.3.2050 
hypothetical protein, conserved, no domains, 
poly(Q) tracts, K-specific 
18 5 6 
Tb927.8.3150 
T-complex protein 1, gamma subunit, putative (TCP-
1-gamma) 
18 11 12 
Tb927.11.1250 
kinetoplast poly(A) polymerase complex 1 subunit, 
MIT ssu-associated 
16 17 18 
Tb927.4.2850 hypothetical protein, conserved 18 11 12 
Tb927.10.13500 60S ribosomal protein L10a 18 15 16 
Tb927.9.15150 60S ribosomal protein L5 18 15 16 
Tb927.10.7700 ABC transporter, putative 4 17 18 
Tb927.7.6850 trans-sialidase (TbTS) 14 16 17 
Tb927.8.5200 Mitchondrial SSU ribosomal associated 17 14 15 
Tb927.10.560 40S ribosomal protein S11 2 16 17 
Tb927.11.9780 hypothetical protein, conserved 10 16 17 
Tb11.02.5420 
NADPH--cytochrome p450 reductase, putative 
(CPR) 
17 5 6 
Tb927.10.7410 
succinyl-CoA ligase [GDP-forming] beta-chain, 
putative 
15 16 17 
Tb927.7.2680 ZC3H22 17 11 12 
Tb927.7.1730 60S ribosomal protein L7 17 15 16 
Tb927.11.11080 Nucleoporin (TbNup149) 17 12 13 
Tb927.11.2610 
hypothetical protein, conserved, no domains, no 
yeast or human match 
17 7 8 
Tb927.10.11540 40S ribosomal protein S3 17 15 16 
Tb927.11.14020 RNA-binding protein (NRBD2) 16 16 17 
Tb927.7.2170 hypothetical protein, conserved 4 16 17 
Tb927.3.5370 hypothetical protein, conserved 17 5 6 
Tb927.4.4940 hypothetical protein, conserved 16 16 17 
Tb927.7.710 heat shock 70 kDa protein, putative (HSP70.4) 16 10 11 
Tb927.11.5500 mitochondrial RNA binding protein 1 KRIPP1 (PPR) 12 15 16 
Tb927.3.3300 hypothetical protein, conserved 16 14 15 
Tb927.11.14730 
metalloprotease, putative,cell division protein FtsH 
homologue, putative 
16 9 10 
Tb927.10.5770 valosin-containing protein homolog 16 3 4 
Tb927.9.8070 60S ribosomal protein L10 16 13 14 
Tb927.9.2590 hypothetical protein, conserved 16 1 2 
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Tb927.8.1270 hypothetical protein, conserved 11 15 16 
Tb927.8.1740 Mitochondrial tRNA import 16 14 15 
Tb927.10.4430 PUF1 16 7 8 
Tb927.11.10760 
KIN-D kinesin, associated with sub-pellicular 
microtubules, essential 
11 15 16 
Tb927.7.210 proline dehydrogenase 16 12 13 
Tb927.8.1330 60S ribosomal protein L7a 13 15 16 
Tb927.2.2520 voltage-dependent anion-selective channel 16 15 16 
Tb927.10.8030 Mitochondrial ATP synthase subunit, putative 16 5 6 
Tb927.10.4310 prohibitin 2, putative (PHB2) 12 15 16 
Tb927.6.4280 
glyceraldehyde 3-phosphate dehydrogenase, 
glycosomal (GAPDH) 
16 15 16 
Tb927.1.1930 TbTOR4 = TOR-like 2 16 1 2 
Tb927.11.13520 hypothetical protein, conserved 15 8 9 
Tb927.7.6090 hypothetical protein, conserved 15 14 15 
Tb927.6.2010 hypothetical protein, conserved 11 14 15 
Tb927.10.1100 60S ribosomal protein L9 15 13 14 
Tb927.9.14160 
rieske iron-sulfur protein, mitochondrial precursor 
(RISP) 
15 4 5 
Tb927.7.3550 
hypothetical protein, conserved, no yeast or human 
match 
7 14 15 
Tb927.11.10150 Mitchondrial SSU ribosomal protein 15 6 7 
Tb927.9.4190 fatty acyl CoA syntetase 1 (ACS1) 15 11 12 
Tb927.11.3790 hypothetical protein, conserved 15 9 10 
Tb927.8.1870 Golgi/lysosome glycoprotein 1 (tGLP1) 15 12 13 
Tb927.6.3630 Sphingosine-1-phosphate lyase 11 14 15 
Tb927.7.5020 60S ribosomal protein L19 15 14 15 
Tb927.11.6210 sterol 14-alpha-demethylase (CYP51) 15 11 12 
Tb927.10.11390 60S ribosomal protein L6 15 12 13 
Tb927.9.8410 chaperone protein DNAj, putative 11 14 15 
Tb927.11.3980 
mitochondrial processing peptidase alpha subunit, 
MMPalpha 
15 11 12 
Tb927.9.11600 
Gim5B protein,glycosomal membrane protein 
(gim5B) 
7 14 15 
Tb927.9.3630 hypothetical protein, conserved 15 4 5 
Tb927.11.16280 60S ribosomal protein L2 L8 13 14 15 
Tb927.10.5340 40S ribosomal protein S18 12 14 15 
Tb927.10.5610 40S ribosomal protein S9 12 14 15 
Tb927.10.5620 fructose-bisphosphate aldolase, glycosomal (ALD) 15 1 2 
Tb927.5.930 NADH-dependent fumarate reductase (FRDg) 15 1 2 
Tb927.11.3490 
hypothetical protein, conserved, no domains, no 
good BLASTp matches 
14 3 4 
Tb927.10.10850 AGO1 14 9 10 
Tb927.10.3840 60S ribosomal protein L18 11 13 14 
Tb927.5.2930 Mitochondrial ATP synthase subunit, putative 14 10 11 
Tb927.3.2600 ATP-dependent DEAD/H RNA helicase, putative 14 1 2 
Tb927.11.5560 hypothetical protein, conserved 14 8 9 
Tb927.5.520 stomatin-like protein, putative 13 13 14 
Tb927.6.1870 eIF4E4 14 8 9 
Tb927.10.14180 protein transport protein Sec13, putative 12 13 14 
Tb927.9.4680 eIF4A1 14 8 9 
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Tb927.3.1120 GTP-binding nuclear protein rtb2, putative (rtb2) 14 13 14 
Tb927.9.3760 poly(A) export protein, putative (TbGLE2) 9 13 14 
Tb927.3.3540 Nucleoporin (TbNup53b) 10 13 14 
Tb927.5.1610 60S ribosomal protein L13a 13 13 14 
Tb927.10.15760 
hypothetical protein, conserved, in flagellar 
proteomes 
14 12 13 
Tb927.11.6300 40S ribosomal protein S5 12 13 14 
Tb927.7.5170 60S ribosomal protein L23a or L25 14 11 12 
Tb927.11.15900 60S ribosomal protein L27 9 13 14 
Tb927.3.3320 60S ribosomal protein L13 14 12 13 
Tb927.9.11110 
PRP8 protein homologue,U5 snRNA-associated 
splicing factor 
14 1 2 
Tb927.10.1170 intraflagellar transport protein IFT172 14 3 4 
Tb927.9.6310 ABC transporter, putative 5 13 14 
Tb927.10.3170 ABC transporter, putative 14 4 5 
Tb927.3.1300 
hypothetical protein, conserved, no domains, no 
yeast or human match 
14 7 8 
Tb927.9.13380 phosphoinositide-binding protein, putative 13 11 12 
Tb927.8.2160 
multidrug resistance protein A,p-glycoprotein 
(PGPA) 
13 8 9 
Tb927.2.5980 
ATP-dependent Clp protease subunit, heat shock 
protein 104 (HSP104) 
13 4 5 
Tb927.4.1850 hypothetical protein, conserved 13 6 7 
Tb927.7.4500 hypothetical protein, conserved 13 7 8 
Tb927.7.3940 mitochondrial carrier protein, MCP16 13 5 6 
Tb927.11.3120 nucleolar GTP-binding protein 1 (NOG1) 10 12 13 
Tb927.3.3460 hypothetical protein, conserved (SDH5 in T cruzi) 13 4 5 
Tb927.9.15460 calcium motive p-type ATPase, putative 5 12 13 
Tb927.6.4320 hypothetical protein, conserved 13 3 4 
Tb927.7.2670 ZC3H21 8 12 13 
Tb927.11.4910 
hypothetical protein, conserved,predicted ankyrin 
repeat family protein 
13 4 5 
Tb927.3.4580 hypothetical protein, conserved 13 6 7 
Tb927.8.6580 succinate dehydrogenase flavoprotein, SDH1 13 9 10 
Tb927.5.1210 short-chain dehydrogenase, putative 13 8 9 
Tb927.5.1300 
vacuolar proton translocating ATPase subunit A, 
putative 
8 12 13 
Tb927.9.10310 mitochondrial carrier protein, MCP11 13 10 11 
Tb927.8.6970 
3-methylcrotonyl-CoA carboxylase alpha subunit, 
putative 
10 12 13 
Tb927.8.8310 chaperone protein DNAj, putative 13 4 5 
Tb927.8.4810 prohibitin 1 (PHB1) 13 12 13 
Tb927.8.6250 hypothetical protein, conserved 11 12 13 
Tb927.6.4090 chaperonin HSP60, mitochondrial precursor 13 8 9 
Tb927.9.3990 40S ribosomal protein S7 13 12 13 
Tb927.11.4820 60S ribosomal protein L17 10 12 13 
Tb927.10.13280 
GCN1 homologue, possibly involved in translation 
control 
13 10 11 
Tb927.3.1790 pyruvate dehydrogenase E1 beta subunit, putative 13 1 2 
Tb927.10.9440 NADH dehydrogenase (54 NDH2) 13 7 8 
Tb927.4.1020 Serine palmitoyltransferase 13 5 6 
Tb927.7.4760 hypothetical protein, conserved 11 12 13 
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Tb927.4.4380 
vacuolar-type proton translocating pyrophosphatase 
1, putative (PPase1) 
9 11 12 
Tb927.10.11760 PUF6 12 11 12 
Tb927.2.5240 PRP19-like protein, putative (TbPRP19) 12 5 6 
Tb927.11.2600 hypothetical protein, conserved 12 8 9 
Tb927.3.3940 DRBD11 12 9 10 
Tb927.10.3990 DHH1 12 5 6 
Tb927.10.13510 zinc metallopeptidase, putative 12 3 4 
Tb927.11.16730 dihydrolipoyl dehydrogenase (GCVL-2) 12 1 2 
Tb927.11.8060 hypothetical protein, conserved 12 1 2 
Tb927.9.8950 
CAAX prenyl protease 1, putative,metallo- 
peptidase, Clan M- Family M48 
12 10 11 
Tb927.1.4100 cytochrome oxidase subunit IV (COXIV) 12 9 10 
Tb927.10.12840 mitochondrial carrier protein, MCP12 12 8 9 
Tb927.10.8190 T-complex protein 1, theta subunit, (TCP-1-theta) 12 11 12 
Tb927.10.540 ATP-dependent DEAD/H RNA helicase, DDX39-like 12 4 5 
Tb927.9.11220 Mitochondrial tRNA import 12 6 7 
Tb927.6.3050 aldehyde dehydrogenase family, putative 12 9 10 
Tb927.10.14550 DED1-1, ATP-dependent DEAD/H RNA helicase, 12 9 10 
Tb927.11.6430 hypothetical protein, conserved 12 3 4 
Tb927.10.3660 aspartate aminotransferase 12 1 2 
Tb927.3.1840 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 12 9 10 
Tb927.8.4330 small GTP-binding protein Rab11 (RAB11) 12 1 2 
Tb927.11.6440 
hypothetical protein, conserved, Bromodomain and 
poly(Q) 
9 11 12 
Tb927.6.2640 importin alpha subunit, putative (TbKap60) 12 10 11 
Tb927.11.680 60S ribosomal protein L21e 12 11 12 
Tb927.4.2180 60S ribosomal protein L35a 10 11 12 
Tb927.11.11820 40S ribosomal protein S17 7 11 12 
Tb927.7.1040 40S ribosomal protein S16 7 11 12 
Tb927.9.8200 PES1 5 11 12 
Tb927.10.13250 hypothetical protein, conserved 12 1 2 
Tb927.11.9890 
signal recognition particle receptor alpha subunit, 
putative 
12 1 2 
Tb927.5.900 oligosaccharyl transferase subunit, putative 12 1 2 
Tb927.6.3500 
RME8 endosomal trafficking protein, clathrin-
associated 
12 1 2 
Tb927.8.5760 hypothetical protein, conserved 12 1 2 
Tb927.8.5770 Elongator-like Protein 3a ELP3a 12 1 2 
Tb927.9.10010 Sec63 homologue, chaperone protein DNAj 12 1 2 
Tb927.9.1780 sec1 family transport protein, putative (SLY1) 12 1 2 
Tb927.2.2970 mitochondrial carrier protein, MCP13 11 4 5 
Tb927.9.12200 60S ribosomal protein L31 9 10 11 
Tb927.4.4210 
ATP-dependent zinc metallopeptidase, 
putative,metallo-peptidase 
11 5 6 
Tb927.4.1540 
POMP27, NAD-dependent epimerase, aldehyde 
reductase 
11 6 7 
Tb927.3.3150 hypothetical protein, conserved 11 4 5 
Tb927.4.3300 
mitochondrial ATP-dependent zinc 
metallopeptidase, putative 
11 4 5 
Tb927.10.520 Mitochondrial ATP synthase subunit, putative 11 8 9 
Tb927.4.5200 nucleoporin (NUP54/57, TbNup62) 10 10 11 
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Tb927.11.4980 
ATP-dependent DEAD/H RNA helicase,  putative 
Dbp9 
6 10 11 
Tb927.10.15310 
hypothetical protein, conserved, linked to 
melarsoprol resistance 
11 10 11 
Tb927.11.11680 
2-oxoglutarate dehydrogenase E2 component, 
putative 
11 6 7 
Tb927.9.7590 60S ribosomal protein L11 8 10 11 
Tb927.11.10790 40S ribosomal protein SA 11 9 10 
Tb927.10.3810 hypothetical protein, in UPF1-TAP 6 10 11 
Tb927.11.4540 nucleoporin 48 (TbNup48) 8 10 11 
Tb927.8.6150 40S ribosomal protein S8 9 10 11 
Tb927.11.2530 mitochondrial RNA binding complex 1 subunit 7 10 11 
Tb927.10.6910 Sterol methyltransferase, putative 11 8 9 
Tb927.11.6740 PUF10 1 10 11 
Tb927.11.9980 
2-oxoglutarate dehydrogenase E1 component, 
putative 
10 8 9 
Tb927.11.14980 Mitchondrial LSU ribosomal protein 5 9 10 
Tb927.10.180 ATP synthase F1 subunit gamma protein, putative 10 3 4 
Tb927.8.1420 
acyl-CoA dehydrogenase, mitochondrial precursor, 
putative 
10 6 7 
Tb927.1.2990 PPR2 10 7 8 
Tb927.7.5230 lanosterol synthase 10 5 6 
Tb927.3.3580 lipophosphoglycan biosynthetic protein 10 1 2 
Tb927.2.2440 
proteasome regulatory non-ATPase subunit 6 
(RPN6) 
10 4 5 
Tb927.11.1980 ZC3H41 10 3 4 
Tb927.11.1450 
2-oxoglutarate dehydrogenase E1 component, 
putative 
10 3 4 
Tb927.4.1920 GPI transamidase, putative (TbGPI16) 10 5 6 
Tb927.8.890 small GTP-binding protein Rab1, putative 10 6 7 
Tb927.10.2320 hypothetical protein, conserved 10 7 8 
Tb927.10.12960 
ras-related protein rab-5,small GTPase, putative 
(RAB5A) 
10 5 6 
Tb927.7.3440 EF hand protein 10 9 10 
Tb927.11.10510 ubiquinone biosynthesis methyltransferase, putative 10 7 8 
Tb927.10.12700 pyruvate dehydrogenase E1 alpha subunit, putative 10 6 7 
Tb927.10.15520 signal recognition particle protein, putative 10 4 5 
Tb927.6.4440 RBP42 10 9 10 
Tb927.5.1810 lysosomal/endosomal membrane protein p67 (p67) 10 4 5 
Tb927.4.1860 40S ribosomal protein S19 10 9 10 
Tb927.10.8430 40S ribosomal protein S12 9 9 10 
Tb927.3.5520 
26S proteasome regulatory non-ATPase subunit 
(RPN1) 
10 4 5 
Tb927.10.14620 hypothetical protein, conserved 10 3 4 
Tb927.3.5430 hypothetical protein, conserved 10 3 4 
Tb927.10.14150 
hypothetical protein, conserved, related to yeast 
BFR1 
10 1 2 
Tb927.5.3800 
glutamine hydrolysingcarbomoyl phosphate 
synthase, putative 
10 1 2 
Tb927.9.11380 60S ribosomal protein L23 9 9 10 
Tb927.3.3190 
serine/threonine-protein kinase, putative,protein 
kinase, putative 
10 7 8 
Tb927.8.6640 hypothetical protein, conserved 10 4 5 
Tb927.4.2080 
CC2D is a FAZ-ER protein, also present on the 
basal bodies. 
6 8 9 
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Tb927.7.3050 Mitchondrial SSU ribosomal associated 6 8 9 
Tb927.5.2530 hypothetical protein, conserved 1 8 9 
Tb927.6.1430 hypothetical protein, conserved 9 4 5 
Tb927.5.1580 ZC3H13 9 6 7 
Tb927.10.6850 
MItochondrial SSU S18 or kinetoplast poly(A) 
polymerase complex 1 sub 
9 5 6 
Tb927.11.15430 
U5 small nuclear ribonucleoprotein U5-116K, 
putative 
9 5 6 
Tb927.11.11690 
vacuolar ATP synthase subunit b, putative,v- 
ATPase B sub 
4 8 9 
Tb927.11.11480 Trichohyalin, putative 1 8 9 
Tb927.10.470 choline dehydrogenase, putative 9 3 4 
Tb927.11.13090 EF1 gamma, elongation factor 1 gamma, putative 9 1 2 
Tb927.11.10690 hypothetical protein, conserved 9 5 6 
Tb927.7.2240 hypothetical protein, conserved 9 6 7 
Tb927.8.8050 Nucleoporin (TbNup75) 9 8 9 
Tb927.10.2240 NTF2-like domain, in Y14 TAP 9 5 6 
Tb927.10.6640 
COP-coated vesicle membrane protein erv25 
precursor, 
9 1 2 
Tb927.10.600 Mitchondrial LSU ribosomal protein 5 8 9 
Tb927.6.4200 Mitchondrial LSU ribosomal protein 3 8 9 
Tb927.7.6260 hypothetical protein, conserved 9 1 2 
Tb927.1.860 hypothetical protein, conserved 9 1 2 
Tb927.6.5040 60S ribosomal protein L15 8 8 9 
Tb927.10.7570 
dihydrolipoamide acetyltransferase E2 subunit, 
putative 
9 4 5 
Tb927.11.9320 hypothetical protein, conserved 9 8 9 
Tb927.10.5370 40S ribosomal protein S10 8 8 9 
Tb927.11.4300 60S ribosomal protein L18 8 8 9 
Tb927.7.2340 40S ribosomal protein S15 8 8 9 
Tb927.11.3230 60S ribosomal protein L44 7 8 9 
Tb927.11.6200 60S ribosomal protein L28 7 8 9 
Tb927.9.14370 60S ribosomal protein L26 6 8 9 
Tb927.10.10570 histone H2B 5 8 9 
Tb927.11.14170 hypothetical protein, conserved 9 4 5 
Tb927.10.4110 60S ribosomal protein L30 3 8 9 
Tb927.10.6300 Mitchondrial SSU ribosomal protein S5 9 3 4 
Tb927.8.1720 Phosphatidylglycerophosphate synthase 9 1 2 
Tb927.9.4500 HSP70, endoplasmatic reticulum, HSP70.a 9 1 2 
Tb927.6.1920 hypothetical protein, conserved 9 1 2 
Tb927.3.3030 
hypothetical protein, conserved, START (lipid-
binding) domain 
9 1 2 
Tb927.5.4040 Mitchondrial SSU ribosomal associated (coiled coil) 8 6 7 
Tb927.11.5060 Mitchondrial SSU ribosomal protein 6 7 8 
Tb927.9.12730 chaperone protein DNAj, endoplasmatic reticulum 8 4 5 
Tb927.11.6000 Mitchondrial LSU ribosomal protein 4 7 8 
Tb927.11.10370 glycosyl hydrolase-like protein 4 7 8 
Tb927.2.3180 TbPPR1 mitochondrial RNA binding protein 1 6 7 8 
Tb927.10.380 PPR5 mitochondrial RNA binding protein 1 4 7 8 
Tb927.9.2900 hypothetical protein, conserved 4 7 8 
Tb927.7.2410 hypothetical protein, conserved 8 1 2 
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Tb927.3.5340 Hsc70-interacting protein (Hip), putative 8 1 2 
Tb927.7.5820 Monooxygenase, putative 8 6 7 
Tb927.2.3370 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase 
6 7 8 
Tb927.9.11120 Mitchondrial SSU ribosomal associated 8 6 7 
Tb927.10.1450 hypothetical protein, conserved, in bilobe 8 4 5 
Tb927.3.4920 LETM1 and EF-hand domain-containing protein 1 8 4 5 
Tb927.11.5400 signal recognition particle 54 kDa (SRP54) 8 4 5 
Tb927.9.9630 hypothetical protein, conserved 8 3 4 
Tb927.11.1840 hypothetical protein, conserved 8 3 4 
Tb927.10.15410 glycosomal malate dehydrogenase (gMDH) 8 1 2 
Tb927.11.14250 
T-complex protein 1, epsilon subunit, putative (TCP-
1-epsilon) 
8 3 4 
Tb927.11.13230 TbVAP, flagellar attachment zone 8 3 4 
Tb927.9.8740 DRBD3 (PTB1) 8 1 2 
Tb927.9.5320 nucleolar RNA binding protein, putative (28G16.220) 4 7 8 
Tb927.5.1520 heat shock protein HslU1, in mitochondrion 8 1 2 
Tb927.7.2640 hypothetical protein, conserved 8 5 6 
Tb927.2.2130 
small GTP-binding protein RAB6, putative 
(25N14.200) 
8 1 2 
Tb927.8.4500 eIF4G5 6 7 8 
Tb927.8.2460 hypothetical protein, conserved 8 7 8 
Tb927.10.3640 hypothetical protein, conserved 7 7 8 
Tb927.11.2300 
ERF1 eukaryotic peptide chain release factor 
subunit 1, putative 
8 3 4 
Tb927.3.4380 Tob55, SAM50 8 6 7 
Tb927.6.3930 Mitchondrial LSU ribosomal protein 4 7 8 
Tb927.6.1770 kinesin 6 7 8 
Tb927.11.7140 cell cycle sequence binding phosphoprotein CSB)II 8 1 2 
Tb927.9.4310 tricarboxylate carrier, putative 8 6 7 
Tb927.7.2190 hypothetical protein, conserved 8 4 5 
Tb927.4.2070 antigenic protein, putative 8 4 5 
Tb927.8.5640 Homologue of T. cruzi Complex II subunit SDH6 8 1 2 
Tb927.5.3980 Mitchondrial LSU ribosomal protein 8 7 8 
Tb927.11.5450 malic enzyme 8 1 2 
Tb927.7.5940 Protein Associated with Differentiation (TbPAD2) 8 7 8 
Tb927.6.720 60S ribosomal protein L14 7 7 8 
Tb927.2.5910 40S ribosomal protein S13 8 6 7 
Tb927.11.6140 40S ribosomal protein S15A 4 7 8 
Tb927.11.6250 Mitochondrial ATP synthase subunit, putative 8 5 6 
Tb927.11.14960 PUF7 1 7 8 
Tb927.2.3990 hypothetical protein, conserved 8 1 2 
Tb927.5.2290 
U5 splicing factor U5-200K, putative or BRR2 
homologue 
8 1 2 
Tb927.8.2770 IP3 inositol trisphosphate receptor. 8 1 2 
Tb927.9.15290 hypothetical protein, conserved 8 1 2 
Tb927.10.1070 cdc2- like protein kinase (CRK1) 8 1 2 
Tb927.10.13360 EF-Tu Mitochondrial elongation factor Tu 7 7 8 
Tb927.11.15560 Nucleoporin (TbNup53a) 8 7 8 
Tb927.11.2410 Flabarin, flagellar membrane protein in Leishmania 7 7 8 
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Tb927.9.11000 
small GTPase, putative,GTP-binding protein, 
putative (RAB7) 
8 6 7 
Tb927.10.9910 hypothetical protein, conserved 8 3 4 
Tb927.11.3740 proteasome regulatory ATPase subunit 2 (RPT2) 8 3 4 
Tb927.10.4080 hypothetical protein, conserved 8 3 4 
Tb927.11.13500 paraflagellar rod protein  par1 8 1 2 
Tb927.10.15850 PEX12 peroxisome assembly protein 8 6 7 
Tb927.2.280 retrotransposon hot spot protein 2 (RHS2), putative 6 7 8 
Tb927.2.470 retrotransposon hot spot protein 4 (RHS4), putative 8 5 6 
Tb927.1.180 retrotransposon hot spot protein 1 (RHS1), putative 8 5 6 
Tb927.3.1010 
hypothetical protein, conserved, Trypanosoma-
specific 
7 1 2 
Tb927.7.270 ribosome biogenesis protein, putative 1 6 7 
Tb927.11.6510 40S ribosomal protein S21 5 6 7 
Tb927.7.4290 
Nuclear migration protein NudC (animals), 46% 
identity 
7 1 2 
Tb927.5.1790 Mitchondrial SSU ribosomal protein 7 3 4 
Tb927.10.13730 60S ribosomal protein L7 1 6 7 
Tb927.6.1900 
U3/U14 snoRNA-associated small subunit rRNA 
processing protein 
7 1 2 
Tb927.4.2000 
ruvB-like DNA helicase, putative,ATP-dependent 
DNA helicase, putative 
7 4 5 
Tb927.6.1470 hypothetical protein, conserved 7 6 7 
Tb927.11.540 ABC transporter, putative 7 5 6 
Tb927.9.7170 Mitchondrial LSU ribosomal protein 5 6 7 
Tb927.10.10360 microtubule-associated protein, putative 2 6 7 
Tb927.11.1680 vesicular-fusion protein SEC18, putative 7 1 2 
Tb927.9.5040 cAMP-specific phosphodiesterase (PDEB1) 7 1 2 
Tb927.4.1300 Amidinotransferase superfamily protein 7 3 4 
Tb927.7.3500 glutathione-S-transferase/glutaredoxin, putative 7 3 4 
Tb927.10.9900 ABC1 protein, putative 7 4 5 
Tb927.10.4850 hypothetical protein, conserved 1 6 7 
Tb927.9.2650 POMP2 7 6 7 
Tb927.3.3560 hypothetical protein, conserved 1 6 7 
Tb927.9.2620 hypothetical protein, conserved 7 6 7 
Tb927.6.2790 L-threonine 3-dehydrogenase, putative 7 1 2 
Tb927.3.5610 ribosomal protein L3 mitochondrial, putative 4 6 7 
Tb927.5.4420 nucleolar RNA helicase 2 human, DDX50 Mouse 6 6 7 
Tb927.11.13470 hypothetical protein, conserved 7 1 2 
Tb927.9.1380 hypothetical protein, conserved 7 6 7 
Tb927.1.3070 hypothetical protein, conserved, poly(Q), poly(H) 7 3 4 
Tb927.9.15360 40S ribosomal protein S6 7 5 6 
Tb927.6.1500 1-Alkyl-dihydroxyacetonephosphate synthase 7 3 4 
Tb927.5.3810 
orotidine-5-phosphate decarboxylase/orotate 
phosphoribosyltransferase 
7 3 4 
Tb927.10.190 40S ribosomal protein S6 7 6 7 
Tb927.8.3530 
glycerol-3-phosphate dehydrogenase [NAD ], 
glycosomal 
7 1 2 
Tb927.11.6870 14-3-3 protein 7 1 2 
Tb927.11.11090 Nucleoporin (TbNup140) 7 5 6 
Tb927.8.1570 hypothetical protein, conserved 7 3 4 
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Tb927.6.4980 40S ribosomal protein S14 7 6 7 
Tb927.7.320 RBP8 7 6 7 
Tb927.10.7330 40S ribosomal protein S24E 6 6 7 
Tb927.8.3060 
cytosolic leucyl aminopeptidase, putative,metallo-
peptidase, Clan MF, Family M17 
7 5 6 
Tb927.9.11470 60S ribosomal protein L27a 5 6 7 
Tb927.10.14010 
RP2 basal body protein, required for axoneme 
formation 
4 6 7 
Tb927.10.5460 60S ribosomal protein L24 4 6 7 
Tb927.11.8200 40S ribosomal protein S26 4 6 7 
Tb927.6.4370 eIF3 subunit 7-like protein 4 6 7 
Tb927.8.7340 trans-sialidase, putative,neuraminidase, putative 4 6 7 
Tb927.9.15420 60S ribosomal protein L32 4 6 7 
Tb927.4.3850 WDR12 3 6 7 
Tb927.8.1510 
ATP-dependent DEAD/H RNA helicase,  putative 
Dbp3 
3 6 7 
Tb927.10.8910 hypothetical protein, conserved 7 3 4 
Tb927.11.9220 
proteasome regulatory non-ATP-ase subunit 2 
(RPN2) 
7 3 4 
Tb927.9.14200 
hypothetical protein, possible component of 
cytochorome oxidase complex 
7 3 4 
Tb927.9.15090 cytosolic coat protein, putative 7 3 4 
Tb927.11.460 
hypothetical protein, conserved,predicted WD40 
repeat protein 
1 6 7 
Tb927.8.3520 hypothetical protein, conserved 1 6 7 
Tb927.10.15680 hypothetical protein, conserved 7 1 2 
Tb927.10.2890 enolase 7 1 2 
Tb927.10.5400 hypothetical protein, conserved 7 1 2 
Tb927.10.770 hypothetical protein, conserved 7 1 2 
Tb927.11.1070 glycosomal transporter (GAT3) 7 1 2 
Tb927.11.14700 hypothetical protein, conserved 7 1 2 
Tb927.11.4280 hypothetical protein, conserved 7 1 2 
Tb927.11.5220 chaperone protein DNAj, putative 7 1 2 
Tb927.2.5800 sedoheptulose-1,7-bisphosphatase (SBPase) 7 1 2 
Tb927.3.3450 ADP-ribosylation factor-like protein 3A, putative 7 1 2 
Tb927.3.750 hypothetical protein, conserved 7 1 2 
Tb927.4.4350 hypothetical protein, conserved 7 1 2 
Tb927.5.2080 guanosine monophosphate reductase, putative 7 1 2 
Tb927.6.2360 adenosine kinase, putative 7 1 2 
Tb927.9.3170 cytochrome oxidase subunit V (COXV) 7 1 2 
Tb927.10.8660 hypothetical protein, conserved 7 1 2 
Tb927.11.5290 mitochondrial carrier protein, MCP9 7 1 2 
Tb927.11.11520 PEX11 glycosomal membrane protein 7 5 6 
Tb927.8.1500 hypothetical protein, conserved 7 1 2 
Tb927.11.13080 hypothetical protein, conserved 4 6 7 
Tb927.9.12500 POMP7 7 4 5 
Tb927.10.15530 ABC transport system ATP-binding protein, putative 6 6 7 
Tb927.9.11840 hypothetical protein, conserved 7 3 4 
Tb927.1.120 retrotransposon hot spot protein 4 (RHS4), putative 7 5 6 
Tb927.10.4130 NADH-ubiquinone oxidoreductase complex I subunit 7 1 2 
Tb927.10.5930 protein kinase, putative 7 1 2 
  
142 
Tb927.10.12240 short-chain dehydrogenase, putative 7 1 2 
Tb927.8.1610 MSP-B, putative 7 6 7 
Tb927.8.6410 short-chain dehydrogenase, putative 5 6 7 
Tb927.11.14380 Kinetoplast polyadenylation/uridylation factor 2 7 3 4 
Tb927.1.2100 
calpain-like cysteine peptidase, putative,cysteine 
peptidase 
7 1 2 
Tb927.2.5160 chaperone protein DNAj, putative 7 6 7 
Tb927.10.2090 EF1-alpha elongation factor 1-alpha, (TEF1) 1 6 7 
Tb927.4.5350 3-methylcrotonyl-CoA carboxylase, pseudogene 6 4 5 
Tb927.2.2950 hypothetical protein, conserved 3 5 6 
Tb927.4.4670 hypothetical protein, conserved 6 3 4 
Tb927.1.2570 coatomer beta subunit (beta-coP) 6 1 2 
Tb927.3.1910 
hypothetical protein, conserved, histone RNA 
binding domain 259-326 
3 5 6 
Tb927.10.9810 hypothetical protein, conserved 6 1 2 
Tb927.8.1890 cytochrome c1 6 1 2 
Tb927.7.2400 
MCP1 Arc1p homologue, assists aa tRNA 
synthetases 
6 3 4 
Tb927.7.4310 hypothetical protein, conserved 6 3 4 
Tb927.9.6510 Mitchondrial SSU ribosomal associated 6 5 6 
Tb927.1.2410 beta tubulin, pseudogene 1 5 6 
Tb927.10.6320 
NOC3, nuclear export of ribosomes, assoc with 
NRG1 
1 5 6 
Tb927.10.14510 hypothetical protein, conserved 6 1 2 
Tb927.7.3980 immunodominant antigen, putative,tc40 antigen-like 6 1 2 
Tb927.2.4090 hypothetical protein, conserved 6 1 2 
Tb927.8.5460 
flagellar calcium-binding protein,44 kDa calflagin, 
(Tb-44) 
5 5 6 
Tb927.7.5700 pATOM36 6 4 5 
Tb927.4.1270 ruvB-like DNA helicase, putative 6 1 2 
Tb927.9.5890 
solanesyl-diphosphate synthase, putative 
(28G16.440) 
6 5 6 
Tb927.6.5070 hypothetical protein, conserved 6 1 2 
Tb927.10.510 LOK1=POMP19 Mitochondrial membrane formation 6 1 2 
Tb927.3.5240 
Mitchondrial SSU ribosomal associated KRIPP8 
(PPR) 
5 5 6 
Tb927.5.890 oligosaccharyl transferase subunit, putative 1 5 6 
Tb927.11.14090 hypothetical protein, conserved, 2 very weak RRMs 4 5 6 
Tb927.6.1090 proteasome regulatory ATPase subunit 3 (RPT3) 6 1 2 
Tb927.6.4740 importin-alpha re-exporter protein, putative 6 4 5 
Tb927.11.6230 pretranslocation protein, alpha subunit, SEC61 6 5 6 
Tb927.11.14460 
ADP-ribosylation factor GTPase activating protein 1, 
putative 
6 1 2 
Tb927.8.750 nucleolar RNA-binding protein, putative 6 5 6 
Tb927.10.2290 chaperone protein DNAj, endoplasmatic reticulum 6 4 5 
Tb927.8.6660 paraflagellar rod protein PFC1 6 1 2 
Tb927.11.10780 Voltage-dependent anion channel (VDAC), putative 6 4 5 
Tb927.8.3750 nucleolar protein (Nop56 homologue) 1 5 6 
Tb927.10.14090 transporter, putative 6 5 6 
Tb927.3.680 cytochrome P450, putative 6 5 6 
Tb927.6.2210 hypothetical protein, conserved 6 5 6 
Tb927.10.7620 mitochondrial ATP-dependent zinc metallopeptidase 5 5 6 
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Tb927.5.1780 hypothetical protein, conserved 5 5 6 
Tb927.8.6030 60S ribosomal protein L12 5 5 6 
Tb927.9.15210 60S ribosomal protein L36 5 5 6 
Tb927.5.3360 Mitchondrial LSU ribosomal protein L2, putative 4 5 6 
Tb927.9.11880 Mitchondrial SSU ribosomal protein 6 4 5 
Tb927.7.2820 histone H2A 3 5 6 
Tb927.9.1850 60S ribosomal protein L35 3 5 6 
Tb927.9.2220 SUMO1/Ulp2, putative 3 5 6 
Tb927.10.1550 
proteasome regulatory non-ATP-ase subunit 5,19S 
proteasome regulatory subunit 
6 3 4 
Tb927.1.1370 rRNA biogenesis protein, putative 1 5 6 
Tb927.1.2430 histone H3 1 5 6 
Tb927.1.450 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1 5 6 
Tb927.10.15660 hypothetical protein, conserved 1 5 6 
Tb927.11.6790 BOP1/Erb1p 1 5 6 
Tb927.4.1080 V-type ATPase, A subunit, putative 1 5 6 
Tb927.4.3890 
ATP-dependent DEAD/H RNA helicase, weak 
match to HsDDX39 
1 5 6 
Tb927.5.1560 
ATP-dependent DEAD/H RNA helicase, putative, no 
clear yeast homologue 
1 5 6 
Tb927.5.4230 histone H4 1 5 6 
Tb927.6.5090 hypothetical protein, conserved 1 5 6 
Tb927.9.13350 hypothetical protein, conserved 1 5 6 
Tb927.10.13620 
NADH-ubiquinone oxidoreductase complex I 
subunit, NDUFA9 subunit, putative 
6 1 2 
Tb927.10.16150 
ATP-dependent zinc metallopeptidase, 
putative,metallo-peptidase 
6 1 2 
Tb927.10.1860 hypothetical protein, conserved, tryp specific 6 1 2 
Tb927.10.3520 
protease regulatory ATPase subunit 4, putative 
(RPT4) 
6 1 2 
Tb927.10.4040 3-Ketosphinganine reductase 6 1 2 
Tb927.11.14910 protein phosphatase 2C, putative 6 1 2 
Tb927.11.3270 squalene monooxygenase, putative 6 1 2 
Tb927.2.4210 
glycosomal phosphoenolpyruvate carboxykinase 
(PEPCK) 
6 1 2 
Tb927.3.1080 POMP23 6 1 2 
Tb927.4.2890 hypothetical protein, conserved 6 1 2 
Tb927.4.730 hypothetical protein, conserved 6 1 2 
Tb927.7.2570 guide RNA associated protein, GAP2 6 1 2 
Tb927.7.7130 TWY1 homologue, tRNA modification 6 1 2 
Tb927.7.7470 
GRESAG 4, putative receptor-type adenylate 
cyclase 
6 1 2 
Tb927.8.4890 
endoplasmic reticulum oxidoreductin, Ero1, oxidises 
PDI 
6 1 2 
Tb927.9.10520 
hypothetical protein, possible component of 
cytochorome oxidase complex 
6 1 2 
Tb927.9.6090 PTP1-interacting protein, 39 kDa PIP39 6 1 2 
Tb927.7.3040 hypothetical protein, conserved 6 1 2 
Tb927.10.8490 glucose transporter, putative 5 5 6 
Tb927.9.9550 
hypothetical protein, conserved, no yeast or human 
match 
6 1 2 
Tb927.8.4450 RBP11 4 5 6 
Tb927.11.6390 hypothetical protein, conserved, START domain 6 1 2 
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Tb927.10.11270 RBP23 6 4 5 
Tb927.11.10570 Mitchondrial LSU ribosomal protein 5 5 6 
Tb927.9.2320 
POMP1 (possible S-Adenosyl methionine methyl 
transferase 
5 5 6 
Tb927.10.730 ATP synthase, putative 3 5 6 
Tb927.11.9730 60S ribosomal protein L34 5 5 6 
Tb927.11.4200 ERGIC53 paralogue, lectin-like, ER quality control 6 1 2 
Tb927.6.5000 hypothetical protein, conserved 6 1 2 
Tb927.8.3690 
isocitrate dehydrogenase [NADP], mitochondrial 
precursor, putative (IDH) 
6 1 2 
Tb927.10.6610 chaperone protein DNAj, putative 6 1 2 
Tb927.10.240 PEX14 peroxin 14 6 4 5 
Tb927.2.4130 
enoyl-CoA hydratase/Enoyl-CoA isomerase/3-
hydroxyacyl-CoA dehydrogenase, putative 
3 4 5 
Tb927.9.9310 hypothetical protein, conserved 4 4 5 
Tb927.10.7090 alternative oxidase (AOX) 5 3 4 
Tb927.7.1790 Adenine phosphoribosyltransferase, putative 5 1 2 
Tb927.11.510 UBP2 5 4 5 
Tb927.8.3110 Mitchondrial SSU ribosomal protein S9 5 4 5 
Tb927.3.970 Mitchondrial SSU ribosomal protein 4 4 5 
Tb927.8.3170 Mitchondrial LSU ribosomal protein 4 4 5 
Tb927.7.7450 GTP-binding protein, putative 4 4 5 
Tb927.11.8870 mitochondrial DEAD box protein,KREH1 (KREH1) 5 4 5 
Tb927.10.8270 eIF3 subunit 8, putative 5 3 4 
Tb927.10.14700 
hypothetical protein, conserved, no human or yeast 
homologue 
5 3 4 
Tb927.3.4600 hypothetical protein, conserved 1 4 5 
Tb927.7.4220 hypothetical protein, conserved 1 4 5 
Tb927.2.100 retrotransposon hot spot protein 1 (RHS1), putative 3 4 5 
Tb927.11.6170 
protein transport protein Sec31, putative,cytosolic 
coat protein, putative 
5 3 4 
Tb927.11.9940 hypothetical protein, conserved 5 3 4 
Tb927.8.560 GEM1, putative 5 3 4 
Tb927.7.570 prefoldin, putative 5 1 2 
Tb927.7.6460 
FG-GAP repeat protein, putative,intergrin alpha 
chain protein, putative 
5 1 2 
Tb927.9.7110 hypothetical protein, conserved 5 1 2 
Tb927.10.1490 Possible splicing factor 5 1 2 
Tb927.5.1460 hypothetical protein, conserved 5 1 2 
Tb927.5.3010 MRB complex protein 4 4 5 
Tb927.11.10140 
hypothetical protein, possible component of 
cytochorome oxidase complex 
5 1 2 
Tb927.10.11220 procyclic form surface glycoprotein (PSSA-2) 5 4 5 
Tb927.10.13800 
hypothetical protein, conserved, no yeast or human 
match 
5 3 4 
Tb927.8.7530 
3,2-trans-enoyl-CoA isomerase, mitochondrial 
precursor, putative 
5 4 5 
Tb927.8.580 hypothetical protein, conserved 1 4 5 
Tb927.11.17000 AIR9 5 3 4 
Tb927.9.12510 
DED1-2, ATP-dependent DEAD/H RNA helicase, 
DED1-2 
5 1 2 
Tb927.10.13780 glycogen synthase kinase 3 (GSK3) 3 4 5 
Tb927.7.4180 Elongase 3 5 3 4 
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Tb927.10.12710 heat shock protein, HSP110 5 1 2 
Tb927.10.4060 hypothetical protein, conserved 5 1 2 
Tb927.3.640 hypothetical protein, conserved 5 1 2 
Tb927.8.6080 POMP42 5 1 2 
Tb927.1.4830 Phospholipase A1 5 1 2 
Tb927.11.2370 MEX67 5 4 5 
Tb927.11.9720 40S ribosomal protein S27 5 4 5 
Tb927.3.5130 hypothetical protein, conserved 5 4 5 
Tb927.7.240 40S ribosomal protein S33 5 4 5 
Tb927.7.540 chaperone protein DNAj, putative 5 4 5 
Tb927.10.1080 40S ribosomal protein S23 4 4 5 
Tb927.3.2440 
serine/threonine-protein kinase, putative,protein 
kinase, putative 
4 4 5 
Tb927.3.4190 endosomal integral membrane protein, putative 4 4 5 
Tb927.5.450 
NADH-ubiquinone oxidoreductase, mitochondrial, 
putative 
4 4 5 
Tb927.7.5970 protein associated with differentiation 5, PAD5 4 4 5 
Tb927.10.12290 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase, putative 
3 4 5 
Tb927.10.2610 hypothetical protein, conserved, DUF1935 domain 3 4 5 
Tb927.10.2840 40S ribosomal protein S25 3 4 5 
Tb927.10.6370 60S ribosomal protein L37a 3 4 5 
Tb927.10.8040 
adaptin complex 1 subunit, putative,beta-adaptin, 
fragment (BAD1) 
5 3 4 
Tb927.11.10260 hypothetical protein, conserved, no known domains 5 3 4 
Tb927.11.3380 Ran-binding protein 1, putative 3 4 5 
Tb927.4.3060 
hypothetical protein, conserved, PLP dependent 
transferases like domain 
3 4 5 
Tb927.7.4550 Mitchondrial LSU ribosomal protein 3 4 5 
Tb927.8.1200 vacuolar-type Ca2 -ATPase 2 (TbA2) 3 4 5 
Tb927.8.2760 Mitchondrial LSU ribosomal protein 3 4 5 
Tb927.8.6980 hypothetical protein, conserved 3 4 5 
Tb927.9.7690 hypothetical protein, conserved 5 4 5 
Tb927.10.2810 hypothetical protein, conserved 3 4 5 
Tb927.11.4650 Mitchondrial LSU ribosomal protein 5 3 4 
Tb927.11.4130 ubiquitin-like protein, putative 4 4 5 
Tb927.10.12430 hypothetical protein, conserved 1 4 5 
Tb927.10.3280 60S ribosomal protein L38 1 4 5 
Tb927.11.2120 hypothetical protein, conserved 1 4 5 
Tb927.2.4890 ribosomal protein L11, putative 1 4 5 
Tb927.8.5490 hypothetical protein, conserved 1 4 5 
Tb927.1.5030 leucine-rich repeat protein (LRRP) 5 1 2 
Tb927.10.14200 syntaxin 5 5 1 2 
Tb927.10.14530 
proteasome regulatory non-ATPase subunit 8,26S 
proteasome regulatory subunit (Rpn8) 
5 1 2 
Tb927.10.14860 hypothetical protein, conserved 5 1 2 
Tb927.10.15430 hypothetical protein, conserved 5 1 2 
Tb927.10.15720 19S proteasome regulatory subunit (RPN9) 5 1 2 
Tb927.10.4050 serine palmitoyltransferase, putative 5 1 2 
Tb927.10.4640 eIF-3 subunit L 5 1 2 
Tb927.10.4760 hypothetical protein, conserved 5 1 2 
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Tb927.10.5300 eIF-6 5 1 2 
Tb927.10.7100 delta-4 fatty acid desaturase 5 1 2 
Tb927.11.15150 
1-acyl-sn-glycerol-3-phosphate acyltransferase, 
putative 
5 1 2 
Tb927.11.16670 hypothetical protein, conserved 5 1 2 
Tb927.11.2690 
succinyl-coA:3-ketoacid-coenzyme A transferase, 
mitochondrial precursor, putative 
5 1 2 
Tb927.11.2750 POMP12 5 1 2 
Tb927.11.3570 
aminopeptidase, putative,metallo-peptidase, Clan 
MA(E) Family M1 
5 1 2 
Tb927.11.3860 hypothetical protein, conserved 5 1 2 
Tb927.11.4160 
hypothetical protein, conserved,predicted C2 
domain protein 
5 1 2 
Tb927.11.5110 hypothetical protein, conserved 5 1 2 
Tb927.2.5760 
hypothetical protein, conserved, small unknown 
domain, SET domain 
5 1 2 
Tb927.3.3850 
hypothetical protein, conserved, Sec23-binding 
domain of Sec16 
5 1 2 
Tb927.3.4820 acyltransferase, putative 5 1 2 
Tb927.6.1040 
cysteine peptidase precursor, Clan CA, family C1, 
Cathepsin L-like (CP) 
5 1 2 
Tb927.7.1220 hypothetical protein, conserved 5 1 2 
Tb927.7.2980 hypothetical protein, conserved 5 1 2 
Tb927.8.3810 hypothetical protein, conserved 5 1 2 
Tb927.8.4940 hypothetical protein, conserved 5 1 2 
Tb927.8.6050 hypothetical protein, conserved 5 1 2 
Tb927.8.7040 hypothetical protein, conserved 5 1 2 
Tb927.8.8120 hypothetical protein, conserved 5 1 2 
Tb927.9.3400 endo-beta-N-acetylglucosaminidase, putative 5 1 2 
Tb927.9.7800 hypothetical protein, conserved 5 1 2 
Tb927.6.1000 
cysteine peptidase precursor, Clan CA, family C1, 
Cathepsin L-like (CP) 
3 4 5 
Tb927.10.15180 nucleosome assembly protein, putative 5 1 2 
Tb927.11.3030 
phosphoribosylpyrophosphate synthetase, putative 
(PRS) 
1 4 5 
Tb927.11.8880 hypothetical protein, conserved 5 4 5 
Tb927.3.1920 NOT5 3 4 5 
Tb927.11.5140 
ubiquitin carboxyl-terminal hydrolase, Clan CA 
cysteine peptidase, family C12, putative 
5 1 2 
Tb927.10.9740 19S proteasome regulatory subunit (RPT6) 4 4 5 
Tb927.7.2550 proteasome regulatory ATPase subunit 5 (RPT5) 4 4 5 
Tb927.11.9920 polyubiquitin, putative 5 4 5 
Tb927.6.3940 hypothetical protein, conserved 5 3 4 
Tb927.4.330 hypothetical protein, conserved 5 1 2 
Tb927.11.2130 
proteasome regulatory non-ATP-ase subunit 3 
(RPN3) 
5 1 2 
Tb927.9.12550 glycerol kinase, glycosomal (glk1) 5 1 2 
Tb927.6.850 NOT2 5 4 5 
Tb927.11.2110 hypothetical protein, conserved 5 1 2 
Tb927.2.1330 
retrotransposon hot spot protein (RHS6, 
pseudogene), putative 
5 4 5 
Tb927.10.2350 
pyruvate dehydrogenase complex E3 binding 
protein, putative 
5 1 2 
Tb927.11.14220 
hypothetical protein, conserved, Phyre2 gives 97% 
probability of RNA-binding domain 
5 3 4 
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Tb927.5.4330 
dihydrolipoamide branched chain transacylase, 
putative 
1 3 4 
Tb927.11.9080 hypothetical protein, conserved 4 3 4 
Tb927.11.15850 kinetoplast poly(A) polymerase complex 1 subunit 4 3 4 
Tb927.4.760 AP-1 adapter complex gamma subunit, putative 4 3 4 
Tb927.11.10560 eIF4G4 3 3 4 
Tb927.10.5760 adenylate kinase, putative 4 1 2 
Tb927.10.5880 Proteophosphoglycan, putative 1 3 4 
Tb927.3.1940 
hypothetical protein, possible component of 
cytochorome oxidase complex 
4 1 2 
Tb927.9.13990 DRBD2 3 3 4 
Tb927.10.12660 PUF2 4 1 2 
Tb927.11.15760 GPI transamidase subunit Tta1 (TTA1) 4 1 2 
Tb927.5.780 hypothetical protein, conserved 4 1 2 
Tb927.5.1510 Mitchondrial SSU ribosomal protein 4 3 4 
Tb927.9.5840 tryparedoxin peroxidase (TRYP1) 4 3 4 
Tb927.6.4560 Mitchondrial SSU ribosomal protein 3 3 4 
Tb927.8.7650 amino acid transporter, putative 3 3 4 
Tb927.9.15380 
NADH-ubiquinone oxidoreductase complex I 
subunit, putative,NDUFA9 subunit, putative 
3 3 4 
Tb927.11.5970 phosphoinositide-specific phospholipase C, putative 1 3 4 
Tb927.7.4970 glutamine synthetase, putative 1 3 4 
Tb927.10.4610 dolicholphosphate-mannose synthase, putative 4 1 2 
Tb927.11.14190 hypothetical protein, conserved 4 1 2 
Tb927.11.3130 glycosomal transporter (GAT2) 4 1 2 
Tb927.2.2210 hypothetical protein, conserved 4 1 2 
Tb927.7.1290 
hypothetical protein, conserved.  DUF2012, 
peptidase superfamily 
4 1 2 
Tb927.9.2450 electron transport protein SCO1/SCO2, putative 4 1 2 
Tb927.11.530 RBP3 4 3 4 
Tb927.11.9570 hypothetical protein, conserved 4 1 2 
Tb927.8.1150 KKT9 Kinetochore protein 4 1 2 
Tb927.8.1190 hypothetical protein, conserved 3 3 4 
Tb927.10.4880 
hypothetical protein, possible component of 
cytochorome oxidase complex 
3 3 4 
Tb927.11.11590 eIF3E eukaryotic translation initiation factor, putative 4 3 4 
Tb927.3.2230 succinyl-CoA synthetase alpha subunit, putative 4 1 2 
Tb927.10.2770 eIF5 3 3 4 
Tb927.10.15390 
kinesin, clathrin-associated, Trypanosome-specific 
kinesin family 2 
1 3 4 
Tb927.11.4210 hypothetical protein, conserved 4 3 4 
Tb927.11.6600 hypothetical protein, conserved 4 3 4 
Tb927.9.5730 nucleosome assembly protein-like protein 4 1 2 
Tb927.8.1960 NOT11 4 3 4 
Tb927.11.720 hypothetical protein, conserved 4 1 2 
Tb927.11.7520 hypothetical protein, conserved 4 1 2 
Tb927.5.4380 
kinetoplastid-specific phospho-protein phosphatase, 
putative 
4 1 2 
Tb927.9.13970 hypothetical protein, conserved 3 3 4 
Tb927.10.3930 40S ribosomal protein S3A 2 3 4 
Tb927.10.2980 19S proteasome regulatory subunit,  (RPN11) 4 1 2 
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Tb927.6.1440 Mitchondrial LSU ribosomal protein 4 1 2 
Tb927.10.16170 potassium voltage-gated channel, putative 4 1 2 
Tb927.10.10610 protein tyrosine phosphatase, putative 4 3 4 
Tb927.11.1630 Mitchondrial LSU ribosomal protein 4 3 4 
Tb927.5.4120 Mitchondrial LSU ribosomal protein 4 3 4 
Tb927.5.960 
MSP1, Mitochondrial protein involved in sorting of 
proteins in the mitochondria, putative 
4 3 4 
Tb927.6.1520 aquaporin 3, putative (AQP1) 4 3 4 
Tb927.6.1880 aspartyl-tRNA synthetase, putative 4 3 4 
Tb927.7.2330 hypothetical protein, conserved 4 3 4 
Tb927.7.3430 
Mitchondrial LSU ribosome-associated cyclophilin 
type peptidyl-prolyl cis-trans isomerase 
4 3 4 
Tb927.9.4230 fatty acyl CoA synthetase 4 (ACS4) 4 3 4 
Tb927.9.6620 hypothetical protein, conserved 4 3 4 
Tb927.1.420 retrotransposon hot spot protein 5 (RHS5), putative 3 3 4 
Tb927.11.11780 acyl-CoA dehydrogenase, putative 3 3 4 
Tb927.11.1850 hypothetical protein, conserved 3 3 4 
Tb927.11.6720 hypothetical protein, conserved 3 3 4 
Tb927.11.9750 hypothetical protein, conserved 3 3 4 
Tb927.3.3220 RNA polymerase-associated protein CTR9, putative 3 3 4 
Tb927.3.3520 POMP25 3 3 4 
Tb927.4.2040 ALBA3 3 3 4 
Tb927.5.2140 UPF1 3 3 4 
Tb927.6.4500 hypothetical protein, conserved 3 3 4 
Tb927.7.4470 hypothetical protein, conserved 3 3 4 
Tb927.7.5960 protein associated with differentiation 4, PAD4 3 3 4 
Tb927.8.6650 DRBD13 3 3 4 
Tb927.8.6820 hypothetical protein, conserved 3 3 4 
Tb927.1.190 
retrotransposon hot spot protein (RHS, 
pseudogene) 
4 2 3 
Tb927.11.6040 hypothetical protein, conserved 2 3 4 
Tb927.4.4910 
3,2-trans-enoyl-CoA isomerase, mitochondrial 
precursor, putative 
4 3 4 
Tb927.1.720 phosphoglycerate kinase (PGKA) 1 3 4 
Tb927.10.15170 NRG1, nucleolar regulator of GPEET expression 1 3 4 
Tb927.10.1560 hypothetical protein, conserved 1 3 4 
Tb927.10.3790 hypothetical protein, conserved 1 3 4 
Tb927.10.6090 tRNA pseudouridine synthase A, putative 1 3 4 
Tb927.10.7630 
hypothetical protein, conserved,transportin2- like 
protein 
1 3 4 
Tb927.10.9330 
hypothetical protein, conserved, partial PSP1 
superfamily (signal peptidase-like) 
1 3 4 
Tb927.11.16530 hypothetical protein, conserved 1 3 4 
Tb927.11.6360 60S ribosomal protein L24 1 3 4 
Tb927.11.8040 Mitochondrial LSU-associated 1 3 4 
Tb927.11.8050 hypothetical protein, conserved 1 3 4 
Tb927.2.5020 acyl-CoA oxidase, putative 1 3 4 
Tb927.2.510 retrotransposon hot spot protein 4 (RHS4), putative 1 3 4 
Tb927.2.6240 adenosine transporter 2 (TbNT5) 1 3 4 
Tb927.3.4080 hypothetical protein, conserved 1 3 4 
Tb927.4.1610 VDAC-like 1 3 4 
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Tb927.4.2790 hypothetical protein, conserved 1 3 4 
Tb927.4.3070 hypothetical protein, conserved 1 3 4 
Tb927.4.3840 nucleolar protein, putative 1 3 4 
Tb927.4.4600 Mitchondrial LSU ribosomal protein 1 3 4 
Tb927.4.4720 
KRIPP7/TbPPR7 Kinetoplast ribosomal PPR-repeat 
containing protein 
1 3 4 
Tb927.5.4020 
hypothetical protein no clear yeast or human 
matches 
1 3 4 
Tb927.7.3060 hypothetical protein, conserved 1 3 4 
Tb927.7.3380 hypothetical protein, conserved 1 3 4 
Tb927.7.650 hypothetical protein, conserved 1 3 4 
Tb927.8.2600 hypothetical protein, conserved 1 3 4 
Tb927.8.3300 Mitchondrial LSU ribosomal protein 1 3 4 
Tb927.9.10560 POMP6 1 3 4 
Tb927.9.14410 RNA 3'-terminal phosphate cyclase-like protein 1 3 4 
Tb927.9.4200 fatty acyl CoA synthetase 2 (ACS2) 1 3 4 
Tb927.9.8290 Mitchondrial LSU ribosomal protein 1 3 4 
Tb927.1.90 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
4 1 2 
Tb927.10.13860 GPI-anchor transamidase subunit 8 (GPI8) 4 1 2 
Tb927.10.13990 hypothetical protein, conserved 4 1 2 
Tb927.10.15330 hypothetical protein, conserved 4 1 2 
Tb927.10.15710 mitochondrial carrier protein, MCP7 4 1 2 
Tb927.10.3210 
delta-1-pyrroline-5-carboxylate dehydrogenase, 
putative 
4 1 2 
Tb927.10.4280 Mitochondrial cytochrome bc1 complex component 4 1 2 
Tb927.10.5220 
hypothetical protein, possible component of 
cytochorome oxidase complex 
4 1 2 
Tb927.10.5640 TbGemin2 4 1 2 
Tb927.10.660 
2-oxoisovalerate dehydrogenase alpha subunit, 
putative 
4 1 2 
Tb927.10.8720 NOT10 4 1 2 
Tb927.10.8730 hypothetical protein, conserved 4 1 2 
Tb927.11.1030 KKT7 Kinetochore protein 4 1 2 
Tb927.11.12890 POMP17 4 1 2 
Tb927.11.14270 protein kinase, putative 4 1 2 
Tb927.11.15230 cytosolic coat protein, putative 4 1 2 
Tb927.11.15870 
hypothetical protein, conserved, no human or yeast 
homologue 
4 1 2 
Tb927.11.16110 
FG-GAP repeat protein, putative,intergrin alpha 
chain protein, putative 
4 1 2 
Tb927.11.16810 dynein light intermediate chain D1bLIC, putative 4 1 2 
Tb927.11.4490 
long-chain-fatty-acid-CoA ligase, putative,acyl-CoA 
synthetase 
4 1 2 
Tb927.11.5520 triosephosphate isomerase (TIM) 4 1 2 
Tb927.11.9820 hypothetical protein, conserved 4 1 2 
Tb927.11.9900 phytoene synthase, putative, complex I 4 1 2 
Tb927.2.4830 TFIIF-stimulated CTD phosphatase, putative 4 1 2 
Tb927.2.5930 hypothetical protein, conserved 4 1 2 
Tb927.3.3950 hypothetical protein, conserved 4 1 2 
Tb927.4.2760 hypothetical protein, conserved 4 1 2 
Tb927.4.4570 
hypothetical protein, conserved, no domains, no 
yeast or human match 
4 1 2 
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Tb927.5.1130 hypothetical protein, conserved 4 1 2 
Tb927.5.1930 hypothetical protein, conserved 4 1 2 
Tb927.5.3190 hypothetical protein, conserved 4 1 2 
Tb927.5.770 hypothetical protein, conserved 4 1 2 
Tb927.6.1140 
dolichyl-P-Man:GDP-Man5GlcNAc2-PP-dolichyl 
alpha-1,2-mannosyltransferase, putative 
4 1 2 
Tb927.6.1990 
hypothetical protein, conserved, no yeast or human 
match 
4 1 2 
Tb927.6.2560 hypothetical protein, conserved 4 1 2 
Tb927.6.3510 tRNA modification enzyme, putative 4 1 2 
Tb927.6.3720 hypothetical protein, conserved 4 1 2 
Tb927.6.4070 hypothetical protein, conserved 4 1 2 
Tb927.6.4080 Mitchondrial LSU ribosomal protein 4 1 2 
Tb927.7.2500 proteasome regulatory ATPase subunit 1 4 1 2 
Tb927.7.3180 
Mu-adaptin 1, putative,adaptor complex AP-1 
medium subunit, putative 
4 1 2 
Tb927.7.3370 intraflagellar transport protein IFT74 4 1 2 
Tb927.7.3880 protein kinase, putative 4 1 2 
Tb927.7.4980 ZC3H23 POMP35 4 1 2 
Tb927.7.5080 ATP-NAD kinase-like protein 4 1 2 
Tb927.7.6930 ATPase, putative 4 1 2 
Tb927.8.1290 hypothetical protein, conserved, no domains 4 1 2 
Tb927.8.3580 mitochondrial chaperone BCS1, putative 4 1 2 
Tb927.8.3770 mitogen-activated protein kinase, putative 4 1 2 
Tb927.8.4050 
flagellar membrane protein that interacts with FLA1, 
similar to FLA3 
4 1 2 
Tb927.8.4610 small GTP-binding protein Rab1 (Trab1) 4 1 2 
Tb927.8.5560 
NADH-ubiquinone oxidoreductase complex I 
subunit, putative 
4 1 2 
Tb927.8.6360 hypothetical protein, conserved 4 1 2 
Tb927.9.10450 hypothetical protein, conserved 4 1 2 
Tb927.9.11540 hypothetical protein, conserved 4 1 2 
Tb927.9.13580 hypothetical protein, conserved 4 1 2 
Tb927.9.13650 ADP-ribosylation factor, putative 4 1 2 
Tb927.9.14080 vesicle-associated membrane protein, putative 4 1 2 
Tb927.9.15000 hypothetical protein, conserved 4 1 2 
Tb927.9.7180 
adenosine monophosphate deaminase, 
putative,AMP deaminase, putative 
4 1 2 
Tb927.9.9150 GTP-binding protein, putative 4 1 2 
Tb927.10.7710 40S ribosomal protein S8 1 3 4 
Tb927.10.6810 guanylate kinase, putative 4 1 2 
Tb927.6.4770 MKT1 4 1 2 
Tb927.10.14930 ZC3H39 4 1 2 
Tb927.4.3590 
EF1 beta, translation elongation factor 1-beta, 
putative 
4 1 2 
Tb927.8.6110 hypothetical protein, conserved 4 3 4 
Tb927.10.2560 mitochondrial malate dehydrogenase (mMDH) 4 1 2 
Tb927.6.4690 60S ribosomal protein L9 4 1 2 
Tb927.11.14750 
hypothetical protein, conserved, PSP1 C-terminal 
region domain 
3 3 4 
Tb927.6.5080 hypothetical protein, conserved 1 3 4 
Tb927.8.7160 UDP-Gal or UDP-GlcNAc-dependent 4 1 2 
  
151 
glycosyltransferase pseudogene 
Tb927.3.2150 protein phosphatase 2C, putative 4 3 4 
Tb927.3.1680 hypothetical protein, conserved 3 3 4 
Tb927.7.6800 Mitchondrial LSU ribosomal protein 1 3 4 
Tb927.8.4540 PBP1 1 3 4 
Tb927.8.980 
Phosphoacetylglucosamine mutase PAGM, acts as 
phosphoglucomutase 
1 3 4 
Tb927.10.10130 
MRB complex component mitochondrial RNA 
binding complex 1 subunit 
4 1 2 
Tb927.11.10020 short-chain dehydrogenase, putative 4 1 2 
Tb927.3.2900 
EF-2 alpha, elongation initiation factor 2 alpha 
subunit, 
4 1 2 
Tb927.7.2160 
hypothetical protein, conserved, no domains, no 
yeast or human match 
4 1 2 
Tb927.7.2710 NADH-cytochrome b5 reductase, putative 4 1 2 
Tb927.8.3380 
electron transfer protein, SDH2N,succinate 
dehydrogenase complex 
4 1 2 
Tb927.2.1170 retrotransposon hot spot protein 5 (RHS5), putative 3 3 4 
Tb927.5.1100 PEX5 peroxisome targeting signal 1 receptor 3 3 4 
Tb927.8.6390 
lysophospholipase, putative,alpha/beta hydrolase, 
putative (TbLysoPLA) 
3 1 2 
Tb927.6.1250 Mitchondrial SSU ribosomal protein S29 3 1 2 
Tb927.10.15650 tRNA pseudouridine synthase A-like protein 3 1 2 
Tb927.7.5340 hypothetical protein, conserved 3 1 2 
Tb927.6.4210 aldehyde dehydrogenase, putative (ALDH) 3 1 2 
Tb927.11.370 repressor activator protein 1 (RAP1) 3 1 2 
Tb927.3.4680 RAB GDP dissociation inhibitor alpha, putative 3 1 2 
Tb927.4.5110 KKT8 Kinetochore protein 3 1 2 
Tb927.8.3970 oxidoreductase, putative 3 1 2 
Tb927.11.760 protein phosphatase 2C, putative 3 1 2 
Tb927.10.2730 hypothetical protein, conserved 3 1 2 
Tb927.6.4000 
small glutamine-rich tetratricopeptide repeat protein, 
putative 
3 1 2 
Tb927.11.870 Mitchondrial LSU ribosomal protein 3 1 2 
Tb927.4.1930 EIF3D 3 1 2 
Tb927.10.12330 ZC3H34 3 1 2 
Tb927.5.3640 Mitchondrial SSU ribosomal protein 3 1 2 
Tb927.7.1110 asparagine synthetase a, putative 3 1 2 
Tb927.10.10160 hypothetical protein, conserved 3 1 2 
Tb927.1.1130 
glycerol-3-phosphate dehydrogenase (FAD-
dependent), putative 
3 1 2 
Tb927.1.1530 protein kinase, putative 3 1 2 
Tb927.1.2120 
calpain, putative,cysteine peptidase, Clan CA, family 
C2, putative 
3 1 2 
Tb927.1.3450 hypothetical protein, conserved 3 1 2 
Tb927.1.710 phosphoglycerate kinase (PGKB) 3 1 2 
Tb927.10.10170 
hypothetical protein, conserved,predicted WD40 
repeat protein 
3 1 2 
Tb927.10.10280 microtubule-associated protein, putative 3 1 2 
Tb927.10.11310 intraflagellar transport protein IFT55/IFT57 3 1 2 
Tb927.10.11340 hypothetical protein, conserved 3 1 2 
Tb927.10.12740 ZC3H35 3 1 2 
Tb927.10.12930 
hypothetical protein, conservedn no domains or 
good BLASTp hits 
3 1 2 
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Tb927.10.13040 
GRESAG 4, putative receptor-type adenylate 
cyclase 
3 1 2 
Tb927.10.13290 ethanolamine phosphotransferase (EPT) 3 1 2 
Tb927.10.14730 chaperone protein DNAj, putative 3 1 2 
Tb927.10.1500 methionyl-tRNA synthetase, putative (MetRS) 3 1 2 
Tb927.10.1660 hypothetical protein, conserved 3 1 2 
Tb927.10.2020 hexokinase (HK2) 3 1 2 
Tb927.10.3080 methionine biosynthetic protein, putative 3 1 2 
Tb927.10.3330 hypothetical protein, conserved 3 1 2 
Tb927.10.430 hypothetical protein, conserved 3 1 2 
Tb927.10.4900 
TPR-repeat-containing chaperone protein DNAJ, 
putative,TPR repeat protein 
3 1 2 
Tb927.10.5030 40S ribosomal protein S27+ ubiquitin 3 1 2 
Tb927.10.7230 
hypothetical protein, conserved, 7 nucleoside 
diphostate kinase domains 
3 1 2 
Tb927.10.760 hypothetical protein, conserved 3 1 2 
Tb927.10.8920 TbGRP  ras-like small GTPase 3 1 2 
Tb927.10.9200 hypothetical protein, conserved 3 1 2 
Tb927.10.9800 60S ribosomal protein L22 3 1 2 
Tb927.11.1010 chaperone protein DNAj, putative 3 1 2 
Tb927.11.10870 32 kDa ER-associated protein (ERAP32) 3 1 2 
Tb927.11.11470 
Mitchondrial SSU ribosomal associated KRIPP14 
(PPR) 
3 1 2 
Tb927.11.11630 Mitchondrial LSU ribosomal protein 3 1 2 
Tb927.11.11740 membrane-bound acid phosphatase, putative 3 1 2 
Tb927.11.13250 eIF-2-gamma 3 1 2 
Tb927.11.13270 hypothetical protein, conserved 3 1 2 
Tb927.11.13360 AAA ATPase, putative 3 1 2 
Tb927.11.13750 small GTPase, putative,ras-related rab-4 (RAB4) 3 1 2 
Tb927.11.13890 RNA ligase asociated with SSU 3 1 2 
Tb927.11.14330 hypothetical protein, conserved 3 1 2 
Tb927.11.15530 C-14 sterol reductase, putative 3 1 2 
Tb927.11.15750 AMP deaminase, putative 3 1 2 
Tb927.11.2670 Nucleoporin (TbNup59) 3 1 2 
Tb927.11.3320 ras-like small GTPase, putative (TbGTR) 3 1 2 
Tb927.11.3750 NADH-cytochrome b5 reductase, putative (B5R) 3 1 2 
Tb927.11.3940 hypothetical protein, conserved 3 1 2 
Tb927.11.4180 hypothetical protein, conserved 3 1 2 
Tb927.11.4330 
hypothetical protein, conserved, no clear yeast or 
human matches 
3 1 2 
Tb927.11.4680 hypothetical protein, conserved 3 1 2 
Tb927.11.4850 hypothetical protein, conserved 3 1 2 
Tb927.11.5420 hypothetical protein, conserved 3 1 2 
Tb927.11.5510 dynein light chain p28, axonemal, putative 3 1 2 
Tb927.11.8320 hypothetical protein, conserved 3 1 2 
Tb927.2.2230 
hypothetical protein, conserved, no domains, 
Kineto-specific 
3 1 2 
Tb927.2.2940 hypothetical protein, conserved 3 1 2 
Tb927.2.3800 
mRNA processing protein, putative GAP1 MRB 
complex protein 
3 1 2 
Tb927.2.450 retrotransposon hot spot protein 4 (RHS4), putative 1 2 3 
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Tb927.2.5270 IAD-3 inner arm dynein heavy chain 3 1 2 
Tb927.2.5280 trans-sialidase, putative (30J2.90) 1 2 3 
Tb927.2.5810 hypothetical protein, conserved 3 1 2 
Tb927.3.2080 hypothetical protein, conserved 3 1 2 
Tb927.3.3260 
hypothetical protein, conserved, kinetoplastid-
specific, poly(E) repeats 
3 1 2 
Tb927.3.3820 hypothetical protein, conserved 3 1 2 
Tb927.3.4040 hypothetical protein, conserved 3 1 2 
Tb927.3.4120 hypothetical protein, conserved 3 1 2 
Tb927.3.4390 
dihydrolipoamide dehydrogenase, putative (GCVL-
1) 
3 1 2 
Tb927.3.4640 POMP26 3 1 2 
Tb927.3.5490 flagellar transport protein, putative (PIFTB2) 3 1 2 
Tb927.4.1600 hypothetical protein, conserved 3 1 2 
Tb927.4.1660 mitochondrial carrier protein, MCP6 3 1 2 
Tb927.4.1970 hypothetical protein, conserved 3 1 2 
Tb927.4.2280 hypothetical protein, conserved 3 1 2 
Tb927.4.2600 hypothetical protein, conserved 3 1 2 
Tb927.4.5300 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase, putative 
3 1 2 
Tb927.5.1020 disulfide isomerase, putative 3 1 2 
Tb927.5.1710 
ribonucleoprotein p18, mitochondrial precursor, 
putative 
3 1 2 
Tb927.5.2060 
cell division control protein CDC5f, putative part of 
PRP19 complex 
3 1 2 
Tb927.5.2150 hypothetical protein, conserved 3 1 2 
Tb927.5.3020 hypothetical protein, conserved 3 1 2 
Tb927.5.3220 signal peptidase type I, putative 3 1 2 
Tb927.6.2170 co-chaperone GrpE, putative 3 1 2 
Tb927.6.2490 
Succinate dehydrogenase complex component 
(SDH7 in T cruzi) 
3 1 2 
Tb927.6.2930 hypothetical protein, conserved 3 1 2 
Tb927.6.3540 zinc-finger protein, conserved 3 1 2 
Tb927.6.3650 ADP-ribosylation factor, putative 3 1 2 
Tb927.6.4990 ATP synthase, epsilon chain, putative 3 1 2 
Tb927.6.580 hypothetical protein, conserved 3 1 2 
Tb927.7.2070 heat shock protein DNAJ, putative 3 1 2 
Tb927.7.4160 Elongase 1 3 1 2 
Tb927.7.4950 
NAD(p)-dependent steroid dehydrogenase-like 
protein 
3 1 2 
Tb927.7.5130 hypothetical protein, conserved 3 1 2 
Tb927.7.5250 hypothetical protein, conserved 3 1 2 
Tb927.7.5320 hypothetical protein, conserved 3 1 2 
Tb927.7.5710 hypothetical protein, conserved 3 1 2 
Tb927.7.6200 chaperone protein DNAj, putative 3 1 2 
Tb927.7.6440 v-SNARE like protein 3 1 2 
Tb927.7.6660 chaperone protein DNAj, putative 3 1 2 
Tb927.7.680 chaperone protein DNAj, putative 3 1 2 
Tb927.7.740 chaperone protein DNAj, putative 3 1 2 
Tb927.7.830 telomerase-associated protein, putative 3 1 2 
Tb927.8.1940 endosomal integral membrane protein, putative 3 1 2 
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Tb927.8.2240 tryptophanyl-tRNA synthetase, putative 3 1 2 
Tb927.8.2540 Acetyl-CoA acetyltransferase 3 1 2 
Tb927.8.2910 
mannosyl-oligosaccharide 1,2-alpha-mannosidase 
IB, ER quality control 
3 1 2 
Tb927.8.4150 hypothetical protein, conserved 3 1 2 
Tb927.8.4770 small GTP-binding protein Rab18 (TbRAB18) 3 1 2 
Tb927.8.5280 Mitchondrial SSU ribosomal associated TbMRPS34 3 1 2 
Tb927.8.5370 
hypothetical protein, conserved, no yeast or human 
match 
3 1 2 
Tb927.8.570 proteasome regulatory non-ATP-ase subunit 10 3 1 2 
Tb927.8.6200 tubulin folding cofactor D, putative 3 1 2 
Tb927.8.7120 Squalene synthase 3 1 2 
Tb927.8.760 nucleolar RNA-binding protein (Nopp44/46) 3 1 2 
Tb927.9.12710 hypothetical protein, conserved 3 1 2 
Tb927.9.14070 short-chain dehydrogenase, putative 3 1 2 
Tb927.9.15010 
NADH-ubiquinone oxidoreductase complex I 
subunit, putative 
3 1 2 
Tb927.9.2560 hypothetical protein, conserved 3 1 2 
Tb927.9.2670 POMP3 3 1 2 
Tb927.9.3620 hypothetical protein, conserved 3 1 2 
Tb927.9.3640 Mitchondrial LSU ribosomal protein 3 1 2 
Tb927.9.3820 syntaxin, putative 3 1 2 
Tb927.9.5280 Mitchondrial SSU ribosomal protein 3 1 2 
Tb927.9.7830 mitochondrial tRNA import complex, putative 3 1 2 
Tb927.9.9710 hypothetical protein, conserved 3 1 2 
Tb927.7.3030 hypothetical protein, conserved 3 1 2 
Tb927.7.4710 Mitchondrial LSU ribosomal protein 3 1 2 
Tb927.9.11580 
Gim5A protein,glycosomal membrane protein 
(gim5A) 
3 1 2 
Tb11.02.5400 cystathionine beta-synthase, putative 3 1 2 
Tb927.2.3780 IF2 translation initiation factor IF-2, putative 3 1 2 
Tb927.2.5060 GTP binding protein, putative 3 1 2 
Tb927.1.3180 40S ribosomal protein S11 3 1 2 
Tb927.10.13710 hypothetical protein, conserved 3 1 2 
Tb927.4.2240 
hypothetical protein, conserved, D-aminoacid 
aminotransferase domain 
3 1 2 
Tb927.7.6890 hypothetical protein, conserved 3 1 2 
Tb927.9.10580 
3-demethylubiquinone-9 3-methyltransferase, 
putative 
3 1 2 
Tb927.5.3970 adenylate kinase, putative (ADKE) 3 1 2 
Tb927.9.4210 fatty acyl CoA synthetase 3 (ACS3) 3 2 3 
Tb927.10.5810 hypothetical protein, conserved 3 1 2 
Tb927.1.2400 alpha tubulin 1 1 2 
Tb927.1.2390 beta tubulin 1 1 2 
Tb927.9.12610 glycerol kinase, glycosomal (glk1) 1 1 2 
Tb927.9.4420 hypothetical protein, conserved 1 1 2 
Tb927.4.3680 protein phosphatase 2C, putative 1 1 2 
Tb927.11.7710 Gp63-1 surface protease homolog, putative 1 1 2 
Tb927.1.1620 
ATP-dependent DEAD/H RNA helicase, putative, no 
clear yeast homologue 
1 1 2 
Tb927.10.12510 P-type H -ATPase, putative 1 1 2 
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Tb927.2.5530 POMP22 1 1 2 
Tb927.1.2670 flagellar protein PF16 1 1 2 
Tb927.9.6920 hypothetical protein, conserved 1 1 2 
Tb927.1.1700 hypothetical protein, conserved 1 1 2 
Tb927.10.14330 hypothetical protein, conserved 1 1 2 
Tb927.6.1020 
cysteine peptidase precursor, Clan CA, family C1, 
Cathepsin L-like (Rhodesain) 
1 1 2 
Tb927.7.3970 hypothetical protein, conserved 1 1 2 
Tb927.7.5110 hypothetical protein, conserved 1 1 2 
Tb927.9.12070 hypothetical protein, conserved 1 1 2 
Tb927.9.15330 hypothetical protein, conserved 1 1 2 
Tb927.9.7540 
calpain-like cysteine peptidase, putative,cysteine 
peptidase, Clan CA, family C2, putative 
1 1 2 
Tb927.7.5930 Protein Associated with Differentiation (TbPAD1) 1 1 2 
Tb927.10.70 retrotransposon hot spot (RHS), putative, (fragment) 1 1 2 
Tb927.10.14320 hypothetical protein, conserved 1 1 2 
Tb927.10.1540 ZC3H30 1 1 2 
Tb927.10.2550 malate dehydrogenase-related 1 1 2 
Tb927.10.9660 CRN/SYF3 part of splicing PRP19 complex, putative 1 1 2 
Tb927.11.12880 hypothetical protein, conserved 1 1 2 
Tb927.11.14970 hypothetical protein, conserved 1 1 2 
Tb927.11.4700 prostaglandin f synthase 1 1 2 
Tb927.11.9530 14-3-3-I protein 1 1 2 
Tb927.4.1790 60S ribosomal protein L3 1 1 2 
Tb927.6.2550 TRRM2 1 1 2 
Tb927.7.2390 hypothetical protein, conserved 1 1 2 
Tb927.8.1980 hypothetical protein, conserved 1 1 2 
Tb927.9.11850 structural maintenance of chromosome 1 (SMC1) 1 1 2 
Tb927.11.9710 60S ribosomal protein L10a 1 1 2 
Tb927.10.10920 heat shock protein 83, HSP83 1 1 2 
Tb927.2.1080 retrotransposon hot spot protein 5 (RHS5), putative 1 1 2 
Tb927.4.410 CAF40 1 1 2 
Tb927.10.6630 
ATP-dependent DEAD/H RNA helicase HEL64, 
putative (cytosolic) 
1 1 2 
Tb927.11.8990 cation transporter, putative 1 1 2 
Tb927.9.8160 chaperone protein DNAj, putative 2 1 2 
Tb10.v4.0052 microtubule-associated protein 2s 1 1 2 
Tb927.1.2730 hypothetical protein, conserved 1 1 2 
Tb927.10.12860 hypothetical protein, conserved 1 1 2 
Tb927.10.14630 fibrillarin, putative 1 1 2 
Tb927.10.3010 hypothetical protein, conserved, in bilobe 1 1 2 
Tb927.10.7500 fibrillarin (NOP1) 1 1 2 
Tb927.10.7810 
Homologue of yeast ESF1,nucleolar protein 
involved in pre-rRNA processing 
1 1 2 
Tb927.10.8870 hypothetical protein, conserved 1 1 2 
Tb927.10.9780 
ATP-dependent DEAD/H RNA helicase, putative 
Mak5 
1 1 2 
Tb927.10.9890 hypothetical protein, conserved, no domains 1 1 2 
Tb927.11.12830 acyl-CoA binding protein, putative 1 1 2 
Tb927.11.3550 
NPA3/XAB1 homologue, interacts with XPA and 
with RNA pol II 
1 1 2 
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Tb927.11.9490 hypothetical protein, conserved 1 1 2 
Tb927.2.5210 3-oxoacyl-ACP reductase, putative 1 1 2 
Tb927.3.2490 hypothetical protein, conserved 1 1 2 
Tb927.3.5020 hypothetical protein, conserved 2 1 2 
Tb927.3.5250 ZC3H8 1 1 2 
Tb927.4.3670 hypothetical protein, conserved 1 1 2 
Tb927.4.920 hypothetical protein, conserved 1 1 2 
Tb927.5.2500 hypothetical protein, conserved 1 1 2 
Tb927.5.980 hypothetical protein, conserved 1 1 2 
Tb927.6.2140 
Mitochondrial RNA binding complex I component, 
putative 
1 1 2 
Tb927.7.1780 Adenine phosphoribosyltransferase, putative 1 1 2 
Tb927.7.4440 hypothetical protein, conserved 1 1 2 
Tb927.7.6620 hypothetical protein, conserved 1 1 2 
Tb927.7.700 hypothetical protein, conserved 1 1 2 
Tb927.8.3310 acetyltransferase, putative 1 1 2 
Tb927.8.5040 hypothetical protein, conserved 1 1 2 
Tb927.8.7170 inositol polyphosphate 1-phosphatase, putative 1 1 2 
Tb927.9.8680 cytochrome c oxidase assembly factor, putative 1 1 2 
Tb927.9.4910 protein kinase, putative 1 1 2 
Tb927.10.4560 EF2 elongation factor 2 1 1 2 
Tb927.6.2300 adenosine kinase, putative 1 1 2 
Tb927.11.12230 heat shock protein HslU2, in mitochondrion 1 1 2 
Tb927.9.13520 hypothetical protein, conserved 1 1 2 
Tb927.11.3300 
hypothetical protein, conserved, HA tagged is in 
mitochondrion, poly(Q), rich in E, K. 
1 1 2 
Tb927.1.1560 
vesicular-fusion protein nsf, putative,N-
ethylmaleimide sensitive factor (NsF) 
1 1 2 
Tb927.3.4720 dynamin, putative,vacuolar sortin protein 1, putative 1 1 2 
Tb927.6.3890 replication factor C, subunit 2, putative 1 1 2 
Tb927.3.1710 Mitchondrial LSU ribosomal protein 1 1 2 
Tb927.10.14160 aquaporin 3, putative 1 1 2 
Tb927.6.1550 POMP30 leucine-rich repeat protein (LRRP) 1 1 2 
Tb927.8.7480 
hypothetical protein, conserved, no clear yeast or 
human matches 
1 1 2 
Tb927.7.7430 ATP synthase F1, alpha subunit 1 1 2 
Tb927.10.14780 
protein kinase, putative,mitogen-activated protein 
kinase kinase kinase, putative 
1 1 2 
Tb427tmp.160.520
0 
0 1 1 2 
Tb927.9.3280 
acidocalcisomal exopolyphosphatase, putative 
(3C4.175) 
1 1 2 
Tb927.7.2140 ZC3H18 1 1 2 
Tb927.10.4980 ubiquitin-like protein DSK2, putative (DSK2) 1 1 2 
Tb927.3.3310 60S ribosomal protein L13 1 1 2 
Tb927.11.4770 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1 1 2 
Tb927.6.140 retrotransposon hot spot protein 5 (RHS5), putative 1 1 2 
Tb927.6.2080 
Mitchondrial SSU ribosomal associated KRIPP22 
(PPR) 
1 1 2 
Tb927.11.10910 40S ribosomal protein SA 1 1 2 
Tb927.10.6880 
glyceraldehyde 3-phosphate dehydrogenase, 
cytosolic (GAP) 
1 1 2 
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Tb927.6.3740 
heat shock 70 kDa protein, mitochondrial precursor, 
putative 
1 1 2 
Tb927.9.12630 glycerol kinase, glycosomal (glk1) 1 1 2 
Tb927.8.6160 40S ribosomal protein S8 1 1 2 
Tb927.6.2780 
U3 small nuclear ribonucleoprotein (snRNP), 
putative 
1 1 2 
Tb927.10.10700 splicing factor Prp31 1 1 2 
Tb927.8.5810 mitochondrial carrier protein, MCP24 1 1 2 
Tb927.10.2010 hexokinase (HK1) 1 1 2 
Tb927.10.15830 hypothetical protein, conserved 1 1 2 
Tb927.5.3410 Mitchondrial LSU ribosomal protein 1 1 2 
Tb927.7.2110 KKT11 Kinetochore protein 1 1 2 
Tb927.3.2100 hypothetical protein, conserved 1 1 2 
Tb11.1790 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1 1 2 
Tb10.v4.0053 hypothetical protein 1 1 2 
Tb927.10.14820 mitochondrial carrier protein, MCP5a 1 1 2 
Tb927.8.1340 60S ribosomal protein L7a 1 1 2 
Tb927.11.8100 hypothetical protein, conserved 1 1 2 
Tb927.10.8440 glucose transporter 1B (THT1-) 1 1 2 
Tb427.11.01.v4 hypothetycal prot conserved 1 1 2 
Tb927.7.1750 60S ribosomal protein L7 1 1 2 
Tb927.6.4800 hypothetical protein, conserved 1 1 2 
Tb10.v4.0247 
s-adenosyl-L-methionine-c-24-delta-sterol-methy lt 
ransferase a, putatives 
1 1 2 
Tb927.10.2110 EF1-alpha elongation factor 1-alpha, (TEF1) 1 1 2 
Tb927.11.14000 RNA-binding protein (NRBD1) 1 1 2 
Tb927.1.2190 RAPTOR-like (TOR complexes) 2 1 2 
Tb927.1.4310 hypothetical protein, conserved 2 1 2 
Tb927.1.4420 ABC transporter, putative 2 1 2 
Tb927.10.1970 hypothetical protein, conserved 2 1 2 
Tb927.10.2880 calcium channel protein, putative 2 1 2 
Tb927.10.3100 Glycerol-3-phosphate acyltransferase 2 1 2 
Tb927.10.5350 IAD-4 inner arm dynein heavy chain 2 1 2 
Tb927.10.6330 KKT1 kinetochore protein 2 1 2 
Tb927.10.740 structural maintenance of chromosome 4 (SMC4) 2 1 2 
Tb927.10.8450 glucose transporter,glucose transporter 1E (THT1E) 2 1 2 
Tb927.10.8780 
P-loop nucleoside hydrolase domain, like a human 
adenylate kinase domain protein 
2 1 2 
Tb927.11.10520 KKT2 kinetochore protein, tyrosine kinase, putative 2 1 2 
Tb927.11.15450 hypothetical protein 2 1 2 
Tb927.11.3100 
POMP13, Trypanosome-specific, putative TM 
domain at Cterminus 
2 1 2 
Tb927.11.5820 
hypothetical protein, conserved, probably in 
mitochondrion 
2 1 2 
Tb927.11.6350 AAA ATPase, putative 2 1 2 
Tb927.2.1260 ESAG4 pseudogene 2 1 2 
Tb927.2.2370 hypothetical protein, conserved 2 1 2 
Tb927.2.3080 
fatty acid desaturase, putative,oleate desaturase, 
putative 
2 1 2 
Tb927.2.5870 hypothetical protein, conserved 2 1 2 
Tb927.3.4030 hypothetical protein, conserved 2 1 2 
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Tb927.4.1500 
RNA editing associated helicase 2 (REH2) MRB 1 
subunit 
2 1 2 
Tb927.4.2530 hypothetical protein, conserved 2 1 2 
Tb927.4.5020 RNA polymerase IIA largest subunit (RPB1) 2 1 2 
Tb927.5.1120 hypothetical protein, conserved 2 1 2 
Tb927.5.3510 structural maintenance of chromosome 3 (SMC3) 2 1 2 
Tb927.6.870 myotubularin, putative 2 1 2 
Tb927.6.920 helicase, putative 2 1 2 
Tb927.7.220 CDP-diacylglycerol synthetase, putative 2 1 2 
Tb927.7.4170 Elongase 2 2 1 2 
Tb927.7.5280 hypothetical protein, conserved 2 1 2 
Tb927.7.7400 hypothetical protein, conserved 2 1 2 
Tb927.8.2200 terbinafine resistance locus protein (yip1), putative 2 1 2 
Tb927.8.2820 hypothetical protein, conserved 2 1 2 
Tb927.8.3630 folate transporter, ESAG10, putative 2 1 2 
Tb927.8.4950 kinesin 2 1 2 
Tb927.8.6620 hypothetical protein, conserved 2 1 2 
Tb927.9.12700 phospholipase A1, putative 2 1 2 
Tb927.9.1770 hypothetical protein, conserved 2 1 2 
Tb927.9.3680 hypothetical protein, conserved 2 1 2 
Tb927.9.5700 hypothetical protein, conserved 2 1 2 
Tb927.9.9450 ZC3H28 2 1 2 
Tb927.9.9740 AMP deaminase, putative 2 1 2 
Tb927.9.9810 hypothetical protein, conserved 2 1 2 
Tb927.6.960 
cysteine peptidase precursor, Clan CA, family C1, 
Cathepsin L-like (CP) 
1 1 2 
Tb927.11.5300 kinesin, Kif13-3, predicted centromere-associated 1 1 2 
Tb927.11.6540 
hypothetical protein, conserved, kinetoplastid-
specific 
1 1 2 
Tb927.2.370 retrotransposon hot spot protein 1 (RHS1), putative 1 1 2 
Tb927.3.1590 
MRB complex protein mitochondrial RNA binding 
complex 1 subunit 
1 1 2 
Tb927.3.4500 fumarate hydratase, class I (FHc) 1 1 2 
Tb927.4.630 hypothetical protein, conserved 1 1 2 
Tb927.5.1090 threonyl-tRNA synthetase, putative 1 1 2 
Tb927.5.1470 NADH-cytochrome b5 reductase, putative (B5R) 1 1 2 
Tb927.5.3920 PEX6 peroxisome assembly protein, AAA ATPase 1 1 2 
Tb927.5.590 protein phosphatase 1, regulatory subunit, putative 1 1 2 
Tb927.5.920 hypothetical protein, conserved 1 1 2 
Tb927.7.1300 
protein disulfide isomerase,ERp72-like, cofactor wth 
calnexin, putative 
1 1 2 
Tb927.7.1360 hypothetical protein, conserved 1 1 2 
Tb927.7.1920 paraflagellar rod protein PFC5 1 1 2 
Tb927.7.2660 ZC3H20 1 1 2 
Tb927.7.2700 NADH-cytochrome b5 reductase, putative (B5R) 1 1 2 
Tb927.7.3080 
hypothetical protein, conserved, kinetoplastid-
specific 
1 1 2 
Tb927.7.4390 threonine synthase, putative 1 1 2 
Tb927.7.7030 hypothetical protein, conserved 1 1 2 
Tb927.7.7460 hypothetical protein, conserved 1 1 2 
Tb927.8.2030 hypothetical protein, conserved 1 1 2 
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Tb927.9.11050 4E-IP, 4E-interacting protein, putative 1 1 2 
Tb927.9.11910 hypothetical protein, conserved 1 1 2 
Tb927.9.6450 PEX16, putative 1 1 2 
Tb927.9.9870 MCAK-like kinesin, putative 1 1 2 
Tb927.9.6100 TFIIF-stimulated CTD phosphatase, in UPF1-TAP 1 1 2 
Tb927.9.7470 purine nucleoside transporter NT10 2 1 2 
Tb927.11.14900 coatomer epsilon subunit, epsilon-COP 1 1 2 
Tb927.10.2640 intraflagellar transport protein IFT81 1 1 2 
Tb927.11.16160 ATP binding protein-like protein 1 1 2 
Tb927.11.3770 hypothetical protein, conserved 1 1 2 
Tb927.2.4980 hypothetical protein, conserved 1 1 2 
Tb927.7.1500 Thiomodification of cytiosolic tRNAs (NBP 2) 1 1 2 
Tb927.9.8850 actin A 1 1 2 
Tb927.11.4900 guanine nucleotide-binding beta subunit-like protein 1 1 2 
Tb927.9.6060 
2Fe-2S iron-sulfur cluster binding domain containing 
protein, POMP4 
1 1 2 
Tb927.1.3110 
soluble N-ethylmaleimide sensitive factor (NSF) 
attachment protein, putative 
1 1 2 
Tb927.4.1170 ankyrin, putative 1 1 2 
Tb927.7.1970 retrotransposon hot spot protein 7 (RHS7), putative 1 1 2 
Tb927.11.670 epsinR 1 1 2 
Tb927.10.9430 
phosphoribosylpyrophosphate synthetase, putative 
(PRS) 
1 1 2 
Tb927.1.2330 beta tubulin 1 1 2 
Tb927.1.1790 hypothetical protein 1 1 2 
Tb927.10.1120 hypothetical protein, conserved 1 1 2 
Tb927.10.460 NIMA-related protein kinase (NRKC) 1 1 2 
Tb927.11.4350 hypothetical protein, conserved 1 1 2 
Tb927.2.2260 PIK-related 1 1 2 
Tb927.4.220 
retrotransposon hot spot protein (RHS2, 
pseudogene), putative 
1 1 2 
Tb927.6.2880 Kinesin-like but poor match 1 1 2 
Tb927.8.3180 hypothetical protein, conserved 1 1 2 
Tb927.8.5330 
MCP2, binds to tRNAs and assists tRNA 
synthetases 
1 1 2 
Tb927.8.800 hypothetical protein, conserved 1 1 2 
Tb927.9.1710 hypothetical protein, conserved 1 1 2 
Tb927.9.3920 40S ribosomal protein S7 1 1 2 
Tb927.11.7610 gp63-1 surface protease pseudogene 1 1 2 
Tb927.9.9420 hypothetical protein, conserved 1 1 2 
Tb927.10.14950 ZC3H40 1 1 2 
Tb927.10.3760 vacuolar ATP synthase subunit d, putative 1 1 2 
Tb927.11.1890 hypothetical protein, conserved 1 1 2 
Tb927.11.5440 malic enzyme 1 1 2 
Tb927.2.4240 GTP binding protein, putative 1 1 2 
Tb927.3.3630 EF-TS Mitochondrial elongation factor ts 1 1 2 
Tb927.4.3370 hypothetical protein, conserved 1 1 2 
Tb927.5.2380 hydrolase, alpha/beta fold family, putative 1 1 2 
Tb927.6.1810 hypothetical protein, conserved 1 1 2 
Tb927.6.4430 homoserine kinase, putative (HK) 1 1 2 
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Tb927.6.4920 
S-adenosylmethionine synthetase, putative 
(METK1) 
1 1 2 
Tb927.7.2020 retrotransposon hot spot protein 7 (RHS7), putative 1 1 2 
Tb927.8.5860 
Mitchondrial LSU ribosomal protein 50S ribosomal 
protein L17, putative 
1 1 2 
Tb927.9.15190 60S ribosomal protein L15 1 1 2 
Tb09.v4.0013 retrotransposon hot spot (RHS) protein 1 1 2 
Tb927.2.3400 hypothetical protein, copurified with splicing complex 1 1 2 
Tb927.3.3610 PEX7 peroxisomal targeting signal type 2 receptor 1 1 2 
Tb927.11.16080 hypothetical protein, conserved 1 1 2 
Tb927.5.550 vacuolar ATP synthase, putative 1 1 2 
Tb927.11.2260 eIF4E1 1 1 2 
Tb927.5.2940 stress-induced protein sti1, putative 1 1 2 
Tb927.8.8330 calpain, putative,cysteine peptidase, putative 1 1 2 
Tb927.10.1900 DNA topoisomerase IA, putative 1 1 2 
Tb927.9.6290 arginine kinase (AK) 1 1 2 
Tb927.11.500 UBP1 1 1 2 
Tb927.8.7980 
vacuolar-type H( )-translocating pyrophosphatase 
(TVP1) 
1 1 2 
 
Supplementary table 2: Proteins that co-purified with the EP 3’-UTR detected 
by DL-QMS  
In this table the enrichment obtained using the method developed in the present 
dissertation is compared to a previous purification done in the laboratory by Cornelia 
Klein. The last two columns in this table correspond to proteins found in membrane 
bound polyribosomes for procyclic form trypanosomes and the number of times 
these peptides were found in previous purifications, respectively. 
 
Accession Description 
3SBP/
No 
SBP 
Coverage 
PC meb 
polys 
Peptides 
no 
times 
found 
before 
Tb927.11.3600 40S ribosomal protein S4 300 25,27 0 0 
Tb927.7.7420 
ATP synthase alpha chain, 
mitochondrial precursor,ATP 
synthase F1, alpha subunit 
300 9,76 11 5 
Tb927.10.12840 
mitochondrial carrier protein, 
MCP12 
300 18,42 0 0 
Tb927.3.2150 
protein phosphatase 2C, 
putative 
292 9,39 0 0 
Tb927.11.11360 
guanine nucleotide-binding 
protein (TRACK) 
277 22,33 15 4 
Tb927.10.4310 prohibitin 2, putative (PHB2) 255 15,93 0 0 
Tb927.5.3400 
calcium-translocating P-type 
ATPase,calcium pump 
230 29,28 0 0 
Tb927.5.1210 
short-chain dehydrogenase, 
putative 
214 18,97 0 0 
Tb927.10.7410 
succinyl-CoA ligase [GDP-
forming] beta-chain, 
putative;with=GeneDB:LmjF36.2
950 
206 5,25 7 1 
Tb927.11.16280 60S ribosomal protein L2 L8 197 37,31 10 9 
Tb927.9.5730 
nucleosome assembly protein-
like protein (28G16.410) 
195 4,50 0 0 
Tb927.9.15150 60S ribosomal protein L5 189 8,44 12 6 
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Tb927.10.3660 aspartate aminotransferase 173 6,20 0 1 
Tb927.11.2050 60S acidic ribosomal subunit 157 71,91 0 0 
Tb927.7.4900 
5'-3' exonuclease XRNA, 
putative,exoribonuclease 1, 
putative (XRNA) 
147 3,74 0 2 
Tb927.4.2850 
hypothetical protein, conserved 
no domains 
141 4,11 0 0 
Tb927.9.4680 
ATP-dependent DEAD box 
helicase, putative (1L12.525) 
135 15,59 8 6 
Tb927.6.1520 aquaporin 3, putative (AQP1) 135 13,71 0 0 
Tb927.10.8520 glucose transporter, putative 129 4,35 0 0 
Tb927.10.8490 glucose transporter, putative 129 4,35 0 0 
Tb927.10.8500 glucose transporter, putative 129 4,35 0 0 
Tb927.7.3040 
hypothetical protein, conserved 
ARM and WD40 repeat 
122 8,35 0 2 
Tb927.11.9920 polyubiquitin, putative 114 38,10 2 3 
Tb927.3.3130 
hypothetical protein, conserved 
SAM (DNA-bindng?) domain, no 
yeast match 
108 2,19 0 0 
Tb927.9.15460 
calcium motive p-type ATPase, 
putative 
106 5,09 0 0 
Tb927.10.8170 
nuclear pore complex protein 
(NUP155), putative,nucleoporin, 
putative 
101 14,87 0 0 
Tb927.11.14190 hypothetical protein, conserved 90 3,46 2 1 
Tb927.8.1870 
Golgi/lysosome glycoprotein 1 
(tGLP1) 
88 11,36 0 2 
Tb927.9.8740 RNA-binding protein (DRBD3) 84 7,03 2 6 
Tb927.10.14830 
mitochondrial carrier protein, 
MCP5b 
83 37,13 0 0 
Tb927.10.8270 
eukaryotic translation initiation 
factor 3 subunit 8, putative 
78 3,38 13 2 
Tb927.11.11460 hypothetical protein, conserved 73 5,78 0 1 
Tb927.9.4210 
fatty acyl CoA synthetase 3 
(ACS3) 
67 5,70 0 1 
Tb927.10.4430 
pumillo RNA binding protein 
PUF1 (PUF1) 
66 3,85 0 1 
Tb927.2.4400 hypothetical protein, conserved 65 1,95 0 1 
Tb927.8.3530 
glycerol-3-phosphate 
dehydrogenase [NAD ], 
glycosomal 
61 16,67 7 6 
Tb927.4.590 hypothetical protein, conserved 59 7,33 0 0 
Tb927.6.2790 
L-threonine 3-dehydrogenase, 
putative 
57 21,69 7 2 
Tb927.10.1100 60S ribosomal protein L9 51 24,34 8 6 
Tb927.6.4690 60S ribosomal protein L9 51 22,99 0 1 
Tb927.6.3750 
heat shock 70 kDa protein, 
mitochondrial precursor, putative 
51 38,36 0 0 
Tb927.7.2190 hypothetical protein, conserved 50 7,52 0 2 
Tb927.1.3070 hypothetical protein, conserved 50 7,02 0 1 
Tb927.6.4800 hypothetical protein, conserved 46 4,31 0 1 
Tb927.11.1900 
T-complex protein 1, beta 
subunit, putative 
44 31,00 16 1 
Tb927.3.5050 60S ribosomal protein L4 38 16,84 23 11 
Tb927.10.8940 hypothetical protein, conserved 37 18,73 0 1 
Tb927.4.5200 
nucleoporin (NUP54/57), 
putative (TbNup62) 
35 8,58 0 0 
Tb927.4.4490 
multidrug resistance protein E,p-
glycoprotein (MRPE) 
31 1,25 0 0 
Tb927.2.3780 
translation initiation factor IF-2, 
putative (28H13.240) 
31 4,92 2 3 
Tb927.10.3990 DHH1 (DHH1) 26 14,78 6 7 
  
162 
Tb927.11.13180 hypothetical protein, conserved 26 7,14 0 3 
Tb927.11.10760 kinesin-like protein, putative 26 8,10 0 0 
Tb927.7.5020 60S ribosomal protein L19 25 18,08 0 0 
Tb927.2.450 
retrotransposon hot spot protein 
4 (RHS4), putative (3B10.180) 
24 14,47 0 1 
Tb927.3.3150 hypothetical protein, conserved 24 4,08 0 0 
Tb927.10.3940 40S ribosomal protein S3A 22 42,58 14 7 
Tb927.10.3930 40S ribosomal protein S3A 22 39,84 0 0 
Tb927.11.330 Nucleoporin (TbMlp-1) 22 10,67 0 0 
Tb927.3.5370 hypothetical protein, conserved 21 13,10 0 2 
Tb927.9.9290 
Polyadenylate-binding protein 1 
(Poly(A)-binding protein 1) 
(PABP 1) (PABP1) 
21 14,84 25 4 
Tb927.5.520 stomatin-like protein, putative 19 10,36 0 2 
Tb927.5.440 trans-sialidase, putative 17 6,58 0 0 
Tb927.5.4420 
nucleolar RNA helicase II, 
putative,nucleolar RNA helicase 
Gu, putative 
16 10,92 0 5 
Tb927.10.4570 elongation factor 2 14 29,79 0 0 
Tb927.2.100 
retrotransposon hot spot protein 
1 (RHS1), putative (3B10.5) 
13 2,41 0 1 
Tb927.11.10790 40S ribosomal protein SA 12 18,44 8 11 
Tb927.11.10910 40S ribosomal protein SA 12 16,25 0 0 
Tb927.9.11600 
Gim5B protein,glycosomal 
membrane protein (gim5B) 
12 12,03 0 2 
Tb927.9.11580 
Gim5A protein,glycosomal 
membrane protein (gim5A) 
12 11,93 0 0 
Tb927.8.3750 nucleolar protein, putative 12 6,00 11 3 
Tb927.9.8880 actin A 11 23,40 0 0 
Tb927.1.2340 alpha tubulin 11 61,20 18 22 
Tb927.11.14020 RNA-binding protein (NRBD2) 11 22,94 12 6 
Tb927.11.14000 RNA-binding protein (NRBD1) 11 18,32 0 1 
Tb927.8.8050 Nucleoporin (TbNup75) 11 7,31 0 0 
Tb927.4.3950 
cytoskeleton-associated protein 
CAP5.5, putative,cysteine 
peptidase 
11 11,14 8 2 
Tb927.11.7460 
glucose-regulated protein 78, 
putative,luminal binding protein 
1 (BiP), putative 
10 23,89 15 10 
Tb927.11.2650 
heat shock protein 84, putative, 
mit HSp90 
10 22,44 2 3 
Tb927.10.12500 P-type H -ATPase, putative 10 7,89 0 0 
Tb927.10.12510 P-type H -ATPase, putative 10 6,52 0 0 
Tb927.9.6230 arginine kinase (AK) 10 28,65 0 4 
Tb927.9.6290 arginine kinase (AK) 10 27,53 9 1 
Tb927.9.6170 
arginine kinase (AK) in cytosol 
and flagellum 
10 26,24 0 1 
Tb927.10.6400 
chaperonin HSP60, 
mitochondrial precursor 
(HSP60) 
9 73,84 15 7 
Tb927.3.1380 
ATP synthase beta chain, 
mitochondrial precursor,ATP 
synthase F1, beta subunit 
9 22,74 15 4 
Tb927.1.2370 beta tubulin 9 77,15 0 0 
Tb927.9.10310 
mitochondrial carrier protein, 
MCP11 
9 13,88 0 1 
Tb927.11.16760 
T-complex protein 1, alpha 
subunit, putative (TCP-1-alpha) 
9 10,30 18 1 
Tb927.10.1060 
T-complex protein 1, delta 
subunit, putative (TCP-1-delta) 
8 13,25 17 2 
Tb927.10.2100 elongation factor 1-alpha,EF-1- 8 43,88 9 6 
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alpha (TEF1) 
Tb927.9.8070 60S ribosomal protein L10 8 10,80 11 9 
Tb927.11.11680 
2-oxoglutarate dehydrogenase 
E2 component, putative 
8 13,58 10 6 
Tb927.11.11330 heat shock protein 70 7 31,88 35 24 
Tb927.11.15990 
nucleoporin Nup109 
(TbNup109) 
7 13,39 0 0 
Tb927.3.4760 
dynamin, putative,vacuolar 
sortin protein 1, putative 
7 8,33 0 0 
Tb927.11.6440 
hypothetical protein, conserved, 
often in TAP MS 
7 13,15 0 13 
Tb927.9.2470 nucleolar protein (NOP86) 6 12,42 9 4 
Tb927.11.3240 
T-complex protein 1, zeta 
subunit, putative (TCP-1-zeta) 
6 12,68 14 6 
Tb927.10.540 
ATP-dependent DEAD/H RNA 
helicase, putative,DEAD box 
RNA helicase, putative 
6 6,88 0 1 
Tb927.10.12700 
pyruvate dehydrogenase E1 
alpha subunit, putative 
6 14,29 12 4 
Tb927.8.1500 hypothetical protein, conserved 6 6,99 0 4 
Tb927.10.10930 heat shock protein, putative 6 39,77 0 0 
Tb927.9.11270 
T-complex protein 1, eta 
subunit, putative,t- complex 
protein 1 (eta subunit) 
6 13,38 11 2 
Tb927.2.470 
retrotransposon hot spot protein 
4 (RHS4), putative (3B10.190) 
6 14,07 0 1 
Tb927.3.3180 Nucleoporin (TbNup98) 6 54,33 0 1 
Tb927.1.120 
retrotransposon hot spot protein 
4 (RHS4), putative 
6 25,70 0 1 
Tb927.9.5900 
glutamate dehydrogenase 
(GDH) 
6 19,86 2 9 
Tb927.10.14180 
protein transport protein Sec13, 
putative,cytosolic coat protein, 
putative 
6 5,88 0 2 
Tb927.2.2520 
voltage-dependent anion-
selective channel (25N14.5) 
6 22,22 0 0 
Tb927.11.17000 AIR9 6 13,55 11 4 
Tb927.9.10770 
Polyadenylate-binding protein 2 
(Poly(A)-binding protein 2) 
5 15,50 24 13 
Tb927.11.1450 
2-oxoglutarate dehydrogenase 
E1 component, putative 
5 16,47 27 4 
Tb927.11.9780 hypothetical protein, conserved 5 4,09 0 0 
Tb927.9.12510 
ATP-dependent DEAD/H RNA 
helicase, DED1 
5 3,95 5 6 
Tb927.6.4770 MKT1 5 4,63 2 5 
Tb927.10.7570 
dihydrolipoamide 
acetyltransferase E2 subunit, 
putative 
5 8,65 8 3 
Tb927.7.2300 Nucleoporin (TbNup132) 5 13,05 0 0 
Tb927.2.1330 
retrotransposon hot spot protein 
(RHS, pseudogene), putative 
5 3,65 0 1 
Tb927.8.1330 60S ribosomal protein L7a 5 10,14 13 8 
Tb927.3.1790 
pyruvate dehydrogenase E1 
beta subunit, putative 
5 11,78 7 2 
Tb927.11.980 Nucleoporin (TbNup158) 5 30,39 0 0 
Tb927.2.1170 
retrotransposon hot spot protein 
5 (RHS5), putative (25N24.105) 
5 7,85 0 1 
Tb927.10.7060 
nucleoporin interacting 
component (NUP93), putative 
5 13,36 0 0 
Tb927.6.4280 
glyceraldehyde 3-phosphate 
dehydrogenase, glycosomal 
(GAPDH) 
5 29,81 0 10 
Tb927.9.12550 glycerol kinase, glycosomal 5 8,40 9 12 
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(glk1) 
Tb927.9.12570 
glycerol kinase, glycosomal 
(glk1) 
5 8,40 0 2 
Tb927.9.12630 
glycerol kinase, glycosomal 
(glk1) 
5 8,40 0 0 
Tb927.9.12610 
glycerol kinase, glycosomal 
(glk1) 
5 8,40 0 0 
Tb927.11.13520 hypothetical protein, conserved 4 2,63 0 0 
Tb927.6.2640 
importin alpha subunit, putative 
(TbKap60) 
4 6,00 4 4 
Tb927.10.9650 hypothetical protein, conserved 4 10,95 0 0 
Tb927.9.14240 Nucleoporin (Nup82) 4 21,14 0 0 
Tb927.11.2950 Nucleoporin (TbNup89) 4 30,03 0 0 
Tb927.5.1060 
mitochondrial processing 
peptidase, beta subunit, putative 
4 16,77 2 2 
Tb927.11.11080 Nucleoporin (TbNup149) 4 37,46 0 0 
Tb927.6.1870 
eukaryotic translation initiation 
factor 4e, putative 
4 6,56 2 3 
Tb927.11.6280 
pyruvate phosphate dikinase 
(PPDK) 
4 10,19 23 4 
Tb927.6.4090 
chaperonin HSP60, 
mitochondrial precursor, putative 
(HSP60) 
4 3,88 0 0 
Tb927.11.11090 Nucleoporin (TbNup140) 4 2,46 0 0 
Tb927.2.4230 
NUP-1 protein, putative 
(28H13.465) 
3 24,49 0 1 
Tb927.2.240 
retrotransposon hot spot protein 
5 (RHS5), putative (3B10.75) 
3 8,16 0 0 
Tb927.2.380 
retrotransposon hot spot protein 
2 (RHS2), putative (3B10.145) 
3 2,53 0 1 
Tb927.1.190 
retrotransposon hot spot protein 
(RHS, pseudogene), putative 
3 2,41 0 0 
Tb927.2.400 
retrotransposon hot spot protein 
2 (RHS2), putative (3B10.155) 
3 2,53 0 0 
Tb927.2.280 
retrotransposon hot spot protein 
2 (RHS2), putative (3B10.95) 
3 2,53 0 0 
Tb927.11.9980 
2-oxoglutarate dehydrogenase 
E1 component, putative 
3 25,67 36 3 
Tb927.8.3950 hypothetical protein, conserved 3 8,21 0 0 
Tb927.11.3120 
nucleolar GTP-binding protein 1 
(NOG1) 
3 4,27 6 2 
Tb927.7.2680 ZC3H22 3 12,15 0 0 
Tb927.10.1510 NOT1 (NOT1) 3 3,44 0 3 
Tb927.4.4940 hypothetical protein, conserved 3 5,08 0 0 
Tb927.6.4440 
RBP42 (binds energy 
metabolism RNA CDSs) 
3 33,52 2 11 
Tb927.9.1410 hypothetical protein, conserved 3 14,89 0 1 
Tb927.8.4820 
eukaryotic translation initation 
factor 4 gamma, putative 
3 5,47 5 2 
Tb927.11.6630 
3-methylcrotonoyl-CoA 
carboxylase beta subunit, 
putative 
2 27,29 0 0 
Tb927.4.4310 Nucleoporin (TbNup64) 2 13,16 0 1 
Tb927.11.3980 
mitochondrial processing 
peptidase alpha subunit, 
putative 
2 9,07 0 0 
Tb927.10.14550 
ATP-dependent DEAD/H RNA 
helicase, DBP1 
2 21,36 3 10 
Tb927.11.6600 hypothetical protein, conserved 2 6,04 0 0 
Tb927.9.6460 hypothetical protein, conserved 2 4,21 0 0 
Tb927.4.5350 
3-methylcrotonyl-CoA 
carboxylase, pseudogene 
2 15,63 0 0 
Tb927.3.3300 hypothetical protein, conserved 2 3,56 0 2 
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Tb927.8.6970 
3-methylcrotonyl-CoA 
carboxylase alpha subunit, 
putative 
2 16,52 0 0 
Tb927.8.7100 
acetyl-CoA carboxylase, 
putative 
1 24,90 0 1 
Tb927.5.2530 hypothetical protein, conserved 1 1,83 0 0 
 
Supplementary table 3: Proteins enriched in the EP 3’-UTR purification  
Proteins detected by mass-spectrometry. The ratio obtained between peptides found 
in the 3SBPs-purification compared to the control purification (without SBPs) of four 
independent replicates (1 to 4) is shown in the table. The table is arranged by largest 
ratio. 
 
Accession Description 
Replicates (ratio 3 SBPs/No SBP) 
1 2 3 4 
Tb927.1.2400 alpha tubulin 34,0 30,0 1,2 1,0 
Tb927.7.710 
heat shock 70 kDa protein, putative 
(HSP70.4) 
1,0 1,0 34,0 0,1 
Tb927.1.2390 beta tubulin 29,0 28,0 1,0 1,0 
Tb927.11.5500 
mitochondrial RNA binding protein 1 
KRIPP1 (PPR) 
13,0 1,0 1,0 1,0 
Tb927.9.12610 glycerol kinase, glycosomal (glk1) 1,0 11,0 1,1 1,0 
Tb927.11.9980 
2-oxoglutarate dehydrogenase E1 
component, putative 
2,6 10,0 2,2 0,3 
Tb927.4.4380 
vacuolar-type proton translocating 
pyrophosphatase 1, putative (PPase1) 
10,0 1,0 1,0 0,2 
Tb927.9.4420 hypothetical protein, conserved 1,0 1,0 9,0 1,0 
Tb927.5.4330 
dihydrolipoamide branched chain 
transacylase, putative 
1,0 1,0 9,0 1,0 
Tb927.3.1010 
hypothetical protein, conserved, 
Trypanosoma-specific 
9,0 1,0 3,0 1,0 
Tb927.11.3490 
hypothetical protein, conserved, no 
domains, no good BLASTp matches 
1,0 1,0 9,0 0,3 
Tb927.8.2630 
Kinesin KIN-C. Trypanosome-specific 
kinesin family 2 
9,0 0,3 7,0 0,1 
Tb927.9.6230 arginine kinase (AK) 8,3 1,2 5,7 0,8 
Tb927.5.4040 
Mitchondrial SSU ribosomal associated 
(coiled coil) 
8,0 1,0 3,0 1,0 
Tb927.4.3680 protein phosphatase 2C, putative 8,0 1,0 2,0 1,0 
Tb927.3.3300 hypothetical protein, conserved 2,0 1,0 8,0 0,3 
Tb927.9.13380 phosphoinositide-binding protein, putative 2,5 0,3 8,0 0,5 
Tb927.2.4130 
enoyl-CoA hydratase/Enoyl-CoA 
isomerase/3-hydroxyacyl-CoA 
dehydrogenase, putative 
3,0 1,0 8,0 0,3 
Tb927.2.2970 mitochondrial carrier protein, MCP13 8,0 3,0 1,3 0,3 
Tb927.2.4400 Mitchondrial SSU ribosomal protein 5,0 0,6 8,0 0,1 
Tb927.11.5060 Mitchondrial SSU ribosomal protein 7,0 1,0 1,0 1,0 
Tb927.4.2080 
CC2D is a FAZ-ER protein, also present 
on the basal bodies. 
7,0 1,0 4,0 1,0 
Tb927.11.7710 
Gp63-1 surface protease homolog, 
putative 
7,0 3,0 4,0 1,0 
Tb927.9.9310 hypothetical protein, conserved 7,0 1,0 1,0 1,0 
Tb927.1.1620 
ATP-dependent DEAD/H RNA helicase, 
putative, no clear yeast homologue 
1,0 1,0 7,0 1,0 
Tb927.7.270 ribosome biogenesis protein, putative 7,0 1,0 6,0 1,0 
Tb927.9.8820 hypothetical protein, conserved, no yeast 7,0 0,7 3,0 0,4 
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or human match 
Tb927.10.10850 AGO1 7,0 1,0 5,0 0,3 
Tb927.11.13520 hypothetical protein, conserved 1,0 1,0 7,0 0,3 
Tb927.10.11760 PUF6 7,0 1,0 1,8 0,2 
Tb927.11.14730 
metalloprotease, putative,cell division 
protein FtsH homologue, putative 
5,0 1,0 7,0 0,1 
Tb927.9.12200 60S ribosomal protein L31 6,0 5,0 1,0 1,7 
Tb927.7.3050 Mitchondrial SSU ribosomal associated 6,0 1,0 1,0 1,0 
Tb927.2.4550 
FtsJ cell division protein, putative 
(30M24.305) 
4,0 1,0 6,0 1,0 
Tb927.11.14980 Mitchondrial LSU ribosomal protein 6,0 1,0 1,0 1,0 
Tb927.10.12510 P-type H -ATPase, putative 6,0 1,3 1,4 1,0 
Tb927.9.12730 
chaperone protein DNAj, endoplasmatic 
reticulum 
1,5 1,0 6,0 1,0 
Tb927.8.6390 
lysophospholipase, putative,alpha/beta 
hydrolase, putative (TbLysoPLA) 
1,0 1,0 6,0 1,3 
Tb927.2.5530 POMP22 6,0 1,0 1,0 1,0 
Tb927.6.1250 Mitchondrial SSU ribosomal protein S29 6,0 1,0 1,0 1,0 
Tb927.5.2530 hypothetical protein, conserved 3,0 1,0 6,0 1,0 
Tb927.3.3130 POMP24 6,0 3,0 1,1 0,4 
Tb927.4.5350 
3-methylcrotonyl-CoA carboxylase, 
pseudogene 
1,7 1,0 6,0 0,2 
Tb927.11.11460 POMP9 5,5 4,0 2,0 0,1 
Tb927.7.6090 hypothetical protein, conserved 5,0 1,0 1,0 1,0 
Tb927.10.3840 60S ribosomal protein L18 1,0 1,0 1,0 5,0 
Tb927.8.2160 
multidrug resistance protein A,p-
glycoprotein (PGPA) 
5,0 1,0 1,7 1,0 
Tb927.11.6510 40S ribosomal protein S21 1,0 1,0 1,0 5,0 
Tb927.11.6000 Mitchondrial LSU ribosomal protein 5,0 1,0 1,0 1,0 
Tb927.4.4210 
ATP-dependent zinc metallopeptidase, 
putative,metallo-peptidase, Clan MA(E) 
Family M41 
1,0 1,0 5,0 1,0 
Tb927.1.2670 flagellar protein PF16 5,0 4,0 5,0 1,0 
Tb927.2.2950 hypothetical protein, conserved 5,0 1,0 1,0 1,0 
Tb927.10.7090 alternative oxidase (AOX) 5,0 1,0 1,0 1,0 
Tb927.2.5980 
ATP-dependent Clp protease subunit, heat 
shock protein 104 (HSP104) 
5,0 1,0 1,2 1,0 
Tb927.9.6920 hypothetical protein, conserved 3,0 1,0 5,0 1,0 
Tb927.4.4670 hypothetical protein, conserved 5,0 1,0 1,3 1,0 
Tb927.11.9080 hypothetical protein, conserved 4,0 1,0 5,0 1,0 
Tb927.1.2570 coatomer beta subunit (beta-coP) 1,0 1,0 5,0 1,0 
Tb927.1.1700 hypothetical protein, conserved 1,0 1,0 5,0 1,0 
Tb927.10.14330 hypothetical protein, conserved 1,0 1,0 5,0 1,0 
Tb927.6.1020 
cysteine peptidase precursor, Clan CA, 
family C1, Cathepsin L-like (Rhodesain) 
1,0 1,0 1,0 5,0 
Tb927.7.3970 hypothetical protein, conserved 1,0 1,0 5,0 1,0 
Tb927.7.5110 hypothetical protein, conserved 5,0 1,0 1,0 1,0 
Tb927.9.12070 hypothetical protein, conserved 1,0 1,0 5,0 1,0 
Tb927.9.15330 hypothetical protein, conserved 1,0 1,0 5,0 1,0 
Tb927.9.7540 
calpain-like cysteine peptidase, 
putative,cysteine peptidase, Clan CA, 
family C2, putative 
5,0 1,0 1,0 1,0 
Tb927.7.1790 
Adenine phosphoribosyltransferase, 
putative 
1,0 1,0 1,0 5,0 
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Tb927.10.15650 
tRNA pseudouridine synthase A-like 
protein 
5,0 1,0 1,0 1,0 
Tb927.10.180 
ATP synthase F1 subunit gamma protein, 
putative 
1,7 5,0 1,8 0,8 
Tb927.11.510 UBP2 5,0 4,0 0,8 1,3 
Tb927.7.5930 
Protein Associated with Differentiation 
(TbPAD1) 
1,7 5,0 1,7 0,6 
Tb927.10.8170 Nucleoporin  (NUP155) 1,7 1,1 5,0 0,5 
Tb927.4.1850 hypothetical protein, conserved 5,0 1,0 0,3 1,0 
Tb927.11.10370 glycosyl hydrolase-like protein 1,3 1,0 5,0 0,3 
Tb927.3.2050 
hypothetical protein, conserved, no 
domains, poly(Q) tracts, K-specific 
5,0 1,0 2,0 0,3 
Tb927.7.4290 
Nuclear migration protein NudC (animals), 
46% identity 
5,0 1,0 2,0 0,3 
Tb927.8.1420 
acyl-CoA dehydrogenase, mitochondrial 
precursor, putative 
3,5 1,0 5,0 0,3 
Tb927.4.1540 
POMP27, NAD-dependent epimerase, 
aldehyde reductase, one putative TM 
domain 
5,0 0,3 1,0 0,2 
Tb927.3.3150 hypothetical protein, conserved 5,0 1,0 3,0 0,2 
Tb927.6.1430 hypothetical protein, conserved 5,0 1,0 1,8 0,2 
Tb927.7.6850 trans-sialidase (TbTS) 5,0 1,0 1,0 0,1 
Tb927.7.4500 hypothetical protein, conserved 5,0 5,0 2,3 0,1 
Tb927.6.2010 hypothetical protein, conserved 4,7 1,0 2,5 0,3 
Tb927.5.2930 
Mitochondrial ATP synthase subunit, 
putative 
4,3 0,8 2,2 0,8 
Tb927.8.7100 acetyl-CoA carboxylase, putative 1,6 1,0 4,2 0,8 
Tb927.7.3940 mitochondrial carrier protein, MCP16 3,0 4,0 1,7 1,7 
Tb927.8.5200 Mitchondrial SSU ribosomal associated 1,0 1,0 4,0 1,0 
Tb927.11.3120 nucleolar GTP-binding protein 1 (NOG1) 4,0 1,0 1,0 1,0 
Tb927.2.3180 
TbPPR1 mitochondrial RNA binding 
protein 1 
4,0 1,0 1,0 1,0 
Tb927.10.1100 60S ribosomal protein L9 4,0 1,0 1,0 2,0 
Tb927.10.380 PPR5 mitochondrial RNA binding protein 1 4,0 1,0 1,0 1,0 
Tb927.9.2900 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.8.3110 Mitchondrial SSU ribosomal protein S9 4,0 1,0 1,0 1,0 
Tb927.2.5240 PRP19-like protein, putative (TbPRP19) 4,0 1,0 1,0 1,0 
Tb927.3.970 Mitchondrial SSU ribosomal protein 4,0 1,0 1,0 1,0 
Tb927.8.3170 Mitchondrial LSU ribosomal protein 4,0 1,0 1,0 1,0 
Tb927.7.7450 GTP-binding protein, putative 3,0 1,0 4,0 1,0 
Tb927.5.1790 Mitchondrial SSU ribosomal protein 4,0 1,0 1,0 1,0 
Tb927.4.3300 
mitochondrial ATP-dependent zinc 
metallopeptidase, putative 
4,0 1,0 3,0 1,0 
Tb927.11.15850 
kinetoplast poly(A) polymerase complex 1 
subunit 
4,0 1,0 1,0 1,0 
Tb927.4.760 
AP-1 adapter complex gamma subunit, 
putative 
1,0 1,0 4,0 1,0 
Tb927.11.8870 
mitochondrial DEAD box protein,KREH1 
(KREH1) 
4,0 1,0 1,3 1,0 
Tb927.3.3460 
hypothetical protein, conserved (SDH5 in T 
cruzi) 
4,0 1,0 3,0 1,0 
Tb927.10.8270 eIF3 subunit 8, putative 4,0 1,0 3,0 1,0 
Tb927.3.1910 
hypothetical protein, conserved, histone 
RNA binding domain 259-326 
2,0 1,0 4,0 1,0 
Tb927.11.10560 eIF4G4 1,0 1,0 4,0 1,0 
Tb927.10.13730 60S ribosomal protein L7 4,0 1,0 1,0 1,0 
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Tb927.10.14700 
hypothetical protein, conserved, no human 
or yeast homologue 
1,0 1,0 4,0 3,0 
Tb927.3.4600 hypothetical protein, conserved 4,0 1,0 1,0 1,0 
Tb927.7.4220 hypothetical protein, conserved 4,0 1,0 1,0 1,0 
Tb927.10.70 
retrotransposon hot spot (RHS), putative, 
(fragment) 
4,0 1,0 1,3 1,0 
Tb927.7.2410 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.10.9810 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.10.5760 adenylate kinase, putative 1,0 1,0 1,0 4,0 
Tb927.10.14320 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.10.1540 ZC3H30 1,0 1,0 4,0 1,0 
Tb927.10.2550 malate dehydrogenase-related 1,0 1,0 4,0 1,0 
Tb927.10.9660 
CRN/SYF3 part of splicing PRP19 
complex, putative 
4,0 1,0 1,0 1,0 
Tb927.11.12880 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.11.14970 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.11.4700 prostaglandin f synthase 1,0 1,0 4,0 1,0 
Tb927.11.9530 14-3-3-I protein 1,0 1,0 1,0 4,0 
Tb927.4.1790 60S ribosomal protein L3 4,0 1,0 1,0 1,0 
Tb927.6.2550 TRRM2 1,0 1,0 4,0 1,0 
Tb927.7.2390 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.8.1980 hypothetical protein, conserved 1,0 1,0 4,0 1,0 
Tb927.9.11850 
structural maintenance of chromosome 1 
(SMC1) 
1,0 1,0 4,0 1,0 
Tb927.10.5880 Proteophosphoglycan, putative 3,0 1,0 4,0 1,0 
Tb927.7.5340 hypothetical protein, conserved 3,0 1,0 4,0 1,0 
Tb927.6.1900 
U3/U14 snoRNA-associated small subunit 
rRNA processing protein, putative 
4,0 1,0 1,5 1,0 
Tb927.5.1580 ZC3H13 1,8 4,0 3,0 1,0 
Tb927.3.1940 
hypothetical protein, possible component 
of cytochorome oxidase complex 
4,0 1,0 3,0 1,0 
Tb927.11.9710 60S ribosomal protein L10a 1,1 0,8 4,0 1,0 
Tb927.9.13990 DRBD2 4,0 1,0 1,3 0,8 
Tb927.3.5340 Hsc70-interacting protein (Hip), putative 1,0 1,0 0,8 4,0 
Tb927.8.1890 cytochrome c1 4,0 0,8 1,5 1,0 
Tb927.4.2000 
ruvB-like DNA helicase, putative,ATP-
dependent DNA helicase, putative 
4,0 1,0 0,7 1,0 
Tb927.9.14160 
rieske iron-sulfur protein, mitochondrial 
precursor (RISP) 
1,6 4,0 1,6 0,6 
Tb927.8.3150 
T-complex protein 1, gamma subunit, 
putative (TCP-1-gamma) 
4,0 0,8 0,5 0,5 
Tb927.11.2600 hypothetical protein, conserved 3,0 1,0 4,0 0,3 
Tb927.6.1470 hypothetical protein, conserved 4,0 1,0 1,0 0,3 
Tb927.7.5820 Monooxygenase, putative 1,5 1,0 4,0 0,3 
Tb927.2.3370 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase, putative (10C8.485) 
3,0 1,0 4,0 0,3 
Tb927.9.15460 calcium motive p-type ATPase, putative 1,7 0,3 4,0 0,3 
Tb927.1.2990 PPR2 4,0 1,0 1,0 0,3 
Tb927.2.100 
retrotransposon hot spot protein 1 (RHS1), 
putative 
4,0 1,0 0,3 1,0 
Tb927.11.4320 
hypothetical protein, conserved, PF02622 
DUF179 
1,0 1,0 4,0 0,3 
Tb927.10.12660 PUF2 0,3 1,0 4,0 1,0 
Tb927.11.15760 GPI transamidase subunit Tta1 (TTA1) 4,0 1,0 1,0 0,3 
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Tb927.7.3550 
hypothetical protein, conserved, no yeast 
or human match 
2,0 1,0 4,0 0,3 
Tb927.5.780 hypothetical protein, conserved 1,0 1,0 4,0 0,3 
Tb927.6.4210 aldehyde dehydrogenase, putative (ALDH) 4,0 1,0 0,3 0,3 
Tb927.3.3940 DRBD11 1,2 4,0 0,8 0,2 
Tb927.10.5770 
valosin-containing protein 
homolog,Transitional endoplasmic 
reticulum ATPase, putative (VCP) 
4,0 1,0 0,3 0,2 
Tb927.8.650 cation-transporting ATPase, putative 3,0 1,0 4,0 0,1 
Tb927.7.990 chaperone protein DNAj, putative 3,7 1,0 1,0 0,1 
Tb927.6.4320 hypothetical protein, conserved 3,5 1,0 2,3 0,4 
Tb927.10.3990 DHH1 3,5 0,3 1,0 1,0 
Tb927.11.1250 
kinetoplast poly(A) polymerase complex 1 
subunit, MIT ssu-associated 
3,5 1,0 1,0 0,2 
Tb927.10.10920 heat shock protein 83, HSP83 3,4 0,7 0,8 1,0 
Tb927.7.2670 ZC3H21 2,3 1,0 3,3 0,3 
Tb927.9.11120 Mitchondrial SSU ribosomal associated 3,0 1,0 1,0 1,0 
Tb927.11.540 ABC transporter, putative 3,0 1,0 1,0 1,0 
Tb927.9.7170 Mitchondrial LSU ribosomal protein 3,0 1,0 1,0 1,0 
Tb927.10.6850 
MItochondrial SSU S18 or kinetoplast 
poly(A) polymerase complex 1 subunit 
3,0 1,0 1,0 1,0 
Tb927.11.15430 
U5 small nuclear ribonucleoprotein U5-
116K, putative 
3,0 1,0 1,0 1,0 
Tb927.7.5230 lanosterol synthase 3,0 1,0 1,0 1,0 
Tb927.10.1450 hypothetical protein, conserved, in bilobe 1,0 1,0 3,0 1,0 
Tb927.3.4920 
LETM1 and EF-hand domain-containing 
protein 1, inner mitochondrial membrane? 
3,0 1,0 1,0 1,0 
Tb927.11.11690 
vacuolar ATP synthase subunit b, 
putative,v- ATPase B subunit,vacuolar 
proton pump B subunit 
1,5 1,0 3,0 1,0 
Tb927.5.1510 Mitchondrial SSU ribosomal protein 3,0 1,0 1,0 1,0 
Tb927.9.5840 tryparedoxin peroxidase (TRYP1) 1,0 1,0 1,0 3,0 
Tb927.11.6170 
protein transport protein Sec31, 
putative,cytosolic coat protein, putative 
1,0 1,0 3,0 1,0 
Tb927.11.9940 hypothetical protein, conserved 1,0 1,0 1,0 3,0 
Tb927.9.8070 60S ribosomal protein L10 2,2 1,0 3,0 1,8 
Tb927.11.10150 Mitchondrial SSU ribosomal protein 3,0 1,0 1,0 1,0 
Tb927.7.2400 
MCP1 Arc1p homologue, assists aa tRNA 
synthetases 
1,0 1,0 1,0 3,0 
Tb927.7.4310 hypothetical protein, conserved 3,0 1,0 1,0 1,0 
Tb927.6.4560 Mitchondrial SSU ribosomal protein 3,0 1,0 1,0 1,0 
Tb927.8.7650 amino acid transporter, putative 1,0 1,0 1,0 3,0 
Tb927.9.15380 
NADH-ubiquinone oxidoreductase complex 
I subunit, putative,NDUFA9 subunit, 
putative 
1,0 1,0 3,0 1,0 
Tb927.10.560 40S ribosomal protein S11 1,0 1,0 1,0 3,0 
Tb927.8.560 GEM1, putative 1,5 1,0 3,0 1,0 
Tb927.11.4910 
hypothetical protein, conserved,predicted 
ankyrin repeat family protein 
1,0 1,0 1,0 3,0 
Tb927.9.6510 Mitchondrial SSU ribosomal associated 3,0 1,0 1,0 1,0 
Tb927.11.5400 signal recognition particle 54 kDa (SRP54) 3,0 1,0 1,3 1,0 
Tb927.10.10360 microtubule-associated protein, putative 1,0 3,0 1,0 1,0 
Tb927.11.11480 Trichohyalin, putative 1,0 1,0 3,0 1,0 
Tb927.10.470 choline dehydrogenase, putative 3,0 1,0 3,0 1,0 
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Tb927.11.7290 pantothenate kinase subunit, putative 1,0 1,0 3,0 1,0 
Tb927.1.2410 beta tubulin, pseudogene 3,0 1,0 1,0 1,0 
Tb927.10.6320 
NOC3, nuclear export of ribosomes, assoc 
with NRG1 
1,0 1,0 3,0 1,0 
Tb927.10.13510 zinc metallopeptidase, putative 3,0 1,0 3,0 1,0 
Tb927.9.9630 hypothetical protein, conserved 1,0 3,0 1,3 1,0 
Tb927.11.5970 
phosphoinositide-specific phospholipase 
C, putative 
3,0 1,0 1,0 1,0 
Tb927.7.4970 glutamine synthetase, putative 1,0 1,0 1,0 3,0 
Tb927.9.2590 hypothetical protein, conserved 1,0 3,0 1,0 1,0 
Tb927.3.2600 
ATP-dependent DEAD/H RNA helicase, 
putative, no clear yeast homologue 
1,0 1,0 3,0 1,0 
Tb927.3.3580 
lipophosphoglycan biosynthetic protein, 
putative (LPG3)=GRP94 ER chaperone 
1,0 1,0 3,0 1,0 
Tb927.11.1680 vesicular-fusion protein SEC18, putative 3,0 1,0 1,0 1,0 
Tb927.10.14510 hypothetical protein, conserved 3,0 1,0 1,0 1,0 
Tb927.7.3980 
immunodominant antigen, putative,tc40 
antigen-like 
1,0 1,0 3,0 1,0 
Tb927.7.570 prefoldin, putative 1,0 1,0 1,0 3,0 
Tb927.7.6460 
FG-GAP repeat protein, putative,intergrin 
alpha chain protein, putative 
1,0 1,0 3,0 1,0 
Tb927.9.7110 hypothetical protein, conserved 1,0 1,0 1,0 3,0 
Tb927.2.1080 
retrotransposon hot spot protein 5 (RHS5), 
putative 
1,0 3,0 1,0 1,0 
Tb927.4.410 CAF40 3,0 1,0 1,3 1,0 
Tb927.10.6630 
ATP-dependent DEAD/H RNA helicase 
HEL64, putative (cytosolic) 
3,0 1,0 1,3 1,0 
Tb927.11.8990 cation transporter, putative 3,0 1,0 3,0 1,0 
Tb927.10.4610 
dolicholphosphate-mannose synthase, 
putative 
1,0 1,0 1,0 3,0 
Tb927.11.14190 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.11.3130 glycosomal transporter (GAT2) 3,0 1,0 1,0 1,0 
Tb927.2.2210 hypothetical protein, conserved 3,0 1,0 1,0 1,0 
Tb927.7.1290 hypothetical protein, conserved. 3,0 1,0 1,0 1,0 
Tb927.9.2450 
electron transport protein SCO1/SCO2, 
putative 
1,0 1,0 3,0 1,0 
Tb927.11.1840 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.11.370 repressor activator protein 1 (RAP1) 3,0 1,0 1,0 1,0 
Tb927.3.4680 
RAB GDP dissociation inhibitor alpha, 
putative 
1,0 1,0 3,0 1,0 
Tb927.4.5110 KKT8 Kinetochore protein 1,0 1,0 3,0 1,0 
Tb927.8.3970 oxidoreductase, putative 1,0 1,0 3,0 1,0 
Tb927.10.15410 
glycosomal malate dehydrogenase 
(gMDH) 
1,0 1,0 1,0 3,0 
Tb927.9.8160 chaperone protein DNAj, putative 3,0 1,0 3,0 1,0 
Tb927.11.530 RBP3 3,0 1,0 1,0 1,0 
Tb927.11.13090 
EF1 gamma, elongation factor 1 gamma, 
putative 
1,0 1,0 1,2 3,0 
Tb927.9.5040 
cAMP-specific phosphodiesterase 
(PDEB1) 
1,0 1,0 3,0 1,0 
Tb927.11.9570 hypothetical protein, conserved 3,0 1,0 3,0 1,0 
Tb927.11.16730 dihydrolipoyl dehydrogenase (GCVL-2) 2,5 1,0 1,8 3,0 
Tb927.8.1150 KKT9 Kinetochore protein 3,0 1,0 1,5 1,0 
Tb10.v4.0052 microtubule-associated protein 2s 3,0 1,0 1,0 1,0 
Tb927.1.2730 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
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Tb927.10.12860 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.10.14630 fibrillarin, putative 1,0 1,0 3,0 1,0 
Tb927.10.3010 hypothetical protein, conserved, in bilobe 1,0 1,0 3,0 1,0 
Tb927.10.7500 fibrillarin (NOP1) 1,0 1,0 3,0 1,0 
Tb927.10.7810 
Homologue of yeast ESF1,nucleolar 
protein involved in pre-rRNA processing 
1,0 1,0 3,0 1,0 
Tb927.10.8870 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.10.9780 
ATP-dependent DEAD/H RNA helicase, 
putative Mak5, ribosome biogenesis? 
1,0 1,0 3,0 1,0 
Tb927.10.9890 
hypothetical protein, conserved, no 
domains 
3,0 1,0 1,0 1,0 
Tb927.11.12830 acyl-CoA binding protein, putative 1,0 1,0 3,0 1,0 
Tb927.11.3550 
NPA3/XAB1 homologue, interacts with 
XPA and with RNA pol II 
1,0 1,0 3,0 1,0 
Tb927.11.9490 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.2.5210 3-oxoacyl-ACP reductase, putative 1,0 1,0 3,0 1,0 
Tb927.3.2490 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.3.5020 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.3.5250 ZC3H8 1,0 1,0 3,0 1,0 
Tb927.4.3670 hypothetical protein, conserved 3,0 1,0 1,0 1,0 
Tb927.4.920 hypothetical protein, conserved 1,0 1,0 1,0 3,0 
Tb927.5.2500 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.5.980 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.6.2140 
Mitochondrial RNA binding complex I 
component, putative 
1,0 1,0 3,0 1,0 
Tb927.7.1780 
Adenine phosphoribosyltransferase, 
putative 
1,0 1,0 1,0 3,0 
Tb927.7.4440 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.7.6620 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.7.700 hypothetical protein, conserved 1,0 1,0 3,0 1,0 
Tb927.8.3310 acetyltransferase, putative 1,0 1,0 3,0 1,0 
Tb927.8.5040 hypothetical protein, conserved 3,0 1,0 1,0 1,0 
Tb927.8.7170 
inositol polyphosphate 1-phosphatase, 
putative 
1,0 1,0 3,0 1,0 
Tb927.9.8680 
cytochrome c oxidase assembly factor, 
putative 
3,0 1,0 1,0 1,0 
Tb927.9.4910 protein kinase, putative 3,0 1,0 1,0 1,0 
Tb927.10.1490 Possible splicing factor 1,0 1,0 3,0 1,0 
Tb927.5.1460 hypothetical protein, conserved 1,0 3,0 1,0 1,0 
Tb927.4.1300 Amidinotransferase superfamily protein 1,0 3,0 1,2 2,0 
Tb927.11.760 protein phosphatase 2C, putative 1,0 1,0 1,0 3,0 
Tb927.10.4560 EF2 elongation factor 2 3,0 1,6 0,9 1,0 
Tb927.11.8060 hypothetical protein, conserved 1,0 1,0 3,0 0,8 
Tb927.2.4090 hypothetical protein, conserved 3,0 1,0 3,0 0,8 
Tb927.10.2730 hypothetical protein, conserved 3,0 1,0 0,7 0,8 
Tb927.8.5460 
flagellar calcium-binding protein,44 kDa 
calflagin, (Tb-44) 
2,3 3,0 1,0 0,7 
Tb927.6.4000 
small glutamine-rich tetratricopeptide 
repeat protein, putative 
3,0 1,0 0,4 3,0 
Tb927.9.8950 
CAAX prenyl protease 1, putative,metallo- 
peptidase, Clan M- Family M48 
1,3 3,0 3,0 0,3 
Tb927.3.4580 hypothetical protein, conserved 3,0 1,0 3,0 0,3 
Tb927.8.1190 hypothetical protein, conserved 3,0 1,0 0,3 1,0 
Tb927.10.4880 hypothetical protein, possible component 1,0 0,3 3,0 1,0 
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of cytochorome oxidase complex 
Tb927.7.5700 pATOM36 1,7 0,3 1,0 3,0 
Tb927.7.3500 
glutathione-S-transferase/glutaredoxin, 
putative 
3,0 0,3 0,8 3,0 
Tb927.11.11590 
eIF3E eukaryotic translation initiation 
factor, putative 
3,0 0,3 0,8 1,0 
Tb927.6.2300 adenosine kinase, putative 3,0 1,0 0,8 0,3 
Tb927.11.12230 heat shock protein HslU2, in mitochondrion 3,0 0,3 1,6 1,0 
Tb927.11.870 Mitchondrial LSU ribosomal protein 3,0 1,0 1,0 0,3 
Tb927.4.1930 EIF3D 1,0 1,0 0,3 3,0 
Tb927.4.1270 ruvB-like DNA helicase, putative 3,0 1,0 0,7 0,3 
Tb927.9.13520 hypothetical protein, conserved 3,0 1,0 0,3 1,0 
Tb927.5.3010 MRB complex protein 1,0 1,0 3,0 0,3 
Tb927.11.9780 hypothetical protein, conserved 3,0 0,3 2,7 0,3 
Tb927.10.9900 ABC1 protein, putative 1,0 1,0 3,0 0,3 
Tb927.2.2440 
proteasome regulatory non-ATPase 
subunit 6 (RPN6) 
3,0 1,0 0,3 0,3 
Tb927.10.4850 hypothetical protein, conserved 3,0 1,0 1,0 0,3 
Tb927.9.5890 
solanesyl-diphosphate synthase, putative 
(28G16.440) 
3,0 0,3 1,2 0,3 
Tb927.3.2230 
succinyl-CoA synthetase alpha subunit, 
putative 
3,0 0,3 0,7 1,7 
Tb927.6.5070 hypothetical protein, conserved 3,0 1,0 2,2 0,3 
Tb927.11.14250 
T-complex protein 1, epsilon subunit, 
putative (TCP-1-epsilon) 
3,0 1,0 0,9 0,3 
Tb927.11.3240 
T-complex protein 1, zeta subunit, putative 
(TCP-1-zeta) 
3,0 0,5 1,1 0,2 
Tb927.9.2650 POMP2 3,0 1,0 1,0 0,2 
Tb927.10.520 
Mitochondrial ATP synthase subunit, 
putative 
2,0 1,0 3,0 0,2 
Tb927.11.5560 hypothetical protein, conserved 1,3 3,0 0,8 0,2 
Tb927.10.2770 eIF5 3,0 1,0 0,2 1,0 
Tb927.11.13230 TbVAP, flagellar attachment zone 3,0 1,0 1,0 0,2 
Tb927.10.8080 hypothetical protein, conserved 3,0 1,0 1,0 0,2 
Tb927.11.10140 
hypothetical protein, possible component 
of cytochorome oxidase complex 
3,0 1,0 3,0 0,2 
Tb927.9.8740 DRBD3 (PTB1) 3,0 0,2 1,1 1,5 
Tb927.4.5200 nucleoporin (NUP54/57, TbNup62) 1,3 1,0 3,0 0,2 
Tb927.11.1980 ZC3H41 3,0 0,2 0,7 0,2 
Tb927.9.4190 fatty acyl CoA syntetase 1 (ACS1) 1,0 3,0 1,3 0,1 
Tb927.5.520 stomatin-like protein, putative 2,8 0,2 2,0 0,2 
Tb927.4.590 
hypothetical protein, quinoprotein alchohol 
dehydrogenase-like domain 
2,8 0,4 0,9 0,1 
Tb927.11.7380 
glycerol-3-phosphate dehydrogenase 
(FAD-dependent), mitochondrial 
2,8 1,0 2,0 0,1 
Tb927.8.1270 hypothetical protein, conserved 2,0 0,3 2,7 0,3 
Tb927.1.4100 cytochrome oxidase subunit IV (COXIV) 2,7 1,2 2,3 0,2 
Tb927.11.7460 BiP 1,2 2,7 0,7 0,1 
Tb927.11.1450 
2-oxoglutarate dehydrogenase E1 
component, putative 
2,4 2,0 2,7 1,0 
Tb927.9.5900 glutamate dehydrogenase (GDH) 2,6 1,0 0,9 0,8 
Tb927.3.3560 hypothetical protein, conserved 2,5 1,0 1,0 1,0 
Tb927.11.3300 
hypothetical protein, conserved, HA tagged 
is in mitochondrion, poly(Q), rich in E, K. 
1,0 1,0 2,5 1,0 
Tb927.9.5320 nucleolar RNA binding protein, putative 2,5 1,0 2,0 1,0 
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(28G16.220) 
Tb927.11.10690 hypothetical protein, conserved 2,5 1,0 0,8 0,6 
Tb927.11.2650 heat shock protein 84, putative, mit HSp90 2,5 0,7 1,0 0,4 
Tb927.5.1520 heat shock protein HslU1, in mitochondrion 2,5 1,0 1,2 0,3 
Tb927.8.6580 
succinate dehydrogenase flavoprotein, 
SDH1 
2,5 1,0 1,0 0,3 
Tb927.4.1920 GPI transamidase, putative (TbGPI16) 2,5 1,0 1,0 0,3 
Tb927.7.2640 hypothetical protein, conserved 2,5 0,2 1,0 0,3 
Tb927.6.1870 eIF4E4 2,5 0,3 1,2 0,2 
Tb927.5.3400 
calcium-translocating P-type ATPase, 
calcium pump 
2,1 1,1 2,4 0,7 
Tb927.8.1740 Mitochondrial tRNA import 2,4 1,0 1,2 0,1 
Tb927.10.4430 PUF1 2,4 0,4 1,3 0,1 
Tb927.10.12840 mitochondrial carrier protein, MCP12 1,7 1,4 1,3 2,3 
Tb927.9.2620 hypothetical protein, conserved 2,3 1,0 1,0 1,0 
Tb927.11.4980 
ATP-dependent DEAD/H RNA helicase,  
putative Dbp9, ribosome assembly? 
2,3 1,0 1,5 1,0 
Tb927.1.1560 
vesicular-fusion protein nsf, putative,N-
ethylmaleimide sensitive factor (NsF) 
1,0 1,0 2,3 1,0 
Tb927.10.510 
LOK1=POMP19 Mitochondrial membrane 
formation 
2,3 1,0 0,3 0,3 
Tb927.10.8190 
T-complex protein 1, theta subunit, (TCP-
1-theta) 
2,3 1,0 0,8 0,3 
Tb927.7.2240 hypothetical protein, conserved 2,3 1,0 0,6 0,3 
Tb927.10.1060 
T-complex protein 1, delta subunit, putative 
(TCP-1-delta) 
2,3 0,3 0,9 0,3 
Tb927.11.15990 Nucleoporin  (TbNup109) 2,3 0,8 0,8 1,3 
Tb927.4.3950 
cytoskeleton-associated protein CAP5.5, 
putative,cysteine peptidase 
1,8 1,1 2,3 0,1 
Tb927.6.2790 L-threonine 3-dehydrogenase, putative 1,0 0,4 1,0 2,2 
Tb927.5.1210 short-chain dehydrogenase, putative 2,2 0,9 1,3 1,5 
Tb927.8.890 small GTP-binding protein Rab1, putative 1,0 1,0 1,0 2,0 
Tb927.3.5240 
Mitchondrial SSU ribosomal associated 
KRIPP8 (PPR) 
2,0 1,0 1,0 1,0 
Tb927.3.5610 
ribosomal protein L3 mitochondrial, 
putative 
2,0 1,0 1,0 1,0 
Tb927.10.15390 
kinesin, clathrin-associated, Trypanosome-
specific kinesin family 2 
2,0 1,0 1,0 1,0 
Tb927.5.4420 
nucleolar RNA helicase 2 human, DDX50 
Mouse 
2,0 1,0 1,1 1,0 
Tb927.3.4720 
dynamin, putative,vacuolar sortin protein 1, 
putative 
1,2 1,0 2,0 1,0 
Tb927.6.3890 replication factor C, subunit 2, putative 1,0 1,0 2,0 1,0 
Tb927.3.1710 Mitchondrial LSU ribosomal protein 2,0 1,0 1,0 1,0 
Tb927.11.13470 hypothetical protein, conserved 1,0 1,0 2,0 1,0 
Tb927.10.14180 protein transport protein Sec13, putative 2,0 0,9 0,9 1,0 
Tb927.2.2130 
small GTP-binding protein RAB6, putative 
(25N14.200) 
2,0 1,0 0,8 1,2 
Tb927.9.4680 eIF4A1 2,0 1,3 0,7 1,4 
Tb927.10.2320 hypothetical protein, conserved 2,0 0,8 0,7 1,0 
Tb927.10.14160 aquaporin 3, putative 2,0 0,7 0,7 1,0 
Tb927.11.3790 hypothetical protein, conserved 0,6 0,9 1,0 2,0 
Tb927.10.540 
ATP-dependent DEAD/H RNA helicase, 
DDX39-like 
2,0 0,6 1,3 0,6 
Tb927.11.15370 
hypothetical protein, conserved 
(TbKap123) 
2,0 2,0 0,9 0,4 
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Tb927.8.4500 eIF4G5 2,0 1,0 1,3 0,3 
Tb927.10.11220 
procyclic form surface glycoprotein (PSSA-
2) 
2,0 1,0 1,0 0,3 
Tb927.5.890 
oligosaccharyl transferase subunit, 
putative 
2,0 0,3 1,0 0,3 
Tb927.10.12330 ZC3H34 2,0 0,3 1,0 1,0 
Tb927.8.1870 Golgi/lysosome glycoprotein 1 (tGLP1) 2,0 1,7 1,8 0,3 
Tb927.10.15310 
hypothetical protein, conserved, linked to 
melarsoprol resistance, no yeast/human by 
NCBI 
0,3 0,3 2,0 0,7 
Tb927.5.1300 
vacuolar proton translocating ATPase 
subunit A, putative 
2,0 1,0 1,0 0,3 
Tb927.3.3270 
ATP-dependent phosphofructokinase 
(TbPFK) 
2,0 0,3 1,0 0,3 
Tb927.6.3630 Sphingosine-1-phosphate lyase 1,6 1,2 2,0 0,3 
Tb927.11.4210 hypothetical protein, conserved 2,0 1,0 0,3 0,3 
Tb927.6.1550 
POMP30 leucine-rich repeat protein 
(LRRP) 
1,0 1,0 2,0 0,3 
Tb927.11.6600 hypothetical protein, conserved 1,7 0,3 2,0 1,0 
Tb927.9.11220 Mitochondrial tRNA import 1,5 1,0 2,0 0,2 
Tb927.8.8050 Nucleoporin (TbNup75) 2,0 0,8 1,6 0,2 
Tb927.11.10760 
KIN-D kinesin, associated with sub-
pellicular microtubules, essential 
2,0 1,0 2,0 0,2 
Tb927.10.2240 NTF2-like domain, in Y14 TAP 2,0 1,0 0,7 0,1 
Tb11.02.5420 
NADPH--cytochrome p450 reductase, 
putative (CPR) 
2,0 1,0 1,0 0,1 
Tb927.10.2900 importin beta-1 subunit, putative 2,0 2,0 1,4 0,1 
Tb927.4.2850 hypothetical protein, conserved 1,0 1,0 2,0 0,1 
Tb927.9.2470 nucleolar protein (NOP86) 1,4 1,1 2,0 0,1 
Tb927.10.7410 
succinyl-CoA ligase [GDP-forming] beta-
chain, putative 
1,9 1,1 0,6 1,0 
Tb927.7.2680 ZC3H22 1,9 1,0 1,2 0,2 
Tb927.8.7480 
hypothetical protein, conserved, no clear 
yeast or human matches 
1,9 1,0 1,5 1,0 
Tb927.5.1060 
mitochondrial processing peptidase, beta 
subunit, MMPbeta 
1,9 0,7 1,2 0,9 
Tb927.11.7780 POMP16 1,9 0,8 0,7 0,8 
Tb927.7.7430 ATP synthase F1, alpha subunit 1,9 1,2 1,4 1,0 
Tb927.9.10310 mitochondrial carrier protein, MCP11 1,9 1,0 1,4 1,3 
Tb927.10.14780 
protein kinase, putative,mitogen-activated 
protein kinase kinase kinase, putative 
1,0 1,0 1,9 0,3 
Tb927.9.9290 PABP1 1,9 0,8 1,1 0,3 
Tb927.7.5020 60S ribosomal protein L19 1,2 1,1 0,9 1,8 
Tb927.11.16760 
T-complex protein 1, alpha subunit, 
putative (TCP-1-alpha) 
1,8 0,8 0,9 0,7 
Tb927.11.11680 
2-oxoglutarate dehydrogenase E2 
component, putative 
1,3 1,8 1,4 1,3 
Tb927.10.12960 
ras-related protein rab-5,small GTPase, 
putative (RAB5A) 
1,3 1,0 1,8 1,1 
Tb927.11.6210 sterol 14-alpha-demethylase (CYP51) 1,8 1,0 0,6 0,4 
Tb927.9.1380 hypothetical protein, conserved 0,3 0,3 1,8 1,0 
Tb927.9.6460 hypothetical protein, conserved 1,8 0,8 1,6 0,4 
Tb927.10.6640 
COP-coated vesicle membrane protein 
erv25 precursor, 
1,0 1,0 1,0 1,8 
Tb927.11.11360 
guanine nucleotide-binding protein beta 
subunit- like protein (TRACK) 
1,1 0,8 0,9 1,8 
Tb927.8.2460 hypothetical protein, conserved 0,3 1,0 1,8 0,8 
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Tb927.10.13800 
hypothetical protein, conserved, no yeast 
or human match 
1,2 0,3 1,8 0,2 
Tb927.6.3050 aldehyde dehydrogenase family, putative 1,8 1,0 1,8 0,1 
Tb927.10.11390 60S ribosomal protein L6 1,2 0,8 1,0 1,7 
Tb927.10.14710 40S ribosomal protein S2 1,1 1,1 1,0 1,7 
Tb927.8.4820 eIF4G3 1,7 1,6 1,0 0,2 
Tb927.10.600 Mitchondrial LSU ribosomal protein 1,7 1,0 1,0 1,0 
Tb927.10.3640 hypothetical protein, conserved 1,0 1,0 1,7 1,3 
Tb927.6.4200 Mitchondrial LSU ribosomal protein 1,7 1,0 1,0 1,0 
Tb927.8.7530 
3,2-trans-enoyl-CoA isomerase, 
mitochondrial precursor, putative 
1,0 1,7 1,0 1,0 
Tb427tmp.160.5
200 
0 1,0 1,0 1,7 1,0 
Tb927.9.3280 
acidocalcisomal exopolyphosphatase, 
putative (3C4.175) 
1,0 1,0 1,7 1,0 
Tb927.5.3640 Mitchondrial SSU ribosomal protein 1,7 1,0 1,0 1,0 
Tb927.7.3440 EF hand protein 1,3 0,9 1,7 0,9 
Tb927.11.14090 
hypothetical protein, conserved, 2 very 
weak RRMs 
1,7 0,8 1,3 0,8 
Tb927.8.6970 
3-methylcrotonyl-CoA carboxylase alpha 
subunit, putative 
1,5 0,5 1,7 0,8 
Tb927.8.8310 chaperone protein DNAj, putative 1,0 1,0 1,7 0,5 
Tb927.11.1900 
T-complex protein 1, beta subunit, putative 
(TCP-1-beta) 
1,7 0,5 1,2 1,0 
Tb927.10.14550 
DED1-1, ATP-dependent DEAD/H RNA 
helicase, 
1,7 1,0 1,3 0,4 
Tb927.11.6430 hypothetical protein, conserved 1,0 1,0 1,7 0,3 
Tb927.7.2140 ZC3H18 1,7 0,3 1,6 1,0 
Tb927.10.4980 
ubiquitin-like protein DSK2, putative 
(DSK2) 
1,0 1,0 0,3 1,7 
Tb927.11.2300 
ERF1 eukaryotic peptide chain release 
factor subunit 1, putative 
0,5 1,0 1,7 0,3 
Tb927.11.13180 POMP10 1,4 1,7 1,3 0,2 
Tb927.10.3660 aspartate aminotransferase 1,7 1,0 1,0 0,2 
Tb927.9.11150 hypothetical protein, conserved 1,1 1,2 1,7 0,2 
Tb927.5.440 trans sialidase, putative 1,7 1,0 1,3 0,1 
Tb927.7.210 proline dehydrogenase 1,4 0,5 1,7 0,1 
Tb927.11.6280 pyruvate phosphate dikinase (PPDK) 1,0 1,0 1,6 1,0 
Tb927.3.1840 
3-oxo-5-alpha-steroid 4-dehydrogenase, 
putative 
1,6 0,8 1,3 1,3 
Tb927.3.1380 ATP synthase F1, alpha subunit 1,3 0,8 1,6 0,8 
Tb927.1.3070 
hypothetical protein, conserved, poly(Q), 
poly(H) 
1,2 1,0 1,6 0,3 
Tb927.11.330 Nucleoporin (TbMlp-1) 1,6 0,9 1,4 0,4 
Tb927.3.1120 
GTP-binding nuclear protein rtb2, putative 
(rtb2) 
1,3 1,1 1,6 1,3 
Tb927.8.1330 60S ribosomal protein L7a 1,0 1,0 1,0 1,6 
Tb927.3.3310 60S ribosomal protein L13 0,9 0,8 1,6 1,0 
Tb927.9.8410 chaperone protein DNAj, putative 1,3 1,2 1,6 0,6 
Tb927.9.3760 poly(A) export protein, putative (TbGLE2) 1,0 1,0 1,6 1,0 
Tb927.7.4900 XRNA 1,0 1,0 1,6 1,0 
Tb927.3.5050 60S ribosomal protein L4 1,5 0,9 0,9 1,3 
Tb927.3.4380 Tob55, SAM50 1,5 1,0 1,0 1,0 
Tb927.9.7590 60S ribosomal protein L11 1,0 1,0 1,0 1,5 
Tb927.6.3930 Mitchondrial LSU ribosomal protein 1,5 1,0 1,0 1,0 
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Tb927.9.15360 40S ribosomal protein S6 1,5 1,3 1,0 1,2 
Tb927.8.580 hypothetical protein, conserved 1,5 1,0 1,0 1,0 
Tb927.11.17000 AIR9 1,5 1,0 1,3 1,0 
Tb927.11.4770 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1,0 1,0 1,5 1,0 
Tb927.9.5730 nucleosome assembly protein-like protein 1,5 1,0 1,0 1,0 
Tb927.6.140 
retrotransposon hot spot protein 5 (RHS5), 
putative 
1,0 1,0 1,5 1,0 
Tb927.6.2080 
Mitchondrial SSU ribosomal associated 
KRIPP22 (PPR) 
1,5 1,0 1,0 1,0 
Tb927.11.10910 40S ribosomal protein SA 1,5 0,9 0,8 1,0 
Tb927.11.3980 
mitochondrial processing peptidase alpha 
subunit, MMPalpha 
1,5 0,8 1,3 0,9 
Tb927.6.1090 
proteasome regulatory ATPase subunit 3 
(RPT3) 
1,5 1,0 0,8 1,0 
Tb927.8.4810 prohibitin 1 (PHB1) 1,5 1,2 1,2 0,6 
Tb927.11.2340 hypothetical protein, conserved 1,0 1,1 1,5 0,6 
Tb927.7.6260 hypothetical protein, conserved 1,5 0,7 1,3 0,4 
Tb927.6.1770 kinesin 1,5 1,0 1,3 0,3 
Tb927.6.1500 
1-Alkyl-dihydroxyacetonephosphate 
synthase 
0,5 1,0 1,5 0,3 
Tb927.6.4740 importin-alpha re-exporter protein, putative 1,5 1,0 0,3 0,2 
Tb927.10.6880 
glyceraldehyde 3-phosphate 
dehydrogenase, cytosolic (GAP) 
1,5 0,2 0,8 1,0 
Tb927.11.7140 
cell cycle sequence binding 
phosphoprotein CSB)II 
1,0 1,0 1,5 0,2 
Tb927.8.3950 hypothetical protein, conserved 1,3 1,2 1,5 0,5 
Tb927.6.3740 
heat shock 70 kDa protein, mitochondrial 
precursor, putative 
1,3 1,5 1,1 1,0 
Tb927.10.13500 60S ribosomal protein L10a 1,0 1,0 1,0 1,5 
Tb927.9.12630 glycerol kinase, glycosomal (glk1) 1,4 0,1 1,0 1,0 
Tb927.9.11270 
T-complex protein 1, eta subunit, putative, 
(TCP-1-eta) 
1,4 0,4 1,0 0,7 
Tb927.9.11600 
Gim5B protein,glycosomal membrane 
protein (gim5B) 
1,0 1,0 1,0 1,4 
Tb927.8.6160 40S ribosomal protein S8 1,1 1,1 1,4 1,0 
Tb927.8.1960 NOT11 1,0 1,0 1,4 1,0 
Tb927.2.2520 voltage-dependent anion-selective channel 1,3 0,9 1,0 1,4 
Tb927.11.10510 
ubiquinone biosynthesis 
methyltransferase, putative 
0,9 1,4 0,8 1,4 
Tb927.9.4310 tricarboxylate carrier, putative 1,3 1,0 1,4 0,8 
Tb927.7.2190 hypothetical protein, conserved 1,0 1,0 1,4 0,8 
Tb927.9.3630 hypothetical protein, conserved 1,0 1,0 1,4 0,6 
Tb927.9.12510 
DED1-2, ATP-dependent DEAD/H RNA 
helicase, DED1-2 
1,0 1,0 1,4 0,3 
Tb927.6.890 hypothetical protein, conserved 1,4 1,3 1,4 0,3 
Tb927.1.860 hypothetical protein, conserved 1,4 0,7 1,2 0,3 
Tb927.7.900 hypothetical protein, conserved 1,4 0,6 0,7 0,1 
Tb927.4.4310 Nucleoporin (TbNup64) 1,3 0,8 1,4 0,1 
Tb927.11.10790 40S ribosomal protein SA 1,0 1,0 1,0 1,4 
Tb927.11.16280 60S ribosomal protein L2 L8 1,1 1,0 1,4 0,9 
Tb927.10.12700 
pyruvate dehydrogenase E1 alpha subunit, 
putative 
1,4 1,0 0,7 0,4 
Tb927.7.1730 60S ribosomal protein L7 1,0 1,0 1,0 1,3 
Tb927.11.6230 
pretranslocation protein, alpha subunit, 
SEC61 
1,3 1,0 1,0 1,3 
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Tb927.4.2070 antigenic protein, putative 1,0 1,0 1,3 1,0 
Tb927.10.15520 signal recognition particle protein, putative 1,0 1,0 1,3 1,0 
Tb927.10.13780 glycogen synthase kinase 3 (GSK3) 1,0 1,0 1,3 1,0 
Tb927.5.3810 
orotidine-5-phosphate 
decarboxylase/orotate 
phosphoribosyltransferase, OMPDCase-
OPRTase 
1,0 1,0 1,3 1,0 
Tb927.6.2780 
U3 small nuclear ribonucleoprotein 
(snRNP), putative 
1,3 1,0 1,3 1,0 
Tb927.10.10700 splicing factor Prp31 1,3 1,0 1,3 1,0 
Tb927.8.5810 mitochondrial carrier protein, MCP24 1,3 1,0 1,3 1,0 
Tb927.8.4330 small GTP-binding protein Rab11 (RAB11) 1,0 1,0 1,0 1,3 
Tb927.11.3600 40S ribosomal protein S4 1,3 1,3 1,0 1,0 
Tb927.10.190 40S ribosomal protein S6 1,3 1,0 1,0 1,0 
Tb927.7.4180 Elongase 3 1,3 1,0 1,3 1,0 
Tb927.10.12710 heat shock protein, HSP110 1,0 1,0 1,3 1,0 
Tb927.10.4060 hypothetical protein, conserved 1,0 1,0 1,3 1,0 
Tb927.10.2010 hexokinase (HK1) 1,0 1,0 1,3 1,0 
Tb927.8.3530 
glycerol-3-phosphate dehydrogenase 
[NAD ], glycosomal 
1,3 1,0 1,2 1,3 
Tb927.11.720 hypothetical protein, conserved 1,0 1,0 1,3 1,0 
Tb927.11.7520 hypothetical protein, conserved 1,0 1,0 1,3 1,0 
Tb927.10.15830 hypothetical protein, conserved 1,3 1,0 1,0 1,0 
Tb927.5.3410 Mitchondrial LSU ribosomal protein 1,3 1,0 1,0 1,0 
Tb927.7.2110 KKT11 Kinetochore protein 1,0 1,0 1,3 1,0 
Tb927.3.640 hypothetical protein, conserved 1,3 1,0 1,3 1,0 
Tb927.8.6080 POMP42 1,3 1,0 1,0 1,0 
Tb927.11.14460 
ADP-ribosylation factor GTPase activating 
protein 1, putative 
1,0 1,0 1,3 1,0 
Tb927.7.1110 asparagine synthetase a, putative 1,0 1,0 1,3 1,0 
Tb927.1.4830 Phospholipase A1 1,0 1,0 0,8 1,3 
Tb927.4.2880 Nucleoporin (TbNup225) 1,3 0,9 1,3 0,7 
Tb927.6.4440 RBP42 1,3 0,7 1,0 0,8 
Tb927.9.9660 
Archaic translocase of the outer 
mitochondrial membrane ATOM 
1,3 1,1 1,3 0,6 
Tb927.11.6870 14-3-3 protein 1,3 1,0 0,6 0,8 
Tb927.10.3810 hypothetical protein, in UPF1-TAP 0,5 0,8 1,3 1,0 
Tb927.5.4380 
kinetoplastid-specific phospho-protein 
phosphatase, putative 
0,5 1,0 1,3 1,0 
Tb927.9.13970 hypothetical protein, conserved 1,3 1,0 0,3 1,0 
Tb927.5.1810 
lysosomal/endosomal membrane protein 
p67 (p67) 
1,3 0,3 1,0 0,8 
Tb927.3.2100 hypothetical protein, conserved 1,0 0,3 1,0 1,3 
Tb927.8.5640 
Homologue of T. cruzi Complex II subunit 
SDH6 
1,3 0,3 1,3 0,3 
Tb11.1790 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1,0 0,3 1,3 1,0 
Tb927.3.3540 Nucleoporin (TbNup53b) 0,8 0,3 1,3 0,3 
Tb927.11.4540 nucleoporin 48 (TbNup48) 1,3 0,7 1,0 0,3 
Tb927.8.750 nucleolar RNA-binding protein, putative 1,3 1,0 1,0 0,3 
Tb10.v4.0053 hypothetical protein 0,3 0,3 1,3 1,0 
Tb927.8.6250 hypothetical protein, conserved 1,1 1,1 1,3 0,1 
Tb927.11.6630 
3-methylcrotonoyl-CoA carboxylase beta 
subunit, putative 
1,0 1,1 1,3 0,5 
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Tb927.10.14820 mitochondrial carrier protein, MCP5a 1,3 1,1 1,1 1,0 
Tb927.10.8940 hypothetical protein, conserved 1,0 1,0 1,3 0,8 
Tb927.3.3180 Nucleoporin (TbNup98) 0,9 0,2 1,3 0,8 
Tb927.6.4090 
chaperonin HSP60, mitochondrial 
precursor 
1,1 0,8 1,3 0,3 
Tb927.8.1340 60S ribosomal protein L7a 1,3 1,1 0,8 1,0 
Tb927.5.1610 60S ribosomal protein L13a 1,2 0,7 1,0 1,3 
Tb927.10.3930 40S ribosomal protein S3A 1,3 1,0 1,1 1,2 
Tb927.10.7060 
nucleoporin interacting component 
(NUP93), putative 
1,2 0,8 1,3 0,2 
Tb927.6.5040 60S ribosomal protein L15 1,0 1,0 1,0 1,3 
Tb927.5.3980 Mitchondrial LSU ribosomal protein 1,3 1,0 1,0 1,0 
Tb927.10.2290 
chaperone protein DNAj, endoplasmatic 
reticulum 
1,0 1,0 1,3 1,0 
Tb927.10.10160 hypothetical protein, conserved 1,0 1,0 1,3 1,0 
Tb927.11.5450 malic enzyme 1,0 1,0 1,3 1,0 
Tb927.11.8100 hypothetical protein, conserved 1,0 1,0 1,3 1,0 
Tb927.10.2980 
19S proteasome regulatory subunit,  
(RPN11) 
1,0 1,0 1,3 1,0 
Tb927.10.8440 glucose transporter 1B (THT1-) 1,3 1,0 0,8 1,0 
Tb427.11.01.v4 hypothetycal prot conserved 1,0 0,8 1,3 1,0 
Tb927.11.11090 Nucleoporin (TbNup140) 1,0 0,8 1,3 1,0 
Tb927.11.11080 Nucleoporin (TbNup149) 0,6 1,3 0,9 0,6 
Tb927.7.1750 60S ribosomal protein L7 1,3 1,0 0,5 1,0 
Tb927.6.4800 hypothetical protein, conserved 1,0 1,0 1,3 0,3 
Tb927.6.1440 Mitchondrial LSU ribosomal protein 1,3 0,3 1,0 1,0 
Tb927.8.6660 paraflagellar rod protein PFC1 0,5 1,0 1,3 0,3 
Tb927.7.5940 
Protein Associated with Differentiation 
(TbPAD2) 
1,3 0,2 1,0 1,0 
Tb927.11.2610 
hypothetical protein, conserved, no 
domains, no yeast or human match 
1,3 0,7 1,1 0,2 
Tb927.10.14830 mitochondrial carrier protein, MCP5b 1,0 1,0 1,0 1,2 
Tb927.2.4230 Nucleoporin NUP-1 protein, putative 1,2 0,7 1,2 0,7 
Tb927.10.9650 hypothetical protein, conserved 1,0 1,2 0,9 0,6 
Tb927.11.6440 
hypothetical protein, conserved, 
Bromodomain and poly(Q), often in TAP 
MS 
1,2 0,1 1,2 0,1 
Tb927.11.2950 Nucleoporin (TbNup89) 0,8 1,2 0,9 0,3 
Tb927.7.2300 Nucleoporin (TbNup132) 1,2 1,1 0,8 0,6 
Tb927.10.8030 
Mitochondrial ATP synthase subunit, 
putative 
1,0 1,0 1,0 1,2 
Tb927.10.6400 
chaperonin HSP60, mitochondrial 
precursor 
1,1 1,0 1,2 0,5 
Tb927.10.16170 potassium voltage-gated channel, putative 1,2 1,0 1,0 0,3 
Tb927.6.2640 importin alpha subunit, putative (TbKap60) 1,2 0,8 1,1 0,3 
Tb927.11.2370 MEX67 1,0 1,0 1,2 0,3 
Tb927.11.15040 
chaperonin HSP60, mitochondrial 
precursor 
1,2 0,3 0,9 0,1 
Tb927.11.980 Nucleoporin (TbNup158) 1,2 0,9 0,9 0,9 
Tb927.10.2100 
EF1-alpha elongation factor 1-alpha, 
(TEF1) 
1,0 1,0 1,0 1,2 
Tb927.10.15760 
hypothetical protein, conserved, in flagellar 
proteomes 
1,2 1,0 1,0 0,9 
Tb927.10.4310 prohibitin 2, putative (PHB2) 1,1 0,8 1,2 0,8 
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Tb927.10.11540 40S ribosomal protein S3 1,1 0,8 1,0 1,2 
Tb927.10.1510 NOT1 1,0 1,0 1,2 1,0 
Tb927.11.14020 RNA-binding protein (NRBD2) 1,0 1,0 1,0 1,2 
Tb927.11.10780 
Voltage-dependent anion channel (VDAC), 
putative 
1,2 0,3 0,3 0,3 
Tb927.8.6150 40S ribosomal protein S8 1,0 1,0 1,0 1,1 
Tb10.v4.0247 
s-adenosyl-L-methionine-c-24-delta-sterol-
methy lt ransferase a, putatives 
1,1 0,8 1,0 1,0 
Tb927.8.1570 hypothetical protein, conserved 1,1 1,0 0,9 0,5 
Tb927.11.2050 60S acidic ribosomal subunit 1,1 0,7 0,8 1,1 
Tb927.9.1410 hypothetical protein, conserved 0,9 1,1 0,8 0,3 
Tb927.9.10770 PABP2 1,1 0,8 1,0 0,5 
Tb927.8.3750 nucleolar protein (Nop56 homologue) 1,0 1,0 1,1 1,0 
Tb927.10.7570 
dihydrolipoamide acetyltransferase E2 
subunit, putative 
1,1 0,4 1,0 0,6 
Tb927.10.2110 
EF1-alpha elongation factor 1-alpha, 
(TEF1) 
1,1 0,9 1,0 1,0 
Tb927.9.15150 60S ribosomal protein L5 1,1 1,0 1,1 1,1 
Tb927.11.14000 RNA-binding protein (NRBD1) 1,1 1,0 0,7 1,0 
Tb927.9.14240 Nucleoporin (Nup82) 1,0 1,0 0,8 0,1 
Tb927.9.3990 40S ribosomal protein S7 1,0 1,0 1,0 1,0 
Tb927.11.680 60S ribosomal protein L21e 1,0 1,0 1,0 1,0 
Tb927.4.1860 40S ribosomal protein S19 1,0 1,0 1,0 1,0 
Tb927.10.8430 40S ribosomal protein S12 1,0 1,0 1,0 1,0 
Tb927.11.9320 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.5370 40S ribosomal protein S10 1,0 1,0 1,0 1,0 
Tb927.11.4300 60S ribosomal protein L18 1,0 1,0 1,0 1,0 
Tb927.7.2340 40S ribosomal protein S15 1,0 1,0 1,0 1,0 
Tb927.11.6300 40S ribosomal protein S5 1,0 1,0 1,0 1,0 
Tb927.6.720 60S ribosomal protein L14 1,0 1,0 1,0 1,0 
Tb927.4.2180 60S ribosomal protein L35a 1,0 1,0 1,0 1,0 
Tb927.6.4980 40S ribosomal protein S14 1,0 1,0 1,0 1,0 
Tb927.7.320 RBP8 1,0 1,0 1,0 1,0 
Tb927.10.7330 40S ribosomal protein S24E 1,0 1,0 1,0 1,0 
Tb927.10.5340 40S ribosomal protein S18 1,0 1,0 1,0 1,0 
Tb927.10.5610 40S ribosomal protein S9 1,0 1,0 1,0 1,0 
Tb927.10.14090 transporter, putative 1,0 1,0 1,0 1,0 
Tb927.3.680 cytochrome P450, putative 1,0 1,0 1,0 1,0 
Tb927.6.2210 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.3940 40S ribosomal protein S3A 1,0 1,0 1,0 1,0 
Tb927.10.7620 
mitochondrial ATP-dependent zinc 
metallopeptidase 
1,0 1,0 1,0 1,0 
Tb927.5.1780 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.6030 60S ribosomal protein L12 1,0 1,0 1,0 1,0 
Tb927.9.15210 60S ribosomal protein L36 1,0 1,0 1,0 1,0 
Tb927.7.5170 60S ribosomal protein L23a or L25 1,0 1,0 1,0 1,0 
Tb927.11.3230 60S ribosomal protein L44 1,0 1,0 1,0 1,0 
Tb927.11.6200 60S ribosomal protein L28 1,0 1,0 1,0 1,0 
Tb927.11.4820 60S ribosomal protein L17 1,0 1,0 1,0 1,0 
Tb927.11.9720 40S ribosomal protein S27 1,0 1,0 1,0 1,0 
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Tb927.3.5130 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.240 40S ribosomal protein S33 1,0 1,0 1,0 1,0 
Tb927.7.540 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.2.5910 40S ribosomal protein S13 1,0 1,0 1,0 1,0 
Tb927.10.1080 40S ribosomal protein S23 1,0 1,0 1,0 1,0 
Tb927.3.2440 
serine/threonine-protein kinase, 
putative,protein kinase, putative 
1,0 1,0 1,0 1,0 
Tb927.3.4190 
endosomal integral membrane protein, 
putative 
1,0 1,0 1,0 1,0 
Tb927.5.450 
NADH-ubiquinone oxidoreductase, 
mitochondrial, putative 
1,0 1,0 1,0 1,0 
Tb927.7.5970 
protein associated with differentiation 5, 
PAD5 
1,0 1,0 1,0 1,0 
Tb927.10.13280 
GCN1 homologue, possibly involved in 
translation control 
1,0 1,0 1,0 1,0 
Tb927.8.3060 
cytosolic leucyl aminopeptidase, 
putative,metallo-peptidase, Clan MF, 
Family M17 
1,0 1,0 1,0 1,0 
Tb927.9.11470 60S ribosomal protein L27a 1,0 1,0 1,0 1,0 
Tb927.10.10610 protein tyrosine phosphatase, putative 1,0 1,0 1,0 1,0 
Tb927.11.1630 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.5.4120 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.5.960 
MSP1, Mitochondrial protein involved in 
sorting of proteins in the mitochondria, 
putative 
1,0 1,0 1,0 1,0 
Tb927.6.1520 aquaporin 3, putative (AQP1) 1,0 1,0 1,0 1,0 
Tb927.6.1880 aspartyl-tRNA synthetase, putative 1,0 1,0 1,0 1,0 
Tb927.7.2330 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.3430 
Mitchondrial LSU ribosome-associated 
cyclophilin type peptidyl-prolyl cis-trans 
isomerase 
1,0 1,0 1,0 1,0 
Tb927.9.4230 fatty acyl CoA synthetase 4 (ACS4) 1,0 1,0 1,0 1,0 
Tb927.9.6620 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.14370 60S ribosomal protein L26 1,0 1,0 1,0 1,0 
Tb927.11.15900 60S ribosomal protein L27 1,0 1,0 1,0 1,0 
Tb927.1.420 
retrotransposon hot spot protein 5 (RHS5), 
putative 
1,0 1,0 1,0 1,0 
Tb927.11.11780 acyl-CoA dehydrogenase, putative 1,0 1,0 1,0 1,0 
Tb927.11.1850 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.6720 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.9750 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.3220 
RNA polymerase-associated protein 
CTR9, putative 
1,0 1,0 1,0 1,0 
Tb927.3.3520 POMP25 1,0 1,0 1,0 1,0 
Tb927.4.2040 ALBA3 1,0 1,0 1,0 1,0 
Tb927.5.2140 UPF1 1,0 1,0 1,0 1,0 
Tb927.6.4500 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.4470 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.5960 
protein associated with differentiation 4, 
PAD4 
1,0 1,0 1,0 1,0 
Tb927.8.6650 DRBD13 1,0 1,0 1,0 1,0 
Tb927.8.6820 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.2530 
mitochondrial RNA binding complex 1 
subunit 
1,0 1,0 1,0 1,0 
Tb927.5.3360 Mitchondrial LSU ribosomal protein L2, 1,0 1,0 1,0 1,0 
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putative 
Tb927.9.11880 Mitchondrial SSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.11.11820 40S ribosomal protein S17 1,0 1,0 1,0 1,0 
Tb927.7.1040 40S ribosomal protein S16 1,0 1,0 1,0 1,0 
Tb927.10.6050 clathrin heavy chain (CHC) 1,0 1,0 1,0 1,0 
Tb927.10.14010 
RP2 basal body protein, required for 
axoneme formation 
1,0 1,0 1,0 1,0 
Tb927.10.5460 60S ribosomal protein L24 1,0 1,0 1,0 1,0 
Tb927.11.8200 40S ribosomal protein S26 1,0 1,0 1,0 1,0 
Tb927.6.4370 eIF3 subunit 7-like protein 1,0 1,0 1,0 1,0 
Tb927.8.7340 
trans-sialidase, putative,neuraminidase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.9.15420 60S ribosomal protein L32 1,0 1,0 1,0 1,0 
Tb927.10.10570 histone H2B 1,0 1,0 1,0 1,0 
Tb927.10.12290 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase, putative 
1,0 1,0 1,0 1,0 
Tb927.10.2610 
hypothetical protein, conserved, DUF1935 
domain 
1,0 1,0 1,0 1,0 
Tb927.10.2840 40S ribosomal protein S25 1,0 1,0 1,0 1,0 
Tb927.10.6370 60S ribosomal protein L37a 1,0 1,0 1,0 1,0 
Tb927.10.8040 
adaptin complex 1 subunit, putative,beta-
adaptin, fragment (BAD1) 
1,0 1,0 1,0 1,0 
Tb927.11.10260 
hypothetical protein, conserved, no known 
domains 
1,0 1,0 1,0 1,0 
Tb927.11.3380 Ran-binding protein 1, putative 1,0 1,0 1,0 1,0 
Tb927.4.3060 
hypothetical protein, conserved, PLP 
dependent transferases like domain 
1,0 1,0 1,0 1,0 
Tb927.7.4550 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.8.1200 vacuolar-type Ca2 -ATPase 2 (TbA2) 1,0 1,0 1,0 1,0 
Tb927.8.2760 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.8.6980 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.4280 
glyceraldehyde 3-phosphate 
dehydrogenase, glycosomal (GAPDH) 
1,0 1,0 1,0 1,0 
Tb927.11.6140 40S ribosomal protein S15A 1,0 1,0 1,0 1,0 
Tb927.7.2820 histone H2A 1,0 1,0 1,0 1,0 
Tb927.9.1850 60S ribosomal protein L35 1,0 1,0 1,0 1,0 
Tb927.9.2220 SUMO1/Ulp2, putative 1,0 1,0 1,0 1,0 
Tb927.9.7690 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.8200 PES1 1,0 1,0 1,0 1,0 
Tb927.10.1550 
proteasome regulatory non-ATP-ase 
subunit 5,19S proteasome regulatory 
subunit (RPN5) 
1,0 1,0 1,0 1,0 
Tb927.4.3850 WDR12 1,0 1,0 1,0 1,0 
Tb927.8.1510 
ATP-dependent DEAD/H RNA helicase,  
putative Dbp3 
1,0 1,0 1,0 1,0 
Tb927.10.6910 Sterol methyltransferase, putative 1,0 1,0 1,0 1,0 
Tb927.3.3320 60S ribosomal protein L13 1,0 1,0 1,0 1,0 
Tb927.1.190 
retrotransposon hot spot protein (RHS, 
pseudogene) 
1,0 1,0 1,0 1,0 
Tb927.11.6040 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.6250 
Mitochondrial ATP synthase subunit, 
putative 
1,0 1,0 1,0 1,0 
Tb927.11.14170 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.4110 60S ribosomal protein L30 1,0 1,0 1,0 1,0 
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Tb927.10.8910 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.9220 
proteasome regulatory non-ATP-ase 
subunit 2 (RPN2) 
1,0 1,0 1,0 1,0 
Tb927.9.14200 
hypothetical protein, possible component 
of cytochorome oxidase complex 
1,0 1,0 1,0 1,0 
Tb927.9.15090 cytosolic coat protein, putative 1,0 1,0 1,0 1,0 
Tb927.3.5520 
26S proteasome regulatory non-ATPase 
subunit (RPN1) 
1,0 1,0 1,0 1,0 
Tb927.4.4910 
3,2-trans-enoyl-CoA isomerase, 
mitochondrial precursor, putative 
1,0 1,0 1,0 1,0 
Tb927.10.2810 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.4650 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.7.2170 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.6300 Mitchondrial SSU ribosomal protein S5 1,0 1,0 1,0 1,0 
Tb927.11.4130 ubiquitin-like protein, putative 1,0 1,0 1,0 1,0 
Tb927.1.2370 beta tubulin 1,0 1,0 1,0 1,0 
Tb927.10.14620 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.5430 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.1.2190 RAPTOR-like (TOR complexes) 1,0 1,0 1,0 1,0 
Tb927.1.4310 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.1.4420 ABC transporter, putative 1,0 1,0 1,0 1,0 
Tb927.10.1970 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.2880 calcium channel protein, putative 1,0 1,0 1,0 1,0 
Tb927.10.3100 Glycerol-3-phosphate acyltransferase 1,0 1,0 1,0 1,0 
Tb927.10.5350 IAD-4 inner arm dynein heavy chain 1,0 1,0 1,0 1,0 
Tb927.10.6330 KKT1 kinetochore protein 1,0 1,0 1,0 1,0 
Tb927.10.740 
structural maintenance of chromosome 4 
(SMC4) 
1,0 1,0 1,0 1,0 
Tb927.10.8450 
glucose transporter,glucose transporter 1E 
(THT1E) 
1,0 1,0 1,0 1,0 
Tb927.10.8780 
P-loop nucleoside hydrolase domain, like a 
human adenylate kinase domain protein 
1,0 1,0 1,0 1,0 
Tb927.11.10520 
KKT2 kinetochore protein, tyrosine kinase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.11.15450 hypothetical protein 1,0 1,0 1,0 1,0 
Tb927.11.3100 
POMP13, Trypanosome-specific, putative 
TM domain at Cterminus 
1,0 1,0 1,0 1,0 
Tb927.11.5820 
hypothetical protein, conserved, probably 
in mitochondrion 
1,0 1,0 1,0 1,0 
Tb927.11.6350 AAA ATPase, putative 1,0 1,0 1,0 1,0 
Tb927.2.1260 ESAG4 pseudogene 1,0 1,0 1,0 1,0 
Tb927.2.2370 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.3080 
fatty acid desaturase, putative,oleate 
desaturase, putative 
1,0 1,0 1,0 1,0 
Tb927.2.5870 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.4030 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.1500 
RNA editing associated helicase 2 (REH2) 
MRB 1 subunit 
1,0 1,0 1,0 1,0 
Tb927.4.2530 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.5020 
RNA polymerase IIA largest subunit 
(RPB1) 
1,0 1,0 1,0 1,0 
Tb927.5.1120 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.3510 
structural maintenance of chromosome 3 
(SMC3) 
1,0 1,0 1,0 1,0 
Tb927.6.870 myotubularin, putative 1,0 1,0 1,0 1,0 
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Tb927.6.920 helicase, putative 1,0 1,0 1,0 1,0 
Tb927.7.220 CDP-diacylglycerol synthetase, putative 1,0 1,0 1,0 1,0 
Tb927.7.4170 Elongase 2 1,0 1,0 1,0 1,0 
Tb927.7.5280 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.7400 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.2200 
terbinafine resistance locus protein (yip1), 
putative 
1,0 1,0 1,0 1,0 
Tb927.8.2820 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.3630 folate transporter, ESAG10, putative 1,0 1,0 1,0 1,0 
Tb927.8.4950 kinesin 1,0 1,0 1,0 1,0 
Tb927.8.6620 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.12700 phospholipase A1, putative 1,0 1,0 1,0 1,0 
Tb927.9.1770 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.3680 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.5700 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.9450 ZC3H28 1,0 1,0 1,0 1,0 
Tb927.9.9740 AMP deaminase, putative 1,0 1,0 1,0 1,0 
Tb927.9.9810 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.6740 PUF10 1,0 1,0 1,0 1,0 
Tb927.11.14960 PUF7 1,0 1,0 1,0 1,0 
Tb927.11.460 
hypothetical protein, conserved,predicted 
WD40 repeat protein 
1,0 1,0 1,0 1,0 
Tb927.8.3520 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.1.1370 rRNA biogenesis protein, putative 1,0 1,0 1,0 1,0 
Tb927.1.2430 histone H3 1,0 1,0 1,0 1,0 
Tb927.1.450 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1,0 1,0 1,0 1,0 
Tb927.10.15660 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.6790 BOP1/Erb1p 1,0 1,0 1,0 1,0 
Tb927.4.1080 V-type ATPase, A subunit, putative 1,0 1,0 1,0 1,0 
Tb927.4.3890 ATP-dependent DEAD/H RNA helicase 1,0 1,0 1,0 1,0 
Tb927.5.1560 
ATP-dependent DEAD/H RNA helicase, 
putative, no clear yeast homologue 
1,0 1,0 1,0 1,0 
Tb927.5.4230 histone H4 1,0 1,0 1,0 1,0 
Tb927.6.5090 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.13350 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.12430 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.3280 60S ribosomal protein L38 1,0 1,0 1,0 1,0 
Tb927.11.2120 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.4890 ribosomal protein L11, putative 1,0 1,0 1,0 1,0 
Tb927.8.5490 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.1.720 phosphoglycerate kinase (PGKA) 1,0 1,0 1,0 1,0 
Tb927.10.15170 
NRG1, nucleolar regulator of GPEET 
expression 
1,0 1,0 1,0 1,0 
Tb927.10.1560 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.3790 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.6090 tRNA pseudouridine synthase A, putative 1,0 1,0 1,0 1,0 
Tb927.10.7630 
hypothetical protein, 
conserved,transportin2- like protein 
1,0 1,0 1,0 1,0 
Tb927.10.9330 
hypothetical protein, conserved, partial 
PSP1 superfamily (signal peptidase-like) 
1,0 1,0 1,0 1,0 
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Tb927.11.16530 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.6360 60S ribosomal protein L24 1,0 1,0 1,0 1,0 
Tb927.11.8040 Mitochondrial LSU-associated 1,0 1,0 1,0 1,0 
Tb927.11.8050 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.5020 acyl-CoA oxidase, putative 1,0 1,0 1,0 1,0 
Tb927.2.510 
retrotransposon hot spot protein 4 (RHS4), 
putative 
1,0 1,0 1,0 1,0 
Tb927.2.6240 adenosine transporter 2 (TbNT5) 1,0 1,0 1,0 1,0 
Tb927.3.4080 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.1610 VDAC-like 1,0 1,0 1,0 1,0 
Tb927.4.2790 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.3070 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.3840 nucleolar protein, putative 1,0 1,0 1,0 1,0 
Tb927.4.4600 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.4.4720 
KRIPP7/TbPPR7 Kinetoplast ribosomal 
PPR-repeat containing protein 
1,0 1,0 1,0 1,0 
Tb927.5.4020 
hypothetical protein no clear yeast or 
human matches 
1,0 1,0 1,0 1,0 
Tb927.7.3060 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.3380 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.650 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.2600 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.3300 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.9.10560 POMP6 1,0 1,0 1,0 1,0 
Tb927.9.14410 
RNA 3'-terminal phosphate cyclase-like 
protein 
1,0 1,0 1,0 1,0 
Tb927.9.4200 fatty acyl CoA synthetase 2 (ACS2) 1,0 1,0 1,0 1,0 
Tb927.9.8290 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.2.5610 POMP22 1,0 1,0 1,0 1,0 
Tb927.6.960 
cysteine peptidase precursor, Clan CA, 
family C1, Cathepsin L-like (CP) 
1,0 1,0 1,0 1,0 
Tb927.1.1130 
glycerol-3-phosphate dehydrogenase 
(FAD-dependent), putative 
1,0 1,0 1,0 1,0 
Tb927.1.1530 protein kinase, putative 1,0 1,0 1,0 1,0 
Tb927.1.2120 
calpain, putative,cysteine peptidase, Clan 
CA, family C2, putative 
1,0 1,0 1,0 1,0 
Tb927.1.3450 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.1.710 phosphoglycerate kinase (PGKB) 1,0 1,0 1,0 1,0 
Tb927.10.10170 
hypothetical protein, conserved,predicted 
WD40 repeat protein 
1,0 1,0 1,0 1,0 
Tb927.10.10280 microtubule-associated protein, putative 1,0 1,0 1,0 1,0 
Tb927.10.11310 intraflagellar transport protein IFT55/IFT57 1,0 1,0 1,0 1,0 
Tb927.10.11340 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.12740 ZC3H35 1,0 1,0 1,0 1,0 
Tb927.10.12930 
hypothetical protein, conservedn no 
domains or good BLASTp hits 
1,0 1,0 1,0 1,0 
Tb927.10.13040 
GRESAG 4, putative receptor-type 
adenylate cyclase 
1,0 1,0 1,0 1,0 
Tb927.10.13290 ethanolamine phosphotransferase (EPT) 1,0 1,0 1,0 1,0 
Tb927.10.14730 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.10.1500 
methionyl-tRNA synthetase, putative 
(MetRS) 
1,0 1,0 1,0 1,0 
Tb927.10.1660 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.2020 hexokinase (HK2) 1,0 1,0 1,0 1,0 
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Tb927.10.3080 methionine biosynthetic protein, putative 1,0 1,0 1,0 1,0 
Tb927.10.3330 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.430 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.4900 
TPR-repeat-containing chaperone protein 
DNAJ, putative,TPR repeat protein 
1,0 1,0 1,0 1,0 
Tb927.10.5030 40S ribosomal protein S27+ ubiquitin 1,0 1,0 1,0 1,0 
Tb927.10.7230 
hypothetical protein, conserved, 7 
nucleoside diphostate kinase domains 
1,0 1,0 1,0 1,0 
Tb927.10.760 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.8920 TbGRP  ras-like small GTPase 1,0 1,0 1,0 1,0 
Tb927.10.9200 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.9800 60S ribosomal protein L22 1,0 1,0 1,0 1,0 
Tb927.11.1010 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.11.10870 32 kDa ER-associated protein (ERAP32) 1,0 1,0 1,0 1,0 
Tb927.11.11470 
Mitchondrial SSU ribosomal associated 
KRIPP14 (PPR) 
1,0 1,0 1,0 1,0 
Tb927.11.11630 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.11.11740 
membrane-bound acid phosphatase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.11.13250 eIF-2-gamma 1,0 1,0 1,0 1,0 
Tb927.11.13270 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.13360 AAA ATPase, putative 1,0 1,0 1,0 1,0 
Tb927.11.13750 
small GTPase, putative,ras-related rab-4 
(RAB4) 
1,0 1,0 1,0 1,0 
Tb927.11.13890 RNA ligase asociated with SSU 1,0 1,0 1,0 1,0 
Tb927.11.14330 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.15530 C-14 sterol reductase, putative 1,0 1,0 1,0 1,0 
Tb927.11.15750 AMP deaminase, putative 1,0 1,0 1,0 1,0 
Tb927.11.2670 Nucleoporin (TbNup59) 1,0 1,0 1,0 1,0 
Tb927.11.3320 ras-like small GTPase, putative (TbGTR) 1,0 1,0 1,0 1,0 
Tb927.11.3750 
NADH-cytochrome b5 reductase, putative 
(B5R) 
1,0 1,0 1,0 1,0 
Tb927.11.3940 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.4180 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.4330 
hypothetical protein, conserved, no clear 
yeast or human matches 
1,0 1,0 1,0 1,0 
Tb927.11.4680 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.4850 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.5420 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.5510 dynein light chain p28, axonemal, putative 1,0 1,0 1,0 1,0 
Tb927.11.8320 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.2230 
hypothetical protein, conserved, no 
domains, Kineto-specific 
1,0 1,0 1,0 1,0 
Tb927.2.2940 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.3800 
mRNA processing protein, putative GAP1 
MRB complex protein 
1,0 1,0 1,0 1,0 
Tb927.2.450 
retrotransposon hot spot protein 4 (RHS4), 
putative 
1,0 1,0 1,0 1,0 
Tb927.2.5270 IAD-3 inner arm dynein heavy chain 1,0 1,0 1,0 1,0 
Tb927.2.5280 trans-sialidase, putative (30J2.90) 1,0 1,0 1,0 1,0 
Tb927.2.5810 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.2080 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.3260 
hypothetical protein, conserved, 
kinetoplastid-specific, poly(E) repeats 
1,0 1,0 1,0 1,0 
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Tb927.3.3820 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.4040 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.4120 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.4390 
dihydrolipoamide dehydrogenase, putative 
(GCVL-1) 
1,0 1,0 1,0 1,0 
Tb927.3.4640 POMP26 1,0 1,0 1,0 1,0 
Tb927.3.5490 
flagellar transport protein, putative 
(PIFTB2) 
1,0 1,0 1,0 1,0 
Tb927.4.1600 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.1660 mitochondrial carrier protein, MCP6 1,0 1,0 1,0 1,0 
Tb927.4.1970 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.2280 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.2600 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.5300 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase, putative 
1,0 1,0 1,0 1,0 
Tb927.5.1020 disulfide isomerase, putative 1,0 1,0 1,0 1,0 
Tb927.5.1710 
ribonucleoprotein p18, mitochondrial 
precursor, putative 
1,0 1,0 1,0 1,0 
Tb927.5.2060 
cell division control protein CDC5f, putative 
part of PRP19 complex 
1,0 1,0 1,0 1,0 
Tb927.5.2150 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.3020 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.3220 signal peptidase type I, putative 1,0 1,0 1,0 1,0 
Tb927.6.2170 co-chaperone GrpE, putative 1,0 1,0 1,0 1,0 
Tb927.6.2490 
Succinate dehydrogenase complex 
component (SDH7 in T cruzi) 
1,0 1,0 1,0 1,0 
Tb927.6.2930 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.3540 zinc-finger protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.3650 ADP-ribosylation factor, putative 1,0 1,0 1,0 1,0 
Tb927.6.4990 ATP synthase, epsilon chain, putative 1,0 1,0 1,0 1,0 
Tb927.6.580 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.2070 heat shock protein DNAJ, putative 1,0 1,0 1,0 1,0 
Tb927.7.4160 Elongase 1 1,0 1,0 1,0 1,0 
Tb927.7.4950 
NAD(p)-dependent steroid 
dehydrogenase-like protein 
1,0 1,0 1,0 1,0 
Tb927.7.5130 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.5250 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.5320 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.5710 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.6200 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.7.6440 v-SNARE like protein 1,0 1,0 1,0 1,0 
Tb927.7.6660 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.7.680 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.7.740 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.7.830 telomerase-associated protein, putative 1,0 1,0 1,0 1,0 
Tb927.8.1940 
endosomal integral membrane protein, 
putative 
1,0 1,0 1,0 1,0 
Tb927.8.2240 tryptophanyl-tRNA synthetase, putative 1,0 1,0 1,0 1,0 
Tb927.8.2540 Acetyl-CoA acetyltransferase 1,0 1,0 1,0 1,0 
Tb927.8.2910 
mannosyl-oligosaccharide 1,2-alpha-
mannosidase IB, ER quality control 
1,0 1,0 1,0 1,0 
Tb927.8.4150 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
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Tb927.8.4770 
small GTP-binding protein Rab18 
(TbRAB18) 
1,0 1,0 1,0 1,0 
Tb927.8.5280 
Mitchondrial SSU ribosomal associated 
TbMRPS34 
1,0 1,0 1,0 1,0 
Tb927.8.5370 
hypothetical protein, conserved, no yeast 
or human match 
1,0 1,0 1,0 1,0 
Tb927.8.570 
proteasome regulatory non-ATP-ase 
subunit 10 
1,0 1,0 1,0 1,0 
Tb927.8.6200 tubulin folding cofactor D, putative 1,0 1,0 1,0 1,0 
Tb927.8.7120 Squalene synthase 1,0 1,0 1,0 1,0 
Tb927.8.760 
nucleolar RNA-binding protein 
(Nopp44/46) 
1,0 1,0 1,0 1,0 
Tb927.9.12710 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.14070 short-chain dehydrogenase, putative 1,0 1,0 1,0 1,0 
Tb927.9.15010 
NADH-ubiquinone oxidoreductase complex 
I subunit, putative 
1,0 1,0 1,0 1,0 
Tb927.9.2560 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.2670 POMP3 1,0 1,0 1,0 1,0 
Tb927.9.3620 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.3640 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.9.3820 syntaxin, putative 1,0 1,0 1,0 1,0 
Tb927.9.5280 Mitchondrial SSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.9.7830 
mitochondrial tRNA import complex, 
putative 
1,0 1,0 1,0 1,0 
Tb927.9.9710 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.1.90 
retrotransposon hot spot protein (RHS, 
pseudogene), putative 
1,0 1,0 1,0 1,0 
Tb927.10.13860 GPI-anchor transamidase subunit 8 (GPI8) 1,0 1,0 1,0 1,0 
Tb927.10.13990 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.15330 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.15710 mitochondrial carrier protein, MCP7 1,0 1,0 1,0 1,0 
Tb927.10.3210 
delta-1-pyrroline-5-carboxylate 
dehydrogenase, putative 
1,0 1,0 1,0 1,0 
Tb927.10.4280 
Mitochondrial cytochrome bc1 complex 
component, Cytochrome bd ubiquinol 
oxidase domain 
1,0 1,0 1,0 1,0 
Tb927.10.5220 
hypothetical protein, possible component 
of cytochorome oxidase complex 
1,0 1,0 1,0 1,0 
Tb927.10.5640 TbGemin2 1,0 1,0 1,0 1,0 
Tb927.10.660 
2-oxoisovalerate dehydrogenase alpha 
subunit, putative 
1,0 1,0 1,0 1,0 
Tb927.10.8720 NOT10 1,0 1,0 1,0 1,0 
Tb927.10.8730 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.1030 KKT7 Kinetochore protein 1,0 1,0 1,0 1,0 
Tb927.11.12890 POMP17 1,0 1,0 1,0 1,0 
Tb927.11.14270 protein kinase, putative 1,0 1,0 1,0 1,0 
Tb927.11.15230 cytosolic coat protein, putative 1,0 1,0 1,0 1,0 
Tb927.11.15870 
hypothetical protein, conserved, no human 
or yeast homologue 
1,0 1,0 1,0 1,0 
Tb927.11.16110 
FG-GAP repeat protein, putative,intergrin 
alpha chain protein, putative 
1,0 1,0 1,0 1,0 
Tb927.11.16810 
dynein light intermediate chain D1bLIC, 
putative 
1,0 1,0 1,0 1,0 
Tb927.11.4490 
long-chain-fatty-acid-CoA ligase, 
putative,acyl-CoA synthetase 
1,0 1,0 1,0 1,0 
Tb927.11.5520 triosephosphate isomerase (TIM) 1,0 1,0 1,0 1,0 
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Tb927.11.9820 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.9900 phytoene synthase, putative, complex I 1,0 1,0 1,0 1,0 
Tb927.2.4830 
TFIIF-stimulated CTD phosphatase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.2.5930 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.3950 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.2760 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.4570 
hypothetical protein, conserved, no 
domains, no yeast or human match 
1,0 1,0 1,0 1,0 
Tb927.5.1130 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.1930 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.3190 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.770 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.1140 
dolichyl-P-Man:GDP-Man5GlcNAc2-PP-
dolichyl alpha-1,2-mannosyltransferase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.6.1990 
hypothetical protein, conserved, no yeast 
or human match 
1,0 1,0 1,0 1,0 
Tb927.6.2560 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.3510 tRNA modification enzyme, putative 1,0 1,0 1,0 1,0 
Tb927.6.3720 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.4070 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.4080 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.7.2500 proteasome regulatory ATPase subunit 1 1,0 1,0 1,0 1,0 
Tb927.7.3180 
Mu-adaptin 1, putative,adaptor complex 
AP-1 medium subunit, putative 
1,0 1,0 1,0 1,0 
Tb927.7.3370 intraflagellar transport protein IFT74 1,0 1,0 1,0 1,0 
Tb927.7.3880 protein kinase, putative 1,0 1,0 1,0 1,0 
Tb927.7.4980 ZC3H23 POMP35 1,0 1,0 1,0 1,0 
Tb927.7.5080 ATP-NAD kinase-like protein 1,0 1,0 1,0 1,0 
Tb927.7.6930 ATPase, putative 1,0 1,0 1,0 1,0 
Tb927.8.1290 
hypothetical protein, conserved, no 
domains 
1,0 1,0 1,0 1,0 
Tb927.8.3580 mitochondrial chaperone BCS1, putative 1,0 1,0 1,0 1,0 
Tb927.8.3770 mitogen-activated protein kinase, putative 1,0 1,0 1,0 1,0 
Tb927.8.4050 
flagellar membrane protein that interacts 
with FLA1, similar to FLA3 
1,0 1,0 1,0 1,0 
Tb927.8.4610 small GTP-binding protein Rab1 (Trab1) 1,0 1,0 1,0 1,0 
Tb927.8.5560 
NADH-ubiquinone oxidoreductase complex 
I subunit, putative 
1,0 1,0 1,0 1,0 
Tb927.8.6360 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.10450 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.11540 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.13580 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.13650 ADP-ribosylation factor, putative 1,0 1,0 1,0 1,0 
Tb927.9.14080 
vesicle-associated membrane protein, 
putative 
1,0 1,0 1,0 1,0 
Tb927.9.15000 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.7180 
adenosine monophosphate deaminase, 
putative,AMP deaminase, putative 
1,0 1,0 1,0 1,0 
Tb927.9.9150 GTP-binding protein, putative 1,0 1,0 1,0 1,0 
Tb927.1.5030 leucine-rich repeat protein (LRRP) 1,0 1,0 1,0 1,0 
Tb927.10.14200 syntaxin 5 1,0 1,0 1,0 1,0 
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Tb927.10.14530 
proteasome regulatory non-ATPase 
subunit 8,26S proteasome regulatory 
subunit (Rpn8) 
1,0 1,0 1,0 1,0 
Tb927.10.14860 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.15430 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.15720 
19S proteasome regulatory subunit 
(RPN9) 
1,0 1,0 1,0 1,0 
Tb927.10.4050 serine palmitoyltransferase, putative 1,0 1,0 1,0 1,0 
Tb927.10.4640 eIF-3 subunit L 1,0 1,0 1,0 1,0 
Tb927.10.4760 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.5300 eIF-6 1,0 1,0 1,0 1,0 
Tb927.10.7100 delta-4 fatty acid desaturase 1,0 1,0 1,0 1,0 
Tb927.11.15150 
1-acyl-sn-glycerol-3-phosphate 
acyltransferase, putative 
1,0 1,0 1,0 1,0 
Tb927.11.16670 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.2690 
succinyl-coA:3-ketoacid-coenzyme A 
transferase, mitochondrial precursor, 
putative 
1,0 1,0 1,0 1,0 
Tb927.11.2750 POMP12 1,0 1,0 1,0 1,0 
Tb927.11.3570 
aminopeptidase, putative,metallo-
peptidase, Clan MA(E) Family M1 
1,0 1,0 1,0 1,0 
Tb927.11.3860 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.4160 
hypothetical protein, conserved,predicted 
C2 domain protein 
1,0 1,0 1,0 1,0 
Tb927.11.5110 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.5760 
hypothetical protein, conserved, small 
unknown domain, SET domain 
1,0 1,0 1,0 1,0 
Tb927.3.3850 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.3.4820 acyltransferase, putative 1,0 1,0 1,0 1,0 
Tb927.6.1040 
cysteine peptidase precursor, Clan CA, 
family C1, Cathepsin L-like (CP) 
1,0 1,0 1,0 1,0 
Tb927.7.1220 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.2980 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.3810 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.4940 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.6050 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.7040 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.8120 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.3400 
endo-beta-N-acetylglucosaminidase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.9.7800 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.13620 
NADH-ubiquinone oxidoreductase complex 
I subunit, NDUFA9 subunit, putative 
1,0 1,0 1,0 1,0 
Tb927.10.16150 
ATP-dependent zinc metallopeptidase, 
putative,metallo-peptidase, Clan MA(E) 
Family M41 
1,0 1,0 1,0 1,0 
Tb927.10.1860 
hypothetical protein, conserved, tryp 
specific 
1,0 1,0 1,0 1,0 
Tb927.10.3520 
protease regulatory ATPase subunit 4, 
putative (RPT4) 
1,0 1,0 1,0 1,0 
Tb927.10.4040 3-Ketosphinganine reductase 1,0 1,0 1,0 1,0 
Tb927.11.14910 protein phosphatase 2C, putative 1,0 1,0 1,0 1,0 
Tb927.11.3270 squalene monooxygenase, putative 1,0 1,0 1,0 1,0 
Tb927.2.4210 
glycosomal phosphoenolpyruvate 
carboxykinase (PEPCK) 
1,0 1,0 1,0 1,0 
Tb927.3.1080 POMP23 1,0 1,0 1,0 1,0 
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Tb927.4.2890 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.730 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.2570 guide RNA associated protein, GAP2 1,0 1,0 1,0 1,0 
Tb927.7.7130 TWY1 homologue, tRNA modification 1,0 1,0 1,0 1,0 
Tb927.7.7470 
GRESAG 4, putative receptor-type 
adenylate cyclase 
1,0 1,0 1,0 1,0 
Tb927.8.4890 
endoplasmic reticulum oxidoreductin, Ero1, 
oxidises PDI 
1,0 1,0 1,0 1,0 
Tb927.9.10520 
hypothetical protein, possible component 
of cytochorome oxidase complex 
1,0 1,0 1,0 1,0 
Tb927.9.6090 PTP1-interacting protein, 39 kDa PIP39 1,0 1,0 1,0 1,0 
Tb927.10.15680 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.2890 enolase 1,0 1,0 1,0 1,0 
Tb927.10.5400 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.770 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.1070 glycosomal transporter (GAT3) 1,0 1,0 1,0 1,0 
Tb927.11.14700 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.4280 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.5220 chaperone protein DNAj, putative 1,0 1,0 1,0 1,0 
Tb927.2.5800 
sedoheptulose-1,7-bisphosphatase 
(SBPase) 
1,0 1,0 1,0 1,0 
Tb927.3.3450 
ADP-ribosylation factor-like protein 3A, 
putative 
1,0 1,0 1,0 1,0 
Tb927.3.750 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.4.4350 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.2080 
guanosine monophosphate reductase, 
putative 
1,0 1,0 1,0 1,0 
Tb927.6.2360 adenosine kinase, putative 1,0 1,0 1,0 1,0 
Tb927.9.3170 cytochrome oxidase subunit V (COXV) 1,0 1,0 1,0 1,0 
Tb927.2.3990 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.2290 
U5 splicing factor U5-200K, putative or 
BRR2 homologue 
1,0 1,0 1,0 1,0 
Tb927.8.2770 IP3 inositol trisphosphate receptor. 1,0 1,0 1,0 1,0 
Tb927.9.15290 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.1720 Phosphatidylglycerophosphate synthase 1,0 1,0 1,0 1,0 
Tb927.9.4500 HSP70, endoplasmatic reticulum, HSP70.a 1,0 1,0 1,0 1,0 
Tb927.10.14150 
hypothetical protein, conserved, related to 
yeast BFR1 
1,0 1,0 1,0 1,0 
Tb927.10.13250 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.9890 
signal recognition particle receptor alpha 
subunit, putative 
1,0 1,0 1,0 1,0 
Tb927.5.900 
oligosaccharyl transferase subunit, 
putative 
1,0 1,0 1,0 1,0 
Tb927.6.3500 
RME8 endosomal trafficking protein, 
clathrin-associated 
1,0 1,0 1,0 1,0 
Tb927.8.5760 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.5770 Elongator-like Protein 3a ELP3a 1,0 1,0 1,0 1,0 
Tb927.9.10010 
Sec63 homologue, chaperone protein 
DNAj 
1,0 1,0 1,0 1,0 
Tb927.9.1780 
sec1 family transport protein, putative 
(SLY1) 
1,0 1,0 1,0 1,0 
Tb927.9.11110 
PRP8 protein homologue,U5 snRNA-
associated splicing factor 
1,0 1,0 1,0 1,0 
Tb927.10.5620 
fructose-bisphosphate aldolase, 
glycosomal (ALD) 
1,0 1,0 1,0 1,0 
Tb927.1.1930 TbTOR4 = TOR-like 2 1,0 1,0 1,0 1,0 
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Tb927.5.3800 
glutamine hydrolysing (not ammonia-
dependent) carbomoyl phosphate 
synthase, putative 
1,0 1,0 1,0 1,0 
Tb927.8.1590 
TOM1, HECT ubiquitin-protein ligase 
involved in mRNA export from nucleus 
1,0 1,0 1,0 1,0 
Tb927.9.6170 
arginine kinase (AK) in cytosol and 
flagellum 
1,0 1,0 1,0 1,0 
Tb927.10.7710 40S ribosomal protein S8 1,0 1,0 1,0 1,0 
Tb927.11.5300 
kinesin, Kif13-3, predicted centromere-
associated 
1,0 1,0 1,0 1,0 
Tb927.11.6540 
hypothetical protein, conserved, 
kinetoplastid-specific 
1,0 1,0 1,0 1,0 
Tb927.2.370 
retrotransposon hot spot protein 1 (RHS1), 
putative 
1,0 1,0 1,0 1,0 
Tb927.3.1590 
MRB complex protein mitochondrial RNA 
binding complex 1 subunit 
1,0 1,0 1,0 1,0 
Tb927.3.4500 fumarate hydratase, class I (FHc) 1,0 1,0 1,0 1,0 
Tb927.4.630 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.5.1090 threonyl-tRNA synthetase, putative 1,0 1,0 1,0 1,0 
Tb927.5.1470 
NADH-cytochrome b5 reductase, putative 
(B5R) 
1,0 1,0 1,0 1,0 
Tb927.5.3920 
PEX6 peroxisome assembly protein, AAA 
ATPase 
1,0 1,0 1,0 1,0 
Tb927.5.590 
protein phosphatase 1, regulatory subunit, 
putative 
1,0 1,0 1,0 1,0 
Tb927.5.920 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.1300 
protein disulfide isomerase,ERp72-like, 
cofactor wth calnexin, putative 
1,0 1,0 1,0 1,0 
Tb927.7.1360 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.1920 paraflagellar rod protein PFC5 1,0 1,0 1,0 1,0 
Tb927.7.2660 ZC3H20 1,0 1,0 1,0 1,0 
Tb927.7.2700 
NADH-cytochrome b5 reductase, putative 
(B5R) 
1,0 1,0 1,0 1,0 
Tb927.7.3080 
hypothetical protein, conserved, 
kinetoplastid-specific 
1,0 1,0 1,0 1,0 
Tb927.7.4390 threonine synthase, putative 1,0 1,0 1,0 1,0 
Tb927.7.7030 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.7460 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.8.2030 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.11050 4E-IP, 4E-interacting protein, putative 1,0 1,0 1,0 1,0 
Tb927.9.11910 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.9.6450 PEX16, putative 1,0 1,0 1,0 1,0 
Tb927.9.9870 MCAK-like kinesin, putative 1,0 1,0 1,0 1,0 
Tb927.6.1920 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.10.8660 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.11.5290 mitochondrial carrier protein, MCP9 1,0 1,0 1,0 1,0 
Tb927.10.6810 guanylate kinase, putative 1,0 1,0 1,0 1,0 
Tb927.7.3030 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.4710 Mitchondrial LSU ribosomal protein 1,0 1,0 1,0 1,0 
Tb927.9.11580 
Gim5A protein,glycosomal membrane 
protein (gim5A) 
1,0 1,0 1,0 1,0 
Tb927.9.6100 
TFIIF-stimulated CTD phosphatase, in 
UPF1-TAP 
1,0 1,0 1,0 1,0 
Tb927.7.3040 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.6.4770 MKT1 1,0 1,0 1,0 1,0 
Tb927.9.7470 purine nucleoside transporter NT10 1,0 1,0 1,0 1,0 
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Tb927.11.14900 coatomer epsilon subunit, epsilon-COP 1,0 1,0 1,0 1,0 
Tb927.10.2640 intraflagellar transport protein IFT81 1,0 1,0 1,0 1,0 
Tb927.11.16160 ATP binding protein-like protein 1,0 1,0 1,0 1,0 
Tb927.11.3770 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.2.4980 hypothetical protein, conserved 1,0 1,0 1,0 1,0 
Tb927.7.1500 
Thiomodification of cytiosolic tRNAs (NBP 
2) 
1,0 1,0 1,0 1,0 
Tb11.02.5400 cystathionine beta-synthase, putative 1,0 1,0 1,0 1,0 
Tb927.10.14930 ZC3H39 1,0 1,0 1,0 1,0 
Tb927.9.8880 actin A 1,0 1,0 1,0 0,9 
Tb927.9.8850 actin A 0,9 0,9 0,9 1,0 
Tb927.4.3590 
EF1 beta, translation elongation factor 1-
beta, putative 
1,0 1,0 0,9 1,0 
Tb927.11.4900 
guanine nucleotide-binding beta subunit-
like protein,G-protein (beta)-like protein 
1,0 1,0 0,9 1,0 
Tb927.10.8490 glucose transporter, putative 1,0 1,0 1,0 0,8 
Tb927.9.6060 
2Fe-2S iron-sulfur cluster binding domain 
containing protein, POMP4 
1,0 1,0 0,8 1,0 
Tb927.2.3780 
IF2 translation initiation factor IF-2, 
putative 
1,0 1,0 0,8 1,0 
Tb927.2.5060 GTP binding protein, putative 1,0 1,0 0,8 1,0 
Tb927.3.1790 
pyruvate dehydrogenase E1 beta subunit, 
putative 
0,9 1,0 1,0 0,8 
Tb927.7.7420 ATP synthase F1, alpha subunit 1,0 1,0 1,0 0,8 
Tb927.11.11520 PEX11 glycosomal membrane protein 1,0 1,0 0,8 1,0 
Tb927.8.6110 hypothetical protein, conserved 1,0 1,0 1,0 0,8 
Tb927.6.1000 
cysteine peptidase precursor, Clan CA, 
family C1, Cathepsin L-like (CP) 
1,0 1,0 1,0 0,8 
Tb927.10.1170 intraflagellar transport protein IFT172 1,0 1,0 0,8 1,0 
Tb927.4.1800 Mitochondrial LSU ribosomal protein L3 1,0 0,8 0,9 0,9 
Tb927.10.2560 
mitochondrial malate dehydrogenase 
(mMDH) 
1,0 0,8 1,0 1,0 
Tb927.10.15180 nucleosome assembly protein, putative 1,0 1,0 1,0 0,8 
Tb927.6.4690 60S ribosomal protein L9 0,8 1,0 1,0 1,0 
Tb927.1.3110 
soluble N-ethylmaleimide sensitive factor 
(NSF) attachment protein, putative 
1,0 1,0 0,8 1,0 
Tb927.4.1170 ankyrin, putative 1,0 1,0 0,8 1,0 
Tb927.7.1970 
retrotransposon hot spot protein 7 (RHS7), 
putative 
1,0 1,0 0,8 1,0 
Tb927.10.4570 EF2 elongation factor 2 1,0 1,0 1,0 0,7 
Tb927.8.1500 hypothetical protein, conserved 1,0 1,0 0,7 1,0 
Tb927.9.12570 glycerol kinase, glycosomal (glk1) 1,0 1,0 1,0 0,7 
Tb927.11.3030 
phosphoribosylpyrophosphate synthetase, 
putative (PRS) 
1,0 1,0 0,7 1,0 
Tb927.11.8880 hypothetical protein, conserved 0,8 1,0 0,7 1,0 
Tb927.3.1920 NOT5 1,0 1,0 0,6 1,0 
Tb927.5.930 
NADH-dependent fumarate reductase 
(FRDg) 
1,0 1,0 0,6 1,0 
Tb927.11.13080 hypothetical protein, conserved 1,0 1,0 0,7 0,6 
Tb927.10.1070 cdc2- like protein kinase (CRK1) 1,0 1,0 1,0 0,6 
Tb927.9.9550 
hypothetical protein, conserved, no yeast 
or human match 
1,0 1,0 1,0 0,6 
Tb927.11.5140 
ubiquitin carboxyl-terminal hydrolase, Clan 
CA cysteine peptidase, family C12, 
putative 
1,0 1,0 0,6 1,0 
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Tb927.11.670 epsinR 1,0 1,0 1,0 0,6 
Tb927.3.3030 hypothetical protein, conserved 0,6 0,6 1,0 1,0 
Tb927.10.9430 
phosphoribosylpyrophosphate synthetase, 
putative (PRS) 
1,0 1,0 0,6 1,0 
Tb927.10.9440 NADH dehydrogenase (54 NDH2) 1,0 1,0 1,0 0,6 
Tb927.1.2330 beta tubulin 0,7 0,5 0,8 1,0 
Tb927.10.13360 EF-Tu Mitochondrial elongation factor Tu 0,5 1,0 1,0 0,8 
Tb927.11.14750 
hypothetical protein, conserved, PSP1 C-
terminal region domain, no yeast or human 
match 
0,5 1,0 1,0 1,0 
Tb927.8.4450 RBP11 0,5 1,0 1,0 1,0 
Tb927.9.12500 POMP7 0,5 1,0 1,0 1,0 
Tb927.6.5080 hypothetical protein, conserved 0,5 1,0 1,0 1,0 
Tb927.8.7160 
UDP-Gal or UDP-GlcNAc-dependent 
glycosyltransferase pseudogene 
0,5 1,0 1,0 1,0 
Tb927.1.1790 hypothetical protein 0,5 1,0 1,0 1,0 
Tb927.10.1120 hypothetical protein, conserved 0,5 1,0 1,0 1,0 
Tb927.10.460 NIMA-related protein kinase (NRKC) 0,5 1,0 1,0 1,0 
Tb927.11.4350 hypothetical protein, conserved 0,5 1,0 1,0 1,0 
Tb927.2.2260 PIK-related 0,5 1,0 1,0 1,0 
Tb927.4.220 
retrotransposon hot spot protein (RHS2, 
pseudogene), putative 
1,0 1,0 0,5 1,0 
Tb927.6.2880 Kinesin-like but poor match 0,5 1,0 1,0 1,0 
Tb927.8.3180 hypothetical protein, conserved 0,5 1,0 1,0 1,0 
Tb927.8.5330 
MCP2, binds to tRNAs and assists tRNA 
synthetases 
0,5 1,0 1,0 1,0 
Tb927.8.800 hypothetical protein, conserved 0,5 1,0 1,0 1,0 
Tb927.9.1710 hypothetical protein, conserved 0,5 1,0 1,0 1,0 
Tb927.9.3920 40S ribosomal protein S7 0,5 1,0 1,0 1,0 
Tb927.11.6390 
hypothetical protein, conserved, START 
domain, possible phoshatidylcholine 
transfer protein 
1,0 1,0 1,0 0,5 
Tb927.10.10900 heat shock protein 83, HSP83 1,0 1,0 1,0 0,4 
Tb927.10.7680 GTPase activating protein, putative 1,0 0,8 0,9 0,4 
Tb927.10.15530 
ABC transport system ATP-binding protein, 
putative 
1,0 1,0 1,0 0,3 
Tb927.9.11380 60S ribosomal protein L23 1,0 1,0 0,3 0,3 
Tb927.10.9740 19S proteasome regulatory subunit (RPT6) 1,0 1,0 0,3 1,0 
Tb927.7.2550 
proteasome regulatory ATPase subunit 5 
(RPT5) 
1,0 1,0 1,0 0,3 
Tb927.3.2150 protein phosphatase 2C, putative 1,0 1,0 1,0 0,3 
Tb927.11.15560 Nucleoporin (TbNup53a) 1,0 1,0 0,3 1,0 
Tb927.3.1680 hypothetical protein, conserved 1,0 1,0 0,3 1,0 
Tb927.10.11270 RBP23 1,0 1,0 1,0 0,3 
Tb927.11.10570 Mitchondrial LSU ribosomal protein 0,8 1,0 1,0 0,3 
Tb927.9.2320 
POMP1 (possible S-Adenosyl methionine 
methyl transferase 
1,0 0,3 0,8 1,0 
Tb927.10.730 ATP synthase, putative 1,0 1,0 1,0 0,3 
Tb927.11.9920 polyubiquitin, putative 0,5 1,0 1,0 0,3 
Tb927.11.9730 60S ribosomal protein L34 0,5 1,0 0,3 0,8 
Tb927.11.2410 
Flabarin, flagellar membrane protein in 
Leishmania 
1,0 0,3 1,0 1,0 
Tb927.9.11000 
small GTPase, putative,GTP-binding 
protein, putative (RAB7) 
0,3 1,0 1,0 0,8 
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Tb927.9.6310 ABC transporter, putative 1,0 1,0 1,0 0,3 
Tb927.9.11840 hypothetical protein, conserved 1,0 1,0 1,0 0,3 
Tb927.4.1020 Serine palmitoyltransferase 1,0 1,0 1,0 0,3 
Tb927.6.3940 hypothetical protein, conserved 1,0 1,0 1,0 0,3 
Tb927.10.9910 hypothetical protein, conserved 0,5 1,0 0,3 0,3 
Tb927.11.3740 
proteasome regulatory ATPase subunit 2 
(RPT2) 
0,5 1,0 1,0 0,3 
Tb927.10.4080 hypothetical protein, conserved 1,0 1,0 1,0 0,3 
Tb927.4.4490 
multidrug resistance protein E,p-
glycoprotein (MRPE) 
1,0 1,0 1,0 0,3 
Tb927.10.3170 ABC transporter, putative 1,0 1,0 1,0 0,3 
Tb927.1.120 
retrotransposon hot spot protein 4 (RHS4), 
putative 
1,0 1,0 1,0 0,3 
Tb927.7.6800 Mitchondrial LSU ribosomal protein 0,3 1,0 1,0 1,0 
Tb927.8.4540 PBP1 1,0 1,0 0,3 1,0 
Tb927.8.980 
Phosphoacetylglucosamine mutase 
PAGM, acts as phosphoglucomutase 
1,0 1,0 1,0 0,3 
Tb927.1.3180 40S ribosomal protein S11 1,0 1,0 1,0 0,3 
Tb927.10.13710 hypothetical protein, conserved 1,0 1,0 0,3 1,0 
Tb927.4.2240 
hypothetical protein, conserved, D-
aminoacid aminotransferase domain 
1,0 1,0 0,3 1,0 
Tb927.7.6890 hypothetical protein, conserved 1,0 1,0 0,3 1,0 
Tb927.9.10580 
3-demethylubiquinone-9 3-
methyltransferase, putative 
1,0 1,0 1,0 0,3 
Tb927.10.10130 
MRB complex component mitochondrial 
RNA binding complex 1 subunit 
1,0 1,0 1,0 0,3 
Tb927.11.10020 short-chain dehydrogenase, putative 1,0 1,0 0,3 1,0 
Tb927.3.2900 
EF-2 alpha, elongation initiation factor 2 
alpha subunit, 
1,0 1,0 1,0 0,3 
Tb927.7.2160 
hypothetical protein, conserved, no 
domains, no yeast or human match 
1,0 1,0 1,0 0,3 
Tb927.7.2710 NADH-cytochrome b5 reductase, putative 1,0 1,0 1,0 0,3 
Tb927.8.3380 
electron transfer protein, SDH2N,succinate 
dehydrogenase complex 
1,0 1,0 1,0 0,3 
Tb927.4.330 hypothetical protein, conserved 1,0 1,0 1,0 0,3 
Tb927.11.4200 
ERGIC53 paralogue, lectin-like, ER quality 
control 
1,0 1,0 1,0 0,3 
Tb927.6.5000 hypothetical protein, conserved 1,0 1,0 1,0 0,3 
Tb927.8.3690 
isocitrate dehydrogenase [NADP], 
mitochondrial precursor, putative (IDH) 
1,0 1,0 0,3 1,0 
Tb927.10.4130 
NADH-ubiquinone oxidoreductase complex 
I subunit, putative,NDUFA5/B13 subunit, 
putative 
1,0 1,0 1,0 0,3 
Tb927.10.5930 protein kinase, putative 1,0 1,0 0,3 1,0 
Tb927.11.7610 gp63-1 surface protease pseudogene 0,3 0,3 1,0 1,0 
Tb927.9.9420 hypothetical protein, conserved 0,3 1,0 0,3 1,0 
Tb927.10.14950 ZC3H40 1,0 1,0 0,3 1,0 
Tb927.10.3760 vacuolar ATP synthase subunit d, putative 1,0 1,0 0,3 1,0 
Tb927.11.1890 hypothetical protein, conserved 1,0 1,0 0,3 1,0 
Tb927.11.5440 malic enzyme 1,0 1,0 1,0 0,3 
Tb927.2.4240 GTP binding protein, putative 1,0 1,0 0,3 1,0 
Tb927.3.3630 EF-TS Mitochondrial elongation factor ts 1,0 1,0 0,3 1,0 
Tb927.4.3370 hypothetical protein, conserved 1,0 1,0 0,3 1,0 
Tb927.5.2380 hydrolase, alpha/beta fold family, putative 1,0 1,0 1,0 0,3 
Tb927.6.1810 hypothetical protein, conserved 1,0 1,0 1,0 0,3 
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Tb927.6.4430 homoserine kinase, putative (HK) 1,0 1,0 0,3 1,0 
Tb927.6.4920 
S-adenosylmethionine synthetase, putative 
(METK1) 
1,0 1,0 0,3 1,0 
Tb927.7.2020 
retrotransposon hot spot protein 7 (RHS7), 
putative 
1,0 1,0 0,3 1,0 
Tb927.8.5860 
Mitchondrial LSU ribosomal protein 50S 
ribosomal protein L17, putative 
0,3 1,0 1,0 1,0 
Tb927.9.15190 60S ribosomal protein L15 1,0 0,3 1,0 1,0 
Tb927.10.12240 short-chain dehydrogenase, putative 1,0 1,0 0,3 0,8 
Tb927.3.5370 hypothetical protein, conserved 1,0 0,8 1,0 0,3 
Tb09.v4.0013 retrotransposon hot spot (RHS) protein 1,0 0,3 1,0 1,0 
Tb927.11.13500 paraflagellar rod protein  par1 1,0 1,0 1,0 0,3 
Tb927.2.3400 
hypothetical protein, copurified with 
splicing complex 
0,3 0,8 1,0 1,0 
Tb927.3.3610 
PEX7 peroxisomal targeting signal type 2 
receptor 
1,0 0,3 0,9 0,3 
Tb927.11.16080 hypothetical protein, conserved 0,3 1,0 1,0 1,0 
Tb927.5.550 vacuolar ATP synthase, putative 1,0 0,3 1,0 1,0 
Tb927.5.3970 adenylate kinase, putative (ADKE) 1,0 1,0 1,0 0,3 
Tb927.10.6610 chaperone protein DNAj, putative 1,0 0,3 1,0 1,0 
Tb927.10.3260 
Long-chain-fatty-acid--CoA ligase 5, Acyl-
CoA synthetase 5  (LACS 5) 
1,0 1,0 1,0 0,3 
Tb927.3.4760 
dynamin, putative,vacuolar sortin protein 1, 
putative 
1,0 1,0 1,0 0,3 
Tb927.8.1610 MSP-B, putative 1,0 1,0 1,0 0,3 
Tb927.10.15850 PEX12 peroxisome assembly protein 0,3 0,3 1,0 0,3 
Tb927.2.280 
retrotransposon hot spot protein 2 (RHS2), 
putative 
1,0 1,0 1,0 0,3 
Tb927.8.6410 short-chain dehydrogenase, putative 1,0 1,0 1,0 0,3 
Tb927.3.3190 
serine/threonine-protein kinase, 
putative,protein kinase, putative 
0,3 1,0 1,0 0,3 
Tb927.10.12500 P-type H -ATPase, putative 1,0 1,0 1,0 0,3 
Tb927.11.14380 
Kinetoplast polyadenylation/uridylation 
factor 2 
1,0 1,0 1,0 0,3 
Tb927.8.6640 hypothetical protein, conserved 1,0 1,0 0,8 0,3 
Tb927.10.240 PEX14 peroxin 14 1,0 0,3 1,0 1,0 
Tb927.11.2130 
proteasome regulatory non-ATP-ase 
subunit 3 (RPN3) 
1,0 1,0 0,3 1,0 
Tb927.9.12550 glycerol kinase, glycosomal (glk1) 1,0 1,0 1,0 0,3 
Tb927.1.2100 
calpain-like cysteine peptidase, 
putative,cysteine peptidase, Clan CA, 
family C2, putative 
1,0 1,0 1,0 0,3 
Tb927.11.2260 eIF4E1 1,0 1,0 0,3 1,0 
Tb927.5.2940 stress-induced protein sti1, putative 1,0 1,0 0,3 1,0 
Tb927.8.8330 
calpain, putative,cysteine peptidase, 
putative 
1,0 1,0 1,0 0,3 
Tb927.2.5160 chaperone protein DNAj, putative 1,0 1,0 1,0 0,2 
Tb927.2.1170 
retrotransposon hot spot protein 5 (RHS5), 
putative 
1,0 1,0 1,0 0,2 
Tb927.6.850 NOT2 0,5 1,0 0,8 0,2 
Tb927.10.7700 ABC transporter, putative 1,0 0,3 1,0 0,2 
Tb927.11.2110 hypothetical protein, conserved 0,2 0,3 1,0 0,3 
Tb927.9.4210 fatty acyl CoA synthetase 3 (ACS3) 1,0 1,0 0,2 0,3 
Tb927.10.5810 hypothetical protein, conserved 1,0 0,2 1,0 1,0 
Tb927.6.3750 
heat shock 70 kDa protein, mitochondrial 
precursor, putative 
1,0 1,0 1,0 0,2 
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Tb927.2.1330 
retrotransposon hot spot protein (RHS6, 
pseudogene), putative 
1,0 1,0 0,2 0,2 
Tb927.2.470 
retrotransposon hot spot protein 4 (RHS4), 
putative 
1,0 1,0 1,0 0,2 
Tb927.10.2090 
EF1-alpha elongation factor 1-alpha, 
(TEF1) 
1,0 1,0 1,0 0,2 
Tb927.10.1900 DNA topoisomerase IA, putative 1,0 0,2 1,0 1,0 
Tb927.9.6290 arginine kinase (AK) 0,2 1,0 1,0 1,0 
Tb927.7.6670 hypothetical protein, conserved 0,7 0,6 1,0 0,1 
Tb927.2.3030 
ATP-dependent Clp protease subunit, heat 
shock protein 78 (HSP78) 
1,0 1,0 1,0 0,1 
Tb927.7.4760 hypothetical protein, conserved 1,0 0,4 1,0 0,1 
Tb927.11.500 UBP1 0,2 0,1 1,0 1,0 
Tb927.3.1300 
hypothetical protein, conserved, no 
domains, no yeast or human match 
1,0 1,0 0,2 0,1 
Tb927.8.7980 
vacuolar-type H( )-translocating 
pyrophosphatase (TVP1) 
0,1 0,7 0,6 1,0 
Tb927.5.1100 
PEX5 peroxisome targeting signal 1 
receptor 
0,8 1,0 0,8 0,1 
Tb927.1.180 
retrotransposon hot spot protein 1 (RHS1), 
putative 
1,0 1,0 1,0 0,1 
Tb927.4.4940 
hypothetical protein, conserved, poly(Q), 
no clear yeast or human matches 
1,0 1,0 1,0 0,1 
Tb927.11.11330 heat shock protein 70, major HSP70 1,0 0,8 0,0 0,4 
Tb927.10.2350 
pyruvate dehydrogenase complex E3 
binding protein, putative 
0,8 0,6 0,8 0,3 
Tb927.11.14220 
hypothetical protein, conserved, Phyre2 
gives 97% probability of RNA-binding 
domain 
0,3 0,3 0,8 0,8 
 
